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Preface to “Marine Polysaccharides”
Volume 1: Advancements in the Discovery of Novel Marine Polysaccharides
  The field of marine polysaccharides is constantly evolving, due to progress in the discovery and 
production of new marine polysaccharides. Seaweed remains the most abundant source of 
polysaccharides, but recent advances in biotechnology have allowed the production of large quantities of 
polysaccharides from a variety of micro-algae, by controlling growth conditions and tailoring the 
production of bioactive compounds in a bioreactor. Of particular interest are polysaccharides produced 
by micro-organisms from extreme marine environments, due to their recognized different biochemistry. 
Extracellular polysaccharides (EPSs) with unique properties produced by a number of micro-algae are 
known. The first volume is a collection of papers concerning the identification and characterization of 
novel marine polysaccharides. It is divided into three chapters; the first two are dedicated to 
polysaccharides from different marine sources (algae, micro-algae, animals), while the third one gathers 
information on the isolation, characterization and bioactivity of new EPSs.
Volume 2: Identification of the Methabolic Pathways Involved in the Biological Activity of 
Marine Polysaccharides
  In the second volume, papers reporting on the elucidation of the mechanisms that underlie the 
biological activity of some marine polysaccharides are collected. The understanding of the underlying 
mechanisms is an important feature to give a rigorous scientific support to the potential use of many 
marine polysaccharides as natural drugs in a wide range of therapies. This volume is divided into three
chapters, each of them devoted to a specific class of polysaccharides.
Volume 3: Biomedical and Pharmaceutical Applications of Marine Polysaccharides
  Recently-developed technology for production of polysaccharides from marine sources makes their 
potential use as additives in pharmacological formulations, food supplements, and support material for 
biomedical implants a real possibility. Although development of low-cost and eco-friendly methods 
remains a challenge, many companies have developed methodologies for extraction and purification of 
high quantities of polysaccharides from a variety of natural sources, as confirmed by the high number of 
trademarks that have been registered to date. Moreover, refinements of technological approaches enable 
further exploitation of available resources. This volume is a collection of papers focusing on the concrete 
application of polysaccharides in the biomedical field. In the first chapter, review articles illustrating all 
the potential applications of polysaccharides are presented. The second chapter includes articles on new 
methodologies for extraction and purification of polysaccharides of different origins, with particular 
attention on the evaluation of potential toxicity strictly related to the production process. Finally, in the 
last chapter, papers dealing with specific examples of biomedical applications are reported. The proposals 
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Abstract: Brown seaweeds contain many bioactive compounds, including polyphenols,
polysaccharides, fucosterol, and fucoxantin. These compounds have several biological activities,
including anti-inflammatory, hepatoprotective, anti-tumor, anti-hypertensive, and anti-diabetic
activity, although in most cases their mechanisms of action are not understood. In this study,
extracts generated from five brown algae (Fucus dichitus, Fucus vesiculosus (Linnaeus), Cytoseira
tamariscofolia, Cytoseira nodacaulis, Alaria esculenta) were tested for their ability to activate SIRT6
resulting in H3K9 deacetylation. Three of the five macroalgal extracts caused a significant increase of
H3K9 deacetylation, and the effect was most pronounced for F. dichitus. The compound responsible
for this in vitro activity was identified by mass spectrometry as fucoidan.
Keywords: sirtuin activators; fucoidan; brown seaweed
1. Introduction
SIRT6 is an NAD+-dependent histone deacetylase (HDACs EC 3.5.1.98) that functions as a
regulator of many cellular processes, is evolutionarily conserved, and exists in a variety of organisms
from eukaryotes to humans [1,2]. SIRT6 controls healthy ageing by regulating genomic stability,
oxidative stress, and glucose metabolism, and it is considered a promising target for age-associated
diseases such as chronic inflammation, diseases associated with metabolic syndrome, obesity, and
insulin resistant type-2 diabetes [3–8]. In a recent study, it was demonstrated that SIRT6 inhibition could
improve glycemia in a mouse model of type 2 diabetes [9]. Also, it was shown that SIRT6-deficient
mice have a premature aging phenotype with a shortened lifespan, while the overexpression of SIRT6
prolongs the lifespan in male mice and prevents diet-induced obesity [4,10]. SIRT6 activity affects
the development of several cancer subtypes, but it is still unclear whether it is a tumor suppressor or
promoter, or both [2,11].
Some compounds that enhance SIRT6 activity have been identified, including fatty acids and
endogenous fatty acid ethanolamides [12,13]. Phenolic compounds, such as quercetin and luteolin,
also enhance SIRT6 deacetylation activity, albeit at very high concentrations [13].
Brown macroalgal species [14–16], specifically Fucaceae and Cystoseira, are rich in molecules that
exert a large range of biological activities including phenolic compounds such as phlorotannins, and
polysaccharides, such as laminarans and fucoidans. Phlorotannins protect cells against Ultraviolet
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(UV)-B-induced DNA modifications by inducing the nucleotide excision repair (NER) pathway of
DNA repair [17]. Fucoidans are a complex heterogeneous group of sulfated polysaccharides composed
of L-fucose and sulphate ester groups with minor amounts of monosaccharides that have robust
anti-inflammatory and anti-proliferative effects [18,19].
Considering the elicited physiological actions of brown seaweeds and their overlap with the
reported bioactivity of SIRT6, the aim of this work was to screen brown seaweed species for novel
SIRT6 modulators as potential candidates that can be used in the prevention of age-associated diseases
and metabolic syndrome associated disorders, including cancer, obesity, and insulin-resistant diabetes.
We used an accelerated solvent extraction (ASE®) method with acetone:water (70:30 v/v) [15,19]
as an extraction solvent to generate phlorotannin- and fucoidan-rich extracts from five species of
brown macroalgae, namely Fucus distichus, Fucus vesiculous, Cytoseira tamariscofolia, Cytoseira nodacaulis,
and Alaria esculenta. The generated extracts were tested for their ability to deacetylate H3K9, a
proxy measure of SIRT6 activity. Three of the five macroalgal extracts significantly enhanced SIRT6
activity, and the effect was most pronounced for F. distichus. Herein, we identify fucoidan as the
compound responsible for SIRT6 activation from F. distichus extract using liquid chromatography and
mass spectrometry.
2. Results
2.1. Screening of Brown Algae
In this study, we used a previously developed HPLC deacetylation assay that estimates SIRT6
activity by measuring changes in the level of deacetylated peptide H3K9, over the substrate
(H3K9Ac) [13,20], to determine SIRT6 activity in complex matrices. Five species of brown algae
were tested for SIRT6 modulating activity at two concentrations (Figure 1). Of these, the A. esculenta
ASE® extract had no activity, while C. nodacaulis displayed SIRT6 stimulating activity, with a ~five-fold
increase at 1 mg/mL compared to control. The ASE® extracts from F. distichus, F. vesiculosus (Linnaeus),
and C. tamariscofolia all displayed an approximate ~35-fold increase in SIRT6 activity when assayed
at a concentration of 1 mg/mL. While the stimulation of SIRT6 activity was dose-dependent for all
species tested, F. distichus displayed the strongest activity at 0.5 mg/mL with a ~10-fold increase. As a
result, F. distichus was studied further.
Figure 1. SIRT6 deacetylation activity in the presence of five species of brown algae extracts. The change
of SIRT6 deacetylation in the presence of 0.5 mg/mL (grey) and 1.0 mg/mL (light grey) extracts is
compared to controls with 500 μM NAD+ and 40 μM H3K9Ac with 30 min of incubation time. The data
are presented as means ± SD, n = 3.
2.2. Separation of F. distichus
F. distichus was separated into eight sub-fractions (F1–F8) using an XDB-C18 column
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sub-fractions, moderate activity was observed for F3–F6, and F8 (Figure 3), with a ~3-fold increase in
SIRT6 activity. Interestingly, F1 and F7 were the most active, with a ~70-fold and ~40-fold increase,
respectively, in SIRT6 activity, at 1 mg/mL. Due to the increased activity observed in F1, the HPLC
method was scaled up for the collection of more active fractions with semi-preparative HPLC-PDA
(Supplementary Figure S1) using an Eclipse XDB-C8 (9.4 mm × 250 mm, 5 μm). Five different fractions
(F1–F5) were collected and the resulting F1 fraction was further purified using a Zorbax Eclipse
XDB-C18 column (4.6 mm × 50 mm, 1.8 μm), resulting in a single peak (Supplementary Figure S2).
Figure 2. HPLC chromatogram of F. distichus and its separation into eight fractions using Zorbax












Figure 3. SIRT6 deacetylation activity (fold activity relative to control) of fractions (F1–F8) from F. distichus
in the presence of 0.5 mg/mL (grey) and 1.0 mg/mL (light grey) fractions (F1–F8) with 500 μM NAD+
and 40 μM H3K9Ac with 30 min of incubation time. The data are presented as means ± SD, n = 3.
2.3. Identification of Fucoidan
The resulting sub-fraction was characterized by mass spectrometry (Figure 4), and identified
as fucoidan, a sulfated polysaccharide present in brown algae, by comparison to the reported
mass spectra of isolated fucoidan from Sargassum genus algae [21,22]. The seaweed fucoidans
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(L-fucopyranose and non-fucose ones) and non-carbohydrate substituents (mainly sulfate and acetyl
groups). The precise determination of their structures with the exact location of structural elements
is complex. The polysaccharide backbones of fucoidans are organized in repeating (1→3)-linked
or alternatively (1→3)- and (1→4)-linked α-L-fucopyranose residues [23,24]. The backbone of the
fucoidan from F. distichus is built up mainly of the repeating A units (Figure 5), whereas fucoidans
from F. vesiculosus are formed mainly of B units [23–25].
Figure 4. HPLC–MS analysis of subfraction F1 in negative ionization mode with a scan range of
m/z 150–600.
A B
Figure 5. Reported structural elements for fucoidan isolated from the brown seaweeds (A) F. distichus,
(B) F. vesiculosus. Modified from [24,25].
While the employed extraction process aimed to isolate phlorotannins, the presence of fucoidan
in the extracts is not unexpected, as it has been previously reported that between 0.26% and 7.0% dry
weight of the algal biomass of F. distichus consists of fucoidan [24]. Furthermore, Béress [26] previously
reported the extraction of both polyphenols and polymers including fucoidan using water-based
solvent systems. It is difficult to separate polyphenols and carbohydrates based on the differential
solubility of these algal components. Pantankar previously reported that fucoidan is soluble in
acetone:water [27], and this is also a well-known extraction solvent for phlorotannins. A dose-response
curve of a sub-fraction of F1 was carried out, and the results demonstrated a significant increase
in SIRT6 activation with a ~140-fold increase observed at a 100 μg/mL concentration (Figure 6A).
However, due to the limitations in the amount of F. distichus available, we were unable to obtain a full
dose-response curve for the sub-fraction of F1. Fucoidan (>95% pure) was purchased (isolated from
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Figure 6. (A) Dose-response curve of the extract sub-fraction of F1 ( ) in the presence of 500 μM NAD+
and 40 μM H3K9Ac with 30 min of incubation time. The data are presented as means ± SD, n = 3;
(B) Dose-response curve of fucoidan () on SIRT6 deacetylation activity in the presence of 500 μM NAD+
and 40 μM H3K9Ac with 30 min of incubation time. The data are presented as means ± SD, n = 3.
2.4. Western Blot Analysis
The in vitro deacetylation activity was also determined by Western blot analysis, where 1 to
16 μg/mL of fucoidan was incubated with the core histones and the remaining levels of histone H3
acetylated on lysine 9 were determined. Using this technique, it was found that fucoidan activated
SIRT6 deacetylation activity in a dose-dependent manner (Figure 7). Both methods demonstrate
that fucoidan is an activator of SIRT6. Interestingly, it was demonstrated that higher concentrations
of fucoidan (>16 μg/mL in the Western blot analysis method) resulted in the reduced activation of
SIRT6 activity (data not shown). A similar observation was made in the HPLC-based assay at higher
concentrations as well, indicating that fucoidan may have a dual role in SIRT6, similar to what was
observed for quercetin and luteolin [13].
Figure 7. Western blot method for the in vitro SIRT6 deacetylation assay. Serially diluted concentrations
of a SIRT6 stimulator (1–16 μg/mL) were incubated for 30 min at 37 ◦C in the presence of 1 μg/well
of a purified recombinant GST-SIRT6 protein, 2 μg purified whole chicken core histones with 500 μM
NAD+ in 25 mM Tris-HCl, pH 8.0. (A) Acetylation level was detected with anti-H3K9Ac antibody
and normalized to total H3 histone. Values indicate final fucoidan concentration in μg/mL. Molecular
weight markers in kDa. (B) Quantification of H3K9 deacetylation. Values represent the averages of
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2.5. Selectivity for SIRT6
In order to determine whether fucoidan was selective for SIRT6, in vitro enzymatic assays were
carried out against SIRT1, SIRT2, and SIRT3. Neither 10 μg/mL nor 100 μg/mL of fucoidan resulted in
any change in the deacetylation activity of SIRT1 or SIRT3. There was a 20% reduction in SIRT2 activity
at 100 μg/mL (Table 1). These results suggest that fucoidan activation of sirtuins is specific to SIRT6.
Table 1. Fucoidan against SIRT1-SIRT3 deacetylation activities. The data are presented as means ± SD,
n = 3.
Fucoidan (μg/mL)
Fold Increase in Activity ± SD
SIRT1 SIRT2 SIRT3
10 0.96 ± 0.04 0.87 ± 0.06 0.99 ± 0.01
100 0.94 ± 0.02 0.82 ± 0.02 0.98 ± 0.02
3. Discussion
From five species of brown algae tested against SIRT6 modulating activity, F. distichus displayed the
most robust increase of SIRT6 deacetylation activity. As a result, the active component from F. distichus
was identified using a guided SIRT6 H3K9Ac deacetylation HPLC-based assay as fucoidan. Due to
the limitations of the starting material, commercially available fucoidan (isolated from F. vesiculosus)
was purchased and tested for SIRT6 activity. A significant increase in deacetylation activity was
observed in a dose-dependent manner using the HPLC-guided deacetylation-based assay as well
Western blot analysis. The commercial fucoidan, from F. vesiculosus, has been reported to contain
fucose (>50%), galactose (6%), glucose (20%), mannose, xylose (15%), uronic acid, glucosamine,
and sulfate [28]. None of these monosaccharides introduced any SIRT6 activity at a concentration
up to 300 μM (data not shown), indicating that the activity is most likely due to the sulfated fucose.
Percival and Ross reported that fucoidan from F. vesiculosus contained 31.7% sulfation [29], while the
sulfate content of commercial fucoidan from F. vesiculosus was estimated to be 31.2% [30,31]. Previous
studies revealed that the degree of sulfation significantly influences the level of anti-angiogenic activity
of fucoidans in human umbilical vein endothelial cells. For example, oversulfated fucoidan from
F. vesiculosus with sulfate contents at 52.4% were significantly stronger at inhibiting angiogenesis
than natural fucoidan from F. vesiculosus with sulfate contents of 31.2% [30,32]. The modulation
of sirtuin activity by negatively charged sulfated polysaccharides, while novel, is not completely
unexpected. For example, Tong et al. [33] reported the activation of SIRT7 deacetylation activity
with negatively charged DNA. In addition, heparin and heparan sulfate proteoglycans have been
reported to be potent inhibitors of HAT (Histone acetyltransferases) activity [34]. Further, fucoidan
has been indicated to play a role in apoptosis [28,35,36]. In one study, it induced the cleavage of PARP
(poly ADP ribose polymerase) to the 89 kDa polypeptide, suggesting that caspases were involved in
the fucoidan-mediated apoptosis [37]. Furthermore, in a study in rabbits investigated fucoidan injected
intramuscular (i.m.)-induced apoptosis in isolated lymphoma cell lines in vitro [28]. Similarly, SIRT6
overexpression has been demonstrated to induce apoptosis in cancer cells and not in normal cells [8].
In cancer cells, the activity was mediated via the activation of both p53 and p73 signaling cascades.
Min et al. [38] reported that the treatment of HepG2 cells with fucoidan (250 and 500 μg/mL) increased
the upregulation of p53 and p14, which are involved in the regulation of apoptosis, by up to two- and
two and half-fold, respectively, thus inhibiting the viability of HepG2 cells. Zhang et al. (2014) [39]
reported a direct interaction between SIRT6 and p53, and the activation of SIRT6 expression by
intact p53, which in turn leads to an elevated association of SIRT6 with FoxO1 and the subsequent
inhibition of gluconeogenesis. In addition to anti-cancer properties, fucoidans have revealed numerous
other health-promoting effects, including anti-oxidative and anti-inflammatory effects. In addition to
observations with SIRT6, it was demonstrated in a mouse model that low molecular weight fucoidan
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of SIRT3 after traumatic brain injury [40]. While these studies suggest that fucoidan could also be
activating other sirtuins, the results of this study demonstrate that fucoidan, isolated from F. distichus
and F. vesiculosus, is a strong stimulator of SIRT6. To our knowledge, this is the first report to identify a
polysaccharide which stimulates SIRT6 deacetylation activity.
4. Materials and Methods
4.1. Materials
Acetylated histone H3 (K9) peptide (residues 1-21) (H3K9Ac) was purchased from AnaSpec
Incorporation (Fremont, CA, USA). Nicotinamide adenine dinucleotide (NAD), formic acid, fucoidan
from F. vesiculosus (F5631), and anti-rabbit HRP-conjugated secondary antibody (A0545) were ordered
from Sigma Aldrich (St. Louis, MO, USA). Core histones proteins (13-107) and rabbit anti-acetyl H3K9
antibody (06-942) were ordered from Merck, EMD Millpore (Temecula, CA, USA). Rabbit anti-histone
H3 antibody (9715S) was purchased from Cell Signaling Technology (Danvers, MA, USA). Novex™
WedgeWell™ 10–20% Tris-Glycine Mini Gels (12-well) (XP10202BOX) and Novex® Tris-Glycine SDS
Running Buffer (10×) (LC2675) were ordered from ThermoFisher Scientifics (Waltham, MA, USA).
Expression and Purification of GST-Tagged SIRT6 Protein. The human SIRT6 expression
vector hSIRT6-pGEX-6P3 was kindly provided by Prof. Katrin Chua (Stanford, CA,
USA). The recombinant GST (Glutathione S-transferases)-tagged SIRT6 was produced by fermentation
in Escherichia coli BL21 (DE3)-pRARE. The production was done at +16 ◦C with 0.1 mM IPTG
(Isopropyl β-D-1-thiogalactopyranoside), for 20 h and the soluble overexpressed protein was affinity
purified on glutathione agarose (Sigma, St. Louis, MO, USA).
4.2. Plant Material and Extraction
4.2.1. Method of Preparation
Accelerated solvent extraction (ASE®) was used to generate macroalgal extracts using the Dionex
PLE system (ASE 200, Dionex, ThermoFisher Scientifics). Briefly, 2 g of each freeze-dried, de-fatted,
and powdered macroalga sample was mixed with 4 g of silica (Merck grades, 60 A, Sigma Aldrich,
Dublin, Ireland). Silica was used as an inert dispersant and the sample plus silica mixture was then
packed into 22-mL extraction cells. The automated extraction method used was 70% acetone in water
and a pressure and temperature of 50 ◦C, 1500 psi, respectively. The extraction time consisted of four
cycles of 5 min. Samples were dried using a rota-evaporator at 37 ◦C and subsequently freeze-dried to
remove water. Hexane was used to de-fat samples as previously described [41].
4.2.2. Species Name
3-Fucus distichus (Newfoundland origin); 4-Fucus vesiculosus (Linnaeus) ISCG 0223; 6-Cytoseira
tamariscofolia ISCG0283; 7-Cytoseira nodacaulis ISCG0070; 11-Alaria esculenta (Newfoundland origin);
Location of Harvest and Time: 3-Fucus distichus (Newfoundland origin) supplied by Oceans Ltd.
(St. John’s, NL, Canada) April 2010; 4-Fucus vesiculosus (Linnaeus) ISCG0223, Golf Course, Galway,
8 June 2011; 6-Cytoseira tamariscofolia ISCG0283, Finnavara, Co. Clare, 28 September 2011; 7-Cytoseira
nodacaulis ISCG0070, Finnavara, Co. Clare, 30 March 2010; 11-Alaria esculenta (Newfoundland origin)
kindly supplied by Dr. Anne Mathieu, Oceans Ltd., St. John’s Newfoundland. It was supplied in a
freeze-dried format. All seaweeds (Irish) were rinsed and subsequently freeze-dried prior to processing
and stored at −80 ◦C.
4.3. SIRT6 Deacetylation Assay
Solutions of macroalgal extracts at 0.5 and 1 mg/mL concentrations were prepared in DMSO.
In this study, 0.6 μL of this solution and DMSO (control) were incubated for 30 min in the presence
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Additional controls were carried out in the absence/presence of SIRT6, with or without NAD+ and
with and without fucoidan. During the reaction, the final solvent concentration of all samples was
1% DMSO. The samples were terminated by adding 6 uL cold 10% formic acid and subsequently
centrifuging for 15 min at 13.4 rpm. Dose-response effects (0.05 mg/mL to 1 mg/mL) were carried out
for sub-fraction F1 from F. distichus and commercial fucoidan from F. vesiculosus.
4.4. HPLC Analysis
The chromatographic separation of H3K9 and acetylated H3K9 was achieved on a Zorbax Eclipse
XDB-C18 column (4.6 mm × 50 mm, 1.8 μm; Agilent Technologies, Santa Clara, CA, USA) at room
temperature using a Shimadzu prominence system (Shimadzu Technology, Kyoto, Japan) consisting
of a CBM-20A, LC-20 AB binary pumps, an SIL-20AC-HT auto-sampler, and a DGU-20A3 degassing
unit. The mobile phase consisted of water with 0.02% formic acid (elute A) and acetonitrile with 0.02%
formic acid (elute B). The gradient eluent at a flow rate of 0.9 mL/min was programmed as follows:
0–2.0 min, 0% B; 2.0–10 min, 0–8% B; 10–10.10 min, 8–80% B; 10.10–12 min, 80%; 12–15 min 80–0% B;
15 min, 0% B. The total run time was 15 min and the injection volume per sample was 20 μL. The
HPLC system was coupled to a 5500 QTRAP from Applied Biosystems/MDS Sciex equipped with
Turbo V electrospray ionization source (TIS)® (Applied Biosystems, Foster City, CA, USA). The data
were acquired and analyzed using Analyst version 1.5.1 (Applied Biosystems). Positive electrospray
ionization data were acquired using multiple reactions monitoring (MRM). The TIS instrumental
source settings for temperature, curtain gas, ion source gas 1 (nebulizer), ion source gas 2 (turbo ion
spray), entrance potential, and ion spray voltage were 550 ◦C, 20 psi, 60 psi, 50 psi, 10 V, and 5500 V,
respectively. The TIS compound parameter settings for de-clustering potential, collision energy, and
collision cell exit potential were 231, 45, and 12 V, respectively, for H3K9Ac; and were 36, 43, and 12 V,
respectively, for H3K9. The standards were characterized using the following MRM ion transitions:
H3K9Ac (m/z 766.339→760.690) and H3K9 (m/z 752.198→746.717).
4.5. HPLC Fingerprint
The chromatographic separation of F. distichus was achieved on a Zorbax Eclipse XDB-C18 column
(4.6 mm × 50 mm, 1.8 μm; Agilent Technologies, Santa Clara, CA, USA) at room temperature using a
Shimadzu prominence system (Shimadzu Technology, Kyoto, Japan) consisting of a CBM-20A, LC-20
AB binary pumps, an SIL-20AC-HT auto-sampler, and a DGU-20A3 degassing unit. The mobile phase
consisted of water with 0.1% formic acid (elute A) and acetonitrile with 0.02% formic acid (elute B).
The gradient eluent at a flow rate of 0.6 mL/min was programmed as follows: 0 min, 0%B; 3.0 min,
0% B; 6.0 min, 83% B; 11.0 min, 83%; 11.1 min 0% B; 15 min, 0% B. The total run time was 15 min and
the injection volume per sample was 10 μl (7.5 mg/mL in 100 mM NaOH). Fractions were collected
(Figure 2) between 0.4–0.5 min (F1), 1.0–1.3 min (F2), 2.0–3.0 min (F3), 3.0–4.0 min (F4), 4.0–5.0 min
(F5), 5.1–5.3 min (F6), 5.4–5.5 min (F7), or 5.5–6.2 min (F8).
The HPLC system was coupled to a 5500 QTRAP from Applied Biosystems/MDS Sciex equipped
with Turbo V electrospray ionization source (TIS)® (Applied Biosystems, Foster City, CA, USA).
The data were acquired and analyzed using Analyst version 1.5.1 (Applied Biosystems). Negative
electrospray ionization data were acquired using enhanced MS (EMS) from 200 to 600 m/z. The TIS
instrumental source settings for temperature, curtain gas, ion source gas 1 (nebulizer), ion source gas 2
(turbo ion spray), entrance potential, and ion spray voltage were 500 ◦C, 20 psi, 50 psi, 60 psi, −10 V,
and −4500 V, respectively. The TIS compound parameter settings for de-clustering potential, collision
energy, and collision cell exit potential were −75, −35, and 12 V, respectively.
4.6. SemiPREP MS
The collection of the F1 sub-fraction of F. distichus was achieved on an Eclipse XDB-C8 column
(9.4 mm × 250 mm, 5 μm; Agilent Technologies, Santa Clara, CA, USA) at room temperature using
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LC-20 ADXR binary pumps, an SIL-20AC-HT auto-sampler, and a DGU-20A3R degassing unit, PDA
(Photodiode array detector) SPD-M20A. The mobile phase consisted of water with 0.1% formic acid
(elute A) and acetonitrile with 0.02% formic acid (elute B). The gradient eluent at a flow rate of
0.9 mL/min was programmed as follows: 0 min, 0%B; 3.0 min, 0% B; 11.0 min, 83% B; 11.1 min, 0%;
15 min, 0% B. The total run time was 15 min and the injection volume per sample was 50 μL (10 mg/mL
in 100 mM NaOH). Fractions were collected (Figure 2) between 0.1–1.0 min (F1), 1.0–1.3 min (F2),
8.0–8.5 min (F3), 10.0–10.5 min (F4), or 11.0–11.4 min (F5).
The collected fractions were evaporated under nitrogen gas and dissolved two times with
methanol to remove impurities. Fractions were analyzed using HPLC–MS negative ionization mode
with a scan range of m/z 150–600.
4.7. H3K9 Western Blot Method
Fucoidan stock solution (10 mg/mL) was prepared and serially diluted in 25 mM Tris-HCl,
pH 8.0. Subsequently, 1 μL of fucoidan solution or buffer control were incubated in 20 μL reaction
for 30 min in the presence of 1 μg of a purified recombinant GST-SIRT6, 2 μg purified chicken core
histones (Millipore, Billerica, MA, USA), and 500 μM NAD+ in 25 mM Tris-HCl, pH 8.0 at 37 ◦C.
The reactions were stopped with Laemmli sample buffer and separated by SDS-PAGE using 4–15%
gradient gels (Bio-Rad, Hercules, CA, USA) and transferred onto polyvinylidene difluoride (PVDF)
membranes. H3K9 acetylation was detected with rabbit anti-acetyl H3K9 antibody (Millipore) followed
by anti-rabbit HRP-conjugated secondary antibody. Membranes were stripped and re-probed with
rabbit anti-histone H3 antibody. Chemiluminescent signal detection and image acquisition were
done using SuperSignal West Femto Substrate (Thermo) and ChemiDoc XRS+ with Image Lab
software (Bio-Rad).
4.8. In Vitro Enzymatic Assays (SIRT1-SIRT3)
The Fluor de Lys fluorescence assays were based on the method described in the BioMol product
sheet (Enzo Life Sciences, Ann Arbor, MI, USA) using the BioMol KI177 substrate for SIRT1 and
the KI179 substrate for SIRT2 and SIRT3. GST-SIRT1 and GST-SIRT2 were produced as described
previously [42,43]. His-SIRT3 (BML-SE270) was purchased from Enzo Life Sciences. DMSO (D2650),
SIRT assay buffer (HDAC assay buffer, KI143, supplemented with 1 mg/mL BSA, A3803), and NAD+
(N6522) were from Sigma. Fluor de Lys developer (KI176) and nicotinamide (BKI 283) were ordered
form BioMol.
Briefly, the reaction mixture including acetylated peptide substrate (0.7 Km: 58 μM for SIRT1 [44],
198 μM for SIRT2 [44], and 32 μM for SIRT3), NAD+ (0.9 Km: 558 μM for SIRT1, 547 μM for SIRT2,
and 2 mM for SIRT3), and DMSO/compounds in DMSO (2.5 μL in 50 μL total reaction volume) were
preincubated for 5 min at room temperature. The reaction was started by adding the enzyme following
incubation for 1 h at 37 ◦C. After that, the developer and nicotinamide (2 mM in HDAC assay buffer
giving total volume of 50 μL) were added and the incubation was continued for 45 min at 37 ◦C.
Fluorescence readings were obtained using a VictorTM 1420 Multilabel Counter (PerkinElmer Inc.,
Waltham, MA, USA) with an excitation wavelength of 355 nm and an emission of 460 nm, or EnVision
2104 Multilabel Reader (PerkinElmer, Waltham, MA, USA) with an excitation wavelength of 370 nm
and an emission of 460 nm.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/6/190/s1,
Figure S1: Fractionation (F1–F5) of F. distichus on the LC-MS/MS API-5500 and on the HPLC-DAD were collected
using an Eclipse XDB-C8 column (9.4 mm × 250 mm, 5 μm). Fractions were collected between 0.1–1.0 min (F1),
1.0–1.3 min (F2), 8.0–8.5 min (F3), 10.0–10.5 min (F4), 11.0–11.4 min (F5). Figure S2: HPLC-MS chromatograph of
subfraction F1 (10 μL). The flow rate was 0.6 mL/min a nd the injection volume was 10 μL of 7.5 mg/mL.
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Abstract: Three marine macroalgae, i.e., Grateloupia filicina, Ulva pertusa and Sargassum qingdaoense,
were selected as the deputies of Rhodophyta, Chlorophyta and Ochrophyta for comparative analysis
of the molecular structures and biological activities of sulfated polysaccharides (SP). The ratio of
water-soluble polysaccharides, the monosaccharide composition and the sulfated contents of three
extracted SPs were determined, and their structures were characterized by Fourier transformation
infrared spectroscopy. In addition, biological activity analysis showed that all three SPs had
immune-modulatory activity both in vitro and in vivo, and SPs from S. qingdaoense had the best
effect. Further bioassays showed that three SPs could not only enhance the immunity level stimulated
by inactivated avian influenza virus (AIV) in vivo but also significantly inhibited the activity of
activated AIV (H9N2 subtype) in vitro. G. filicina SP exhibited the strongest anti-AIV activity. These
results revealed the variations in structural features and bioactivities among three SPs and indicated
the potential adjuvants for immune-enhancement and anti-AIV.
Keywords: marine macroalgae; sulfated polysaccharides; structure features; immune
enhancement; anti-AIV
1. Introduction
Sulfated polysaccharides have attracted increasing attention due to their diversified biological
and pharmacological activities, such as anti-viral, immune enhancement, anti-tumor, anti-infective
and antioxidant effects (Table 1) [1–4]. Among organisms that produce sulfated polysaccharides,
marine algae are regarded as the most abundant and important sources of non-animal sulfated
polysaccharides [5–7]. Various biological functions of sulfated polysaccharides from marine algae
have been reported in recent decades, but these analyses were mainly focused on a single species
(Table 1) [8–11]. For example, the sulfated polysaccharides obtained from green alga Enteromorpha
clathrata showed immune-enhancement activity that could stimulate TNF-α expression in serum and
induce lymphocyte proliferation [9]. The sulfated polysaccharide purified from Sargassum horneri was
reported to have antitumor activity that could inhibit the growth of human colon cancer DLD cells [12].
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The S. vulgare polysaccharides illustrated an ability to enhance serum antibody titers and lymphocyte
proliferation [10]. Furthermore, the sulfated polysaccharides extracted from the red alga Laurencia
papillosa could inhibit breast cancer cells (MDA-MB-231) via apoptosis regulatory genes [13]. While
significant attention has been paid to one or two biological and pharmacological activities of sulfated
polysaccharides from a single species of marine algae, little information is available regarding the
bioactivity comparison of sulfated polysaccharides from different algae and the structure-function
relationship. The three main divisions of marine algae (i.e., Chlorophyta, Ochrophyta and Rhodophyta)
are valuable sources of structurally diverse sulfated polysaccharides. However different sulfated
polysaccharides from these three algae still remain largely unknown in the comparative analysis of the
molecule structures and diverse bioactivities.
Table 1. Previous studies on the biological effects of sulphated polysaccharides from seaweed.
Author Phylum Species Bioactivities
Qi, et al., 2005 [14]
Chlorophyta
Ulva pertusa Antioxidant activity




Cho et al., 2010 [15] Enteromorpha prolifera Antitumor and immunomodulating activities
Jiao et al., 2010 [16] Enteromorpha intestinalis Antitumor and immunomodulating activities
Tabarsa et al., 2012 [17] Ulva pertusa Immunomodulatory, anticancer activities
Zhang et al., 2013 [18] Enteromorpha linza Immunological and antioxidant activities
Aguilar-Briseño et al., 2015 [19] Ulva clathrata Antiviral activity
Zhang et al., 2010 [2]
Ochrophyta
Laminaria japonica Antioxidant activity
Ye et al., 2008 [20] Sargassum pallidum Antitumor and antioxidant activities
Wang et al., 2011 [21] Laminaria japonica Anticoagulant activity
Li et al., 2012 [22] Sargassum pallidum Immune responses
Dore et al., 2013 [10] Sargassum vulgare Anticoagulant, antithrombotic, antioxidant andanti-inflammatory effects
Suresh et al., 2013 [23] Sargassum plagiophyllum Anticancer and antioxidant activities
Imbs et al., 2014 [24] Fucus evanescens Antioxidant activity
Hwang et al., 2015 [25] Sargassum hemiphyllum Anti-inflammatory
Wen et al., 2014 [26] Sargassum horneri Antioxidant activity
Shao et al., 2014 [27] Sargassum horneri Antioxidant and antitumor activities
Shobharani et al., 2014 [28] Sargassum sp. Antioxidant and anticoagulant activities
Aguilar-Briseño et al., 2015 [19] Cladosiphon okamuranus Antiviral activity
Zhang et al., 2014 [29] Ascophyllum nodosum Induces Th1 and Tc1 Immune Responses
Yuan et al., 2015 [30] Ascophyllum nodosum Antioxidant activity
Ammar et al., 2015 [31]
Cystoseira sedoides, Anti-radical, anti-inflammatory and
gastroprotective activitiesCystoseira compressa,
Cystoseira crinita
Shao et al., 2015 [32] Sargassum horneri Antioxidant and moisture-preserving activities
Athukorala et al., 2005 [33]
Rhodophyta
Grateloupia filicina Antioxidant activity, protecting ability forH2O2-induced DNA damage
Wang et al., 2007 [34] Grateloupia longifolia Anti-virus activity
Grateloupia filicina
Zhang et al., 2010 [2] Porphyra haitanensis Antioxidant activity
Yu et al., 2012 [35] Eucheuma denticulatum Anti-virus activity
Shi et al., 2014 [36] Porphyra haitanensis Anti-allergic activity
Chen et al., 2015 [37] Grateloupia filicina Anticoagulant activity
Fleita et al., 2015 [38] Pterocladia capillacea Antioxidant activity
Sulfated polysaccharides from algae produce immune-modulatory activities that might have great
potential for stimulating immune responses or controlling immune cell activity [8]. Karnjanapratum
reported that the biological activities of water-soluble sulfated polysaccharides isolated from
Monostroma nitidum could stimulate Raw 264.7 cells in vitro, and induce considerable prostaglandin-2
(PGE-2) and nitric oxide (NO) production [39]. Oral ingestion of polysaccharides isolated from
E. intestinalis could increase the relative spleen and thymus weight of tumor-bearing animals and
stimulate lymphocyte proliferation in vitro [16]. In addition to immune-modulatory activity, the
antiviral activity of sulfated polysaccharides is also important [40]. It has been suggested that sulfated
polysaccharides from algae confer activities that are anti-viral to herps simplex virus type 1 (HSV-1),
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As a lowly pathogenic avian influenza virus (AIV) group, H9N2 subtype influenza virus is
considered to be the common cause of disease epidemics [41,42]. Additionally, outbreaks of H9N2 are
associated with significant economic loss in the chicken industry [43,44]. More seriously, this subtype
is characterized by cross-species infections and has been passed to pigs, ferrets and guinea pigs as well
as to humans, in a small number of cases [45–49]. These cross-species infections indicate a potentially
serious threat to human health [50,51]. The first human infection was detected in 1999, and ever since
there have been several reports about the isolation of H9N2 viruses from humans and swine [52]
including the latest H9N2 human case in China at the end of 2013 [53]. Sulfated polysaccharides were
considered to be novel sources of natural compounds for antiviral drug discovery, but whether they
could confer antiviral activity to H9N2 AIV remains elusive [54–56].
In this study, three marine algae, i.e., Grateloupia filicina, Ulva pertusa and Sargassum qingdaoense,
were selected as the deputies of Rhodophyta, Chlorophyta, and Ochrophyta for comparative
analysis of the molecular structures and immune-modulatory and anti-AIV activities of sulfated
polysaccharides. The variations in chemical compositions and molecular structures of three sulfated
polysaccharides, including polysaccharide components and sulfate contents, might function as
determinants of their bioactivities [17,34,57]. Thus, it is worth making an effort to analyze and
determine the structure-function relationship of these sulfated polysaccharides. Here, we report a
comprehensive analysis of structural features and immune-modulatory and anti-AIV activities of
sulfated polysaccharides from three types of marine algae, i.e., S. qingdaoense, G. filicina, and U. pertusa.
These polysaccharides were characterized structurally and their biological activities were tested both
in vitro and in vivo, which has not only enhanced our understanding of the characteristic of algae
sulfated polysaccharides but also provided a comparison of algae from different categories and
contributed further theoretical and experimental evidence for the exploration and development of
polysaccharide-based immune-potentiators that are anti-AIV.
2. Results
2.1. Chemical Characterization of Three Sulfated Polysaccharides
2.1.1. Chemical Analysis
Three sulfated polysaccharides were extracted and purified from U. pertusa, G. filicina,
S. qingdaoense, with a yield of 12.1%, 19.7% and 7.2%, respectively (Table 2). The purified sulfated
polysaccharides were further characterized regarding monosaccharide composition molar ratios.
Individual variations were found in the components of monosaccharides, and the most abundant
components in UPP, GFP and SQP were rhamnose, galactose, and fucose, respectively. The UPP
also had glucuronic acid and xylose, and a small amount of mannose, glucose, galactose and fucose
was found. For GFP, except for the main component, the content of other monosaccharides, such as
mannose, glucuronic acid, glucose, xylose and fucose were low. As for SQP, which mainly consists
of fucose, galactose and mannose, it also contained glucuronic acid and glucose. The ratio of total
saccharides to UPP (53.13%) were also shown to be much higher than the others. Regarding sulfate
contents, GFP (19.89%) was higher than UPP (13.54%) and SQP (5.64%). These results suggested
significant variations in chemical compositions among the three sulfated polysaccharides.
Table 2. Yield and chemical composition of three sulfated polysaccharides sample (%w/w of dry weight).
Sample Yield (%) Total Sugar (%) Sulfate (%)
Monosaccharides Composition (Molar Ratio)
Man Rha Glc A Glc Gal Xyl Fuc
UPP 12.1 53.13 13.54 0.06 1 0.53 0.19 0.09 0.39 0.02
GFP 19.7 40.9 19.89 0.01 - 0.02 0.07 1 0.1 0.05
SQP 7.2 20.81 5.64 0.56 - 0.13 0.37 0.6 - 1
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2.1.2. FT-IR Spectrometric Characterization
To further understand the structure of sulfated polysaccharides, FT-IR spectroscopy was used.
The results revealed that all three sulfated polysaccharides shared several common absorption peaks
(Figure 1), which were considered to correspond to the O-H stretching vibrations (3420 cm´1), the S=O
asymmetry stretching vibrations (1250 cm´1) the C-O-H deformation vibrations (1050 cm´1), and the
stretching vibrations of -COO´ (1650 cm´1 and 1420 cm´1) which also indicated that the extraction
was composed of acidic polysaccharides [58].
Figure 1. FT-IR spectra of three extracted sulfated polysaccharides. GFP, Grateloupia filicina; UPP, Ulva
Pertusa; SQP, Sargassum qingdaoens.
Additionally, there exist some differences in the FT-IR spectra of the three polysaccharides. For
example, the absorption peaks at 2950 cm´1 for C-H stretching vibrations and at approximately
830 cm´1 that appeared in the FT-IR spectrum of GFP indicated the presence of α-type glycosidic
linkages. The band at 1030 cm´1 of SQP was found and corresponded to C-O-H deformation vibrations.
As for UPP, the peak attributed to C-O-S symmetry stretching vibrations appeared at approximately
850 cm´1 [10,34,59].
2.2. Cytotoxic Activity of the Polysaccharides
MTT assays to determine the cytotoxicity of sulfated polysaccharides showed that the safe
concentration for GFP was 2.5 mg/mL, whereas it was 5 mg/mL for both UPP and SQP (Table A1).
The concentrations of the three polysaccharides used in our experiments were all within the safe range.
2.3. Immunologic Modulation of Three Sulfated Polysaccharides in Vitro
To understand their potential effects in immunology, these compounds were first used to test the
immune response at a lymphocyte level. A lymphocyte proliferation experiment was used to evaluate
the stimulation efficiency of the sulfated polysaccharides on spleen cell proliferation. As illustrated in
Figure 2, the lymphocyte proliferation values for each sulfated polysaccharide treatment group were
significantly higher than those of the control group (Mock; p < 0.05), suggesting a dramatic effect on
the stimulation of spleen cell proliferation. Further analysis showed that, both UPP and GFP showed a
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stimulation efficiency of SQP was in dose-dependent manner. As a result, 500 μg/mL of SQP conferred
the strongest efficiency in stimulation among all the tests.
Figure 2. Mouse spleen cell proliferation effects of GFP, UPP and SQP. Mock treated with PBS instead
of polysaccharides as a negative control. Values with different letters in the same column (a–d) are
significantly different (p < 0.05) from each other. Data are shown as the Mean + SD and are fully
representative of the individual experiment.
2.4. Immune-Modulation of Three Sulfated Polysaccharides in Vivo
To further verify the immune-modulation results obtained by in vitro analysis, in vivo experiments
were carried out in mice. Antibody titer, cytokine production and T-cell subpopulation were tested.
Additionally, H9N2-AIV was selected as the immunologic stimulant.
2.4.1. H9N2-Specific Antibody Titer
After the first injection (Prime), the antibody titer of the control group was almost undetectable,
while the antibody levels of the treated group rose dramatically (p < 0.05; Figure 3). Moreover, after
the second injection (Boost), the antibody titer of the control group still stayed at the base level, while
further significant enhancement was detected relative to the prime for all the treatment doses especially
for the case of 50 mg/kg of GFP and 50 mg/kg of SQP (Figure 3A,C). These results suggested that the
assayed sulfated polysaccharides significantly increased H9N2-specific antibody titers.
2.4.2. Effect on Cytokine Production Stimulation
The results of cytokine production stimulation are presented in Figure 4. The levels of IFN-γ and
IL-4 were significantly increased in the experimental groups compared to the control and the vaccine
groups (p < 0.05). However, individual variations were observed among the groups treated by three
sulfated polysaccharides, and the most efficient stimulations resulted from the optimal doses tested.
For example, a concentration of 10 mg/kg were more efficient for stimulation of IFN-γ production
compared to that of 50 mg/kg for all three sulfated polysaccharides. By contrast, 50 mg/kg was a
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Figure 3. Avian influenza virus (AIV)-specific antibody titer detection. Kunming mice were immunized
with an AIV vaccine and polysaccharides, following the prime-boost vaccination programme (days 0
and 14), respectively. (A) GFP; (B) UPP; (C) SQP. Values with different letters in the same column (a–d)
are significantly different (p < 0.05) from each other. Data are shown as the Mean + SD and are fully
representative of an individual experiment.
Figure 4. Cytokine production stimulating effect of GFP, UPP and SQP. Kunming mice were immunized
with an AIV vaccine and polysaccharides, and sera were collected on day 28 after two immunizations
to detect the cytokines IFN-γ (A) and IL-4 (B). Values with different letters in the same column (a–d)
are significantly different (p < 0.05) from each other. Data are shown as the Mean + SD and are fully
representative for the individual experiment.
2.4.3. T-Cell Subpopulation
Results presented in Figure 5 show how each of the three sulfated polysaccharides could elevate
the CD3+CD4+ levels in the experimental groups significantly compared to the control and vaccine
groups (p < 0.05), and the elevations were in a dose-dependent manner in such a way that 50 mg/kg
gained a much stronger effect relative to 10 mg/kg. For stimulation of the CD3+CD8+, only the SQP
stimulated groups showed a significant effect.
2.5. Anti-H9N2 Effect of Three Sulfated Polysaccharides in Vitro
Because all these sulfated polysaccharides could significantly enhance immune responses with
the deactivated AIV as an immunologic stimulant, we were especially interested in whether they could
show significant resistance to activated H9N2 AIV.
Based on the Hemagglutination test (HA test), treatment with 0.2 mg/mL UPP and 1 mg/mL
SQP in the experimental groups decreased the virus titer significantly, although the effects of other
groups were not significant (Figure 6A).
From the real-time PCR results, the expression of the H9N2 gene decreased significantly after
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inhibition of H9N2 replication, and was followed by UPP. SQP showed the weakest effect compared
to the other two; however, it still had a significant effect. As for the determination of the optimal
concentrations for suppressing the virus, the 20 ug/mL groups had relatively lower virus expression
and that was the best suppression effect compared to the other doses tested (Figure 6B).
Figure 5. T-cell subpopulation tests. The blood cells of the treated mice were collected and analyzed
with flow cytometry. (A) CD3+CD4+. (B) CD3+CD8+. Values with different letters in the same column
(a–d) are significantly different (p < 0.05) from each other. Data are shown as the Mean + SD and are
fully representative of the individual experiment.
Figure 6. Haemagglutination test (HA) of the cell culture and relative expression of H9N2. Antiviral
activity in vitro was measured with a HA test (A) and RT-PCR (B). Data from samples without
polysaccharides were used as a basic control. Values with different letters in the same column (a–c)
are significantly different (p < 0.05) from each other. Data are shown as the Mean + SD and are fully
representative of the individual experiment.
3. Discussion
Sulfated polysaccharides from algae have been acknowledged to bear diversified biological and
pharmacological functions [22,60–62]. Moreover, the chemical composition and structural features of
polysaccharides were confirmed to function as determinants of their bioactivities [17,57]. Therefore,
it is necessary to determine which group(s) in the molecule play(s) an essential roles in conferring
the biological function(s), and this was one of our key focuses for the present study. As expected,
significant variations in the chemical composition of monosaccharides, the ratio of total saccharides and
sulfated content were detected among all three sulfate polysaccharides. The results were similar to the
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of saccharide is usually described using total saccharides, but there were some metal ions attached to
the polysaccharide molecules (such as Ca2+, Na+, K+ and Mg2+), and also the SO42+; therefore, the level
of total saccharides was much lower than the real saccharide amount. Moreover, the results of FT-IR
showed the variations in the structural features. For example, GFP contained C-H stretching vibrations,
α-type glycosidic linkages, and the highest sulfate content compare to the other two polysaccharides.
Further analyses were performed to determine the structure-function relationship.
Immune-modulatory effects are some of the most important activities of polysaccharides,
and they have attracted much attention and are already a focus of research [8,63]. To verify the
immune-modulatory function of sulfated polysaccharides from algae, splenic lymphocyte proliferation
was tested in vitro. It is well known that lymphocytes play important roles in the immune response;
hence, the proliferation of lymphocytes becomes the most pertinent criterion to evaluate the cellular
immune functions [64,65]. Our results revealed that, all three polysaccharides tested could significantly
enhance spleen cell proliferation. However, it is difficult to wholly evaluate immune responses
only in vitro; in vivo tests are necessary for further verification of the effect. Thus we chose mice
as the model animal and selected the AIV, which is a cross-species infection, as the immunologic
stimulant to examine the immune-enhancing activity of polysaccharides in vivo. The antibody titer is a
measure of the specific humoral immune response in animals after vaccination [66]. Cytokines are
believed to function as the important mediators of immune responses, such as IFN-γ, a pleiotropic
cytokine with immune-modulatory effects on different types of immune cells, while IL-4 is a cytokine
essential for immune-modulation [44]. IFN-γ and IL-4 were tested in the absence or presence of the
polysaccharides. CD+ T lymphocytes are primarily responsible for mediating cytotoxic effects, and
CD3+, CD8+ and CD4+ are important T lymphocyte markers [65]. Collectively, the results showed
that the administration of UPP, GFP and SQP could significantly enhance AIV-specific antibody
production and improve the humoral immunity level, and the optimal doses that most efficiently
stimulated the production of immunity level varied depended on the type of algae. It was revealed
that, 50 mg/kg SQP exhibited the highest AIV-specific antibody titer and IL-4, while 10 mg/kg
SQP was the best activator of IFN-γ. As for the T-cell subpopulation, 50 mg/kg of GFP and SQP
elicited the best efficiency for CD3+CD4+, while for CD3+CD8+, 10 mg/kg of SQP produced higher
levels compared to others. In sum, SQP might have the best immune-enhancing effects among
these three algae polysaccharides, particularly at 50 mg/kg. The reason why SQP showed the best
humoral immune-enhancing response might be related to the most abundant monosaccharide that SQP
contained, which was fucose. This result is supported by studies that showed fucose plays an important
role in immune-enhancing activity [67]. Thelen et al. reported that fucoidin from F. vesiculosus had
been shown to induce macrophage activation [68]. Moreover, fucose from F. vesiculosus could function
as an effective adjuvant as reported by Jin et al. [69]. Our results confirmed and inferred that the
fucose group in polysaccharide molecules might contribute more to the enhancement of spleen cell
proliferation and humoral immune responses than other components. These results also suggested that
the polysaccharides could function as enhancers in the immune responses and SQP was recommended.
As described above, because all three sulfated polysaccharides could significantly enhance the
immune response with the deactivated AIV as an immunologic stimulant, we were especially interested
in whether they could resist the activated AIV. In this study, the significant suppressions of virus
replication and virus gene expression were detected by both the HA test and the real-time PCR,
suggesting that these sulfate polysaccharides could suppress the replication and expression of AIV
in vitro. GFP suppressed the AIV-replication and expression more significantly compared to the other
two polysaccharides, which might be related to the high sulfate content of GFP. The sulfated content
was thought to be related to higher anti-virus activity [54,70]. Chen et al. found that the antiviral activity
of sulfated polysaccharides from bush sophora roots was stronger than regular polysaccharides that
were not sulfated [71]. The anti-duck hepatitis A virus (DHAV) activities of sulfated polysaccharides
from Astragalus were stronger than those of Astragalus polysaccharides, both in vitro and in vivo [72].
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a vaccination is one of the most promising measures to control AIV, the high frequency of virus
antigenic variation has led to difficulties in the use of the H9N2-specific vaccines [44,64,73]. Thus,
it is important to seek effective and broad-spectrum antiviral drugs for the treatment of H9N2. Based
on these results, these three sulfated polysaccharides are suggested to be a potential alternative to
vaccine-based prevention to reduce the breakage of AIV H9N2, among which GFP is recommended.
4. Materials and Methods
4.1. Algal Samples
Both G. filicinaand and U. Pertusa were collected from the No. 2 Bathing Beach of Qingdao, China.
S. qingdaoens was preserved at IOCAS (Institute of Oceanology, Chinese Academy of Sciences, Qingdao,
China). The algae were washed with distilled water, dried at 50 ˝C and stored at room temperature for
later use (within one year). All reagents were analytical grade and commercially available.
4.2. Extraction of Water-Soluble Sulfated Algal Polysaccharide
Water-soluble sulfated algal polysaccharides were extracted according to the protocol reported by
Zhang. et al. protocol with improvements [18]. The water volume, temperature and extraction time for
each type of seaweed were decided according to the optimized methods before. For G. filicina, a 50-fold
volume of water was used at 100 ˝C for 2 h with stirring, and for U. Pertusa, 4000 mL H2O/100 g was
mixed at 125 ˝C for 4 h, while 100 g of S. qingdaoens was soaked with 30-fold water at 91 ˝C for 4 h
with stirring. Then, the polysaccharides solution gained by filtration was condensed and dialyzed
for salt removal. The solution was condensed again and freeze-dried to obtain the purified sulfated
polysaccharides named UPP, GFP and SQP for U. Pertusa, G. filicina, and S. qingdaoens, respectively.
4.3. Chemical Characterization
Total carbohydrate content was analyzed with phenol–sulfuric acid method using galactose,
rhamnose, and fucose as the standard for GFP, UPP, and SQP, respectively [74].
The molar ratios of monosaccharide composition were measured in reference to Zhang et al. [66].
Briefly, polysaccharides (10 mg/mL) were hydrolysed in trifluoroacetic acid, followed by neutralization
with sodium hydroxide. Then, pre-column derivatization with 3-methyl-1-phenyl-2-pyrazolin-5-one
(PMP; 99%) to neutralize the mixture was carried out and separated by HPLC on a YMC Pack ODS
AQ column (4.6 mm ˆ 250 mm) [75]. The standards for monosaccharide composition analysis and
PMP were obtained from Sigma Aldrich (St Louis, MO, USA).The sulfated content was measured by
the barium chloride gelatin method following Kawai et al. [76].
FT-IR spectra of the three types of polysaccharides were determined on a Nicolet-360 FT-IR
spectrometer (36 scans, at a resolution of 6 cm´1) between 400 cm´1 and 4000 cm´1. The dried
polysaccharide samples were grinded with potassium bromide (KBr) and pressed into pellets for
spectrometric measurement [71].
4.4. Animals and Maintenance
Kunming mice at the age of six weeks were purchased from Qingdao Laboratory Animal Center
(Qingdao, China) for this study. All animals were housed under standard environmental conditions
(22 ˘ 0.5 ˝C, 55% ˘ 5% humidity and a 12 h light/12 h dark cycle) and maintained with free access
to a standard laboratory pellet diet and water. All procedures involving animals throughout the
experiments were conducted in strict accordance with the Chinese Legislation on the Use and Care
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4.5. Cell Lines, Virus, and Tissue Culture
Madin-Darby canine kidney (MDCK) cells were purchased from American type culture collection
(ATCC, Manassas, VA, USA). The cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)
(Corning INC., Corning, NY, USA) supplemented with 100 units/mL penicillin, 100 mg/mL
streptomycin (HyClone Laboratories, Logan, Utah, USA), and 10% (v/v) fetal bovine serum (FBS;
GIBCO BRL Life Technologies, Grand Island, NY, USA) for normal growth and 1% (v/v) for
viral infection.
AIV H9N2 was kept in Qingdao Boite Biopharmaceutical CO., LTD Company (Qingdao,
China). It was propagated on ten-day-old embryonating specific-pathogen-free (SPF) chicken eggs.
Titers of the AIV H9N2 were quantified using MDCK cell monolayers by determining the 50%
Tissue Culture Infective Dose (TCID50), and the 100 TCID50 of purified virus were used in the
subsequent experiments.
4.6. Cytotoxic Activity Evaluation
An MTT assay was applied to determine the relative survival rate of cells during culture [77–79].
After 24 h incubation of 2.5 ˆ 104 cells/mL MDCK cells on 96-well plates either in DMEM as a control
or in sulfated polysaccharides dissolved in DMEM (the concentrations was 10 mg/mL and diluted in
2-fold steps), the cells were treated with the MTT (5 mg/mL, 30 μL/well, Beijing Solarbio Science &
Technology Co. Ltd., Beijing, China) reagent. After 4 h, the supernatant was removed and 100 μL of
DMSO (Beijing Solarbio Science & Technology Co. Ltd., Beijing, China) were added. The absorbance
of each well was measured using a microliter enzyme-linked immunosorbent assay reader (iMarkTM
BIO-RAD) at a wavelength of 490 nm. All experiments were performed in triplicate. The relative
survival rate of cells was calculated using the formula: living rate (%) = (AP/AC) ˆ 100%, where AC
and AP are the optical density without (AC) and with polysaccharides (AP), respectively. When the
living rate is over 85%, it is considered that the polysaccharide does not exert toxicity on the living
cells [80,81].
4.7. Immuno-Modulatory Effect
4.7.1. Mouse Splenic Lymphocyte Proliferation Assay
The spleen was harvested from a Kunming mouse aseptically, and then transferred into a petri
dish with PBS. The spleen was minced and blown fully to obtain the cells suspended and filtrated
through a 200 meshes steel sieve. A total of 2.5 ˆ 104 cells per well in 96-well plates were treated
with three sulfated polysaccharides at a final concentration of 0 μg/mL (control group), 20 μg/mL,
100 μg/mL, and 500 μg/mL followed by incubation for 48 h in a humid atmosphere with 5% CO2
at 37 ˝C. The control group (Mock) used PBS instead of the polysaccharide solution. For each
concentration, five repeats were performed. An MTT assay was used to detect the proliferation
of lymphocytes. Meanwhile, the lymphocytes proliferation rate was calculated using the formula
Proliferation rate (%) = [(A (test group) ´ A (control group))/ A (control group)] ˆ 100% [82]. A is
the average absorbance of the wells with the same treatment.
4.7.2. Animals Grouping and Treatment
The mice were randomly divided into eight groups with eight mice in each group, including the
experimental group, control group, and vaccine group. The experimental groups were given sulfated
polysaccharides UPP, GFP and SQP, at doses of 10 mg/kg and 50 mg/kg, mixed with inactivated
AIV solution by intraperitoneal injection. Mice in the control group were given the same volume of
physiological saline (25 mL/kg) instead. Each mouse in the vaccine group (positive control group) was
treated with inactivated AIV H9N2 solution mixed with white oil (100 mg/kg). On Day 1 and 14, the
mice were separately immunized (Prime and Boost), and the sera were collected after 14 days of the
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4.7.3. AIV-Specific Antibody Titer Detection
Using the sera collected in 4.7.2, the H9N2-specific antibody titers were tested with an ELISA
method [83,84], and each treatment was assayed in triplicate. Briefly, a sample or standard was added
in ELISA plates coated with capture antibody for 2 h at 37 ˝C to detect the bound cytokines using a
biotinylated anti-cytokine antibody, Avidin HRP, and tetramethylbenzidine. Color development was
stopped with 2 M H2SO4 and optical densities were read at 450 nm.
4.7.4. Cytokines Production
The sera samples collected in 4.7.2 were used to detect cytokines production. Two cytokines (i.e.,
IL-4 and IFN-γ) in the treated mice were measured with an ELISA kit (Longtun, Shanghai, China) per
the manufacturer’s instructions.
4.7.5. T-Cell Subpopulation and Flow Cytometry
The blood cells of the treated Kunming mice were collected, and three-color flow cytometry
analyses were performed using different mixtures of specific mAbs, CD3, CD4, and CD8 were labelled
with PE-Cy5, FITC or PE, respectively. Data analysis was conducted with the FAC Scan flow cytometer
(BD, FACS Aria ii, Franklin Lakes, NJ, USA) using Cell Quest software.
4.8. Anti-AIV Effect in Vitro
In the antiviral experiment, the MDCK cells treated with neither AIV nor polysaccharides served
as a cell control group, and the cells infected with the virus only served as a virus control group, while
the test group was treated with both the virus and polysaccharides. For all groups, MDCK cells were
seeded at 2 ˆ 105 cells/well into 24-well plates, and incubated at 37 ˝C in an atmosphere of 5% CO2
until a cell monolayer had formed. The virus control group and test group were treated with 100 μL of
the virus solution at a multiplicity of infection (MOI) of 0.2, while for the cell control group, 100 μL of
DMEM (1% FBS) was added instead. After incubation for 1 h, the supernatant was discarded, and
hereafter, 1 mL of the test polysaccharide solution (GFP, UPP, and SQP, at a concentration of 100 μg/mL
and 20 μg/mL, respectively) were added to the test group, while 1 mL of DMEM was added to the
virus control and cell control groups. For each group, three biological repetitions were carried out.
Treated cells were then incubated at 37 ˝C with 5% CO2 for 24 h.
4.8.1. Virus Titers Assay
Virus titers were determined by the HA test. A total of 25 μL of supernatant from the 24-well plate
described above were serially two-fold diluted in saline on a 96-well microtiter V-plate. To each well,
25 μL of 1% red blood cell suspension was added, and the mixtures were gently mixed and incubated
at 37 ˝C for 30 min. HA was observed and judged as positive if more than 50% of the red blood cells
were agglutinated in the well [85].
4.8.2. Relative Expression of Viruses
Real-time PCR was applied for quantitative analysis of AIV replication levels in vivo. Briefly, total
RNA was extracted from the treated MDCK cells in 4.8 section using 1 mL of RNAiso Plus Reagent (Takara
BIO INC, Liaoning, China) as per the manufacturer’s instructions. Reverse transcription was immediately
performed with Reverse Transcriptase M-MLV (RNase H-; Takara BIO INC, Liaoning, China). Finally,
first strand cDNA was used as a template for real-time PCR with a SYBR®Premix ExTaqTM Kit (Takara
BIO INC, Liaoning, China). The primers for AIV were: Sense 51-ACCAGTGCATGGAGACAATTC-31
and anti-sense 51-CAAATGTTGCATCTGCAAGAC-31; and the primers for internal control β-actin were:
Sense 51-CTGGACTTCGAGCAGGAGATG-31 and anti-sense 51-CGGATGTCCACGTCACACTTC-31. The
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β-actin was used as an internal control to normalize the relative gene expression levels calculated based
on the comparative Ct method with the formula 2´ΔΔCt [86].
4.9. Statistical Analysis
Data in the figures are expressed as the Mean + SD. A t-test was used to analyses the difference
among groups with SPSS Software. Differences between means with p < 0.05 were considered
statistically significant.
5. Conclusions
For understanding and comparing the molecular structures and biological activities of algae
sulfated polysaccharides, three marine algae G. filicina, U. pertusa and S. qingdaoense were selected from
Rhodophyta, Chlorophyta and Ochrophyta, respectively. We characterized the structure determination,
the humoral immune responses, and cell immune responses to antiviral assays in this study. According
to the results, these three types of sulfate polysaccharides shared chemical characteristics and basic
structures, with some variations. Further experiments revealed that the sulfate polysaccharides not
only enhanced the immunity level stimulated by inactivated AIV in vivo but also significantly inhibited
the activity of activated AIV in vitro. The results indicated that these sulfated polysaccharides from
algae could be a potential immune-stimulant and adjuvant against AIV. Moreover, comparative
studies of different species polysaccharides were our focus with the goal of obtaining profound and
refined insights into this topic. Sulfated polysaccharides from S. qingdaoense had the best immune
enhancement bioactivity both in vitro and in vivo. G. filicina sulfated polysaccharides showed the
best effect in anti-AIV activity. Comprehensive analyses were performed to determine whether the
differences in bioactivities could be explained by the differences in structures. These comprehensive
analyses enhanced our understanding of algae sulfated polysaccharides and their potential use in future
research but also gave guidance for further selection of immunologic stimulant and anti-viral drugs.
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Appendix
Table A1. Relative Survival Rate of the Madin-Darby canine kidney (MDCK) Cells.
Conc (mg/mL) 10 5 2.5 1.25 0.625 0.3125 0.156 0.078
UPP 0.82 1.03 1.16 1.09 1.05 1.08 1.06 1.02
GFP 0.74 0.81 0.89 0.9 0.95 0.92 1.01 1.13
SQP 0.78 0.96 1.01 1 0.97 1.05 0.99 1.03
Determination of the safe concentration by pre-experiment cytotoxicity tests. Cytotoxic activity of the sulfate
polysaccharides. The relative living cell rate measured with an MTT assay reflected the cytotoxic activity of the
sulfate polysaccharides.
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Abstract: Ultrasound assisted extraction (UAE), purification, characterization and antioxidant
activity of laminarin from Irish brown seaweeds Ascophyllum nodosum and Laminarina hyperborea
were investigated. UAE was carried out using 60% ultrasonic power amplitude and 0.1 M
hydrochloric acid for 15 min. Separately, solid-liquid extraction was carried in an orbital shaker
using 0.1 M hydrochloric acid at 70 ◦C for 2.5 h. UAE with hydrochloric acid resulted in the
highest concentration of laminarin, 5.82% and 6.24% on dry weight basis from A. nodosum and
L. hyperborea, respectively. Purification of all extracts was carried out using molecular weight cut off
dialysis at 10 kDa. Characterization of the laminarin fraction was carried out using matrix assisted
laser desorption/ionization time-of-flight mass spectrometry. Antioxidant activity of A. nodosum
and L. hyperborea extracts had 2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition levels of 93.23%
and 87.57%, respectively. Moreover, these extracts have shown inihibition of bacterial growth of
Staphylcoccus aureus, Listeria monocytogenes, Escherichia coli and Salmonella typhimurium.
Keywords: laminarin; antioxidant; antimicrobial; bioactive; Laminaria hyperborea; Ascophyllum nodosum
1. Introduction
Half of all global biodiversity is present in the marine ecosystem. Marine organisms are an
excellent source of bioactive compounds. Marine algae, one of the important components of the marine
ecosystem, are a good source of carotenoids, vitamins, minerals, phenolic compounds, sulphated
polysaccharides, peptides and proteins [1]. These compounds have been demonstrated to possess
diverse biological activities including anti-tumor, anti-viral, anti-coagulant, anti-allergic, anti-viral,
anti-tumor and antibacterial [2]. Extracts from these seaweeds have been investigated for use as
ingredients in food and feed products [3]. Ascophyllum nodosum is a brown seaweed which belongs to
the Phaeophyceae class and it is the only species in the genus Ascophyllum. It is good source of fucoidan,
alginates, ascophyllan, laminarins and polyphenols [4]. Laminaria hyperborea is a large, leathery brown
seaweed from the Laminariaceae species which is found on the coast of Norway, Scotland and Ireland.
It is commercially exploited by the hydrocolloid industry for alginate production [5]. Crude extracts
from this seaweed are rich in phenolic compounds and β-glucan polysaccharides known as laminarins.
Laminarins are composed of (1,3)-β-D-glucan [6]. They consist of (1,3)-β-D-glucopyranose
residues with some 6-O-branching in the main chain and some β-(1,6)-intrachain links are also present.
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The molecular weight of laminarin is approximately 5 kDa [7]. Both water soluble and insoluble
forms of laminarin exist depending mainly on the level of branching [8]. In general, extraction of
laminarin involves grinding, precipitation in an mild acid medium, ultrafiltration and dialysis [9].
Characterization of laminarin rich extracts can be carried out by high performance size exclusion
chromatography using a refractive index detector [10], matrix assisted laser desorption/ionization
time-of-flight (MALDI-TOF) with dehydroxy-benzoic acid as matrix [11] and nuclear magnetic
resonance spectroscopy using the 1H-13C heteronuclear single quantum coherence method [12].
However, current methods of extraction of laminarin are time and energy intensive, and result
in poor yields. The development of novel eco-friendly extraction techniques is required to improve
extraction rate and yield. Ultrasound is a low cost, easy to use, environment friendly technology
suitable for the extraction of bioactive compounds from natural sources [13]. There are no reported
studies on the use of ultrasound assisted extraction for laminarin applications. Only a limited number
of studies on the characterization of laminarin-rich extract from brown seaweeds are available in
the literature [6,11,12]. This study investigates the efficiency of ultrasound assisted extraction of
laminarin in comparison to traditional extraction methods, and characterizes the resultant laminarin
rich extracts with respect to molecular weight, chemical properties in addition to antioxidant and
antimicrobial activities.
2. Results and Discussion
2.1. Laminarin and Phenolics Content
In this study two seaweed species harvested from the west coast of Ireland were selected for the
extraction of laminarin. Laminarin was extracted using ultrasound assisted extraction and conventional
solid liquid extraction using water and 0.1 M HCl (Table 1).
Table 1. Laminarin and total phenolic content of different extracts.





Laminaria hyperborea Water Ultrasound 15 LHWU 5.975 ± 0.467 0.365 ± 0.039
Laminaria hyperborea 0.1 M HCl Ultrasound 15 LHAU 6.240 ± 0.008 0.343 ± 0.003
Laminaria hyperborea Water Solid liquid 150 LHWS 4.362 ± 0.197 0.363 ± 0.057
Laminaria hyperborea 0.1 M HCl Solid liquid 150 LHAS 3.254 ± 0.235 0.352 ± 0.021
Ascophyllum nodosum Water Ultrasound 15 ANWU 5.290 ± 0.480 0.156 ± 0.014
Ascophyllum nodosum 0.1 M HCl Ultrasound 15 ANAU 5.822 ± 0.343 0.128 ± 0.008
Ascophyllum nodosum Water Solid liquid 150 ANWS 4.599 ± 0.030 0.166 ± 0.015
Ascophyllum nodosum 0.1 M HCl Solid liquid 150 ANAS 4.304 ± 0.165 0.110 ± 0.007
The highest laminarin content was measured in the extract of L. hyperborea and A. nodosum
obtained using ultrasound and 0.1 M HCl. In previous studies, 0.1 M HCl was also found to give
higher extraction yields compared to water [14]. Moreover HCl at higher temperatures is more effective
than at room temperature for laminarin extraction [7]. Laminarin content varies with species, with L.
hyperborea having a higher level of laminarin compared to A. nodosum. Laminarin content also varies
with factors such as harvesting season and geographical location. Laminarin is absent during the
period of fast growth in spring, but in autumn and winter, it may represent up to 35% of the dried
weight of the fronds [15]. Ultrasound was found to give higher extraction yields of laminarin. High
power ultrasound treatment for 15 min achieved a higher extraction yield than conventional solid and
liquid extraction for both seaweeds investigated. Laminarin yield for L. hyperborea extracted using
ultrasound was 36.97% and 91.76% higher using water and 0.1 M HCl solvents respectively, whereas
for A. nodosum laminarin yield was 15.02% and 35.62% higher using water and 0.1 M HCl solvents
respectively. This can be attributed to the bubble cavitation phenomena generated by ultrasound
waves. The implosion of cavitation bubbles generates macroturbulence, high-velocity interparticle
collisions, and perturbations in microporous particles of the biomass. Cavitation near liquid-solid
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these microjets results in surface peeling, erosion, and particle breakdown, facilitating the release of
bioactive compounds and other components from the biological matrix. These effects increase the
efficiency of extraction by increasing mass transfer by eddy and internal diffusion mechanisms [16].
Ultrasound assisted extraction (UAE) has also been successfully used for extraction of A. nodosum
bioactive compounds including phenolic compounds, fucose and uronic acids [17,18]. The phenolic
content was higher in L. hyperborea extracts. Water was demonstrated to be a better solvent than HCl
for extraction of phenolics. This may be attributed to fact that acid solvents at a temperature of 70 ◦C
may be detrimental to phenolic compounds leading to a lower content in acid extracts. The highest
content of phenolics observed in L. hyperborea and A. nodosum was 0.365 mg PGE/gdb and 0.166 mg
PGE/gdb, respectively.
2.2. Characterization of Extracts
Laminarin rich extracts were analyzed for their molecular weight distribution using
Matrix Assisted Laser Desorption Ionization Quadrupole Time-of-Flight Mass Spectrometry
(MALDI-Q-TOF-MS). Figure 1A,B show the mass spectra obtained in negative ion mode for a laminarin
standard and an ultrasound assisted extract of L. hyperborea, respectively.
 
Figure 1. Matrix Assisted Laser Desorption Ionization Quadrupole Time-of-Flight Mass Spectrometry
(MALDI-Q-TOF-MS) spectra showing the distribution of molecular weights of (A) commercial
laminarin in sinapinic acid and (B) Laminaria hyperborea extract obtained by ultrasound assisted
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The degree of polymerization (DP) for each laminarin peak is shown in bracketed bold numbers
above the corresponding m/z peaks. Four extracts were evaluated to investigate the effect of ultrasound
and seaweed species on extraction of laminarin. Since M-chains and G-chains in the native laminarins
differ by only 2 mass units, they cannot be distinguished from high molecular weight profiles [11].
Laminarin extracted using UAE from L. hyperborea had higher molecular weight laminarins ranging
from 3242 to 5052 Da (corresponding to DP20 to DP31) compared to the other extracts measured.
Meanwhile, L. hyperborea obtained with conventional extraction yielded laminarins from DP20 to
DP24 only. This demonstrates that ultrasound assisted extraction is more efficient than solid liquid
extraction for extracting higher molecular weight laminarins. This can be attributed to the bubble
cavitation phenomena releasing high molecular weight laminarins from L. hyperborea. Similar results
were reported for extraction of high molecular weight phlorotannins from A. nodosum using ultrasound
assisted extraction [18].
Ultrasound treated A. nodosum extracts yielded laminarins from DP25 to DP30 (molecular weights
in the range of 4075 to 4884 Da). A. nodosum extracts did not yield lower molecular weight laminarins
compared to L. hyperborea extracts. Moreover, L hyperborea extracts had a wide range of degree of
polymerization compared to A. nodosum extracts.
2.3. Bioactivities of Laminarin Rich Extract
Laminarin has been found to possess various biological activities. The antioxidant and
antimicrobial activities of the crude laminarin extract are shown in Table 2. The % of
2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition of seaweed extracts was found to be highest in
ultrasound treated extracts using acid solvent for L. hyperborea (87.58%) and A. nodosum (93.24%).
O’Sullivan et al. [19] also found that A. nodosum was one of the most effective extracts for scavenging
DPPH radicals. The extracts obtained with acid were found to have higher antioxidant activity than
those obtained using water solvent. Further, authors reported that A. nodosum with 0.45 g/100 g (Gallic
acid equivalent) of phenolic content exhibited antioxidant activity of 25.6% DPPH inhibition [19].
Balboa et al. [20] have extensively reviewed antioxidant activities in brown seaweeds and they have
reported that phenolic compounds possess antioxidant properties.
Table 2. Antioxidant activity as %DPPH inhibition and antimicrobial activity as minimum inhibition





E. coli S. typhimurium S. aureus L. monocytogenes
LHWU 52.78 21.0 21.0 5.3 2.6
LHAU 87.58 13.1 13.1 6.6 3.3
LHWS 73.91 45.6 22.8 11.4 5.7
LHAS 86.04 28.2 28.2 7.0 7.0
ANWU 61.46 43.2 21.6 NI * NI
ANAU 93.24 596.8 14.9 29.8 59.7
ANWS 15.13 NI 25.5 NI NI
ANAS 87.82 NI 33.4 66.8 66.8
NI, no inhibition.
The extracts were tested for inhibition against two Gram positive (Staphylcoccus aureus and Listeria
monocytogenes) and two Gram negative (Escherichia coli and Salmonella typhimurium) bacterial strains.
All extracts of L. hyperborea were found to inhibit the growth of all the micro-organisms tested. The acid
extracts had better inhibition of bacterial growth compared to water extracts. However, A. nodosum
extracts only inhibited the growth of S. typhimurium completely. Only the acid extract of A. nodosum
proved effective in inhibiting the bacterial growth of all species. The higher phenolic content and
antioxidant activity of L. hyperborea extracts may enhance the antimicrobial efficacy of these extracts
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rich extracts prepared using ultrasound and acid solvents had minimum inhibitory concentrations
(MIC) of 13.1 mg/mL for E. coli and S. typhimurium and 6.6 mg/mL and 3.3 mg/mL for S. aureus
and L. monocytogenes, respectively. This is the first reported study demonstrating that laminarin
rich extracts possess microbial inhibitory activity. There are number of reports of seaweed extracts
such as Sargassum polyophyllum, Sargassum flavellum, Padina australis and Sargassum binderi possessing
antimicrobial activity [22]. However, ultrasound can be a novel alternative to high energy consuming
traditional solid liquid extraction methods. These seaweed extracts have potential application in
the preparation of antimicrobial products for example, a hydrogel wound dressing incorporating a
seaweed Polysiphonia lanosa extract [23].
3. Experimental Section
3.1. Chemicals and Reagents
Laminarin produced from Laminaria digitata, 2,2-diphenyl-1-picrylhydrazyl (DPPH),
phloroglucinol, sodium carbonate, Folin-Ciocalteu reagent (FCR), and hydrochloric acid (37%) were
obtained from Sigma-Aldrich (Wicklow, Ireland). GOPOD (glucose oxidase/peroxidase) reagent and
β-glucosidase were obtained from Megazyme, Wicklow, Ireland.
3.2. Seaweed Samples
Brown seaweed A. nodosum and L. hyperborea were harvested from Finavarra, Co. Clare, Ireland
in May 2014. Seaweed samples were washed thoroughly with fresh water to remove epiphytes and
salt. Fresh seaweed samples were freeze dried. Dried seaweed was powdered using a hammer mill.
Samples were stored at 4 ◦C prior to extraction studies.
3.3. Ultrasound Assisted Extraction
Ten grams of A. nodosum and L. hyperborea powders were extracted using 200 mL of solvent
(distilled water or 0.03 M HCl). HCl was used as the solvent for extraction based on preliminary
studies and previously reported studies for the extraction of laminarin [24–26]. A 750 W ultrasonic
processor (VC 750, Sonics and Materials Inc., Newtown, CT, USA) with a 13 mm diameter probe and
constant frequency of 20 kHz was used. Ultrasonic energy was controlled by setting the amplitude of
the sonicator probe. Ultrasound treatment was applied for 15 min at an amplitude level of 60% which
corresponds to an ultrasonic intensity of 35.61 W cm−2. Ultrasonic power dissipated was calculated at
each amplitude level, with temperature (T) recorded as a function of time (t) under adiabatic conditions
using a T-type thermocouple. From temperature versus time data, the initial temperature rise dT/dt was
determined by polynomial curve fitting. The ultrasonic power (P) was determined using Equation (1)
where dT/dt is the change in temperature over time (◦C s−1), Cp is the specific heat of water (4.18 kJ
kg−1 ◦C−1), and m is the mass (kg).
P = mCp(dT/dt)t=0 (1)






The traditional solid-liquid method of extraction involved stirring at 70 ◦C for 2.5 h using distilled
water and 0.1 M HCl as solvents and no ultrasound pretreatment was employed. The extracted samples
were then centrifuged at 9000 rpm for 30 min. The supernatant was separated and precipitated with
ethanol overnight at 4 ◦C. The precipitated extract was freeze dried and stored at −20 ◦C for further
analysis. The different methods of extraction carried out in this experiment are listed in Table 3. The
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Table 3. Different methods of extraction and corresponding sample codes.
Seaweed Species Solvent Type Extraction Time (min) Sample Code
Laminaria hyperborea Water Ultrasound 15 LHWU
Laminaria hyperborea 0.1 M HCl Ultrasound 15 LHAU
Laminaria hyperborea Water Solid liquid 150 LHWS
Laminaria hyperborea 0.1 M HCl Solid liquid 150 LHAS
Ascophyllum nodosum Water Ultrasound 15 ANWU
Ascophyllum nodosum 0.1 M HCl Ultrasound 15 ANAU
Ascophyllum nodosum Water Solid liquid 150 ANWS
Ascophyllum nodosum 0.1 M HCl Solid liquid 150 ANAS
3.4. Laminarin Assay
Laminarin in the extract was quantified by measuring the glucose concentration released by
the enzymatic hydrolysis of laminarin [27]. A 100 μL sample volume was incubated in 100 μL
of β-glucosidase enzyme at 40 ◦C for 15 min. After incubation, 3 mL of GOPOD (glucose
oxidase/peroxidase) reagent was added. This mixture was incubated at 40 ◦C for 20 min. Finally the
absorbance of the sample was measured at 510 nm by UV-VIS spectrophotometer (UV3100PC, VWR
International). Laminarin produced from Laminaria digitata was used as a standard.
3.5. Total Phenolic Content
Total phenolic content was determined using the method of Wang et al. [28]. Folin-Ciocalteau
reagent was diluted with distilled water at a ratio of 1:10. An extract of 100 μL was mixed with 100 μL
of diluted Folin-Ciocalteau reagent and 100 μL of sodium bicarbonate (20%, w/v) was added to the
mixture and diluted to 1000 μL with distilled water. This solution was maintained at room temperature
for 30 min and the absorbance was measured at 735 nm by UV-VIS spectrophotometer (UV3100PC,
VWR International). Results were expressed as mg phloroglucinol equivalents (PGE)/gdb.
3.6. Matrix Assisted Laser Desorption Ionization Quadrupole Time-of-Flight Mass Spectrometry
(MALDI-Q-TOF-MS)
Mass spectrometry of samples was performed using MALDI-Q-TOF-MS Waters Corporation,
Milford, MA, USA). Prior to analysis, samples were dialyzed (molecular weight cut off of 10 kDa)
in distilled water overnight. Aliquots of 5 μL of sample were mixed with 5 μL of matrix sinapinic
acid. Finally 1–2 μL of sample was plated on a 96 well stainless steel MALDI plate. Samples were
allowed to dry and co-crystallize with the matrix at room temperature and the plate was loaded in
MALDI-Q-TOF mass spectrometer. Mass spectral data were obtained in the negative-ion mode for a
mass range of m/z 1000 to m/z 10,000.
3.7. Antioxidant Activity—DPPH Method
DPPH free radical scavenging inhibition assay was used to determine the antioxidant capacity
of extracted samples [29]. Extract sample of 200 μL was added to 800 μL of 60 μM DPPH in ethanol,
decrease in absorbance was monitored at 517 nm by UV-VIS spectrophotometer (UV3100PC, VWR
International) after 30 min incubation in dark. The readings were compared with the controls, which
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3.8. Antimicrobial Activity—Iodonitrotetrazolium Chloride (INT) Dye Method
3.8.1. Bacterial Strains and Culture Conditions
Seaweed extracts were tested for antimicrobial activity against the following strains of bacteria:
Staphylcoccus aureus NCTC 8178, Escherichia coli DSM 1103, Listeria monocytogenes NCTC 11994 and
Salmonella typhimurium SARB 65. The strains were stored on ceramic beads in glycerol at −80 ◦C prior
to use. A bead of each strain was streaked on a nutrient agar plate and incubated for 18 h at 37 ◦C.
A single colony was removed from each plate and inoculated into tubes containing 25 mL of sterile
Mueller-Hinton Broth (MHB) and incubated for 22 h at 37 ◦C. Overnight cultures were vortexed and
aliquots diluted appropriately in sterile MHB to produce solutions containing log10 6.0 ± 0.5 cells/mL.
Cell numbers were confirmed by plate counting. Antibiotic Gentamicin (0.2 mg/mL) was used as
standard for negative growth.
3.8.2. Minimum Inhibitory Concentration (MIC) Assay
The MIC of each seaweed extract was carried out using a previously described microtitre method
of Kenny, Smyth, Walsh, Kelleher, Hewage and Brunton [21]. Each extract (2 mg/mL) was prepared by
dissolving the material in distilled water added to the first well of the plate followed by a serial dilution
across the plate. Iodonitrotetrazolium chloride (INT) dye was used identify microbial growth [30].
The MIC of each extract against a bacterial strain was determined as the lowest sample concentration
at which no pink color appeared. This process was repeated in triplicate for each bacterial strain to
ensure reproducibility.
4. Conclusions
In this study, water and acid extracts from L. hyperborea and A. nodosum were obtained using
ultrasound assisted extraction and solid liquid extraction. The extracts were purified to obtain
laminarin rich extracts. The L. hyperborea extracts contained higher contents of laminarin. The overall
laminarin content in all the extracts was low which may be attributed to seasonal and geographical
factors. Ultrasound was demonstrated to be a more efficient method of extraction than solid liquid
extraction based on laminarin content and molecular weight distribution observed in the extracts.
The laminarin rich extracts were also studied for biological activities including anti-oxidant and
anti-microbial activity. This study is the first report of laminarin rich extracts possessing anti-microbial
activity. The use of laminarin as a nutraceutical ingredient should be further investigated due to
its dietary fiber properties in addition to the anti-oxidant and anti-microbial activities reported in
this paper.
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Abstract: In this study, polysaccharides from Grateloupia filicinia (GFP) were extracted and several
low molecular weight (Mw) G. filicina polysaccharides (LGFPs) were prepared by the hydrogen
peroxide (H2O2) oxidation method. Additionally, the effect of different experimental conditions on
the degradation of GFP was determined. Results showed that the GFP degradation rate was positively
related to H2O2 concentration and temperature, and negatively related to pH. Chemical analysis
and Fourier transform infrared spectra (FT-IR) of GFP and LGFPs showed that the degradation
caused a slight decrease of total sugar and sulfate content. However, there was no obvious change
for monosaccharide contents. Then, the anti-ALV-J activity of GFP and LGFPs were determined
in vitro. Results revealed that all of the samples could significantly inhibit ALV-J and lower Mw
LGFPs exhibited a stronger suppression, and that the fraction LGFP-3 with Mw 8.7 kDa had the best
effect. In addition, the reaction phase assays showed that the inhibition effect was mainly because
of the blocking virus adsorption to host cells. Moreover, real-time PCR, western-blot, and IFA were
further applied to evaluate the blocking effects of LGFP-3. Results showed that the gene relative
expression and gp85 protein for LGFPS-3 groups were all reduced. Data from IFA showed that
there was less virus infected cells for 1000 and 200 μg/mL LGFPS-3 groups when compared to virus
control. Therefore, lower Mw polysaccharides from G. filicina might supply a good choice for ALV-J
prevention and treatment.
Keywords: Grateloupia filicina; degradation; low molecular weight polysaccharides;
antiviral activity; ALV-J
1. Introduction
Avian leucosis virus subgroup J (ALV-J) is an immunosuppressive virus, which generally causes
a diversity of tumors, such as hemangioma and myeloid leucosis in birds [1]. It has spread worldwide
since the first time it was discovered in British broiler breeds in 1988. In China, ALV-J was first detected
and officially recorded in 1999 [2], and after that the ALV-J infection appeared around the country.
The virus could infect chickens through both horizontal and vertical transmission; initially it was
mainly found in turkeys and broilers, but recently it also brought disease and death in egg layers
and broiler breeders [3], which caused heavy losses to the poultry breeding industry. Due to the
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complex genetic sequence and the antigenic variability, there are still no commercial vaccines against
ALV-J infection [4–6]. Currently, the only way to prevent ALV-J is by quarantining and eliminating
positive chickens. Therefore, it is urgent and necessary to find effective antiviral medicine to control
ALV-J spread.
On the other hand, the red seaweed genus Grateloupia, which belongs to Halymeniaceae,
is an intertidal alga [7], which is widely distributed in the countries of the west Pacific bank such as
China, Japan, and South Korea. It has enormous commercial value because it may be used as raw
materials for carrageenan. In addition, the protein content of Grateloupia turuturu can account for
20% of the dry weight therefore being of potential in the food industry [8]. Polysaccharide is another
important chemical compound of Grateloupia. It has attracted wide attention in recent years due to its
multiple biological activities. For example, Nikapitiya et al. reported a good anticoagulant activity of
a sulfated polysaccharide that is extracted from Grateloupia filicina [9]. In addition, Yu et al. isolated
an agaran-type polysaccharide from G. filicina and demonstrated that the polysaccharide carried
antiangiogenic effects [10]. Further, the polysaccharides that are extracted from G. livida were reported
to have antioxidant, antibacterial, and antisachistosomal activity [11,12]. Scientists also studied the
antiviral activity of Grateloupia and found that polysaccharides obtained from G. indica, G. filicina,
and G. longilia had anti-HSV-1, HSV-2, HIV-1, and dengue virus activity [13,14]. However, the studies
on antiviral activity of the polysaccharide from Grateloupia were mainly focused on human suffering
virus, and few studies aimed at finding the effects against poultry viruses.
Even though the high Mw Grateloupia polysaccharide has various biological activities, its huge Mw
causes low solubility and tough organism absorption, which greatly restricts its application. Commonly,
lower Mw algal polysaccharides are obtained by the degradation of high Mw polysaccharides. When
compared with original high Mw polysaccharide, low Mw polymers are characterized by having
a higher water solubility and stability, and easy organism absorption [15]. In order to obtain lower
Mw polysaccharide a chain of polysaccharides is usually broken, as according to the 1 → 3, 1 → 4
and 1 → 6 glycosidic linkages fractures, and some of their original activity might be improved in
different degrees [16–18]. Additionally, in recent years, it has been found that low Mw polysaccharides
from seaweeds presented some effects on the suppression H1N1 influenza virus and HIV [19–22].
However, research on the anti-ALV-J activity of algal polysaccharides still scarce. Therefore, it would
be innovative and promising applying the low Mw polysaccharide from Grateloupia to prevent ALV-J.
In this study, polysaccharides from G. filicina (GFP) were extracted by hot water extraction
and were degraded via H2O2 oxidative degradation. The effect of different conditions (including
concentration of H2O2, pH and temperature) on the degradation of GFP was determined. Several
low Mw fractions of GFP (LGFPs) were prepared and their chemical composition was tested. Finally,
the anti-ALV-J activity of LGFPs was explored. The results of this study would provide a possible
useful application of seaweeds polysaccharides as a veterinary medicine in the prevention of ALV-J.
2. Results
2.1. Influence of Degradation Conditions on the Mws of Polysaccharides
The yield of the GFP that was extracted by traditional hot water extraction and alcohol
precipitation methods was 34.44%. Freeze-dried GFP was dissolved in distilled water and degraded
by H2O2 oxidative method. The influence of different conditions on the degradation of GFP
was determined.
2.1.1. Effect of Temperature
In order to investigate the effect of temperature on the Mw of GFP, 60 ◦C, 70 ◦C, 80 ◦C, 90 ◦C,
and 100 ◦C were selected. As shown in Figure 1, the Mw of the products was high at a comparatively
low temperature (such as 60 ◦C and 70 ◦C). At 120 min, the Mws changed to 76.9 kDa, 36 kDa and
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3.2 kDa and 2.2 kDa in 60 min when temperatures were 90 ◦C and 100 ◦C and the curves were tend to
stay after 120 min. At last, the Mws of the polysaccharides for 60 ◦C, 70 ◦C, 80 ◦C, 90 ◦C, and 100 ◦C
groups were 63 kDa, 16 kDa, 5.7 kDa, 2.0 kDa, and 1.8 kDa, respectively. The results showed that high
temperature was more favorable for degradation and feasible to generate lower Mws polysaccharides.
 
Figure 1. Effects of temperature on the molecular weight (Mw) of Grateloupia filicinia polysaccharide
(GFP). The reaction was carried out in pH 1 and 0.15% H2O2 under different temperature conditions.
2.1.2. Effect of H2O2 Concentration
Figure 2 shows the effect of H2O2 concentration (0.03%, 0.15%, 0.30%, 0.6%, and 1.5%) on the
Mw of the polysaccharides. In the first 60 min, Mw of 0.03% and 0.15% concentrations degradation
products were similar and was bigger than the other groups, it decreased to about 9.5 kDa after 60 min.
By contrast, the reaction with 0.3%, 0.6%, and 1.5% concentration groups presented no differences
and were faster; the Mw of the products were all about 6.7 kDa after 60 min. However, after 90 min,
the degradation results were similar for all of the groups. The curves of all H2O2 concentrations were
closer, and the Mw of the final low molecular weight (LMw) polysaccharides were all around 2 kDa.
Figure 2. Effect of H2O2 concentration on the Mw of GFP. GFP was degraded at pH 1 and 90 ◦C under
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2.1.3. Effect of pH
Figure 3 illustrates the pH impact on the degradation of GFP. (pH 1, 2, 3, 4, and 8) were tested.
As shown in Figure 3, the pH had a significant influence on GFP degradation. In 30 min, the Mw were
remarkably reduced to 20 kDa and 54 kDa when under the lowest pH 1 and 2, respectively; but when
pH was increased to 3, 4, or 8, the Mw of GFP were approximately 120 kDa at 30 min. After 120 min,
the Mw of GFP changed slightly to a final Mw of 2.1 kDa and 3.2 kDa for pH 1 and 2, respectively.
However, when the pH increased to 3, 4, or 8, the Mw decreased drastically to 4.2 kDa, 4.5 kDa and
7.6 kDa at 240 min, respectively. This suggested that the higher pH (such as 3, 4, and 8) could also
degrade GFP, but a lower pH would accelerate the reaction to a shorter time.
 
Figure 3. Effects of pH on the Mw of GFP. GFP was degraded in 0.3% H2O2 at 90 ◦C under different
pH conditions.
2.2. Preparation and Chemical Characterization of LGFP
2.2.1. Preparation of LGFP
Depending on the influence of different conditions on the degradation of GFP, a series of conditions
were screened to prepare four kinds of LGFP solutions. After being neutralized to pH 7, the solution
was dialyzed against tap water for 24 h and was then changed to distilled water for 24 h. The dialysis
tube for LGFP-1 to LGFP-4 were 10 kDa, 3.5 kDa, 1 kDa, and 0.5 kDa Mw cut off, respectively. After
dialysis, the solutions were filtered by common filter paper, freeze dried, and then the yield was
calculated. The specific preparation conditions and yield are shown in Table 1.
Table 1. Preparation conditions and yield of LGFPs.
Sample Temperature (◦C) pH H2O2 (%) Time (min) Yield (%)
LGFP-1 90 4 0.3 75 73.4
LGFP-2 90 4 0.3 135 46.28
LGFP-3 90 4 0.3 210 42.99
LGFP-4 90 4 0.3 240 40.38
2.2.2. Chemical Characterization
According to the conditions exhibited in Table 1, four LGFPs with different Mw were prepared.
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and Table 2. The HPLC standard curve equation was y = −2.4616x + 24.507 with the Log Mw as
the abscissa and elution time as the ordinate. The R square was 0.991. With the decrease of Mw of
the polysaccharides, the total sugar content has decreased as well, but the sulfate content decreased
slightly. The protein content of LGFPs also reduced. Results of monosaccharide composition showed
that all samples were mainly composed of galactose.
Figure 4. HPLC profiles of the GFP and LGFPs.
Table 2. Chemical composition of polysaccharides (%w/w of dry weight).
Sample Total Sugar (%) Sulfate (%) Protein (%) Mw (kDa)
Monosaccharides Composition (Molar Ratio)
Man Rha Glc A Glc Gal Xyl Fuc
GFP 55.22 ± 0.96 21.52 ± 0.04 1.45 ± 0.08 216.7 ± 1.2 0.00 0.01 0.03 0.01 1 0.03 0.03
LGFP-1 49.74 ± 1.22 20.99 ± 0.28 0.96 ± 0.01 40.2 ± 0.3 0.01 0.01 0.03 0.01 1 0.03 0.02
LGFP-2 47.21 ± 1.32 16.86 ± 0.10 0.45 ± 0.02 14.0 ± 0.3 0.01 0.01 0.05 0.01 1 0.03 0.02
LGFP-3 44.73 ± 2.43 18.33 ± 0.43 0.18 ± 0.01 8.7 ± 0.2 0.01 0.01 0.05 0.01 1 0.03 0.01
LGFP-4 41.00 ± 0.25 17.01 ± 0.44 0.29 ± 0.00 2.7 ± 0.1 0.01 0.02 0.04 0.01 1 0.02 0.02
Man: mannose; Rha: rhamnose; Glc A: glucuronic acid; Glc: glucose; Gal: galactose; Xyl: xylose; Fuc: fucose.
In order to further characterize the chemical structure of the GFP and LGFPs, the respective
FT-IR spectra were examined (Figure 5). Based on previous reports [17,23,24], the O–H stretching
vibration appeared at 3300 cm−1, and C–H stretching vibration appeared at 2940 cm−1. The absorption
peaks at 1620 cm−1 and 1420 cm−1 represents the asymmetric and symmetric stretching vibration of
C=O, respectively. The absorption peaks at 1220 cm−1 indicates S=O stretching vibration and that
at 1020 cm−1 correspond to C–O–H deformation vibration. Feature absorption at 840 cm−1 reflects
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Figure 5. Fourier transform infrared (FT-IR) spectra of GFP and LGFPs in regions from 4000 to 500 cm−1.
2.3. Cytotoxic Activity
The specific results of MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide)
assay used to detect the cytotoxicity of GFP and LGFPs on DF-1 cells were shown in Table 3. It was
considered that the polysaccharides do not have cytotoxic activity to DF-1 cells as the relative survival
is over 85% [25,26]. These results suggested that 2 mg/mL was still safe for all samples.
Table 3. Relative Survival Rate of DF-1 cells.
Concentration
(mg/mL)
2 1 0.5 0.25 0.125 0.0625 0.03125
GFP 0.95 ± 0.02 1.00 ± 0.06 1.03 ± 0.07 1.08 ± 0.01 1.07 ± 0.04 1.05 ± 0.09 1.02 ± 0.06
LGFP-1 0.96 ± 0.02 1.00 ± 0.05 1.05 ± 0.04 1.05 ± 0.08 1.01 ± 0.04 0.99 ± 0.04 1.00 ± 0.04
LGFP-2 0.9 4± 0.05 1.06 ± 0.04 1.01 ± 0.02 1.05 ± 0.04 1.05 ± 0.05 1.01 ± 0.04 1.03 ± 0.07
LGFP-3 0.9 5± 0.02 1.02 ± 0.05 1.04 ± 0.10 0.99 ± 0.03 1.03 ± 0.03 0.99 ± 0.05 1.03 ± 0.04
LGFP-4 0.96 ± 0.10 0.98 ± 0.03 1.03 ± 0.06 1.01 ± 0.05 1.01 ± 0.03 1.04 ± 0.07 1.09 ± 0.03
The safe concentration of GFP and LGFPs was tested using MTT assay. All treatments were performed in triplicate.
The relative survival rate reflected the cytotoxity of GFP and LGFPs.
2.4. Anti-ALV-J Activity In Vitro
2.4.1. ALV-Specific Antigen Detection
ELISA method was applied to preliminary verify the anti-ALV-J activity of polysaccharides
preliminary. S/P value represented the relative expression of p27 antigen and was calculated by
the following equation: S/P = (Sample mean − Negative control mean)/(Positive control mean −
Negative control mean). As presented in Figure 6, under the concentration of 2 mg/mL, the S/P value
of all of the tested groups were lower than the virus control, which means that the ALV p27 antigen
of polysaccharides treated groups were dramatically lower than virus control. The effect of LGFP-2,
LGFP-3, and LGFP-4 was better than that of GFP and LGFP-1, which possess higher Mw. Among them,
LGFP-3 showed the best anti-ALV-J activity with a S/P value of 0.13, thus, LGFP-3 was cautiously
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Figure 6. Expression of ALV-J p27 antigen. Antiviral activity of GFP and LGFPs were determined by
ALV p27 antigen test kit. Results are recognized as positive when S/P value is greater than 0.2. Data
are shown as the Mean + SD. Values with different letters in the same column (a–f) are significantly
different (p < 0.05) from each other.
2.4.2. Action Phase of Polysaccharides
Different plant polysaccharides exerted various antiviral characteristics [1,27,28]. In order
to explore the action phase of the samples, LGFP-3 was assayed following different conditions,
as indicated in Section 4.7.2. All of the treatments were applied to cells and virus in vitro, and the
antiviral activity was detected by ELISA. The results showed in Figure 7 illustrated that the S/P value
of Ad group was 0.15, significantly lower than the virus control that was 0.24, and also lower than that
of BA and AA. This means that the GFP-3 might inhibit virus adsorption onto the DF-1 cells. The p27
expression of BA and AA (both 0.23) groups was lower than the virus control but the difference was
not significantly (p > 0.05), which indicated that the treatment with polysaccharides before or after
virus inoculation did not significantly decrease the virus infection.
Figure 7. Expression of p27 after different modes of administration: LGFP-3 treated DF-1 cells before
adsorption (BA); LGFP-3 treated virus at the adsorption phase (Ad); and, LGFP-3 treated DF-1 cells after
adsorption (AA). The final concentrations of LGFP-3 were all 1 mg/mL in these three administration.
DF-1 cells with and without inoculation were used as the virus and cell control, respectively. Data
are shown as the Mean + SD. Values with different letters in the same column (a–c) are significantly
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2.4.3. Gene Relative Expression of ALV-J
Real time PCR was performed to evaluate the ALV-J gene expression with or without LGFP-3
treatment. The results were presented in Figure 8. The expression of ALV-J gene decreased significantly
after treatment with LGFP-3 (1000 and 200 μg/mL), and the suppression was dose-dependent.
Treatment with 1000 μg/mL LGFP-3 caused the strongest inhibition against ALV-J adsorption;
the relative gene expression of 200 μg/mL in the experiment group was 42.52, weaker than 1000 μg/mL
group but significantly lower than virus control. While handling with 40 μg/mL LGFP-3, the gene
expression was higher than the other two concentrations and even higher than the virus control.
This suggested that under a low concentration, the LGFP might promote ALV-J adsorption.
Figure 8. Gene relative expression of ALV-J measured with real-time PCR. DF-1 cells with or without
inoculation were used as the virus and cell control, respectively. Data are shown as the Mean + SD.
Values with different letters in the same column (a–d) are significantly different (p < 0.05) from
each other.
2.4.4. Western-Blot and Indirect Immunofluorescence Assay (IFA) Analysis
To further investigate the variation of ALV-J when treated with LGFP-3 as compared to cell
and virus control, western-blot and IFA were also used; the results were shown in Figures 9 and 10,
respectively. As it happened with the results of real time PCR, in western-blot analysis, expression
of ALV-J gp85 protein was almost the same as virus control when treated with 40 μg/mL LGFP-3.
However, when the concentration was 1000 μg/mL, the gp85 protein expression significantly decreased
and gained a much greater effect when compared with 200 μg/mL and 40 μg/mL LGFP-3. These results
also showed that the antiviral effects were dose dependent.
A more direct observation of DF-1 cells infected by ALV-J could be obtained from IFA. Results
showed that five days after inoculation, the green fluorescence signal intensity of 40 μg/mL group
was the strongest and similar to that of the virus control. The majority of the DF-1 cells were also
infected with ALV-J in the 200 μg/mL group but less in number than the virus control group. Cells that
were treated with 1000 μg/mL LGFP-3 had the lowest virus expression. The antiviral effects increased
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Figure 9. Expression of ALV-J gp85 protein evaluated by western-blot. DF-1 cells with or without
inoculation were used as the virus and cell control, respectively.
Figure 10. Expression of ALV-J gp85 protein evaluated by IFA. (a): virus control; (b): cell control;
(c): ALV-J treated with 40 μg/mL LGFP-3; (d): ALV-J treated with 200 μg/mL LGFP-3; and, (e): ALV-J
treated with 1000 μg/mL LGFP-3.
3. Discussion
The GFP was recognized for its various biological activities [14,29,30]. However, researches
focusing on the degradation of GFP and antiviral activity of LGFP are still scarce. Therefore, it is
necessary and significant to explore the influence of degradation conditions on the Mw of GFP and
the antiviral activity of LGFP. For all of the degradation methods, H2O2 oxidative degradation was
characterized for its mild reaction and low cost; besides, the unreacted excess H2O2 is easy to remove.
Because of the advantages mentioned above, H2O2 oxidative degradation has been widely used in
degrading polysaccharides such as chitosan, starch, and cellulose [31–33]. Further, the pH, H2O2
concentration and temperature were considered to have a great impact on the degradation rate [17,34].
In this study, the GFP degradation rate was shown to be positively related to temperature, H2O2
concentration, and negatively to pH in general. Probably, during the degradation process, H2O2
could generate free radicals such as HOO−, •O2, and HO•, which could remove a H atom bonded to
contributing to the fracture of the glycosidic linkages [35]. Our results showed that the degradation
for 0.03% and 0.15% H2O2 were slower than that of 0.3% in the first 90 min. This might suggest
that a higher H2O2 concentration meant that more free radicals are produced in solution, therefore
accelerating the degradation. When considering that the degradation results for 0.6% and 1.5% H2O2
were same as the 0.3% from the beginning to the end, so, concentration at 0.3% was enough for GFP
degradation. However, after 90 min, the 0.03% and 0.15% groups were gradually approached to the
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a high H2O2 concentration might speed up the degradation rate, but it dose not influence the final
results. Another parameter that affects the degradation of GFP might be pH. For example, Iqbal et al.
degraded dextran at 80 ◦C for 2 h, and verified that the Mw of the product was 270 kDa with pH of 1.8,
while the Mw decreased to only 77 kDa for pH 1.4 [36]. In our study, compared with pH 3, 4, and 8,
pH 1 and 2 could significantly accelerate the degradation probably because pH could also affect the
generation rate of free radicals in the solution. Therefore, in an acidic environment provided by a low
pH, polysaccharides could be degraded more easily. Another important factor in GFP degradation is
temperature. As shown in Figure 3, 10 kDa products could be obtained within 60 min at 90 ◦C and
100 ◦C, but at 60 ◦C and 70 ◦C, the Mw of the products were 63 kDa and 16 kDa only after 240 min.
Hence, the Mw of the degradation products decreased significantly with the increase of temperature.
There, we adopted 90 ◦C to prepare LGFPs (Table 1).
Based on the degradation results, several LGFPs were prepared and the chemical composition
of GFP and LGFPs were also characterized. According to the results, we found that the protein
content were reduced with the decrease of Mw in general, which indicated that the degradation
was a benefit for protein removal. Along with the decrease of Mw, and the total sugar content also
decreased, it might because of the comprehensive effect, which is caused by the temperature, H+,
and free radicals in the degradation process. The monosaccharide composition results showed that all
of the samples were mainly composed of galactose, the other monosaccharide content was extremely
low. The pattern mentioned in FT-IR indicated that GFP and LGFPs were all sulfated polysaccharides
and the degradation process did not change the chemical structure of GFP.
ALV-J has gradually spread in China and caused great losses to poultry breeding industry [37–39].
When compared with other ALVs, high recombination of ALV-J and selection pressure lead to the
faster variation rate [40,41], which caused great difficulties in preventing and treating ALV-J outbreaks.
Polysaccharides from the algae were found to exert inhibition to many viruses [42–44]. To verify
the suppression of GFP and LGFPs to ALV-J, the ALV p27 antigen was detected in the presence or
absence of the polysaccharides. P27 antigen is a common protein in ALVs, but it is often used to
determine the ALV-J infection levels in the laboratory when the pathogen is ensured. Results in
the study showed that all of the samples could significantly inhibit the expression of p27 antigen,
and LGFP-2, 3, and 4 were better than GFP and LGFP-1. Among them, LGFP-3 with a Mw of 8.7 kDa
exerted the best inhibition effect.
In order to determine the function time-point of polysaccharides on ALV-J, LGFP-3 was chosen
for further experiments. Figure 5 demonstrated that p27 antigen levels reduced only when the virus
and LGFP-3 were administered simultaneously. Further, the BA and AA treatments were similar to
the virus control. Therefore, the polysaccharides might mainly inhibit ALV-J adsorption on host cells.
This was also observed in some other reports. Bouhlal et al., for example, found that polysaccharides
extracted from Sphaerococcus coronopifolius and Boergeseniella thuyoides inhibited HSV-1 adsorption onto
host cells [28], and Bourgougnon et al. suggested that the polysaccharides from Schizymenia dubyi could
suppress HIV and the activity was mainly attributed to the inhibition of virus to cell attachment [45].
While Wang et al. found that fucoidan from Kjellmaniella crassifolia could inhibit the influenza A
virus (IAV) treated with fucoidan before or after inoculation [27]. It seems that the action phase of
fucoidan was not the same as LGFP. This is probably because the monosaccharide composition and
the chemical structure of fucoidan, and also the viruses were different from this study. In addition,
many researches showed that the sulfate content played a very important role in polysaccharides
activities [46–49]. However, in this research, although the inhibition effect of LGFP-3 was the best,
the sulfate content of LGFP-3 was not the highest. Perhaps, the inhibition effect of GFP and LGFPs
to ALV-J was not only related to the sulfate content but also to the Mw of the polysaccharides or the
sulfate pattern of distribution. According to the results, we may deduce that LGFP with a Mw of about
8.7 kDa might bind to some specific receptors on the cells with a more suitable structure and ionic
interactions between polysaccharides and cells, or it could fully bind to ALV-J particles and block the
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further prove the LGFP-3 anti-ALV-J effect, virus genes, and specific protein expression were tested
by real-time PCR, Western-blot and IFA. A significant suppression of ALV-J gene and gp85 protein
expression were detected. Based on the real-time PCR results, gene expression of virus control were
24-times higher than that of 1000 μg/mL LGFP-3 group, thus the virus replication was significantly
decreased. From the western-blot and IFA results, it can be observed that the virus protein expression
and the number of ALV-J decreased significantly in the groups under 1000 and 200 μg/mL treatment.
Thus the quantity of viral protein synthesis was also reduced. All of the above results showed that
LGFP-3 could inhibit the ALV-J adsorption and reduce the infection probability of virus. Similar results
were obtained by Yu et al., who discovered that the polysaccahrides from Taishan Pinus massoniana
pollen could directly coat to the virus envelope protein, which would bind to the cell surface receptor,
thereby affecting the virus adsorption [1]. Because LGFP-3 had no impact on ALV-J when applied
before adsorption (BA), we speculated that our samples could not bind to the cell membrane, and the
possible way was to interact with the virus envelope protein just like the polysaccahrides from Taishan
Pinus massoniana pollen. But, considering the complex configuration of our samples, the action targets
might be more and the specific mechanism needs to be elucidated in the future.
4. Materials and Methods
4.1. Seaweeds Samples and Reagents
G. filicina was collected from the number two bathing beach of Qingdao, China in January 2016.
The seaweeds were washed with distilled water to remove salt, sediment, and other impurities,
then dried at 50 ◦C in an oven to constant weight and stored at room temperature. All of the reagents
used were of analytical grade.
4.2. Extraction of GFP
Traditional hot water extraction and alcohol precipitation method [26] was used with some
modifications. Briefly, the dried algae were mixed with 60-fold volume of distilled water and
maintained at 100 ◦C for 4 h. After cooling down, the polysaccharide solution was filtered and
condensed to 1/2 volume by a rotavapor. Then, the supernatant was dialyzed at tap water for 24 h
and then changed to distilled water for 24 h, respectively, using dialysis tube with a 3.5 kDa Mw cut
off. The liquid was concentrated to 1/4 volume and after that 3-fold volume anhydrous ethanol was
added to precipitate polysaccharides. The mixture was placed over-night at 4 ◦C and then centrifuged.
The precipitate was freeze-dried and the yield (%) of the polysaccharide was calculated.
4.3. Influence of H2O2 Oxidation on GFP Degradation and Preparation of LGFP
A 0.8 g mass of GFP was dissolved in 40 mL distilled water, added with H2O2 solution,
and adjusted pH by hydrochloric acid or sodium hydroxide, and then heated in a water bath with
stirring. Every 30 min, 0.5 mL samples were removed from the reaction solution. After being filtrated
with a 0.22 μm polyethersulfone filter (Tianjin Jinteng Experiment Equipment Co., Ltd, Tianjin, China),
the Mw of the samples was determined by high performance gel permeation chromatography (HPGPC)
to investigate the effect of pH (1, 2, 3, 4, and 8), final concentration of H2O2 (0.03%, 0.15%, 0.3%,
0.6%, and 1.5%) in reaction solution and temperature (60 ◦C, 70 ◦C, 80 ◦C, 90 ◦C, and 100 ◦C) on
the GFP degradation. Afterwards, according to the above results, LGFPs were prepared under
different conditions.
4.4. Chemical Characterization
The Mw of GFP and LGFPs was measured by HPGPC method with a TSK gel G3000PWxl column,
and using 0.1 mol/L Na2SO4 as the mobile phase on Agilent 1260 HPLC systerm equipped with
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standards (Mw 1000, 5000, 12,000, 50,000, 80,000, 270,000, and 670,000, Sigma, Mendota Heights, MN,
USA) were used to calibrate the column.
Total sugars were analyzed by phenol-sulphuric acid method [50] using galactose as the standard.
Bradford’s method [51] was used to detect the protein content and using bovine serum albumin (BSA)
as the standard. Sulfated content was determined by barium chloride gelatin method [52]. The Fourier
transform infrared (FT-IR) spectra of the samples were recorded by Nicolet-360 FT-IR spectrometer
(Thermo Fisher, Waltham, MA, USA) in KBr disks using a scan range from 500 to 4000 cm−1.
The monosaccharide composition (molar ratio) was analyzed using 1-phenyl-3-methyl-5-
pyrazolone (PMP) pre-column derivation HPLC [53]. Briefly, 10 mg samples were put into the ampoule
and 1 mL distilled water was added then the mixture was hydrolyzed in 4 mol/L trifluoroacetic acid
for 4 h at 110 ◦C in an oven followed by neutralization with sodium hydroxide to pH 5–6. Later,
the pre-column derivatives were carried out with PMP and separated by HPLC using a YMC Pack
ODS AQ column. The mannose, rhamnose, fucose, galactose, xylose, glucose, and glucuronic acid
standards were obtained from Sigma Aldrich (St. Louis, MO, USA).
4.5. Cell Lines, Cell Culture, Virus and Antibodies
A DF-1 cell line, a NX0101 strain of ALV-J, and the ALV-J gp85-specific monoclonal antibody
were kindly gifted by Prof. Cheng, Shandong Agricultural University. The DF-1 cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) provided with 100 units/mL of penicillin and
100 μg/mL of streptomycin, and supplemented with 10% (v/v) or 1% (v/v) fetal bovine serum (FBS) as
the growth medium (GM) or maintenance medium (MM), respectively. The ALV-J titer was tested using
DF-1 monolayers and expressed by tissue culture infectious dose 50 (TCID50) using the Reed-Muench
formula. 100 TCID50 of ALV-J was used in subsequent experiments.
4.6. Determination of Cytotoxic Activity
MTT assay was used to evaluate the cytotoxic activity of GFP and LGFP on DF-1 cells. DF-1 cell
monolayers grown in 96-well plate were supplied with the 100 μL MM as the cell control or 100 μL
polysaccharides solution that were dissolved in MM (the maximum concentration was 2 mg/mL and
diluted in 2-fold steps to 0.03125 mg/mL). All of the treatments were performed in triplicate. After 24 h,
the liquid was removed; 20 μL MTT was added and the cells were incubated for another 4 h. Then,
the MTT was discarded and 100 μL DMSO was added. Finally, the enzyme-linked immunosorbent
assay reader (iMarkTM BIO-RAD, Hercules, CA, USA) was used to determine the absorbance of each
well at 490 nm. The cytotoxic activity was represented by the relative survival rate of DF-1 cells and
calculated by the formula: survival rate (%) = (As/Ac) × 100%, where Ac and As were the absorbance
of cell control (Ac) and experimental group (As), respectively. When the survival rates were higher
than 85%, it was considered that the samples had no cytotoxicity on DF-1 cells.
4.7. Anti-ALV-J Activity In Vitro
4.7.1. ALV Specific Antigen Detection
DF-1 cell monolayers grown in 96-well plate were infected with 100 TCID50 of ALV-J, meanwhile,
different polysaccharides solutions at a final concentration of 2 mg/mL, which were dissolved in MM
were added. After 2 h incubation at 37 ◦C, the cells were washed and covered with MM containing
corresponding polysaccharides at a concentration of 2 mg/mL, subsequently, the cell control (without
infection of ALV-J) and virus control (without exposure to polysaccharides) were also set. After 24 h of
incubation, the viral titers were measured using the ALV p27 antigen test kit (Beijing IDEXX-Yuanheng
Laboratories, Co. Ltd., Beijing, China) following by the instructions of the manufacturer. The relative
expressions of p27 antigen were calculated by the following equation: S/P = (Sample mean − Negative
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4.7.2. Detection of the Polysaccharides Action Phase
DF-1 cells grown in 96-well plate were infected with 100 TCID50 of ALV-J. Then, they were treated
with MM containing polysaccharides at a final concentration of 1 mg/mL in different ways. According
to the artificially divided viral infection phase, the specific operations were as follows:
Before Adsorption (BA): The DF-1 cells were covered with MM containing polysaccharides for
2 h before the inoculation. After that, the cells were washed and then incubation with ALV-J for 2 h.
After inoculation, the cells were washed again and maintained with MM for 24 h.
Adsorption (Ad): The cells were treated with MM containing polysaccharides at the time they
were infected with ALV-J. After incubation at 4 ◦C for 2 h, the supernatant was removed and replaced
by simple MM.
After Adsorption (AA): The DF-1 cells were infected with ALV-J and incubated for 2 h, and then
the cells were washed and recovered with polysaccharides dissolved in MM.
The cell control and virus control were also served. After 24 h incubation, all of the supernatants
were collected and the viral titers were measured by ALV p27 antigen test kit.
4.7.3. Viral Gene Relative Expression and Protein Expression
DF-1 cells grown in 12-well plate to monolayers in simple MM medium were infected with
100 TCID50 of ALV-J and treated with MM containing polysaccharides at a final concentration of
1000 μg/mL, 200 μg/mL, and 40 μg/mL. After 2 h adsorption at 37 ◦C, the supernatant was discarded
and replaced by simple MM, then the cells were incubated at 37 ◦C with 5% CO2 for about 24 h.
Real-time PCR: The ALV-J gene replication levels in DF-1 cells were determined by real-time
PCR. In brief, RNAprep Pure Cell/Bacteria Kit (TIANGEN BIOTECH Co. Ltd., Beijing, China)
was used to extract the total RNA from the treated DF-1 cells following the manufacturer’s
instructions. Then, PrimeScriptTM RT reagent Kit with gDNA Eraser (Takara BIO INC, Dalian,
China) was applied for reverse transcription immediately. The cDNA produced by reverse
transcription was used for real-time PCR as performed by SYBR® Premix ExTaqTM Kit (Takara
BIO INC, Dalian, China). The forward primer (5′-GCGTGCGTGGTTATTATTTC-3′) and reverse
primer (5′-AATGGTGAGGTCGCTGACTGT-3′) were used as the ALV-J primers, the forward
primer for internal control GAPDH was (5′-GAACATCATCCCAAGCGTCCA-3′) and reverse primer
(5′-CGGCAGGTCAGGTCAACAAC-3′). The amplification cycles were carried out as follows: 95 ◦C
for 30 s; 95 ◦C for 5 s and 60 ◦C 34 s (34 cycles); 95 ◦C for 15 s and 60 ◦C for 60 s. The results were
calculated by the formula 2−ΔΔCt [54,55].
The expression of ALV-J gp85 protein was detected by western blot and IFA.
Western-blot: After 24 h incubation, the cells were lysed and separated by SDS-PAGE (12%
acrylamide gels). Proteins were blocked with Tris-buffered saline (TBS) buffer containing 5% (w/v) dry
skimmed milk, and 0.1% (v/v) Tween 20 for 1 h at room temperature. Membranes were then incubated
overnight at 4 ◦C with mouse ALV-J gp85-specific monoclonal antibody or β-tubulin antibody as
control. The membranes were washed with TBS-Tween and then incubated with HRP-linked secondary
antibody (1:10,000) for 1 h at room temperature. Membranes were washed and protein densities were
detected using chemiluminesence detection reagents.
IFA: After inoculation, the DF-1 cells were incubated at 37 ◦C with 5% CO2 for five days and then
IFA was executed as follows. The cells were fixed with cold acetone and ethanol (3:2 for v/v) for about
10 min washed with PBS and the gp85-specific monoclonal antibody was added. The mixture was
incubated overnight at 4 ◦C and washed thoroughly with PBS to eliminate the uncombined antibodies.
Afterwards, the cells were treated with goat anti-mouse IgG-FITC at 37 ◦C for 1 h, washed with PBS
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4.8. Statistical Analysis
Statistical analysis was performed using SPSS and the difference among groups was analyzed by
one-way ANOVA.
5. Conclusions
In this study, the polysaccharides (Mw 216 kDa) extracted from G. filicina were degraded by H2O2
oxidative method. The degradation rate was positively related to temperature, H2O2 concentration,
and negatively to high pH. Several LGFPs (Mw 40, 14, 8.7, and 2.7 kDa) were prepared under different
conditions and their anti-ALV-J activity were also investigated. The results showed that initial GFP
and LGFPs all possessed antiviral activity, and low Mw is better for the inhibition of ALV-J, LGFP-3
(Mw 8.7 kDa) had the best effect. The action phase of our samples was also determined. The results
showed that LGFP-3 were mainly take effect when treated by Ad administration the time that ALV-J
adsorbing on host cells. Further experiments indicated that after being treated with LGFP-3, the ALV-J
gene and protein expression decreased significantly: it revealed that LGFP-3 inhibited virus adsorption
onto DF-1 cells and contributed to the decrease of ALV-J expression. The results demonstrated that
polysaccharides from G. filicina have great potential in developing as an anti-ALV-J drug. However,
the antiviral activity of LGFPs in vivo and complicated mechanism in detail require further study.
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Abstract: A number of polysaccharides have been reported to show immunomodulatory and
antiviral activities against various animal viruses. AEX is a polysaccharide extracted from the
green algae, Coccomyxa gloeobotrydiformis. The aim of this study was to examine the function of
AEX in regulating the immune response in chickens and its capacity to inhibit the infectious bursal
disease virus (IBDV), to gain an understanding of its immunomodulatory and antiviral ability. Here,
preliminary immunological tests in vitro showed that the polysaccharide AEX can activate the chicken
peripheral blood molecular cells’ (PBMCs) response by inducing the production of cytokines and NO,
promote extracellular antigen presentation but negatively regulate intracellular antigen presentation
in chicken splenic lymphocytes, and promote the proliferation of splenic lymphocytes and DT40
cells. An antiviral analysis showed that AEX repressed IBDV replication by the deactivation of viral
particles or by interfering with adsorption in vitro and reduced the IBDV viral titer in the chicken
bursa of Fabricius. Finally, in this study, when AEX was used as an adjuvant for the IBDV vaccine,
specific anti-IBDV antibody (IgY, IgM, and IgA) titers were significantly decreased. These results
indicate that the polysaccharide AEX may be a potential alternative approach for anti-IBDV therapy
and an immunomodulator for the poultry industry. However, more experimentation is needed to
find suitable conditions for it to be used as an adjuvant for the IBDV vaccine.
Keywords: Coccomyxa; polysaccharide; IBDV; AEX; cytokine
1. Introduction
Polysaccharides present an enormous variety of structures in organisms and are an
under-exploited novel source of natural compounds for drug discovery. Plant and marine
microalgae-derived polysaccharides have been shown to have a variety of bioactivities, such
as immune-modulatory, anti-viral, anti-tumor, anticoagulant, and antioxidant properties [1].
The polysaccharide from Astragalus radix can increase the production of TNF, GM-CSF, and NO
in mice [2]. The sulfated polysaccharide, p-KG103, which is purified from the marine microalgae,
Gyrodinium impudium, can activate NO production in a JNK-dependent manner to stimulate the
production of cytokines, such as interleukin-1 (IL-1), IL-6, and TNF-α, in macrophages, thereby
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preventing tumor cell growth both in vitro and in vivo [3,4]. Polysaccharides are also crucial regulatory
factors for the adaptive immune response, especially humoral immunity. Jingjing Yang et al. reported
that a water-soluble polysaccharide (WSPA), which is isolated from the stem of Physalis alkelengi L.,
significantly enhanced specific antibody IgG titers in mice [5]. The polysaccharides derived from
Taishan Pinus massoniana pollen (TPPPS) also improved the effects of different vaccines when used as
an immunoadjuvant [6–8]. In addition, several types of polysaccharides (such as carrageenan, alginate,
fucan, laminarin, ulvan, dextran sulfate, heparin, and fucoidan (fuc)) possess a broad-spectrum of
antiviral activity in vitro against dengue virus, herpes simplex virus (HSV), human immunodeficiency
virus (HIV), and influenza virus by targeting several steps of the viral cycle [9–16].
Infectious bursal disease virus (IBDV) is the etiological agent of infectious bursal disease (IBD),
which is an acute, highly contagious disease in young chickens [17] that contributes to a huge economic
loss in the public poultry industry. IBDV is a non-enveloped, double-stranded RNA (dsRNA) virus
belonging to the Birnaviridae family [18–20]. IBDV infection causes a massive destruction of B cells
in lymphoid organs, resulting in lymphopenia (immunosuppression) [21]. This leads to an increased
susceptibility to secondary infection [22].
Coccomyxa gloeobotrydiformis is a species of green algae that was first isolated in 1969 by Reisigl [23].
It belongs to the family of Coccomyxaceae and distributes in Iceland, Himalayas, Japan, New Zealand
and Antarctica [24]. Previous studies have shown that Coccomyxa gloeobotrydiformis has a variety of
bioactivities in a rat model, such as neuroprotective effects in ischemic stroke [25], learning and memory
improvement effects in intrinsic aging rats [26], inhibitory effects in benign prostate hyperplasia [27],
and a protective effect in cerebral ischemia-reperfusion injury [28]. AEX is an acidic polysaccharide
isolated from Coccomyxa gloeobotrydiformi. Monosaccharide composition analysis revealed that AEX
contained galactose (Gal), mannose (Man), glucose (Glc), arabinose (Ara), xylose (Xyl) and rhamnose
(Rha) [29]. Takayuki Komatsu et al. have demonstrated that AEX possesses antiviral activity
against human influenza A virus infection in vitro [29]. However, its bioactivities, such as the
immunomodulatory and antiviral activities of AEX in chicken, are still unknown.
This study analyzed the in vitro effects of AEX on cytokine production in chicken PBMCs and
spleen lymphocytes, spleen lymphocyte proliferation, NO production and cytotoxicity. We also
evaluated the in vitro and in vivo effects of AEX on IBDV replication in the chicken bursa of Fabricius
and specific antibody levels in peripheral blood.
2. Results
2.1. Effects of AEX on Cytokine and NO Production in Chicken PBMCs
Cytokines play a critical role in innate immunity and adaptive activation during infection.
Inflammatory stimulation or cytokines can induce the expression of inducible nitric oxide synthase,
which uses NADPH, O2, and Arg to synthesize NO. To assess the effect of AEX on cytokine and NO
production in chicken PBMCs, the PBMCs were isolated from the peripheral blood of 4-week-old
SPF chickens and then treated with AEX, LPS, or PBS at the indicated concentrations. Inflammatory
cytokines (IFN-β, IL-1β, IL-6, TNF-α), T-helper cell differentiation cytokines (IL-10, IL-12p40), and
iNOS mRNA levels were analyzed by qRT-PCR. Figure 1A–D shows that AEX significantly increased
IL-1β, IL-6, and TNF-α mRNA levels in a dose-dependent manner but did not affect IFN-β, whereas
LPS increased IFN-β mRNA expression by 1.8-fold. As shown in Figure 1E,F, IL-10 and IL-12p40
mRNA levels were also remarkably increased by AEX in a dose-dependent manner. In addition,
the mRNA expression of iNOS was significantly increased by AEX (Figure 1G). Moreover, the NO
concentration analysis showed that AEX also induced NO production in a dose-dependent manner
(Figure 1H). These observations suggest that AEX can up-regulate various pro-inflammatory cytokines,
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Figure 1. Multiple cytokines and iNOS expression were upregulated and NO production were increased
by AEX in PBMCs. (A–G) PBMCs were isolated and cultured with AEX (0–100 μg/mL) or LPS
(100 ng/mL) for 24 h. Then total RNA was extracted and analyzed by qRT-PCR for IFN-β, IL-1β, IL-6,
TNF-α, IL-10, IL-12p40, and iNOS; (H) PBMCs were isolated and cultured with AEX (0–100 μg/mL)
or LPS (100 ng/mL) for 24 h and 48 h. Then, the culture supernatants were collected and nitrite
contents were determined by Griess reaction. Data represent means ± SEM from three wells per group.
* p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001. Results are representative of two independent experiments.
2.2. Effect of AEX on Gene Expression in Splenic Lymphocytes
As the major lymphoid organ for antigen presentation, the spleen contains a mass of DCs and T
and B lymphoid cells. To investigate the effect of AEX on inflammatory cytokines (IL-1β and IL-6),
major histocompatibility complexes (MHC I and MHC II), and T lymphocyte surface markers (CD3,
CD4, CD8) mRNA expression in chicken splenic lymphocytes, the lymphoid cells were isolated from
the chicken spleen and treated with AEX, LPS, or PBS at the indicated concentrations. As shown
in Figure 2A,B, AEX significantly increased IL-1β and IL-6 mRNA expression in a dose-dependent
fashion. MHC I mRNA levels were reduced by AEX treatment, whereas the expression of MHC II
was not (Figure 2C,D), implying that AEX may negatively regulate the antigen presentation of viral
infection between the antigen presenting cells (APCs) and the CD8+ T lymphoid cells. However, the
expression of CD3, CD4, and CD8 mRNA was not affected by AEX treatment (Figure 2E–G). These
data suggest that AEX can up-regulate inflammatory cytokines (IL-1β and IL-6) mRNA levels but
down-regulate MHC I expression.
2.3. Effect of AEX on Lymphocyte Proliferation
To assess the effect of AEX on lymphocyte proliferation, we isolated splenic lymphocytes
from 4-week-old SPF chickens and co-cultured them with AEX, Con A or PBS. The MTT assays
indicate that AEX only slightly promoted splenic lymphocyte proliferation at 24 h and 72 h,
but a significant promotion of proliferation was observed at 48 h in a dose-dependent manner
(Figure 3B). The lymphocyte proliferation assay was also performed on the DT40 cells (chicken
bursa of Fabricius derived cell line) and the peripheral blood lymphocytes. AEX significantly
promoted the proliferation of the DT40 cells (Figure 3A). However, the proliferation of peripheral blood
lymphocytes was reduced by AEX treatment in a dose-dependent manner (Figure 3C). Consistent
with the lymphocyte proliferation effect, AEX up-regulated IL-2 mRNA levels in chicken splenic
lymphocytes but down-regulated it in chicken peripheral blood lymphocytes (Figure 3D,E), suggesting
that AEX may promote splenic lymphocyte proliferation by up-regulating IL-2 expression and inhibit
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Figure 2. Inflammatory cytokines and surface molecules on splenic lymphocytes were regulated by
AEX. Splenic lymphocytes were isolated and cultured with AEX (0–100 μg/mL) or LPS (100 ng/mL)
for 24 h. Then, total RNA was extracted and analyzed by qRT-PCR for IL-1β (A), IL-6 (B), MHC I (C),
MHC II (D), CD3ε (E), CD4 (F), and CD8α (G). Data represent means ± SEM from three wells per
group. * p ≤ 0.05; ** p ≤ 0.01. Results are representative of two independent experiments.
Figure 3. AEX promoted DT40 and splenic lymphocytes proliferation, but reduced peripheral blood
lymphocyte proliferation in vitro. (A–C) DT40 cells, splenic lymphocytes and peripheral blood
lymphocytes were cultured in 96-well plates. After being stimulated by AEX (0–250 μg/mL) or
Con A (40 μg/mL) for 24 h, 48 h, and 72 h, respectively, the proliferation was examined by MTT
method as described in the Materials and Methods section; (D,E) Splenic lymphocytes and peripheral
blood lymphocytes were isolated and cultured with AEX (0–100 μg/mL) or LPS (100 ng/mL) for
24 h, respectively. Then, total RNA was extracted and analyzed by qRT-PCR for IL-2. Data represent
means ± SEM from three wells per group. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001. Results are representative
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2.4. In Vitro Anti-Viral Effect of AEX on the IBDV TS Strain Virus
First, we investigated the cytotoxicity of AEX on the metabolism of the Vero cells. The MTT assay
showed that there was no observable difference in the metabolic activity of the Vero cells treated with
62.5–1000 μg/mL of AEX and the untreated cells. However, at a concentration of 5000 μg/mL, the AEX
treatment reduced the relative metabolic activity by 62% (Figure 4A).
Figure 4. AEX inhibited IBDV replication by deactivating viral particle and interfering with adsorption.
(A) The Vero cells were treated with different concentrations of AEX for 24 h and cell viability was
measured by MTT assay; (B) The Vero cells infected with IBDV (MOI = 1.0) were treated with different
concentrations of AEX, and viral titers in the supernatant were identified by TCID50 assays on the Vero
cells. PBS treatment wells served as the control; (C,D) The Vero cells infected with IBDV (MOI = 1.0)
were treated with different concentrations of AEX, and immunofluorescence staining was performed
using anti-IBDV antibodies. (C) Scale bar represents 100 μm; (D) IBDV positive cells number was
calculated; (E) The Vero cells were incubated with IBDV (MOI = 1.0) for 1 h and treated with AEX at
the indicated time points (0, 2, 4, 24 h p.i.). Viral titers in the supernatant were determined by TCID50
assays on the Vero cells at 48 h p.i. (F) The Vero cells were infected with IBDV (MOI = 1.0) via different
polysaccharide treatment method (IBDV pretreatment, adsorption, and after adsorption) and viral
titers in the supernatant were determined by TCID50 assays on the Vero cells at 48 h p.i. Data represent
means ± SEM from three wells per group. * p ≤ 0.05; ** p ≤ 0.01. Results are representative of two
independent experiments.
Then, we tested the in vitro anti-IBDV activity of AEX on the Vero cells. The Vero cells were
first infected with the IBDV TS strain (MOI = 1.0) and then treated with compounds at the indicated
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cells were identified by PFU and IFA assays. As shown in Figure 4B–D, AEX significantly reduced
viral titers when used at a concentration greater than 100 μg/mL (p < 0.05). AEX reduced the IBDV
positive cell number from 250 (CTR) to 50 at a concentration of 250 μg/mL. Furthermore, the influence
of the treatment duration with AEX on IBDV multiplication was examined.
AEX was added to the Vero cells at different times after IBDV adsorption. As shown in Figure 4E,
the viral titers were decreased by AEX only when it was added to the Vero cells at 0 and 2 h, whereas
AEX showed no anti-IBDV effect when it was added at 4 and 24 h. Moreover, when IBDV was
pretreated with AEX, the inhibitory effect was more than 70%. However, there was less of an inhibitory
effect when AEX was added during adsorption (50%) or after-adsorption (50%) (Figure 4F). These data
indicate that the antiviral activity of AEX is largely related to its deactivation of viral particles and
inhibition of virus life-cycle early events that occur 0–2 h after adsorption.
2.5. In Vivo Anti-Viral Effect of AEX on the IBDV TS Strain Virus
To further explore the therapeutic potential of AEX, SPF chickens were infected with
105.5TCID50 of the IBDV TS strain and treated with AEX at the concentrations indicated in Figure 5.
Oral administration of AEX was started 24 h post infection and repeated once daily for 3 days. As
shown in Figure 5A,B, IBDV replicated efficiently in chicken bursa of Fabricius in the CTR group.
AEX slightly decreased VP2 mRNA expression at concentrations of 62.5 and 125 mg/kg body weight.
When 250 mg/kg body weight of AEX was used, VP2 mRNA was significantly reduced (Figure 5A).
The viral titer in the bursa of Fabricius detection also showed that AEX decreased the IBDV viral titer
at concentrations of 62.5 to 500 mg/kg body weight. (Figure 5B). 125 mg/kg body weight of AEX
decreased the viral titer from 105.5TCID50 (CTR) to 103.5TCID50. These data suggest that AEX can
suppress the replication of the IBDV TS strain in chicken bursa of Fabricius.
Figure 5. AEX inhibited IBDV replication in chicken bursa of Fabricius. SPF chickens (6 chickens per
group) were oral inoculated with different concentrations of AEX (0, 62.5, 125, 250 and 500 mg/kg
body weight) per day. After three days, chickens were eye-dropped with IBDV (105.5TCID50). Bursa
of Fabricius were collected at 5 d.p.i. and divided into two parts. (A) Half of the bursa of Fabricius
were grinded and virus titers were determined by TCID50; (B) The other half bursa of Fabricius were
subjected to isolate total RNA and the expression lever of IBDV VP2 was evaluated by qRT-PCR. Data
represent means ± SEM from five wells per group. * p ≤ 0.05; ** p ≤ 0.01. Results are representative of
two independent experiments.
2.6. Effect of AEX on Anti-IBDV Antibodies in Immunized Chickens
The B cells in chicken bursa of Fabricius are the major target of IBDV, which causes B cell apoptosis
and depletion in the bursa of Fabricius to repress humoral immunity. To investigate the regulation
of AEX on specific antibody titers against IBDV, we immunized SPF chickens with an intermediate
IBDV vaccine every two weeks for a total of three times and detected the IBDV antibody titers (IgY,
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titers significantly increased after the first and second immunization and peaked 14 days after the
secondary immunization. However, IgA antibody titers were only slightly increased after 7 days after
the secondary immunization. Surprisingly, the IgY and IgM antibody titers in the IBDV immunized
chickens were slightly decreased by AEX at concentrations from 12.5 to 50 mg/mL, and the IgY and
IgM antibody titers of the FA + 100AEX groups were significantly lower than those of the FA + IBDV
group (Figure 6A,B). In addition, AEX showed an inhibitory effect on the IgA antibody titers in a
dose-dependent manner (Figure 6C). These results suggest that in some case AEX may negatively
regulate specific antibody production when we immunized the chickens with live attenuated vaccines.
Figure 6. AEX reduced specific anti-IBDV antibody (IgY, IgM, and IgA) titers in the sera of chickens
immunized with IBDV. SPF chickens (6 chickens per group) were immunized with IBDV vaccine by
subcutaneous injection in the absence or presence of AEX (PBS used as control) thrice at a 14-day
interval. The sera were collected (14 days after the first immunization, 7 days and 14 days after
secondary immunization, and 7 days after tertiary immunization) and specific antibody (A) IgY;
(B) IgM; (C) IgA were detected by ELISA. Data represent means ± SEM from five wells per group.
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3. Discussion
AEX was previously reported to exert an antiviral effect on the influenza virus [29]. In this study,
we investigated the immunoregulatory effect of AEX on chicken immune cells and the antiviral effect
of AEX against IBDV, as well as the adjuvant effect of AEX.
Immunomodulators are natural or synthetic substances that regulate or modify the function
of the immune system [30]. According to their effects, Immunomodulators can be divided into
immunostimulants and immunosuppressants. It has been reported that many polysaccharides have
immunoregulatory activities [31]. Here, we observed that AEX significantly increased IL-1β, IL-6,
TNF-α, and iNOS mRNA levels, and promoted the secretion of NO in chicken PBMCs. The activation of
chicken PBMCs was characterized by the release of inflammatory cytokines and NO production [32–34],
which implied that AEX could effectively activate chicken PBMCs. So AEX is an immunostimulant.
Interestingly, though, the mRNA expression levels of IFN-β were not regulated by AEX. As IRF3
is a transcription factor essential for IFN-β [35], we theorize that it may not be involved in the AEX
receptor signaling pathway.
The activation of T cells generally requires a signal delivered by the interaction of the TCR
with a specific antigen on the MHC molecules (MHC I and MHC II). By interacting with CD8
molecules on surfaces of cytotoxic T cells, MHC I mediates the destruction of intracellular antigens,
especially virus infections, and establishes cellular immunity. MHC II mediates humoral immunity
by interacting with CD4 molecules on the surface of T-helper cells. In this study, the expression
of MHC I mRNA was down-regulated by AEX treatment whereas MHC II mRNA levels were
increased, which implies that AEX promotes extracellular antigen presentation but negatively regulates
intracellular antigen presentation.
Lymphocytes proliferate extensively before they differentiate into functional effector cells of
a particular specificity. Tang et al. demonstrated that Sophy β-glucans significantly improved the
lymphocyte proliferative response of duck PBMCs and potentially enhanced the cellular immune
response [36]. In the current study, the proliferation of both chicken primary splenic lymphocytes and
DT40 cells, which are a chicken bursa of Fabricius lymphoma cell line, was significantly improved by
AEX treatment. However, peripheral blood lymphocyte proliferation was decreased by AEX treatment.
Considering that DT40 is a B lymphocyte line and splenic lymphocytes consists of both B and T
lymphocytes [37], whereas most peripheral blood lymphocytes are T lymphocytes [38], AEX could
improve the B lymphocyte proliferation but suppress the proliferation of T lymphocytes.
Astragalus polysaccharides, fucoidan, rape pollen polysaccharide, epimedium polysaccharide,
and echinacea polysaccharide have been reported to show anti-IBDV activity and improve chicken
immune response [39–41]. Here, we observed that AEX showed an in vitro anti-IBDV effect, especially
when added at 0–2 h post infection or when pretreated with IBDV particles, which suggests that AEX
can inhibit replication by inactivating IBDV particles. Our in vivo anti-IBDV assay also indicated that
AEX can down-regulate IBDV VP2 mRNA expression and viral titers when AEX was delivered by
oral administration. Therefore, AEX could be a suitable alternative approach to therapy meant to
address anti-IBDV.
Immunomodulators are potential agents for improving poultry immunity and growth
performance [42]. Several glucans have been used as an adjuvant for vaccines [43–45].
Sulfated polysaccharides isolated from both Grateloupia filicina, Ulva pertusa and Sargassum qingdaoense,
could increase H9N2-specific antibody titers in the sera of mice immunized with inactivated avian
influenza virus [46]. Despite the fact that chicken PBMCs activation and lymphocyte proliferation
were improved by AEX treatment, specific antibodies against IBDV in the sera of immunized chicken
were decreased instead of showing improvement. That may due to the direct virucidal action of AEX.
The vaccine we used in this experiment is an intermediate vaccine which has the similar action as
normal IBDV. The AEX, as an effective virucidal substance, may affect the immunogenicity of the
vaccine particles or block its surface antigen, which results in lower specific antibodies titers. To
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antibody and the inhibition of vaccine particles, or we could inject AEX adjuvant before vaccines,
lowering the negative impact on vaccines activity. In addition, we suppose that AEX may be a good
choice as adjuvant for an inactivated IBDV vaccines.
4. Materials and Methods
4.1. Animals, Cells, Compounds and Reagents
Ten-day- and 4-week-old specific pathogen-free (SPF) White Leghorn chickens were purchased
from Meria (Meria, Beijing, China) and raised in a laboratory animal house. Peripheral blood
lymphocytes, spleen lymphocytes and DT 40 cells were maintained in RPMI-1640 medium (HyClone,
Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; HyClone, Logan, UT, USA) and 1%
antibiotics (Sigma, St. Louis, MO, USA). The Vero cells were purchased from ATCC and maintained
in DMEM medium (HyClone, Logan, UT, USA) supplemented with 10% FBS and 1% antibiotics.
The acidic polysaccharide of the Coccomyxa gloeobotrydiformis Nikken strain (AEX) was supplied by
the Nikken Sohonsha Corporation (Hashima, Gifu, Japan). LPS and Concanavalin A (Con A) were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
4.2. Cell Isolation
The peripheral blood collected from 4-week-old SPF chickens was diluted with Ca2+- and
Mg2+-free Hank’s balanced salt solution (1:1, vol/vol), carefully layered onto the Histopaque-1077
(Sigma) in 15 mL conical centrifuge tubes, and centrifuged at 400× g for 30 min at room temperature.
The lymphocyte layer was collected, washed 3 times in Hank’s solution, and spun at 250× g for 10 min.
Then, the cells were resuspended in RPMI-1640 medium containing 10% FBS and cultured for 2 h.
The suspension cells (peripheral blood lymphocytes) were collected and used for the lymphocyte
proliferation assay, whereas the anchorage-dependent cells (peripheral blood molecular cells) were
used for the cytokine and NO analyses.
The spleens from the 4-week-old SPF chickens, sacrificed under aseptic conditions, washed
with Hank’s solution and crushed to isolate the spleen cells. The spleen cell mass was passed
through a 200 mesh copper sieve to obtain a homogeneous cell suspension. Spleen lymphocytes were
isolated from the suspension using the same method as that used for the isolation of the peripheral
blood lymphocytes.
4.3. Lymphocyte Proliferation Assay
Isolated peripheral blood lymphocytes, spleen lymphocytes and DT 40 cells were resuspended in
RPMI-1640 medium containing 10% FBS and adjusted to 1 × 107 cells/mL. The lymphocytes were
distributed (100 μL per well) onto 96-well plates (Costar, Corning, Grand Island, NY, USA) and
treated with different concentrations of AEX (1, 10, 100, and 250 μg/mL) for 24 h, 48 h and 72 h,
respectively. Con A served as the positive control. Lymphocyte proliferation activity was tested by
a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT; Sigma, St. Louis, MO, USA)
assay [47]. 10 μL of PBS containing MTT (final concentration: 0.5 mg/mL) was added to each well.
After a 4 h incubation at 37◦C, the absorbance values were measured in a microplate reader (Bio-Rad,
Hercules, CA, USA) at 550 nm.
4.4. Nitric Oxide (NO) Production Assay
After a 24 h treatment with various concentrations of AEX, the culture supernatants of the PBMCs
were collected, and the nitrite contents were determined by the Griess reaction using the Griess Reagent
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4.5. qRT-PCR Analysis
Total RNA was first extracted from the AEX-treated PBMCs, spleen lymphocytes and bursa of
Fabricius using a TRIgene (GeneStar, Beijing, China) and treated with Dnase I (Promega, Madison, WI,
USA) to remove the DNA. Then, 1 μg of RNA was reverse-transcribed into cDNA using a GoScript
reverse transcription system (Promega, Madison, WI, USA) in a 20 μL reaction mixture. Quantitative
real-time PCR amplification was performed in 15 μL of the LightCycler® 480 SYBR Green I Master Mix
(Roche, Rotkreuz, Switzerland) with the LightCycler® 480 Real-time PCR System (Roche, Rotkreuz,
Switzerland). The individual primers used were designed by Primer Express 3.0 and are shown
in Table 1. The qRT-PCR was performed under the following cycling conditions: 95 ◦C for 10 min,
40 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min, and one cycle of 95 ◦C for 15 s, 60 ◦C for 15 s, 95 ◦C for
15 s and 40 ◦C for 30 s. The relative mRNA abundances were calculated using the 2−ΔΔCt method with
GAPDH as a reference and plotted as the fold changed relative to the control samples.
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4.6. Viruses and Infection
The IBDV Ts strain was amplified in the Vero cells, and the viral titers were determined as TCID50
by IFA on the Vero cells as previously described [50]. For the virus infection, the virus propagation
solution was diluted in DMEM and was added to the cells at the indicated multiplicity of infection
(MOI). The virus was allowed to adsorb for 1 h at 37 ◦C. After removing the virus inoculum, the
cells were maintained in infective media (DMEM) at 37 ◦C in 5% CO2. All of the experiments with
the IBDV Ts strain were performed under biosafety level 2 (BSL-2) conditions with investigators
wearing the appropriate protective equipment and complying with the general biosafety standards
for microbiological and biomedical laboratories of the Ministry of Health of the People’s Republic of
China (WS 233-2002).
4.7. Cytotoxicity Assay
Cell viability was measured by an MTT assay. The Vero cells were seeded into 96-well plates
(1 × 105 cells/well) overnight. Subsequently, the medium was supplied with different concentrations
of AEX or LPS. After a 24 h incubation at 37 ◦C and 5% CO2, 10 μL of PBS containing MTT (at a
final concentration of 0.5 mg/mL) was added to each well for 4 h. After 4 h of incubation at 37 ◦C,
the supernatant was removed, and 200 μL of DMSO was added to each well to solubilize the formazan
crystals. After a vigorous shaking, the absorbance values were measured in a microplate reader
at 570 nm.
4.8. Antiviral Assay (TCID50)
Antiviral activity was evaluated by the TCID50 assay in Vero cells. The Vero cells were incubated
with the IBDV at an MOI of 1 for 1 h at 37 ◦C and washed to remove the unbound virus; then,
the infecting media containing different concentrations of AEX was added to the cells, which were
incubated at 37 ◦C for 48 h. Subsequently, the supernatant was removed and collected, 10-fold serially
diluted, and incubated with the Vero cells for 36 h. The TCID50 was determined according to Reed and
Muench (1938) [51].
4.9. Immunization of SPF Chicken
Five-day-old SPF chickens were randomly divided into 6 groups (n = 6/group) and immunized
with different concentrations of AEX and IBDV live vaccine (strain B87, Lufang Biology, Yangling,
Shaanxi, China). Immunization of chickens with IBDV and AEX was performed as described
previously [52]. For the first injection, vaccine (following the dosing recommendations in the labeling)
and different doses of AEX (0, 12.5, 25, 50, 100 mg/mL) were solved in PBS and emulsified with an
equal volume of complete Freund’s adjuvant (FA, Sigma). Each chicken received 0.1 mL emulsion by
subcutaneous injection in the neck. Booster injections were given subcutaneously in the neck region
2 week and 4 week after the first injection respectively with the same dose emulsified with incomplete
FA (Sigma).
4.10. Measurement of Specific Antibody in the Sera of Immunized Chickens
The sera samples were collected from immunized chickens 14 days after the first immunization,
7 days and 14 days after the secondary immunization, and 7 days after the tertiary immunization. Then,
specific antibodies were detected by ELISA. Briefly, flat-bottom 96-well ELISA plates (Costar, Coring,
NY, USA) were coated with IBDV (TCID50 of 105.5/0.1 mL) in 0.05 mol/L carbonate-bicarbonate buffer
pH 9.6 for 24 h at 4 ◦C. The wells were washed three times with phosphate-buffered saline (PBS)
containing 0.05% (v/v) Tween 20 (PBST), and blocked with PBS containing 1% gelatin at 37 ◦C for 1 h.
After washing the wells with PBST three more times, 100 μL of a series of diluted sera from immunized
chickens or PBS containing 0.1% gelatin were added to the triplicate wells as control. The plates were
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IgG-HRP, IgM-HRP, and IgA-HRP (Cwbio, Beijing, China) (diluted 1:5000 with PBS containing 0.1%
gelatin, respectively) were added to each plate. The plates were further incubated for 1 h at 37 ◦C.
Substrate 3,3′,5,5′-tetramethylbenzidine (TMB) was added to each well after being washed with PBST,
and the plate was incubated for 10 min at room temperature. Reaction was terminated by adding 50 μL
of 2 mol/L H2SO4 to each well, and optical density (OD) was detected at 465 nm with a microplate
reader (Bio-Rad, Hercules, CA, USA).
4.11. Statistics
All data analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA). One-way
ANOVA was used to detect significant differences between compound-treated groups and control
groups. p values < 0.05 were considered significant. Data are presented as mean ± SEM from at least
three wells per group. Results are representative of two independent experiments.
4.12. Ethics Statements
This study was approved by the Laboratory Animal Care and Use Committee of the China
Agricultural University (Permit Number: SKLAB-2014-06-06). All efforts were made to minimize
animal suffering and the number of animals used.
5. Conclusions
In summary, our study first reported that AEX, derived from Coccomyxa gloeobotrydiformis, activates
chicken PBMCs by up-regulating cytokine and NO production, promotes chicken splenic lymphocyte
proliferation, and inhibits IBDV replication by interfering with the early events of IBDV replication
or inactivating IBDV particles in vitro and in vivo. AEX is a promising antiviral candidate for the
prevention or treatment of IBDV in the poultry industry. However, it has some limitations and still
needs more testing to find suitable conditions for use as an adjuvant for the IBDV vaccine.
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Abstract: A fucoidan extracted from Saccharina japonica was fractionated by anion exchange
chromatography. The most complex fraction F0.5 was degraded by dilute sulphuric acid and then
separated by use of an activated carbon column. Fraction Y1 was fractionated by anion exchange and
gel filtration chromatography while Fraction Y2 was fractionated by gel filtration chromatography.
The fractions were determined by ESI-MS and analyzed by ESI-CID-MS/MS. It was concluded that
F0.5 had a backbone of alternating 4-linked GlcA and 2-linked Man with the first Man residue from
the nonreducing end accidentally sulfated at C6. In addition, F0.5 had a 3-linked glucuronan, in
accordance with a previous report by NMR. Some other structural characteristics included GlcA 1→3
Man 1→4 GlcA, Man 1→3 GlcA 1→4 GlcA, Fuc 1→4 GlcA and Fuc 1→3 Fuc. Finally, it was shown
that fucose was sulfated at C2 or C4 while galactose was sulfated at C2, C4 or C6.
Keywords: ESI-CID-MS/MS; fucoidan; oligosaccharide; Saccharina japonica
1. Introduction
Fucoidan, which is a family of sulfated heteropolysaccharides extracted from brown algae and
invertebrates, has been increasingly studied because of its biological activity, including antitumor
activity [1,2], protective effects against γ-radiation-induced blood cell damage [3], antiangiogenic
activity [4], immunodulating activity [5], inhibition of colony formation in human melanoma and
colon cancer cells [6] and the most studied anticoagulant activity [7–11]. However, the relationships
between fucoidan structure and biological activity are poorly understood due to the complexity of
fucoidan structure. Research on structural features has traditionally been conducted using chemical
methods, such as methylation analysis and NMR [7,9,12]; however, structural characteristics are still
largely unknown. It has been reported that fucoidan contains two different main backbones, one made
up of (1→3)-linked fucopyranose residues with fucose branches [12] and another with repeating (1→3)
and (1→4) glycosidic bonds [13]. It was also demonstrated that the positions of the sulfate groups
and of the branching units, including fucose residues, sulfated fucose residues, galactose residues and
glucuronic acid residues, were different. These results are similar to previous studies [14,15].
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Sulfated and fucosylated glucuronomannan was also found in Kjellmaniella crassifolia and
investigated by Sakai et al. [16]. Later, it was reported [17] that fucoidan extracted from Hizikia
fusiforme was composed of →2) α-D-Man (1→ and →4) β-D-GlcA (1→ alternatively while slight →4)
β-D-Gal (1→ was mixed in the main chain. The branched points were at C-3 of →2) α-D-Man (1→,
C-2 of →4) β-D-Gal (1→ and C-2 of →6) β-D-Gal (1→. About 2/3 of fucose were at the nonreducing
ends, and left of them were 1→4, 1→3 and 1→2 glycosidic linkages. About 2/3 of xylose were at
the nonreducing ends, and left of them were 1→4 glycosidic linkage. It was sulfated at C-6 of →2,3)
α-D-Man (1→, C-4 and C-6 of →2) α-D-Man (1→, C-3 of →6) β-D-Gal (1→, C-2, C-3 or C-4 of fucose,
while some fucose had two sulfate groups. In addition, Bilan et al. [12] also found the existence of
glucuronomannan in Saccharina latissima.
However, mass spectrometry (MS) applied to the structural analysis of saccharides has allowed
the determination of minor structural components. Along with NMR spectroscopy, electrospray mass
spectrometry (ESI) and Matrix-Assisted Laser Desorption/Ionization Time of Flight mass spectrometry
(MALDI-TOF) have become primary analytical tools, providing high sensitivity and selectivity. In
addition, electrospray mass spectrometry in tandem with collision-induced dissociation tandem
mass spectrometry (ESI-CID-MS/MS) has yielded information on the type of linkages, sulfation,
and the backbone sequences of saccharides. Through electrospray ion trap mass spectrometry
and capillary electrophoresis, it has been possible to differentiate the three isomers 2-O-, 3-O- and
4-O-sulfated fucose [18]. Finally, oligosaccharide mixtures derived from sulfated carrageenan-derived
oligosaccharides [19] and fucoidan of Ascophyllum nodosum [20], Fucus evanescens [13] and Laminaria
cichorioides [21] have been analyzed by ESI-CID-MS/MS to elucidate the structural features of
oligosaccharides. Recently, it was reported [22] that a fucoidan isolated from Hizikia fusiforme
was analyzed by partial acid hydrolysis followed by characterization of the oligosaccharide fragments
using ESI-CID-MS/MS.
This study is also dedicated to structural characteristics of fucoidan extracted from Saccharina
japonica using NMR, ESI-MS and ESI-MS/MS.
2. Results and Discussion
2.1. Preparation of Fucoidan and Oligosaccharides
In this paper, we separate three fractions. With respect to monosaccharide and sulfate content
(Table 1), the first fraction (F0.5) contained a large amount of uronic acid and a small amount of
sulfate while the subsequent two fractions (F1 and F2) contained trace amounts of uronic acid and
large amounts of sulfate. In other words, F0.5 consisted mainly of sulfated fucomannoglucuronan
whereas F1 and F2 consisted mainly of sulfated galactofucan and sulfated fucan. To further study
its structure, F0.5 was degraded with 4% sulphuric acid, and the resulting mixture separated by
95% ethanol precipitation and ran through the activated carbon column to yield two main fractions,
Y1 and Y2. Y1 was fractioned by anion exchange chromatography to produce three fractions: YF
(water), YD (0.05 M NaCl) and YT (0.1 M NaCl). Fraction YD and YT were purified by gel filtration
chromatography with an elution of water (Supplementary data). YD had two peaks named YD-1
and YD-2 while YT showed a symmetric peak. In addition, Y2 was presumed to be a mixture of
neutral oligosaccharides, it was immediately fractionated by gel filtration chromatography to yield six
fractions: G1–G6 (Figure 1). The molecular weight and degree of polymerization (DP) of all fractions
were determined by negative-ion ESI-MS. The apparent structural composition of each fraction is
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Table 1. Chemical composition (%, dry weight) of the degraded polysaccharides.
Sample Fuc (%) U A (%) SO4 (%)
Monosaccharides (molar ratio)
Mw
Fuc Gal Man Glc A Rha Xyl Glc
F0.5 13.77 20.34 29.07 1 0.98 0.80 0.95 0.12 0.30 0.40 5954
F1 54.84 7.3 32.26 1 0.36 0.13 0.10 0.02 0.04 0.10 8436
F2 35.04 0.71 53.40 1 0.07 0.03 0.01 0 0 0.02 12586
YF - - - 1 0.43 0.32 0.28 0.41 0 0.26 -
YD-1 - - - 0 1.10 11.14 12.59 0.17 0 1.08 -
YD-2 - - - 1 0.28 3.53 1.96 0 0 0.29 -
YT - - - 0 0 8.21 9.30 0 0 1.48 -
G5 - - - 1 0.11 0.02 0 0 0 0.07 -
G6 - - - 1 0.04 0 0 0 0 0.05 -
 
Figure 1. Gel filtration chromatography of Y2 oligosaccharide on a Bio-Gel P-4 Gel column.
Table 2. Structural compositions of all fractions separated from degraded F0.5.
Samples DP Ions (charges) m/z Predicted structural
compositions
YF
1 193.035(−1) 193.035 GlcA
2 355.086(−1) 355.086 GlcAMan
2 369.065(−1) 369.065 GlcA2
2 339.091(−1) 339.091 GlcAFuc
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Table 2. Cont.














4 386.059(−2) 773.117 GlcA2Man2SO3H
6 515.123(−2) 1031.249 GlcA3Man3
YD-2
1 193.035(−1) 193.035 GlcA
1 243.017(−1) 243.017 FucSO3H
1 259.012(−1) 259.012 GalSO3H
2 339.231(−1) 339.231 GlcAFuc
2 355.086(−1) 355.086 GlcAMan
2 217.072(−2) 435.033 GlcAManSO3H
YT
2 217.072(−2) 435.033 GlcAManSO3H
3 257.037(−3) 545.096 GlcA3
3 305.033(−2) 611.068 GlcA2ManSO3H
4 386.059(−2) 773.118 GlcA2Man2SO3H












G4 2 355.086(−1) 355.086 GlcAMan
2.2. Analysis of the Oligosaccharides of All Fractions by ESI-MS
YF was obtained by anion exchange chromatography on a DEAE-Bio Gel Agarose FF gel with
elution by water. Thus YF was a mixture of neutral oligosaccharides, which was approved by the













Figure 2. Negative-ion mode electrospray mass spectrometry (ESI-MS) spectra of YF (a), YD-1 (b),
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In the ESI-MS spectrum of YD-1 (Figure 2b), there were six apparent structural compositions
(GlcA2, GlcAManSO3H, GlcA2Man, GlcA2Man2, GlcA2Man2SO3H and GlcA3Man3) corresponding
to the ions at m/z 184.032 (−2)/369.065 (−1), 217.017 (−2), 265.055 (−2)/531.117 (−1), 346.081
(−2)/693.170 (−1), 386.059 (−2) and 515.123 (−2), respectively. Six ions at m/z 193.035, 243.017, 259.012,
339.231, 355.086 and 435.033 were detected in the ESI-MS spectrum of YD-2 (Figure 2c), suggesting the
presence of GlcA, FucSO3H, GalSO3H, GlcAFuc, GlcAMan and GlcAManSO3H, respectively. Inference
of structural composition was based on the analysis of the molar ratio of monosaccharide (Table 1).
Interestingly, the main fraction of YD-2 was FucSO3H while the main fraction of YD-1 was GlcA2Man2;
these data might suggest that the eluting power of 0.05 M NaCl (Fraction YD) was equivalent to
the substances containing one sulfate group (such as FucSO3H) or two uronic acid residues (such as
GlcA2Man2).
Our data further suggested that the eluting power of 0.1 M NaCl (Fraction YT) was equivalent
to the substances consisting of two sulfate groups (such as Fuc(SO3H)2), one sulfate group and two
uronic acid residues (GlcA2ManSO3H) or four uronic acid residues (GlcA4). In the ESI-MS spectrum of
fraction YT, the main ion at m/z 386.059 (−2) (Figure 2d) was identified as GlcA2Man2SO3H while the
less intensive ions detected at m/z 217.017 (−2), 257.037 (−3), 305.033 (−2), 386.059 (−2), 474.073 (−2),
369.731 (−3)/555.101 (−2) corresponded to GlcAManSO3H, GlcA3, GlcA2ManSO3H, GlcA2Man2SO3H,
GlcA3Man2SO3H, and GlcA3Man3SO3H, respectively. These results helped us to confirm the above
speculation. The absorptive capacity of the DEAE-Bio Gel Agarose FF gel permitted detection of ions
at m/z 386.059 (−2) (Figure 2b,d).
Y2 was fractionated by gel filtration chromatography to obtain six fractions (G1–G6). The results
(Figure 3) of HPLC analysis confirmed that G1, G2, G3 and G4 were relatively pure. Fractions G1, G2,
G3 and G4 were identified by NMR (supplementary data) as a series of oligosaccharides consisted of a
repeating disaccharide unit of GlcA and Man. The degrees of polymerization (DP) of each fraction
were 8, 6, 4 and 2, respectively (Figure 3). The results suggest that the bonds between mannose and
glucuronic acid were stable against the acid condition and that F0.5 had a backbone of –[Man-GlcA]n–.
Owing to the separation of gel filtration chromatography, it was indicated that Fraction G5 consisted
of disaccharides and monosaccharides while G6 consisted mainly of fucose and a smaller quantity of
galactose and glucose (Table 1). To further study the exact structural features of F0.5, some samples














Figure 3. Negative-ion mode ESI-MS spectra and HPLC spectra of G1 (d,D-1), G2 (c,C-1), G3 (b,B-1)
and G4 (a,A-1).
2.3. Analysis of the Structural Features of the Fractions by ESI-CID-MS/MS
The 0,2X (m/z 138.970) and 0,2A (m/z 182.996) ions indicated sulfation of Fuc at C2 or C4 in the
ESI-CID-MS/MS spectrum of the ion at m/z 243.017 (not shown), whereas the 0,2A (m/z 198.991), 2,5A
(m/z 180.980) and 0,3A (m/z 168.981) ions suggested sulfation of Gal at C4 or at C6 in the ESI-CID-MS/MS
spectrum of the ion at m/z 259.011 (not shown).
In fraction G5, the ion at m/z 309.112 (Figure 4), corresponding to [Fuc2 − H]− (supplementary
data), was detected. The ions at m/z 145.048 and 163.058 were assigned as B1/Z1 and C1/Y1,
respectively. The low intensity fragmentation ion at m/z 249.093 was 0,2A2, suggesting the prevalence
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confirmed by previous study [15]. Therefore, the ion (m/z 309.112), corresponded to disaccharide,
was major Fuc 1→3 Fuc and minor Fuc 1→4 Fuc.
 
Figure 4. Negative-ion mode electrospray mass spectrometry in tandem with collision-induced
dissociation tandem mass spectrometry (ESI-CID-MS/MS) spectrum of the ion at m/z 309.112.
The ion detected at m/z 339.230 (Figure 5) confirmed that the oligosaccharides with the GlcA
residue were more stable in the acid condition. The C1 (m/z 163.112) and Y1 (193.034) ions corresponded
to Fuc and GlcA residues, respectively. The characteristic ion at m/z 235.044, assigned to the 0,2X1
ion, suggested that the reducing terminal was a GlcA residue. Therefore, the ion at m/z 339.230 was
Fuc-GlcA. In addition, the 2,5A2 (m/z 261.060) and 0,2A2 (m/z 279.070) ions indicated that the linkage
between the Fuc and GlcA residues was a 1→4 linkage. Moreover, we could also speculate that the
ions at m/z 163.112 (Y1), 175.024 (B1), 193.034 (C1) and 235.044 (0,2A2) suggested that the structural
feature of the ion at m/z 339.230 was GlcA 1→2 Fuc.
 
Figure 5. Negative-ion mode ESI-CID-MS/MS spectrum of the ion at m/z 339.230.
The ions at m/z 193.035, 184.032 (−2)/369.065 (−1) and 257.037 (−3) corresponded to GlcA, GlcA2
and GlcA3, suggesting the presence of glucuronan. To elucidate the fine structure of glucuronan,
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Y/Z-type ions suggested that glucuronan was a trisaccharide with GlcA-GlcA-GlcA. The low intensity
characteristic ions at m/z 309.043 and 485.075, corresponding to 0,2A2 and 0,2A3 ions, respectively,
indicated the prevalence of a 3-linked GlcA. These data suggest a backbone of 1→3 linked glucuronan.
 
 
Figure 6. Negative-ion mode ESI-CID-MS/MS spectra of the ions at m/z 545.096 (a) and 531.117 (b).
The analyses of glucuronomannan and sulfated glucuronomannan suggest that the linkage of
1→4 was more sensitive in the acid condition than that of linkage of 1→2. However, we also detected
the less intensive ion at m/z 531.117 (Figure 6b), assigned as [GlcA2Man − H]−. The ions at m/z 175.024
and 193.034 are indicative of dehydrated GlcA and GlcA residues from the nonreducing or reducing
end, corresponding to the B1/C1-type or Z1/Y1-type ions, respectively. The 0,2X1-type ion suggests
that the reducing end consisted of a GlcA residue. However, we found two 0,2X2-type ions at m/z
397.096 and 411.075, named 0,2X2 and 0,2X2, respectively, which suggests two structural sequences of
trisaccharide. As the 0,2X1-type ion suggests a reducing end of GlcA residue, we conclude that one
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confirmed by the presence of the ion at m/z 351, corresponding to a Z2-type ion. The ions at m/z 337.075
and 355.086 were identified as B2/Z2-type and C2/Y2-type ions, respectively. The characteristic ions
at m/z 453.086 and 471.096 corresponded to 2,5A3-type and 0,2A3-type ions, respectively, suggesting
that the two residues from reducing terminal had a 1→4 glycosidic bond. 0,2A2-type ions were not
found, indicating that the two residues from the nonreducing terminal had a 1→3 glycosidic bond.
In summary, the two structural sequences of trisaccharide were Man 1→3 GlcA 1→4 GlcA and GlcA
1→3 Man 1→4 GlcA.
The fragmentation pattern of ions at m/z 355.086, 346.082 (−2) /693.173 (−1) and 1369.333 (not
shown) were similar to that of the ion at m/z 343.081 (−3)/ 515.125 (−2)/ 1031.249 (−1) (Figure 7a).
The fragment ion at m/z 1031 corresponded to [GlcA4Man4 − H]−. The ions at m/z 175.024 and 193.249
were the characteristic fragments, corresponding to fragment B1 ion and C1 ion, respectively. The
results suggest that the nonreducing terminal was a GlcA residue. Two series of B-type and C-type
ions from the nonreducing end were found with Y-type and Z-type ions from the reducing end; this
pattern confirmed a linear backbone of alternating GlcA and Man. In addition, the characteristic ions
of 0,2A-type were detected. However, the ions at m/z 235 and 573 do not appear in (Figure 7a) because
of their lower intensity. The 0,2A-type [23] ions were the cross-ring cleavage by releasing the C1-C2
portion of the reducing-ring, leading to the loss of C4H8O4 at m/z 120. However, no characteristic ion of
0,2A-trpe was detected. And there was no information obtained regarding the linkage of GlcA residue
in the spectra of ESI-CID-MS/MS. The linkage of GlcA residue was therefore determined by NMR
(supplementary data) and confirmed the results of ESI-CID-MS/MS. Finally, it was concluded that
F0.5 had a backbone of repeating 4-linked GlcA and 2-linked Man, in accordance with Bilan et al. [12]
and Sakai et al. [16].
Bilan et al. [12] also reported the presence of sulfated glucuronomannan. YT was primarily
composed of a sulfated tetrasaccharide. The ion at m/z 555.100 (−2) corresponded to [GlcA3Man3SO3H
− H]− (Figure 7b). The ions at m/z 175.024 and 193.034 were identified as dehydrated GlcA and GlcA
residues, suggesting that the nonreducing end was GlcA residue. The reducing terminal was identified
as Man based on the presence of ions at m/z 931.131/465.069 (−2) and 474.072 (−2), assigned as B5
and C5, respectively. A series of B-type ions at m/z 175.024 (B1), 417.022 (B2), 377.045 (−2) (B4), 931.131
(B5) along with C-type ions at m/z 193.034 (C1), 773.111 (C4) indicated that the linear sequence was
GlcA-ManSO3H-GlcA-Man-GlcA-Man. The ion at m/z 259.011 (ManSO3H) was also confirmed in the
above analysis. The ions at m/z 513.102 (B’3), 693.161 (C’4) and 851.173 (B’5) suggested that the sulfate
group was lost whereas the ions at m/z 407.055 [(0,2A6-GlcA)2−] and 597.077 (C4-GlcA) suggested that
the GlcA residue from the nonreducing end was sensitive in the negative mode. The characteristic
ion at m/z 495.079 (−2) was detected, suggesting that the glycosidic bond between the GlcA and Man
residues was 1→2 linkage. However, the ion at m/z 326 (−2) did not appear due to its low intensity.
Although the linkage of the Man residue was identified as a 2-linked Man, the linkage of the GlcA
residue was not determined by ESI-CID-MS/MS. With the assistances of NMR (supplementary data)
and the above results, the linkage of the GlcA residue was determined to be a 4-linked GlcA and the
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3. Experimental Section
3.1. Materials
The brown algae S. japonica was obtained from Shazikou, Qingdao, China in May 2011. Seven
standard monosaccharides (L-fucose (Fuc), D-galactose (Gal), D-mannose (Man/M), D-glucuronic acid
(GlcA), L-rhamnose monohydrate (Rha), D-xylose (Xyl) and D-glucose (Glc)) were purchased from
Sigma-Aldrich. 3-Methyl-1-phenyl-2-pyrazolin-5-one (99%) was purchased from Aldrich chemistry.
3.2. Preparation and Purification of Fucoidans
Crude fucoidan was extracted following Wang et al. [14] and degraded using hydrogen dioxide
and ascorbic acid to obtain a fucoidan of low molecular weight. Briefly speaking, crude fucoidan
(1 g) was dissolved in water (100 mL). Then ascorbic acid (0.5 g) and hydrogen dioxide (0.3 mL)
were added and the solution was stirred for 1 h at room temperature. Then, it was ultrafiltrated,
concentrated and precipitated by 72% ethanol before further precipitation with 95% ethanol. Finally,
the degraded polysaccharides were dried by using an infrared lamp. The degraded polysaccharides
(60 g) underwent anion exchange chromatography on a DEAE-Bio Gel Agarose FF gel (12 cm × 70 cm)
with elution by 0.5 M (35L) (F0.5), 1 M (35L) (F1) and 2 M NaCl (35L) (F2). The polysaccharides were
then ultrafiltrated, concentrated and precipitated by 72% ethanol before further precipitation with 95%
ethanol. Finally, the F0.5, F1 and F2 factions were dried by using an infrared lamp.
3.3. Preparation and Purification of Oligosaccharides from F0.5
Polysaccharide F0.5 was dissolved with reflux in 4% sulphuric acid (60 mg mL−1) for 5 h and then
neutralized with barium hydroxide after cooling to room temperature. The solution was centrifugated
and the supernate was concentrated. The concentrated solution was fractionated using the activated
carbon column (2.6 cm × 30 cm) with a gradient elution from 50% ethanol to 95% ethanol. Then, eluent
(Y1) was concentrated and precipitated in 95% ethanol. The activated carbon column was washed with
a gradient elution from 50% ethanol to 95% ethanol. The elution (Y2) was combined, concentrated
and freeze-dried. Y1 (1.0 g) was separated by anion exchange chromatography on a DEAE-Bio Gel
Agarose FF gel (2.6 cm × 30 cm) with elution by water (YF), 0.05 M NaCl (YD) and 0.1 M NaCl (YT).
The concentrated solutions of fractions YD and YT were desalted and separated on a Sephadex G-10
column (2.6 cm × 100 cm) with an elution of water. Y2 (0.5 g) was separated on a Bio-Gel P-4 Gel (Extra
Fine, <45 μM) column (2.6 cm × 100 cm) (Figure 1) eluted with 0.5 M NH4HCO3 at a flow rate 0.14 mL
min−1. It was collected every 14 min per pipe after 27 h. Six fractions were collected and lyophilized.
3.4. Composition Analysis
The sulfated content was determined by ion chromatography on Shodex IC SI-52 4E column
(4.0 × 250 mm) eluted with 3.6 mM Na2CO3 at a flow rate of 0.8 mL min−1 at 45 ◦C. The molar ratio of
monosaccharide composition and the content of fucose were determined following Zhang et al. [24].
Briefly speaking, a solution of sample (10 mg mL−1) was hydrolyzed in 2 M trifluoroacetic acid in
a 10 mL ampoule. The ampoule was sealed in a nitrogen atmosphere and hydrolyzed for 4 h at
110 ◦C. Then the hydrolyzed mixture was neutralized to pH 7 with sodium hydroxide. Later the
mixture was converted into its 1-phenyl-3-methyl-5-pyrazolone derivatives and separated by HPLC
chromatography. Uronic acid was analyzed by a modified carbazole method [25]. Molecular weight
was determined by GPC-HPLC on TSK gel PWxl 3000 column (7 μm 7.8 × 300 mm) eluted with 0.2 M
Na2SO4 at a flow rate of 0.5 mL min−1 at 30 ◦C.
3.5. MS Analysis of Oligosaccharides
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Samples were dissolved in CH3CN-H2O (1:1, v/v). Mass spectra were registered in the negative
ion mode at a flow rate of 5 μL min−1. The capillary voltage was set to −3000 V, and the cone voltage
was set at −50 V. The source temperature was 80 ◦C, and the desolvation temperature was 150 ◦C. The
collision energy was optimized between 10 and 50 eV. All spectra were analyzed by MassLynx software.
3.6. Condition of HPLC
The fractions were analyzed by HPLC with an ELSD detector, performed on a “click” maltose
column (10 μm, 10 × 150 mm) at 1 mL min−1 in a gradient solution. Gradient 1: 0–30 min,
water-acetonitrile-ammonium formate buffer (100 mM, pH 3.0): 10:80:10 (v/v/v)→40:50:10(v/v/v).
Gradient 2: 30–35 min, water-acetonitrile-ammonium formate buffer (100 mM, pH 3.0): 40:50:10
(v/v/v)→75:15:10(v/v/v).
4. Conclusions
To further determine the precise structure of F0.5, it was degraded with partial acid hydrolysis
(due to the absence of available enzymes). The depolymerized mixture was then separated by use of
an activated carbon column. Y1 was purified using anion exchange and gel filtration chromatography
while Y2 was purified using gel filtration chromatography. The results suggest that F0.5 consisted of
two types of polysaccharides: (1) a glucuronomannan and a sulfated glucuronomannan with the same
backbone of repeating 4-linked GlcA and 2-linked Man, and the latter with the first mannopyranose
residue from the nonreducing terminus sulfated at C-6 and (2) a glucuronan with a backbone of
3-linked GlcA. There were also some other structural fragments, including GlcA 1→3 Man 1→4 GlcA,
Man 1→3 GlcA 1→4 GlcA, Fuc 1→4 GlcA and Fuc 1→3 Fuc. Combined with the results obtained
in this study and a previous study [15], it was concluded that it might provide the whole structural
model of fucoidan.
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Abstract: Two polysaccharides, named KCA and KCW, were extracted from Kjellmaniella crassifolia
using dilute hydrochloric acid and water, respectively. Composition analysis showed that these
polysaccharides predominantly consisted of fucose, with galactose, mannose and glucuronic
acid as minor components. After degradation and partial desulfation, electrospray ionization
mass spectrometry (ESI-MS) was performed, which showed that the polysaccharides consisted
of sulfated fucooligosaccharides, sulfated galactofucooligosaccharides and methyl glycosides of
mono-sulfated/multi-sulfated fucooligosaccharides. The structures of the oligomeric fragments were
further characterized by electrospray ionization collision-induced dissociation tandem mass spectrometry
(ESI-CID-MS2 and ESI-CID-MS3). Moreover, the activity of KCA and KCW against the hemolytic
activity of both the classical and alternative complement pathways was determined. The activity of
KCA was found to be similar to KCW, suggesting that the method of extraction did not influence the
activity. In addition, the degraded polysaccharides (DKCA and DKCW) displayed lower activity levels
than the crude polysaccharides (KCA and KCW), indicating that molecular weight had an effect on
activity. Moreover, the desulfated fractions (ds-DKCA and ds-DKCW) showed less or no activity, which
confirmed that sulfate was important for activity. In conclusion, polysaccharides from K. crassifolia may
be good candidates for the treatment of diseases involving the complement pathway.
Keywords: polysaccharide; Kjellmaniella crassifolia; anti-complement
1. Introduction
Kjellmaniella crassifolia is a brown alga that is widely distributed in the waters around the
southern area of Hokkaido, Japan. Compared to other seaweeds, K. crassifolia contains high levels of
polysaccharides (fucoidan) and the water extract shows very high viscoelasticity. The polysaccharide
extract from K. crassifolia is an effective immunomodulator and a potent immune adjuvant [1,2].
The structural features of the polysaccharide (fucoidan, not alginate) from K. crassifolia have been
previously analyzed by extracellular enzyme assays [3] and NMR [4]. The former reported that
the novel polysaccharide was fucoglucuronomannan, with a backbone consisting of alternating
4-linked GlcA and 2-linked Man, and was branched at the C-3 position of mannose by a fucopyranose
residue. The latter study suggested that the polysaccharide was sulfated fucan, with a backbone of
3-linked fucopyranose sulfated at C-2 and C-4. Because of its accuracy, sensitivity and selectivity,
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mass spectroscopy (MS) with electrospray ionization (ESI-MS) is an important tool for the analysis
of polysaccharides; this technique has been used to successfully elucidate the structures of other
heteropolysaccharides [5–7].
The complement pathway is an important part of the immune system, playing an essential
role in host defense against pathogens. However, inappropriate activation of the complement
pathway has been implicated in certain diseases, such as rheumatoid arthritis, Alzheimer’s disease,
ischemia-reperfusion injury and systemic lupus erythematosus [8]. Polysaccharides from alga
were non-toxic. Numerous natural or semi-synthetic polyanions, such as derivatized dextran,
chondroitin sulfate, dextral sulfate, fucoidan and heparin, have been reported to inhibit complement
activation [9–14].
Recently, K. crassifolia was introduced into the Rongcheng coastal area in Shandong Province,
China. Thus, in the present study, the structural features of the polysaccharides from K. crassifolia
cultured in Rongcheng were elucidated by ESI-MS, ESI-CID-MS2 and ESI-CID-MS3, and the
potential activity of the polysaccharides against the classical and alternative complement pathways
were investigated.
2. Results and Discussion
2.1. Preparation of Polysaccharides
The molar ratios of monosaccharides, contents of uronic acid (UA), fucose (Fuc) and sulfate,
and average molecular weights of all samples are shown in Table 1. KCA and KCW were found to
contain high levels of Fuc together with a small amount of mannose (Man), glucuronic acid (GlcA)
and galactose (Gal). With respect to the contents of sulfate and Fuc, KCA contained a higher amount
than KCW. In addition, the molecular weight of KCW was higher than KCA, suggesting that KCA
degraded slightly during the extraction process. Only trace contents of UA and protein were found.
Interestingly, the molecular weight of DKCA was higher than DKCW, indicating that KCW was more
sensitive to degradation. Desulfation resulted in a substantial decrease in the molecular weights for
both ds-DKCW and ds-DKCA, indicating that the parent compounds were likely to be highly sulfated.
In addition, the ratios of other monosaccharides, such as rhamnose (Rha), glucose (Glc) and xylose
(Xyl), were increased.
Table 1. Chemical composition (%, dry weight) of KCA, KCW and their derived fractions.
Sample Total Sugar Fuc (%) UA (%) SO4 (%) Protein (%)
Monosaccharides (Molar Ratio)
Mw (kDa)
Man Rha GlcA Glc Gal Xyl Fuc
KCW 58.06 37.07 – 24.21 0.45 0.12 0.05 0.09 0.06 0.08 0.02 1 168.7
DKCW 53.56 30.75 – 22.52 0.74 0.12 0.10 0.12 0.06 0.06 – 1 5.2
ds-DKCW 82.42 38.79 3.72 8.93 1.22 0.23 0.11 0.19 0.16 0.21 0.20 1 3.5
KCA 53.40 40.43 – 35.49 – 0.05 0.02 0.06 0.02 0.03 0.02 1 153.7
DKCA 45.76 35.87 – 32.37 – 0.04 0.04 0.05 0.02 0.02 – 1 9.7
ds-DKCA 65.58 48.97 3.51 12.72 0.77 0.13 0.05 0.12 0.27 0.14 0.03 1 2.3
2.2. IR Analysis
The IR spectra (Figure 1) showed that KCA, DKCA, KCW and DKCW had the same infrared
absorption properties, suggesting that they contained the same functional groups. The band at 1260
cm−1 corresponded to the S=O stretching vibration, and the band at approximately 845 cm−1 was
assigned to the C–O–S vibration, suggesting that the presence of the sulfate group was mainly at the
C-4 axial position on fucose [15–17]. Thus, it was concluded that KCW and KCA were mainly sulfated
at C-4 on fucose. After desulfation, the intense band at 1260 cm−1 vanished, indicating that ds-DKCW
and ds-DKCA lost a high amount of sulfate during the process of desulfation, which was confirmed by
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Figure 1. The IR spectra of polysaccharides.
2.3. MS Analysis of Structure
MS is an important tool for the analysis of heteropolysaccharides because of its speed and
sensitivity. Though there have been many studies on the structural features of heteropolysaccharides [5,
6,18–23], it was previously not possible to analyze heteropolysaccharides that contained large, highly
charged molecules. Thus, heteropolysaccharides needed to be degraded. The ESI-MS spectrum of
ds-DKCW determined in the present study was shown in Figure 2a. There were five types of fragment
ions. The most intense peaks at m/z 257.042, 403.103, 549.164, 695.226, 841.288, 987.350 and 1133.415
were determined to be [MeFucnSO3Na-Na]− (n = 1–7). The less intense fragment ions at m/z 389.089,
535.148, 681.210, 827.272 and 973.333 revealed a distribution of singly charged ions, corresponding
to sulfated fucooligosaccharides [FucnSO3Na-Na]− (n = 2–6). In addition, the set of fragment ions at
m/z 314.089, 387.089, 460.120, 533.148, 606.184 and 679.194 was determined to be methyl glycosides
of di-sulfated fucooligosaccharides [MeFucn(SO3Na)2-2Na]2− (n = 3–8), and the fragment ions at
m/z 307.051, 380.089, 453.112, 526.141 and 599.174 corresponded to di-sulfated fucooligosaccharides
[Fucn(SO3Na)2-2Na]2− (n = 3–7). Finally, the last set of doubly charged ions at m/z 275.069, 348.100,
421.129, 494.161 and 567.193 was determined to be [Gal(Fuc)nSO3Na-Na]2− (n = 2–7) (the hexose was
determined to be D-Gal based on the analysis of monosaccharides).
The ESI-MS spectrum of ds-DKCA is shown in Figure 2b. The fragment ions were
similar to those of ds-DKCW. However, ds-DKCA mainly consisted of methyl glycosides
of mono-sulfated fucooligosaccharides and had few multi-sulfated fucooligosaccharides or
sulfated galactofucooligosaccharides.
The fragmentation pattern for the singly-charged ion at m/z 1133.415 (−1), assigned as
[MeFuc7SO3Na-Na]−, was displayed in Figure 3. Singly-charged fragment ions at m/z 371.075, 517.136,
663.197, 809.258, 955.319 and 1101.381 corresponded to B-type ions, arising from the glycosidic bond
cleavage from the reducing end, suggesting that the sulfate was located at the non-reducing end.
Another set of fragment ions at m/z 403.075, 549.063, 841.285 and 987.347 (a loss of fucopyranose
residue (146 Da)) arose from the glycosidic bond cleavage from the non-reducing end, indicating that
the sulfate was located at the reducing end. Thus it was concluded that the ion [MeFuc7SO3Na-Na]−
at m/z 1133.415 (−1) was a mixture of isomers Fuc(SO3Na)→Fuc→Fuc→Fuc→Fuc→Fuc→Fuc-OMe
and Fuc→Fuc→Fuc→Fuc→Fuc→Fuc→Fuc(SO3Na)-OMe. This finding was in agreement with
previous studies on the structural features of polysaccharides from Saccharina japonica and Sargassum
fusiforme [22–24], suggesting that polysaccharides from K. crassifolia might have the same backbone as
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Figure 2. Negative ion mode ESI-MS spectra of ds-DKCW (a) and ds-DKCA (b).
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The fragmentation pattern for the doubly charged ion at m/z 421.129 (−2) assigned to the ion
[Gal(Fuc)4SO3Na-Na-H]2− was displayed in Figure 4a. The fragment ion at m/z 225.014 resulted from
breakage of glycosidic bonds and cleavage of the dehydrated, sulfated fucose residue. No ions at
m/z 241 or 259 were detected, suggesting that the sulfate group was substituted at the Fuc residue.
One set of fragment ions at m/z 389.086, 535.147 and 681.208, assigned as C- or Y-type fragment
ions, corresponded to [(Fuc)2SO3Na-Na]−, [(Fuc)3SO3Na-Na]− and [(Fuc)4SO3Na-Na]−, respectively.
Another series of less intense fragment ions at m/z 551.143(C'3/Y'3) and 697.204(C'4/Y4) corresponded
to [Gal(Fuc)2SO3Na-Na]− and [Gal(Fuc)3SO3Na-Na]−, respectively. In addition, the characteristic
fragment ion at m/z 383.103 (−2) corresponded to 2,5A5, suggesting that the linkage between Fuc
and Gal was a 1→4 linkage or a 1→3 linkage. Moreover, no characteristic ion of 0,2A was detected,
suggesting that the linkage between Fuc and Fuc was mainly 3-linked. Thus, it was hypothesized that
Gal(Fuc)4SO3Na consisted of Fuc(SO3Na)→Fuc→Fuc→Fuc→Gal, Fuc(SO3Na)→Fuc→Fuc→Gal→Fuc,
Fuc(SO3Na)→Fuc→Gal→Fuc→Fuc, Fuc(SO3Na)→Gal→Fuc→Fuc→Fuc, Fuc→Gal→Fuc→Fuc→
Fuc(SO3Na), Gal→Fuc→Fuc→Fuc→Fuc(SO3Na), Fuc→Fuc→Gal→Fuc→Fuc(SO3Na) and
Fuc→Fuc→Fuc→Gal→Fuc(SO3Na).
To confirm the above hypothesis, the fragmentation pattern for the singly-charged ion at m/z
681.208 was characterized by ESI-CID-MS3 and was found to correspond to the ion [Fuc4SO3Na-Na]−,
as shown in Figure 4b. One set of fragment ions at 225.014, 371.075 and 517.136 assigned as B-type
ions arose from the glycosidic bond cleavage from the reducing end, suggesting that the sulfate was
located at the non-reducing end. Anastyuk et al. and Saad and Leary [18,25] reported that, when
an oligosaccharide’s sulfate group was close to the glycosidic linkage spatially, it would undergo
easier B-type fragmentation, which indicated that the sulfate group was substituted at C-2. Another
set of less intense fragment ions, 389.086 and 535.147, corresponded to Y-type ions, suggesting the
sulfate was substituted at the reducing end. In addition, the characteristic ion at m/z 607.170 was a
0,3X3-type ion, suggesting that the linkage was a 1→3 linkage. No 0,2A-type ions were detected, which
confirmed that the linkage between Fuc and Fuc was 3-linked. In sum, Fuc4SO3Na consisted primarily
of Fuc(2SO3Na)→Fuc→Fuc→Fuc, and, to a lesser degree, of Fuc→Fuc→Fuc→Fuc(2 or 4SO3Na).
The fragmentation pattern for the doubly charged ion at m/z 383.103 (−2) was also elucidated
by ESI-CID-MS3 in Figure 4c. The characteristic ion at m/z 361.090 (−2) (2,4A5) arose from the loss
of C2H4O (44 Da) from the ion at m/z 383.103 (−2) (2,5A5), suggesting that the reducing end was a
Gal residue. In addition, it also indicated that the linkage between Fuc and Gal was a 1→4 linkage.
Moreover, a set of fragment ions at m/z 243.014, 389.086 and 535.147 were determined to be C-type ions,
suggesting that the sulfate was located at the non-reducing end. This glycosidic cleavage observation
was not consistent with the previous study [18,25], indicating that the sulfate was at C-4. Therefore, it
was concluded that Gal(Fuc)4SO3Na was Fuc(4SO3Na)→Fuc→Fuc→Fuc→Gal.
Thus, it was concluded that Gal(Fuc)4SO3Na was mainly made of
Fuc(2 or 4SO3Na)→Fuc→Fuc→Fuc→Gal. In addition, it also might contain
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Figure 4. Negative ion mode ESI-CID-MS2 spectrum of the ion at m/z 421.129 (−2) (a) and negative ion
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The fragmentation for the doubly charged ion at m/z 460.120 (−2), corresponding to the ion
[MeFuc5(SO3Na)2-2Na]2−, was shown in Figure 5. Five types of fragments ions were found: (1) doubly
charged fragment ions at m/z 225.014 (B2), 298.075 (B3), 371.063 (B4) and 444.106 (B5) corresponded to
[Fuc2(SO3Na)2-2Na]2−, [Fuc3(SO3Na)2-2Na]2−, [Fuc4(SO3Na)2-2Na]2− and [Fuc5(SO3Na)2-2Na]2−,
respectively. No fragment ion at m/z 152 ([Fuc(SO3Na)2-2Na]2−) was observed, suggesting that
one isomer of MeFuc5(SO3Na)2 was Fuc(SO3Na)→Fuc(SO3Na)→Fuc→Fuc→Fuc-OMe; (2) Less
intense, doubly charged fragment ions at m/z 314.058 (Y3') and 387.089 (Y4') were determined to be
[MeFuc3(SO3Na)2-2Na]2− and [MeFuc4(SO3Na)2-2Na]2−, most likely having arisen from glycosidic
bond cleavage at the non-reducing terminus. Thus, it was hypothesized that MeFuc5(SO3Na)2
contained Fuc→Fuc→Fuc→Fuc(SO3Na)→Fuc(SO3Na)-OMe; (3) Singly charged fragment ions
at m/z 225.014, 371.063, 517.136 and 663.198 (namely, B1'', B2'', B3'' and B4'', respectively) arose
from the loss of a methyl glycoside of sulfated fucose (257 Da) from the reducing terminus,
suggesting that MeFuc5(SO3Na)2 might consist of Fuc(SO3Na)→Fuc→Fuc→Fuc→Fuc(SO3Na)-OMe
or Fuc→Fuc→Fuc→Fuc(SO3Na)→Fuc(SO3Na)-OMe; (4) A singly-charged fragment ion at m/z 695.225
(namely, Y4''), assigned as [MeFuc4SO3Na-Na]−, arose from the loss of a sulfated fucopyranose
residue (225 Da) from the side chain or from the non-reducing terminus. A singly-charged
fragment ion at 549.163 (namely, Y3''), corresponding to [MeFuc3SO3Na-Na]−, arose from the
loss of fucopyranose after the loss of the sulfated fucopyranose. Thus it was hypothesized that
MeFuc5(SO3Na)2 was made up of Fuc(SO3Na)→Fuc→Fuc→Fuc→Fuc(SO3Na)-OMe, Fuc(SO3Na)→
Fuc(SO3Na)→ Fuc→Fuc→Fuc-OMe and Fuc→Fuc→Fuc→Fuc(SO3Na)→Fuc(SO3Na)-OMe;
(5) Singly-charged fragment ions at m/z 243.025 and 389.086 (namely, C1''and C2'')
arose from the loss of sulfated fucose from the non-reducing terminus, suggesting
that MeFuc5(SO3Na)2 might consist of Fuc(SO3Na)→Fuc→Fuc→Fuc→Fuc(SO3Na)-OMe.




Figure 5. Negative ion mode ESI-CID-MS2 spectrum of the ion [MeFuc5(SO3Na)2-2Na]2− at
m/z 460.120 (−2).
The fragmentation pattern for the doubly charged ion at m/z 526.141 (−2), assigned to the ion
[Fuc6(SO3Na)2-2Na]2−, was displayed in Figure 6. The ion at m/z 526.141 (−2) was the prototype of








Mar. Drugs 2015, 13, 1360–1374
words, both the ion [MeFuc6(SO3Na)2-2Na]2− and the ion [Fuc6(SO3Na)2-2Na]2− were generated
under the condition of desulfation. However, the former was methylated, while the latter was not.
Figure 6. Negative ion mode ESI-MS2 spectrum of ion [Fuc6(SO3Na)2-2Na]2− at m/z 526.141 (−2).
2.4. Anti-Complement Activity
As shown in Figure 7a–d, the effects of the polysaccharides on activation of human complement
through the classical pathway (Figure 7a,b) and the alternative pathway (Figure 7c,d) were examined
in 1:10-diluted NHS, with heparin used as a reference. The complement group (i.e., positive control)
displayed a 93.11% ± 2.96% activation of the classical complement pathway. The activities of KCA,
KCW, DKCA, DKCW and heparin were dose-dependent, while ds-DKCA and ds-DKCW showed little
or no activity (Figure 7a,b). The activities of KCA and KCW reached a plateau at a concentration of
10 μg/mL, while DKCA plateaued at 50 μg/mL. In addition, the concentration that resulted in 50%
inhibition of the classical complement pathway (CH50) for DKCW was approximately 218 μg/mL,
which was lower than heparin. Therefore, KCA, KCW, and DKCA were more potent than heparin in
inhibiting activation of the classical pathway. On the other hand, the concentrations of KCA, KCW,
DKCA, DKCW and heparin that resulted in 50% inhibition of the alternative pathway (AP50) were 4.83,
18.60, 24.50, 19.97 and 137.25 μg/mL, respectively (Figure 7c,d). This finding indicated that KCA, KCW,
DKCA and DKCW were more potent than heparin in inhibiting activation of the alternative pathway.
KCA and KCW displayed similar activity levels against the two complement pathways, indicating
that the extraction methods did not affect the activity levels. The degraded polysaccharides DKCA
and DKCW exhibited weaker activity compared to the crude polysaccharides KCA and KCW,
which suggested, as others have reported, that the change in molecular weight influenced the
anti-complement activity of the two compounds [9,26]. In addition, the finding that ds-DKCA and
ds-DKCW showed little or no activity against the two pathways suggested that sulfate was important
for anti-complement activity, which was in agreement with other reports [13,27,28].
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Figure 7. Inhibition of the classical pathway-mediated hemolysis of EA (a and b) and alternative
pathway-mediated hemolysis of ER (c and d) in 1:10-diluted NHS in the presence of increasing
amounts of the polysaccharides. Heparin was used as the reference. The results are expressed as
percent inhibition of hemolysis. Data are the means from 3 determinations ± S.E.M.
3. Experimental Section
3.1. Preparation of Polysaccharides
K. crassifolia was collected in Rongcheng, Shandong Province, China, in June of 2013.
The polysaccharides were extracted from K. crassifolia as previously described [29]. Briefly, the
dried algae were cut into pieces, and the polysaccharides were extracted three times in water at
room temperature for 2 h. The solution was dialyzed against water and distilled water. Finally, the
polysaccharide was concentrated and precipitated with ethanol. The resultant precipitate was named
KCW. In an alternative extraction, the dried algae were cut and extracted with 0.1 M HCl at room
temperature for 2 h. The solution was neutralized, concentrated, dialyzed and precipitated with
ethanol. This precipitate was named KCA.
3.2. Preparation of Low Molecular Weight Fucoidans and Their Desulfated Mixtures
The crude polysaccharides KCA and KCW were degraded using hydrogen dioxide and
ascorbic acid to obtain low molecular weight polysaccharides, as previously described [21]. Briefly,
crude polysaccharide (1 g) was dissolved in water (100 mL). Ascorbic acid (0.5 g) and hydrogen
dioxide (0.3 mL) were then added, and the solution was stirred for 2 h at room temperature.
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The desulfation of DKCA and DKCW was performed according to the modified method of
Nagasawa et al. [30]. Desulfation was carried out using its pyridinium salt. Briefly, the sample was
dissolved in distilled water (10 mL) and mixed with cationic resin for 3 h. After filtration, the solution
was neutralized with pyridinium and lyophilized. The polysaccharide was then dissolved in 20 mL of
a 9:1 ratio of dimethyl sulfoxide: methanol (v:v) at 80 ◦C for 5 h. The desulfated solution was dialyzed
and lyophilized to give desulfated products (e.g., ds-DKCA and ds-DKCW).
3.3. Composition Methods
Total sugar and fucose content were determined according to the method of Dubois et al. [31]
and Gibbons [32], using fucose as a standard. The level of sulfation was analyzed by the barium
chloride-gelatin method of Kawai et al. [33]. The uronic acid (UA) content was estimated with
a modified carbazole method using D-glucuronic acid as a standard [34]. The protein level was
determined according to the method of Bradford et al. [35]. For the determination of sugar composition,
the acid-hydrolyzed glycoses were converted into their 1-phenyl-3-methyl-5-pyrazolone derivatives
(PMP) and separated by HPLC chromatography [36]. The molecular weight of the samples was
assayed by a HP-GPC system on a TSK gel PWxl 3000 column (7 μm, 7.8 × 300 mm) eluted with 0.2 M
Na2SO4 at a flow rate of 0.5 mL min−1 at 30 ◦C [37].
3.4. Spectroscopic Analysis
Infrared spectra (IR) were recorded from polysaccharide powder in KBr pellets on a Nicolet-360
FTIR spectrometer between 400 and 4000 cm−1 (36 scans, at a resolution of 6 cm−1).
MS was performed on a LTQ ORBITRAR XL (Thermo Scientific, Waltham, MA, USA). Samples,
dissolved in CH3CN-H2O (1:1, v:v), were introduced into the MS at a flow rate of 5 μL min−1 in the
negative ionization mode. The capillary voltage was set to −3000 V, the cone voltage was set to −50 V,
the source temperature was set to 80 ◦C, and the desolvation temperature was set to 150 ◦C. The
collision energy was optimized between 20 and 50 eV. All spectra were analyzed by Xcalibur (Thermo
Scientific, Waltham, MA, USA).
3.5. Anti-Complement Activity
The anti-complement activity of the polysaccharides was determined by measuring their ability
to inhibit classical [38] and alternative [39] complement-mediated hemolysis. For the classical pathway,
100 μL of various dilutions of tested samples were mixed with 100 μL of 1:10-diluted normal human
serum (NHS, which was obtained from healthy, adult donors), 200 μL GVB2+ (veronal buffer saline
(VBS) containing 0.1% gelatin, 0.5 mM Mg2+ and 0.15 mM Ca2+) and 200 μL of sensitized erythrocytes
(EA). The mixture was then incubated at 37 ◦C for 30 min. The following assay controls were incubated
under the same conditions: (1) 100% lysis: 200 μL of EA in 400 of μL water; (2) sample control:
100 μL of sample in 500 of μL GVB2+; (3) complement: 100μL of 1:10-diluted NHS and 200 μL EA in
300 μL GVB2+; and (4) blank: 200 μL of EA in 400 μL of GVB2+. After incubation, the mixture was
centrifuged (5000 rpm × 10 min) and the erythrocyte lysis was determined at 405 nm. Decreased
lysis in the presence of tested polysaccharides indicated anti-complement activity. All of the samples
were dissolved in GVB2+. Heparin sodium salt (Beijing Rui Taibio Co., Ltd., Beijing, China), at a
concentration of 160 IU/mg, was used as the reference (The molecular weight was 54.1 kDa and sulfate
content was 13.60%). The inhibition percentage was calculated using the following equation: inhibition
of EA lysis (%) = (Acomplement − [Asample − Asample control])/Acomplement × 100.
To assay sample inhibition of the alternative complement pathway, 150 μL of various dilutions of
tested samples were mixed with 150 μL of 1:10-diluted NHS and 200 μL of rabbit erythrocytes (ER).
The mixture was then incubated for 30 min at 37 ◦C. Cell lysis was determined by the same method as
described above for the classical pathway. Controls for 100% lysis, sample control, complement and
blank were included. The percent inhibition was calculated using the following equation: inhibition of
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4. Conclusions
In this study, two polysaccharides, KCW and KCA, were extracted from K. crassifolia using water
and dilute hydrochloric acid, respectively, and their degraded fractions and desulfated fractions were
prepared. The chemical compositions indicated that KCA had higher contents of sulfate and Fuc and
less of other monosaccharides than KCW. To elucidate the structural features of KCA and KCW, they
were degraded and partly desulfated. The desulfated mixtures were determined by ESI-MS. Both were
found to contain sulfated fucooligosaccharides, sulfated galactofucooligosaccharides and methyl
glycosides of mono-sulfated/multi-sulfated fucooligosaccharides. The major difference between
ds-DKCA and ds-DKCW was the intensity of the fragment ions. In addition, the structural features
of oligomeric fragments were characterized by ESI-CID-MS2 and ESI-CID-MS3. It was shown that
the polysaccharides had a backbone of 3-linked Fuc residues sulfated at C-2, C-4 or C-2 and C-4.
Some oligomers had the 4-linked Gal residue at the reducing terminus. Some fucooligomers were
interspersed by Gal residues. Moreover, activities of the polysaccharides against the classical and
alternative complement pathways were measured. The crude polysaccharides KCA and KCW had
the highest activity levels, while the desulfated fractions ds-DKCA and ds-DKCW had little or no
activity. These data suggested that the change in molecular weight and sulfate content influenced
the activity levels. In summary, polysaccharides from K. crassifolia may be a good candidate drug for
anti-complement therapy.
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Abstract: Sulfated polysaccharides produced by microalgae, which are known to exhibit various
biological activities, may potentially serve as natural antioxidant sources. To date, only a few studies
have examined the antioxidant bioactivity of red microalgal polysaccharides. In this research, the
effect of different salts on the antioxidant activities of two red microalgal sulfated polysaccharides
derived from Porphyridium sp. and Porphyridium aerugineum were studied in a soy bean-based infant
milk formula. Salt composition and concentration were both shown to affect the polysaccharides’
antioxidant activity. It can be postulated that the salt ions intefer with the polysaccharide chains’
interactions and alter their structure, leading to a new three-dimensional structure that better exposes
antiooxidant sites in comparison to the polysaccharide without salt supplement. Among the cations
that were studied, Ca2+ had the strongest enhancement effect on antioxidant activities of both
polysaccharides. Understanding the effect of salts on polysaccharides’ stucture, in addition to
furthering knowledge on polysaccharide bioactivities, may also shed light on the position of the
antioxidant active sites.
Keywords: antioxidants; calcium; microalgae; polysaccharides; Porphyridium sp.; Porphyridium aerugineum
1. Introduction
Antioxidants have a positive effect on human health as they can slow down oxidative stress
processes caused by reactive oxygen species (ROS), e.g., OH, H2O2 and O2− [1–3]. These ROS attack
macromolecules such as membrane lipids, proteins and DNA [1,4], leading to many health disorders
with severe tissue injuries such as cancer, diabetes mellitus, neurodegenerative and inflammatory
diseases [5–8]. In the food industry, oxidation of lipids can lead to food product deterioration (e.g., in
nutritional value, safety and appearance) due to formation of undesirable secondary lipid peroxidation
products. Therefore, many synthetic commercial antioxidants such as butylated hydroxytoluene (BHT),
butylated hydroxyanisole (BHA), tert-butylhydroquinone (TBHQ) and propyl gallate (PG) are used to
retard the oxidation and peroxidation processes [9]. However, the use of these synthetic antioxidants
must be under strict regulation due to potential health hazards [10–12], hence there is an ongoing
search for safe, natural alternatives [13,14].
Recently, both the food and pharmaceutical industries have become interested in the development
of antioxidants from natural sources. Sulfated polysaccharides derived from marine algae, which are
known to exhibit many biological activities, may be a potential natural antioxidant source for these
industries [15]. Among the scant studies conducted regarding the antioxidant potential of sulfated
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polysaccharides, most efforts were focused on those derived from seaweeds [16–22], whereas very little
is known regarding red microalgal sulfated polysaccharides [23–25]. The mechanism of these sulfated
polysaccharides’ antioxidant activity is not certain. It is also known that various residues which could
bind to these polysaccharides, such as pigments, flavones, peptides, proteins, and polyphenols can
improve their antioxidant activities [26].
Our research is focused on two soluble-sulfated polysaccharide fractions produced by red
microalgal species—the seawater Porphyridium sp. (hereafter—PS1) and the freshwater Porphyridium
aerugineum (hereafter—PS2). These microalgae, in contrast to seaweeds, are encapsulated by a thick
layer of mucilaginous sulfated polysaccharides that lack the rigid microfibrillar component typical in
most of alga species [27]. During growth, the external fraction of these polysaccharides is released to
the surrounding aqueous medium, where it accumulates and increases medium viscosity [28–30]. The
precise structures of the soluble-sulfated polysaccharide fractions are not fully understood due to their
complexity and the lack of known carbohydrolases that degrade them [30–32]. The soluble-sulfated
polysaccharide fractions are of high molecular weight (~1–7 × 106 g·mol−1), and due to the presence
of glucuronic acid residues and sulfates they are anionic heteropolymers, containing approximately
10 different mono sugars, mainly glucose and galactose [33–36]. In addition, both are built from
the same disaccharide building block [37]. PS1 was found to contain several proteins, which are
non-covalently bound to it [38]. The most prominent protein detected was a 66-kDa glycoprotein;
This protein consists of a polypeptide of approximately 58 kDa and glycan moieties of approximately
8 kDa [38,39]. Sequencing of a cDNA clone encoding the 66-kDa glycoprotein revealed that this is
a novel protein, which lacks similarity to any protein in the public domain databases. However,
in the SCOP databases, some structural similarities were found between the carbohydrate-binding
domain (CBD) and protein superfamilies, such as glycosyltransferases, pectin lyase-like proteins,
sialidases, and conA-like lectins/glucanases, indicating a possible role for this 66-kDa glycoprotein in
synthesis/modification of the cell-wall polysaccharide [38]. In addition, the glycoprotein was shown
to play a role in biorecognition [40].
Physicochemical analysis conducted on these soluble-sulfated polysaccharide fractions indicate
that even at low concentrations they create highly viscous polymer solutions, compared to the viscosity
of aqueous solutions containing polysaccharides such as xanthans or carrageenans [41]. It is believed
that red microalgal polysaccharide layers protect the cells against drought, solar irradiation and
maintain the humidity required by the cells [30].
PS1 is stable over a wide range of temperatures (30–160 ◦C), pH values (2–9), light and salinities [31,
41–49]. Rheological studies have demonstrated that it is comprised of an oriented, single two-fold
helical structure with a pitch of 1.6 nm, i.e., a single chain helix with a regular chemical repeat [49].
The stiffness of PS1 was reported to be in the same rigid helical range as that of xanthan gum and
DNA [43]. A conformational transition state in the PS1 chain was observed at low ionic strength
(<0.01 M), most likely reflecting a contraction of the polymer chain from a highly stretched to a stiff,
wormlike chain [43]. Furthermore, rheological studies have also indicated that the nature of PS1 is
affected by ionic strength, valence, type and concentration of cations, pH, polymer concentration,
and temperature [43]. For example, in a salt-free solution, PS1 favors a stretched chain conformation,
the result of long-range electrostatic effects, but the addition of an electrolyte such as NaCl, masks
the electrostatic interactions and allows a more flexible configuration resulting in lower intrinsic
viscosities [43].
To our knowledge, only a few reports have evaluated the antioxidant activity of PS1 and PS2 [23,
24]. These fractions were shown to exhibit dose-dependent antioxidant activity, and were found to
serve as better inhibitors of linoleic acid auto-oxidation compared to carrageenan and cellulose [24].
In addition, PS1 inhibited the oxidative damage to 3T3 cells caused by FeSO4 in a dose-dependent
manner [24]. A search for the active antioxidant component was also conducted; PS1 polysaccharide
fragments created by microwave and sonication exerted an inhibitory effect on oxidative damage in
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part of the polysaccharide is not required for its antioxidant activity. The 66-kDa glycoprotein within
PS1 may also play role in the polysaccharide’s antioxidant activity [24]. It was suggested that the
antioxidant activity helps the cells cope with the ROS to which they are exposed under stress such as
drought, extreme temperature, solar irradiation, etc. [24]. Taking together these findings, together with
the fact that they are safe to use in food, are stable over a wide range of temperatures/environmental
conditions, and have favorable rheological and chemical properties, the PS1 and PS2 polysaccharides
may be used as antioxidant additives in food or/and biomedical products. Despite this potential
of PS1 and PS2, knowledge on their antioxidant activity is still lacking, and the effect of salt on this
activity has not been studied to date.
Herein, the effect of salt on the antioxidant activity of PS1 and PS2 in the presence of soy
bean-based infant milk formula was studied. Infant milk formula based on soy bean was chosen as a
good platform for oxidative stress because of its composition; it is rich in polyunsaturated fatty acids
(PUFA) (Table S1 in supplementary information) which are sensitive to oxidative stress. The results of
this study contribute to our understanding of red microalgal polysaccharide structure and function,
especially as antioxidants, under various salt conditions.
2. Results and Discussion
The antioxidant activity of red microalgal soluble-sulfated polysaccharide fractions in infant milk
formula was evaluated by measuring the Malondialdehyde (MDA)-oxidant product after adding
KO2 as an oxidative reagent. MDA levels were significantly reduced in oxidant-damaged formulas
containing either of the polysaccharides, in comparison to the control, see Figure 1. MDA levels
were also measured in pure PS solutions with and without KO2; in both cases MDA levels were
negligible; thus it can be assumed that the polysaccharides are probably not affected by KO2—induced
oxidant damage.
 
Figure 1. Antioxidant activity of PS1 and PS2 in soy bean milk formula following addition of KO2.
CMDA was measured by thiobarbitoric acid (TBA) method. All treatments contained 0.5 g formula, 0.35
mM KO2, with or without 0.075/0.15% w/v of either PS1 or PS2 polysaccharides. Values are expressed
as mean ± SD, n = 3.
The effective antioxidant activity of polysaccharides derived from red microalgae that was
demonstrated in infant milk formula (Figure 1) is in accordance with previous reports demonstrating
the antioxidant activity of red microlagal polysaccharides [23–25]. The antioxidant activity of both
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increase in the polysaccharide concentration (PS1/PS2) also improved their antioxidant activity, but it
seems that PS1 has a better dose-concentration effect than that of PS2 (Figure 1). The similarity in the
antioxidant capability of these polysaccharides is not surprising since it is known that the structure
and the physical behavior of the polysaccharides are similar; they are composed of the same building
block with the same predominant monosaccharides and are both negatively charged. The relative
advantage of PS1 may be attributed to differences between the polysaccharides, such as sulfate content,
ratio of monosaccharides, etc. [41].
In order to expand our knowledge on the antioxidant activity of the polysaccharides, it is
important to study their activities under different conditions. Ionic strength and cation type were
found to influence the intrinsic viscosity of PS1, probably by varying the electrostatic forces and leading
to conformational changes [43]. Herein, the effect of potassium, sodium and divalent cation salts with
different anions on the antioxidant ability of polysaccharides was tested in an oxidant-damaged infant
formula. Salts were added to the polysaccharides prior to their exposure to the oxidant-damaged
infant formula, and MDA concentrations were measured as will be explained in the experimental
section, to assess the effect of salts on the antioxidant activity of the polysaccharides. All results are
displayed as MDA reduction percentages, relative to each experimental setup without the salt.
All types of salts tested, regardless of their anion/cation composition and their concentrations,
positively induced the antioxidant activity of both polysaccharides in comparison to the native
polysaccharide (control-without salt supplement). We were thus interested in elucidating the effect of
different cations and anions, as well as different salt concentrations, on this induction.
Monovalent cation type effect: In order to elucidate the effect of different monovalent cations on
the polysaccharides’ antioxidant bioactivity, a comparison was performed between NaCl and KCl,
between Na2SO4 and K2SO4 and between Na3PO4 and K3PO4. Generally, regardless of the anion
present, the K+ cations were found to have a stronger influence on the antioxidant activity of the
polysaccharides, inducing a marked improvement in MDA level reduction, in comparison to the
Na+—formula treatments, as seen by comparing Figures 2 and 3.
 
Figure 2. Polysaccharide antioxidant activity induction by sodium salts. CMDA was measured by TBA
method. Experimental setup included 0.5 g formula with 0.35 mM KO2, 0.15% w/v polysaccharide and
various sodium salts at two different concentrations, in a final volume of 10 mL. Values represent the
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The cation antioxidant enhancement effect can be explained: cations derived from the salts bind
to negatively charged residues in the polysaccharide, such as sulfate and glucuronic acid residues. This
interaction with the polysaccharide, depending on the cation type, may change the polysaccharide’s
three-dimensional structure due to conformational or structural changes in the solution, by masking
the electrostatic repulsions between the polysaccharide chain molecules (which decreases association
between the polysaccharide chains). The newly formed structure probably better exposes the potential
antioxidant sites in comparison to a reduced-salt native polysaccharide. This postulation is based on a
former viscometry study, which indicated that salts can change the polysaccharide conformational
structure [43]. In our case, the potassium ions probably induced a change in the intermolecular bonds
in the polysaccharide—leading to better exposure of the antioxidant sites in comparison to the three
dimensional structure that was formed in the presence of sodium salts. It was expected that an incease
in cation concentration will lead to stronger reduction of MDA levels. However, this is not always the
case, as seen by comparing the results obtained for Na2SO4 with those obtained for Na3PO4 (Figure 2),
and K2SO4 with those obtained for K3PO4 (Figure 3)—where an increase in the cation concentration
did not lead to an increase in MDA reduction rates by the polysaccharide. This phenomenon can be
explained by the anion effect detailed below.
Figure 3. Polysaccharide antioxidant activity induction by potassium salts. CMDA was measured by
TBA method. Experimental setup included 0.5 g formula with 0.35 mM KO2, 0.15% w/v polysaccharide
and various potassium salts at two different concentrations, in a final volume of 10 mL. Values represent
the mean of at least 3 repeats; Maximum standard deviation equals 8%.
Based on former reports which suggested that proteoglycans and proteins which are arrayed with
carbohydrate polymers contribute to induction of polysaccharide antioxidant activities and therefore
are probably involved in the polysccharide antioxidative protective activities [24,50–54], another
possible explanation for the cation antioxidant effect can be postulated; a specific interaction of cations
with the cell-wall proteins, which are part of the polysaccharides, probably through specific amino
acid residues (most likely negatively charged) may occur. The interaction may cause conformational
or structural changes, leading to better exposure of the antioxidant sites.
Divalent cation type effect: Comparing the divalent cation treatments indicats that Ca2+ had the
strongest influence on the reduction of MDA levels: 0.5M CaCl2 reduced MDA level by 75% and
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Ca2+ ions are known to be effective molecules that stabilize polysaccharides by creating a cross-linked
network [55]; for example, Ca2+ ions are used for alginate gel formation, which is commonly explained
by the egg-box model [56]. According to this model, the structural features of the glucoronic acid allow
strong complexation with Ca2+ ions, which are embodied in cavities of stiff alginate chains like eggs in
a cardboard egg box. Since PS1 and PS2 also contain anionic glucuronic acid blocks and sulfate groups,
Ca2+ ions probably create a strong complexation with the anions, stabilizing the interactions between
polysaccharide chains. The Ca2+ ions induced a significantly stronger enhancement in the antioxidant
activity of both polysaccharides, in comparison to other divalent ions (Mg2+/Sr2+), see Figure 4. This
enhancement is attributed to the conformational change of the polysaccharide which occurs due to the
masking of its negative charges by the cation. It is likely that the cation’s charge density and radius
play an important role in this sense—thus, we suggest that, of the three divalent cations tested, Ca2+
is best suited for rendering stability to the polysaccharide, due to the suitability of its charge density
and radius.
Figure 4. Polysaccharide antioxidant activity induction by divalent cation salts. CMDA was measured
by TBA test. Experimental setup included 0.5 g formula with 0.35 mM KO2, 0.15% w/v polysaccharide,
and various divalent salts at two different concentrations, in a final volume of 10 mL. Values represent
the mean of at least 3 repeats. Maximum standard deviation equals 8%.
The weakest antioxidant effect among the divalent ion treatments was observed in the low
concentration MgCl2-polysaccharide treatments: 0.1 M MgCl2 reduced the MDA level by 12% and
16% in the PS1- and PS2-formula treatments respectively, compared to the same treatment without
salt (Figure 4). This is also not suprising, since alginate hydrogels have been obtained with various
divalent ions except for Mg2+ [57,58].
Anion type effect: It can be postulated that anion type also influence the polysaccharide
antioxidant activity. A comparison between the effects of potassium and sodium sulfate salts (Na2SO4
and K2SO4), and between the potassium and sodium phosphate salts (Na3PO4 and K3PO4) point out
that the type of anion does not only play a role in the induction of the polysaccharides’ antioxidant
activity, but also differs between the two polysaccharides examined. For PS1 % salt effect values were
much higher in the presence of SO42− in comparison to PO43− ions, the opposite effect was apparent
in PS2 system, % salt effect values were higher in the presence of phosphate ions in comparison to
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The counter anion (e.g., PO43− in the presence of PS1-formula or SO4−2 in the presence of
PS2-formula), can cause the salt and/or the polysacchride to aggregate. In the case of salt aggregation
the actual concentration of the free cations which could bind to the PS is not the analytical concentration.
In the case of polysaccharide aggregation, the concentration of available polysaccharide chains is
reduced, leading to less interactions between the cations and the negatively charged residues within
the polysaccharide chains. The different effect that the anions have on the two polysaccharides is
probably due to their chemical structure difference.
Salt concentration effect: Salt concentration affects the antioxidant activity of both polysaccharides.
High concentration of each salt (including NaCl/KCl/MgCl2/CaCl2/SrCl2), 0.5 M, was resulted in
higher % salt effect, indicating that the polysaccharides act as better antioxidants in comparison to the
low salt concentrations, 0.1 M (Figures 2–4). The antioxidant activity is not linearly dose-dependent
and differs in correspondence to the salt type, e.g., formula-polysaccharide treatments that contained
0.5 M KCl reduced the MDA levels up to two fold in comparison to treatments that contained 0.1 M KCl,
see Figure 3. Increasing the salt concentration in the PS1-MgCl2/SrCl2 formula-treatments, Figure 4,
also led to an increase in the antioxidant activity (up to three fold of MDA reduction). Noticeably,
increasing the NaCl concentration had only a slight effect on the MDA levels in comparison to the
other salts studied (Figure 2). The nonlinear effect of the salt concentration could be explained by
the same explanation as was explained above in the anions effect. High concentration could cause to
salt aggregation which reduced the actual free cation concentration in the solution. As a result less
cation-polysaccharide interactions could be formed.
3. Experimental Section
3.1. Materials
All solutions were prepared from analytical-grade chemicals and double distilled water (DDW)
that was passed through a Millipore setup at a final resistivity that was above 10 MΩ/cm.
All reagents and solvents were of analytical grade. Trichloroacetic acid (TCA), thiobarbituric
acid (TBA), and butylated hydroxyl toluene (BHT), KO2, KCl, NaCl, K2SO4, Na2SO4, K3PO4, Na3PO4,
MgCl2, CaCl2, SrCl2 were purchased from Sigma-Aldrich (Rechovot, Israel). Milk sample was
a commercial newborn formula based on soy bean; its composition is given in Table S1 in the
supplementary information.
3.2. Algae and Growth Conditions
P. sp. (UTEX 637) was obtained from Culture Collection of Texas University, Austin, Texas, USA.
P. arg. (B111.79) was obtained from the culture collection of the University of Göttingen, Göttingen,
Germany. Both species were cultivated in 250 mL Erlenmeyer flasks, each containing 100 mL of growth
medium—P. sp. in artificial sea water (ASW) [59], and P. arg. in freshwater [45]. Algae were grown
under shaking speed of 100 rpm; temperature of (25 ± 3) ◦C; illumination was supplied continuously
from above with fluorescent cool-white lamps at a photon flux density of 90 μmol photons m−2·s−1;
aeration was provided through bubbling air containing 2%–3% CO2 into the shaker. All cultures were
inoculated with 48-h-old cells. Initial cell concentration was adjusted to 2 × 106 cells/mL.
3.3. Isolation and Quantitative Analysis of Soluble-Sulfated Polysaccharide Fraction
Cultures at stationary phase of growth were centrifuged (3000 g, 10 min, 4 ◦C) and the supernatants
containing the dissolved polysaccharides were dialyzed (MW cutoff 8000 Da) against DDW at 4 ◦C
until the conductivity of the water reached 300 μs × cm−1. The dialyzed polysaccharide was then
freeze-dried and resuspended in DDW to reach 1% w/v, comprising the PS stock. The polysaccharide
concentration was determined by a known procedure [60], with D-galactose (Sigma G-0625, St. Louis,
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3.4. Sample Preparation
The sample preparation procedure included three steps: (1) Preparation of the PS-salt solution
samples: The diluted PS solution (0.15% w/v in DDW) was incubated for 60 min with an appropriate
concentration of one of the following salts: KCl, NaCl, K2SO4, Na2SO4, K3PO4, Na3PO4, MgCl2,
CaCl2, SrCl2 at 0.1 M, or KCl, NaCl, MgCl2, CaCl2, SrCl2 at 0.5 M. The solubility of K2SO4, Na2SO4,
K3PO4, Na3PO4 in aqueous solutions is lower than 0.5 M, therefore the only concentration used was
0.1 M; (2) Preparation of the PS-formula systems: The PS-salt solution samples were added to 0.5 g
milk powder with 35 mM KO2, at a total volume of 10 mL; (3) Malondialdehyde (MDA) levels were
determined according to the thiobarbitoric acid (TBA) method described below. Control experiments
were performed separately in order to study the oxidation of the polysaccharides and the formula by
KO2 (without salts) using the same procedure detailed above. To extend our knowledge regarding
the dose-dependency of the polysaccharide effect on the milk powder without salt supplement, two
polysaccharide concentrations (0.075/0.15% w/v) were studied for PS1 and PS2.
3.5. Production of Free Radicals
The free radicals were formed by addition of KO2 to the samples. As mentioned above O2− is
known as an oxidative agent [4,61].
The KO2 solution was prepared fresh for each experiment and added to the sample immediately
after its preparation.
3.6. Malondialdehyde (MDA) Measurements
MDA levels were measured spectroscopically according to Fenaille et al. [62] with minor
modifications. The assay is based on a reaction between oxidized lipids and TBA under acidic conditions
to yield a pink chromogen with a maximum absorbance at 532 nm. After sample preparation an aliquot
of the slurry (2 mL) was transferred to a 5-mL tube, to which the following were added: 1.6 mL DDW,
0.8 mL TBA 0.67%, 0.8 mL TCA 5% and 0.0128 g of BHT. The mixture was homogenized and centrifuged
at 3500 rpm for 30 min. The supernatant was incubated in a 70 ◦C water bath for 60 min, and cooled
to room temperature before measuring absorbance. The color produced by the chemical reaction was
read at 532 nm in a Cary 100 Bio UV-Visible spectrophotometer, and the amount of MDA formed was
determined by using the molar extinction coefficient ε(532 nm) = 1.56 × 10−5 cm·nmol−1 [62].
3.7. Calculation of % Salt Effect
The induction levels of the PS antioxidant activity under different salt environments was
calculated according to the following formula: % salt effect = (A0 − A)/A0 × 100, where A0 is
the absorbance of the control sample without salt, and A is the absorbance of the test sample with
the salt.
3.8. Statistical Analyses
All data were expressed as means ± standard deviation (SD) of at least three replications, and the
ANOVA test was used for statistical analysis. Each experiment was repeated at least three times.
4. Conclusions
Red microalgae polysaccharides hold great potential to be used as agents in various products
for human benefit, for example, as natural antioxidants in food or cosmetic products. However,
there are very few reports on sulfated red micoalgae polysaccharide antioxidant bioactivities and
there are still many open questions to be answered regarding the mechanisms through which
the polysaccharide copes with the ROS. The results of this study show that both red microalgae
soluble-sulfated polysaccharide fractions (PS1 and PS2) exhibit significant radical scavenging abilities
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It was demonstrated that salt composition (cation and anion type) and concentration affect the
antioxidant activity of these red microalgal polysaccharides. Thus we can postulate that the salt ions
intefere with the polysaccharide chain interactions by changing the intermolecular bonds and causing
changes in the three-dimensional structure of the polysaccharide, leading to a newly formed structure
that better exposes the antiooxidant sites. Among the cations which were tested, Ca2+ had the strongest
enhancement effect on antioxidant activities of both polysaccharides. Since proteins are also part of the
cell-wall complex polysaccharides [26,38] they can be involved in the newly-formed three-dimensional
structure. It seems, however, that the activity of the polysaccharides does not result from one single
component but from synergism of its oligomeric components. Due to the polysaccharide complexity
and the lack of knowledge regarding its structure, the mechanism of the salt effect cannot be explained
in depth.
Here we report for the first time the potential of the polysaccharides to act as an antioxidant
ingredient in infant food formula, which can be used as a model for food products, as well as for
other disciplines. We further demonstrate the enhancing effect of salts on this antioxidant activity
and propose a hypothesis which can explain the differential effect of the various cations and anions
on the two polysaccharides. The physicochemical properties which enable the polysaccharides to
be used as a stabilizer or thickener, the relative ease in which they can be produced by controlling
algal growth conditions and their uniqueness as a natural material which is dissolved in aqueous
systems, reinforce their potential to be used as antioxidants in industrial systems. Our findings have a
contribution in furthering knowledge on the polysaccharides’ antioxidant behavior under different
environmental conditions.
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Abstract: A new chrysolaminarin, named CL2, with a molecular mass of 7.75 kDa, was purified
from the marine diatom, Odontella aurita, using DEAE-52 cellulose anion-exchange chromatography
and Sephadex G-200 gel-filtration chromatography. The monosaccharide and structural analysis
revealed that CL2 was a glucan mainly composed of glucose, which was linked by the β-D-(1→3)
(main chain) and β-D-(1→6) (side chain) glycosidic bond, demonstrated by infrared spectroscopy
(IR) and nuclear magnetic resonance (NMR). The antioxidant activity tests revealed that the CL2
presented stronger hydroxyl radical scavenging activity with increasing concentrations, but less was
effective on reducing power analysis and scavenging 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical.
The influences of nitrogen concentration and light intensity on chrysolaminarin production of O.
aurita were further investigated in a glass column photobioreactor, and a record high chrysolaminarin
productivity of 306 mg L−1 day−1 was achieved. In conclusion, the chrysolaminarin CL2 from
O. aurita may be explored as a natural antioxidant agent for application in aquaculture, food and
pharmaceutical areas.
Keywords: Odontella aurita; chrysolaminarin; structural characteristics; antioxidant activity; productivity
1. Introduction
Oxidative stress causes lots of damage to biological macromolecules, such as nucleic acids,
proteins, lipids and carbohydrates, which may lead to the development of chronic and degenerative
ailments [1]. Although a variety of synthetic chemicals, such as phenolic compounds, are found to
be effective radical scavengers, they usually have side effects. Thus, many efforts have been spent on
searching for compounds with antioxidant activity and low cytotoxicity from natural materials.
Recently, accumulated evidence has demonstrated that natural polysaccharides are effective
antioxidants for scavenging reactive oxygen species (ROS) [2–4]. Marine diatoms accumulate
β-D-1,3-glucans, also called chrysolaminarin, as an energy storage carbohydrate, especially upon
nutrient-depletion conditions [5]. The chrysolaminarin from several diatoms have been characterized
and found to be a β-1,3-glucan with a degree of polymerization (DP) in the range of 5–60 and a degree
of branching (DB) of 0–0.2 at Position 6 [6]. A large number of studies indicated that β-glucans obtained
from various organisms, such as plants, algae and microorganisms, are effective agents in scavenging
ROS, stimulating immunity in fish, as well as treating diseases, like cancer, infection, inflammation and
influenza [7–10]. However, little attention has been devoted to the production and biological activities
of chrysolaminarin from marine diatoms.
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The marine diatom, Odontella aurita, has been industrially cultured in raceways and used as a
dietary supplement rich in ω-3 polyunsaturated fatty acids (PUFAs) for several years [11,12]. Some
other bioactive compounds contained in this microalga, such as fucoxanthin and phytosterols, have been
isolated, structurally elucidated and proved to be beneficial to human health [13–15]. No studies have
been reported, to our knowledge, on the structural characteristics and bioactivities of chrysolaminarin in
O. aurita. In this study, a new storage chrysolaminarin was purified from O. aurita. Its monosaccharide
composition, chemical structure and antioxidant activity were characterized. The production of
chrysolaminarin from O. aurita was also investigated in glass column photobioreactors. This research is
aimed at characterizing the structure and antioxidant capacity of a new chrysolaminarin purified from
the marine diatom, O. aurita, and evaluating its production potential in glass column photobioreactor.
2. Results and Discussion
2.1. Isolation, Purification and Characterization of Chrysolaminarin
2.1.1. Purification and Homogeneity of Chrysolaminarin
The crude polysaccharide was isolated from freeze-dried O. aurita and then chromatographed
on a DEAE-52 cellulose column (Pharmacia, Uppsala, Sweden). After being gradient eluted with an
aqueous solution of NaCl (0.1, 0.3 and 0.5 M), one major peak, named CL1, was obtained from the 0.1 M
NaCl eluate (Figure 1). Next, the fraction CL1 was applied to Sephadex G-200 gel-filtration column
chromatography (Pharmaci, Uppsala, Sweden) for further purification, yielding a single, symmetric
and sharp peak, which indicated that the obtained polysaccharide, named CL2 (chrysolaminarin 2),
was homogeneous (Figure 2). The UV spectrum showed no significant absorbance at 260 nm or 280 nm,
indicating that CL2 contained no protein or nucleic acid (data not shown).
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Figure 2. Sephadex G-200 gel-filtration chromatogram of the fraction CL1 (chrysolaminarin 1) obtained
from DEAE-cellulose column elution.
2.1.2. Monosaccharide Composition and Molecular Weight of CL2
Chrysolaminarins from various diatoms span a great number of different molecular weights,
from ~1 to 40 kDa [6]. The average molecular weight of CL2 was found to be 7.75 kDa based on the
results of gel-filtration chromatography. The monosaccharide composition of CL2 was analyzed by
complete acid hydrolysis and the GC-MS analysis methods. The results shown in Table 1 indicate
that the sugar components of CL2 are mainly composed of glucose (82.23%) with smaller amounts of
mannose (13.27%) and traces of ribose, arabinose, xylose and galactose.
Table 1. Monosaccharide composition of CL2 from O. aurita.
Sugar Components (Total Sugar a %)
Glucose Mannose Ribose Arabinose Xylose Galactose
82.23 13.27 0.46 3.62 0.26 0.16
a Total sugar: the sum of the six monosaccharides.
2.1.3. FTIR Spectra Analysis
As shown in Figure 3, the FTIR spectra of CL2 showed a significant, strong broad characteristic
peak at around 3431 cm−1, corresponding to the stretching vibration of O-H groups, as well as a
C-H band at 2923 cm−1 [16,17]. Two prominent absorption bands between 1200 and 1000 cm−1 are
dominated by ring vibrations overlapped with C-O glycosidic band vibration [10,18,19]. The stretching
peak at 1639 cm−1 and a weak stretching peak appeared at 1377 cm−1 were due to the presence of
carboxyl groups [20]. The characteristic peak of β-glycosidic linkage at 889 cm−1 demonstrated that
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Figure 3. The FTIR spectra of CL2 from O. aurita.
2.1.4. NMR Spectra Analysis
The 1H-NMR and 13C-NMR spectra of CL2 are presented in Figure 4. The anomeric proton
single at δ 4.39 and 4.08 ppm in the 1H NMR were assigned to H-1 of the β-1,3-linkage and the
β-1,6-linkage, respectively [21,22], which agree with the presence of an IR band at 889 cm−1. Based
on the respective peak areas at 4.39 and 4.08 ppm on the 1H-NMR spectrum, the ratio of the β-1,3- to
β-1,6-linkage was estimated to be 4:1. The 13C-NMR spectrum showed major signals at δ 104.2–104.6,
86.5–87.3, 78.1–78.4, 77.6–78.1, 75.1–75.4, 71.5, 69.1–70.6 and 62.3–63.1 (Figure 4b). These signals are in
agreement with the results from previous analysis of microalgae Chaetoceros muelleri and Pleurochrysis
haptonemofera [21,23], which indicated that the CL2 obtained from O. aurita has a β-D-(1→3)- (main
chain) and β-D-(1→6) (branch chain)-linked glucopyranan structure. The integrated analysis of
structural information demonstrated that the obtained polysaccharide CL2 from O. aurita is a medium









Mar. Drugs 2014, 12, 4883–4897
 
Figure 4. (a) 1H-NMR and (b) 13C-NMR spectrum of CL2 from O. aurita (NA: not assigned).
2.2. Assay for Antioxidant Activity
2.2.1. Reducing Power
For the assessment of the reducing power, the Fe3+–Fe2+ transformation of CL2 was investigated
using the potassium ferricyanide reduction method (Figure 5a). The results revealed that the reducing
power of CL2 was weak. At 2 mg mL−1, CL2 showed a reducing power of 0.046 ± 0.015 abs,
which gradually increased to 0.554 ± 0.139 abs at 100 mg mL−1; whereas the reducing power of
ascorbic acid (VC) reached a plateau of 2.508 ± 0.13 abs at 2 mg mL−1. Kozarski et al. [24] declared
that starch exhibited no reducing power in their study. Lo et al. [25] reported a weak relationship
between reducing power and monosaccharide composition, and they also found that the reducing
power of polysaccharides was much lower than that of ascorbic acid. Kanmani et al. [26] found that
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at 2 mg mL−1), which was much lower than that of ascorbic acid (reaching its plateau of 2.5 abs at
0.4 mg mL−1).
Figure 5. Antioxidant assays for the chrysolaminarin CL2 from O. aurita. (a) Reducing power; (b)
scavenging of DPPH radicals; (c) scavenging of hydroxyl radicals. Values are the means ± SD (n = 3).
When error bars cannot be seen, the error is less than the size of the symbol.
2.2.2. DPPH Radical Scavenging Activity
The DPPH free radical has been widely used as a tool to evaluate the antioxidant activity. The
results shown in Figure 5b indicated that the scavenging activity of CL2 increased slowly with the
increase of dosage in a concentration-dependent manner. When the concentration of CL2 was at
100 mg mL−1, its scavenging activity reached 42.455% ± 4.671%. Ascorbic acid expressed a much
higher scavenging ability and reached a plateau of 93.774% ± 2.089% at 2 mg mL−1. The structural
characteristics of polysaccharide, such as molecular weight, monosaccharide composition, availability
of hydroxyl group and conformation of side chains, were reported to be responsible for the scavenging
ability of polysaccharide [2,25,27].
2.2.3. Hydroxyl Radical Scavenging Activity
Hydroxyl radical is believed to be the most harmful free radical in the reactive oxygen species, as
it could induce severe damage to adjacent biomolecules [28]. The hydroxyl radical scavenging activity
of CL2 is shown in Figure 5c. The CL2 exhibited high scavenging activity on hydroxyl radical, and the
scavenging effect of polysaccharide enhanced with increasing dosage. At 1 mg mL−1, CL2 showed
hydroxyl radical scavenging activity of 17.72% ± 1.98%, which gradually increased to 83.54% ± 6.71%
at 10 mg mL−1. However, the scavenging activity of CL2 was much lower than that of ascorbic
acid, as it reached a plateau of 99.38% ± 2.089% at 1 mg mL−1. The potential antioxidant activity of
chrysolaminarin from O. aurita may lead to the development of a novel natural antioxidant agent. The
results were in accord with Kanmani et al. [26], who found that the purified exopolysaccharide exhibited
low reducing power, but relatively strong hydroxyl radical scavenging activity; at 1.2 mg mL−1,
the hydroxyl radical scavenging activity of purified exopolysaccharide reached almost 20%, which
increased to 40%–45% at 2.4 mg mL−1. In all experiments, the control ascorbic acid showed much
better antioxidant activity than exopolysaccharide produced from S. phocae.
There are a number of reports on the evaluation of antioxidant activity in diatoms (Phaeodactylum
tricornutum and Chaetoceros calcitrans) or other microalgae (Botryococcus braunii, Porphyridium cruentum
and Scenedesmus obliquus) [29,30]. These studies concluded that several microalgal genera contain
potent antioxidants. However, the experiments were carried out with lipophilic and hydrophilic
extracts, not a purified compound. Kanmani et al. [26] also found that crude exopolysaccharide
extract showed higher reducing power and hydroxyl radical scavenging activity than purified
exopolysaccharide, which may be due to the antioxidant components, such as proteins, amino acids,
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2.3. Production of Chrysolaminarin from O. aurita in a Column Photobioreactor
To investigate the accumulation pattern of chrysolaminarin in O. aurita, the biomass concentration
and chrysolaminarin content of O. aurita cultivated in the glass column photobioreactor were studied
(Figure 6). The biomass concentration of O. aurita had been illustrated in our previous paper [15], which
concluded that high light intensity (300 μmol photons m−2 s−1) and nitrogen-replete condition (18 mM)
were favorable to obtain high biomass accumulation, and the maximum biomass concentration of
6.36 g L−1 was achieved on Day 10 (Figure 6b). Under low light, the chrysolaminarin content in the low
nitrogen cultures increased from 15.09% of dry weight (DW) to 61.34% DW during a 12-day cultivation.
In the high nitrogen cultures, chrysolaminarin content remained stable in the first eight days and then
gradually increased to 39.67% DW at the end of the culture period (Figure 6c). Under high light, the
changes in chrysolaminarin content followed the similar trends of their counterparts under low light
with the difference being that the chrysolaminarin accumulated earlier. A maximum chrysolaminarin
content of 64.86% DW was obtained in the low nitrogen cultures (Figure 6d). These results indicated
that chrysolaminarin acts as storage products in O. aurita, especially in nitrogen-depleted condition.
Myklestad [31] also found that the chrysolaminarin contents of marine diatoms Chaetoceros affinis and
Skeletonema costatum were usually low in the exponential phase of growth, but they increased very
rapidly when nutrients were exhausted in the stationary phase. The light intensity also affects the
content of glucan; at nutrient saturation, high light led to the higher level of chrysolaminarin, which
was consistent with the results in this study.
However, nutrient depletion also limited the growth of O. aurita, leading to the decline of
biomass concentration (Figure 6a,b). Chrysolaminarin productivity, as a combined effect of biomass
concentration and chrysolaminarin content, was a more suitable evaluation index for chrysolaminarin
production. The chrysolaminarin volumetric productivity of O. aurita cultivated under different
conditions was compared (Table 2). High light (HL) was demonstrated to be beneficial for maximizing
chrysolaminarin productivity, as the biomass concentration and chrysolaminarin content of O. aurita
under HL were significantly higher than their counterparts under low light (LL). Under HL, because
of the significant enhancement in biomass concentration, the obtained chrysolaminarin productivity
in high nitrogen (HN) was 14.18% higher than that in low nitrogen (LN), resulting in a record high
chrysolaminarin productivity of 306 mg L−1 day−1. The results indicated that the microalga, O. aurita,
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Figure 6. The biomass (a,b) and chrysolaminarin content (c,d) of O. aurita cultivated in the column
photobioreactor under 100 (a,c) and 300 (b,d) μmol photons m−2 s−1 with a replete (18 mM) and
deficient (6 mM) nitrate supply. Values are the means ± SD (n = 3). When error bars cannot be seen,
the error is less than the size of the symbol.
Table 2. The chrysolaminarin volumetric productivity of O. aurita cultivated under different conditions





Content (% Dry Weight)
Chrysolaminarin
Productivity (mg L−1 Day−1)
LL + LN 4.04 59.33 240
LL + HN 4.23 34.05 144
HL + LN 4.24 63.11 268
HL + HN 6.36 48.16 306
a LL: low light (100 μmol photons m−2 s−1); HL: high light (300 μmol photons m−2 s−1); LN: low nitrogen (6 mM);
HN: high nitrogen (18 mM).
3. Experimental Section
3.1. Organism and Culture Conditions
The diatom, Odontella aurita K-1251, was obtained from the Scandinavian Culture Collection
of Algae and Protozoa (SCCAP) at the University of Copenhagen (Copenhagen, Denmark) and
deposited in our laboratory with modified L1 medium. The influences of nitrogen concentration
and light intensity on chrysolaminarin accumulation were conducted with column photobioreactors
(60 cm length, 3 cm diameter). Cultures were aerated with air supplemented with 1% CO2 through
a hollow glass rod and maintained at 25 ± 2 ◦C in an air-conditioned room. The growth medium
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(100 and 300 μmol photons m−2 s−1) and two nitrogen concentrations (6 and 18 mM) were designed
for investigating the accumulation pattern of chrysolaminarin in O. aurita. The paste of algal cells
collected by centrifugation was inoculated into different treatments at roughly the same starting cell
concentration based on the optical density at a 750-nm wavelength. The cultures were harvested every
two days, and the corresponding biomass concentration and chrysolaminarin content were determined.
3.2. Biomass Measurement
Briefly, 10-mL cultures were filtered onto a pre-weighed GF/B filter paper and dried at 105 ◦C.
The biomass concentration was determined by the difference in weight [15].
3.3. Determination of Chrysolaminarin Content
Chrysolaminarin was extracted from O. aurita according to Granum and Myklestad [32] with
minor modification. Briefly, freeze-dried algal powder (50 mg) was extracted with 5 mL of 50 mM
sulfuric acid at 60 ◦C for 30 min. The extract was assayed quantitatively for chrysolaminarin content
using the phenol-sulfuric acid method [33]. Briefly, 1 mL of chrysolaminarin extract was mixed with
0.5 mL 6% (w/v) phenol solution and 5 mL concentrated sulfuric acid. After standing for 30 min, the
absorbance of the mixture at 490 nm was measured, and the chrysolaminarin content was determined
by comparison to a calibration curve prepared with glucose.
3.4. Preparation of Chrysolaminarin
The isolation and purification procedure of chrysolaminarin from O. aurita was performed
according to the flowchart shown in Figure 7. Freeze-dried microalgal powder (10 g) was extracted twice
with 500 mL sulfuric acid (50 mM) in a 60 ◦C water bath for 30 min. The supernatants were collected by
centrifugation and precipitated with four volumes of 95% ethanol at 4 ◦C. The precipitate was recovered
by centrifugation (5000 rpm, 5 min) and washed twice with ethanol and acetone, then freeze-dried.
The freeze-dried extracts were dissolved in deionized water, and the proteins were removed by the
mixture of chloroform: n-butyl alcohol (4:1, v/v) according to the Sevag method [34]. The deproteinized
solution was dialyzed against deionized water for 48 h, and the crude chrysolaminarin was obtained
under freeze drying. Then, 3 mL of crude chrysolaminarin solution (10 g L−1) were applied to a
DEAE-52 cellulose chromatography column (2 × 30 cm) and gradient eluted with sodium chloride
(0.1 M, 0.3 M and 0.5 M). Each 5 mL of eluate was collected at a flow rate of 0.5 mL/min and monitored
for the presence of polysaccharides using the phenol-sulfuric acid method [33]. The collected fraction
(named CL1) was dialyzed, concentrated and loaded on a Sephadex G-200 column (Pharmacia, Uppsala,
Sweden) with 0.1 M sodium chloride as the mobile phase. Each 2 mL of eluate was collected at a
flow rate of 0.2 mL/min. The corresponding chrysolaminarin fraction was collected, dialyzed against
distilled water for 48 h and concentrated with air flow. Freeze drying of the resulting solution obtained
the chrysolaminarin as a faintly white powder (named CL2) and gave the chrysolaminarin in a 10%
yield, which was used for gas chromatography-mass spectrometry (GC-MS), infrared spectroscopy (IR)
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Figure 7. Isolation and purification procedure of chrysolaminarin from O. aurita.
3.5. Structural Analysis
3.5.1. Molecular Weight
The average molecular weight of chrysolaminarin CL2 was determined by comparison to a
calibration curve prepared with the T-series Dextran standards (Sigma-Aldrich, ST, Louis, MO, USA)
as molecular mass markers using gel-filtration chromatography (GPC) [35].
3.5.2. Monosaccharide Composition
GC-MS (TRACE, Thermo Finnigan, Waltham, MA, USA) was used for analysis of the
monosaccharide components. The chrysolaminarin, CL2 (10 mg), was hydrolyzed in 10 mL 3 M
trifluoroacetic acid (TFA) at 105 ◦C for 6 h. The product was reduced with NaBH4 for 2 h at room
temperature, acetic anhydride at 100 ◦C for 2 h and then analyzed by gas chromatography at a
temperature program of 150–220 ◦C with a rate of 4 ◦C/min using N2 as the carrier. A standard curve
was set up with standard monosaccharides derivatized and measured under the same procedure [10].
3.5.3. IR Spectroscopy
The chrysolaminarin, CL2, was ground with dry KBr powder and pressed for Fourier transform
infrared (FTIR) measurement using an EQUINOX55 spectrometer (Bruker, Bremen, Germany) at the
frequency range of 4000–400 cm−1.
3.5.4. NMR Analysis
Dried chrysolaminarin CL2 (15 mg) was dissolved in D2O for NMR measurements. NMR spectra
were obtained on a Bruker AVANCE III 500 spectrometer (Bruker Biospin, Rheinstetten, Germany) and
recorded at 500.26 MHz for 1H and 125.8 for 13C nuclei, using a 5-mm broadband probe head. Spectra
were obtained at 298 K in D2O, with DSS as the internal reference standard. The signals were assigned
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3.6. Antioxidant Activity Assessment
3.6.1. Reducing Power
The reducing power of chrysolaminarin CL2 was determined based on Deng et al. [10] with minor
modification. Briefly, 1 mL of chrysolaminarin CL2 solution was mixed with 0.2 mL 2 M sodium
phosphate buffer (pH 6.6) and 0.5 mL 1% (w/v) aqueous potassium ferricyanide. The mixture was
incubated at 50 ◦C for 20 min in a water bath. Then, 2.5 mL 10% (w/v) of trichloroacetic acid were
added to the mixture. The resultant mixture was centrifuged at 3500 rpm for 10 min. Two milliliters of
the supernatant were diluted with 3 mL distilled water and then mixed with 0.5 mL 0.3% (w/v) ferric
chloride. The absorbance was measured at 700 nm against distilled water. The increase in absorbance
indicated an increase in reducing power.
3.6.2. DPPH Radical Scavenging Activity
The scavenging activity of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical was carried out
according to Sachindra et al. [36]. Briefly, 2 mL 0.16 mM ethanolic DPPH solution was added to
2 mL of related solution. The mixture was shaken vigorously and left to stand for 30 min at room
temperature in the dark, and then, the absorbance was measured at 517 nm. The inhibition of DPPH
radicals by the samples was calculated as follows: DPPH radical scavenging activity (%) = [1 −
(absorbance of sample − absorbance of blank)/absorbance of control)] × 100%.
3.6.3. Hydroxyl Radical Scavenging Activity
Hydroxyl radical scavenging activity was determined based on Yang et al. [2] with minor
modification. Briefly, 0.2 mL of chrysolaminarin CL2 solution were mixed with 2 mL EDTA-Fe solution
(0.15 mM) and 0.8 mL salicylic acid (2 mM). Afterwards, 2 mL H2O2 (6 mM) were added to the reaction
mixture and incubated for 30 min at 37 ◦C. Absorbance was measured at 510 nm. The capability of
hydroxyl radical scavenging by the samples was calculated as follows: hydroxyl radical scavenging
activity (%) = [1 − (absorbance of sample − absorbance of blank)/Abs. of control)] × 100%.
4. Conclusions
The new chrysolaminarin, CL2, was purified from marine diatom, O. aurita, and structurally
determined as a glucan linked by the β-D-(1→3) (main chain) and β-D-(1→6) (side chain) glycosidic
bond. The results of antioxidant experiments indicate that CL2 possesses potent antioxidant, especially
for scavenging hydroxyl radicals. The high volumetric productivity of chrysolaminarin in the column
photobioreactor suggests that the microalga O. aurita could be developed as a new natural source of
antioxidant or as a food supplement.
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Abstract: Sulfated fucans, the complex polysaccharides, exhibit various biological activities. Herein,
we purified two fucans from the sea cucumbers Holothuria edulis and Ludwigothurea grisea. Their
structures were verified by means of HPGPC, FT-IR, GC–MS and NMR. As a result, a novel structural
motif for this type of polymers is reported. The fucans have a unique structure composed of a central
core of regular (1→2) and (1→3)-linked tetrasaccharide repeating units. Approximately 50% of the
units from L. grisea (100% for H. edulis fucan) contain sides of oligosaccharides formed by nonsulfated
fucose units linked to the O-4 position of the central core. Anticoagulant activity assays indicate that
the sea cucumber fucans strongly inhibit human blood clotting through the intrinsic pathways of
the coagulation cascade. Moreover, the mechanism of anticoagulant action of the fucans is selective
inhibition of thrombin activity by heparin cofactor II. The distinctive tetrasaccharide repeating units
contribute to the anticoagulant action. Additionally, unlike the fucans from marine alga, although the
sea cucumber fucans have great molecular weights and affluent sulfates, they do not induce platelet
aggregation. Overall, our results may be helpful in understanding the structure-function relationships
of the well-defined polysaccharides from invertebrate as new types of safer anticoagulants.
Keywords: polysaccharide; sulfated fucan; chemical structure; anticoagulant
1. Introduction
Thromboembolic diseases continue to be the leading cause of death throughout the world [1].
Most thromboembolic processes require anticoagulant therapy. Thus, the current efforts are to develop
specific and potent anticoagulant agents.
Unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs) have been
cornerstones of antithrombotic treatment and prophylaxis for the last 70 years, which are the only
sulfated polysaccharides currently used as anticoagulant drugs. However, these compounds have
several side effects such as hemorrhagic effects, development of thrombocytopenia, ineffectiveness
in congenital or acquired antithrombin deficiencies, incapacity to inhibit thrombin bound to fibrin,
and so on [1–3]. In addition, the commercial sources of heparins are mainly pig intestinal mucosa or
bovine lung, where they occur in low concentrations. The possibility that prions and viruses could be
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carried by these molecules in addition to the increasing needs for antithrombotic therapies indicate the
necessity to look for alternative sources of anticoagulant agents [3,4].
Marine invertebrate and alga are abundant sources of anticoagulant polysaccharides, such
as a variety of sulfated fucans (also called as fucoidan from brown alga) [3–11]. The proposed
mechanisms of action of these compounds are predominantly related to the inhibition of factors
Xa and thrombin (IIa) mediated by antithrombin (AT) and heparin cofactor II (HCII) [6–8]. Besides the
anticoagulant and antithrombotic activities, some sulfated fucans also possess other important
biological activities such as inducing the sperm acrosome reaction, gastroprotective activities and
inhibition of osteoclastogenesis [12–14].
In spite of the high level of interest shown in functional aspects of sulfated fucans, their structural
properties have been relatively little studied. Thus, the structure-activity relationships remain to be
elucidated. Most of the difficulties for these studies arise from the fact that these compounds are
very heterogeneous polysaccharides or various sulfate substituted homogeneous ones which give
complex NMR spectra with broad signals hampering resolution [4,11,15]. It is not always possible to
define whether these polysaccharides from invertebrates have repetitive units. For example, a study
on the structure of the sulfated fucan from sea cucumber, containing regular 1→3-linked units, was
reported [16,17]. Furthermore, the structure of sulfated fucans may vary according to the species
of invertebrates, as it is the case for heparan sulfates in vertebrates [18]. Thus, each new sulfated
polysaccharide purified from a sea cucumber may be a new compound with unique structures and,
consequently, with potential novel biological activities.
Recently, during the process of searching for new anticoagulant sulfated polysaccharide, we
obtained the sulfated fucans from two species of sea cucumbers Holothuria edulis and Ludwigothurea
grisea, and preliminarily described physicochemical characteristics of the H. edulis fucan [9]. Here
we report structural characterization and pharmacological activities of two new sulfated fucans in
detail. These two polysaccharides have a similar unique structure composed of a central core of regular
α(1→3)- and α(1→2)-linked tetrasaccharide repeating units. Approximately 50% of the units from L.
grisea (100% for H. edulis fucan) contain branches of oligosaccharides formed by nonsulfated fucose
units linked to the O-4 position of the central core. Of particular significance was the finding that
the type of sulfated fucan exhibits selectively antithrombin activity by heparin cofactor II and shows
potent anticoagulant activity without inducing platelet aggregation.
2. Results and Discussion
2.1. Physicochemical Characteristics
Sulfated fucans were extracted from the body wall of two species of sea cucumbers H. edulis
and L. grisea. Purification was achieved by Sephadex G-100 and anion exchange chromatography
on a DEAE-Sepharose FF column according to our previous method [9]. Analysis of sulfated fucans
by anion exchange chromatography on a DEAE Sepharose FF column confirmed the high negative
charge densities of the two polysaccharides [9]. The purities of these polysaccharides were confirmed
by gel filtration chromatography on a Shodex OH-pak SB-804 HQ column. The results show that
they each migrate as a single homogeneous peak [9] and do not have any ultraviolet absorption
near 260 or 280 nm by the measurement of an UV-detector, indicating no contaminants such as protein
and peptide.
These polysaccharides were obtained as water-soluble white powder after lyophilization.
These polysaccharide fractions have been characterized by different analytical techniques to compare
their physicochemical properties, as shown in Table 1. The chemical analysis of purified sulfated fucan
revealed fucose as the only sugar with a high content of sulfate ester with a ratio ~1:(0.80–0.90).
The molecular masses of H. edulis fucan and L. grisea fucan are 616 and 554 kDa, respectively,
as determined by the high-performance gel permeation chromatography. Their FT-IR spectra display








Mar. Drugs 2015, 13, 2063–2084
bands corresponding to sulfate ester: the peaks at 1266 and 854 cm−1 are derived from the stretching
vibration of S=O of sulfate and the bending vibration of C–O–S of sulfate in axial position, respectively.
The signals at 3442 and 1031 cm−1 are from the stretching vibration of O–H and C–O, respectively.
Additionally, the strongly negative specific rotation of the sulfated fucans is compatible with residues
of L-fucopyranose [20]. Thus, partial physicochemical characteristics of these polysaccharides from the
body walls of sea cucumbers H. edulis and L. grisea confirm that they are sulfated fucans. As shown in
Table 1, comparison analysis of the sulfated fucans shows that their physicochemical characteristics
vary according to the species of invertebrates, possible reflecting other important structural differences.
Table 1. Chemical composition and physicochemical properties of the sulfated fucans from the body









Holothuria edulis 1.0 0.80 a 616 b −181◦ [9]
Ludwigothurea grisea 1.0 0.89 a 554 b −178◦ Thiswork
Apostichopus japonicas 1.0 0.57 c 420 b −182◦ [9]




a 100 d ND [7]
Strongylocentrotus
purpuratus 1.0 1.3
a 100 d ND [7]
a Based on interpretation of the 1H-NMR spectrum; b Determined by high-performance gel permeation





































































































Figure 1. FT-IR spectrum of the sulfated fucan from sea cucumber.
2.2. Methylation Analysis
The position of the glycosidic linkages as well as the position of the sulfate ester in the
polysaccharide was determined by methylation analysis (Table 2). Methylation analysis confirms
the occurrence of (1→2) and (1→3) linkages in the sulfated L-fucans: ~40% of 4-methylfucose,
25% of 2-methylfucose, ~20% of 2,3,4-tri-O-methylfucose in the H. edulis sulfated L-fucan (~10% of
2,3,4-tri-O-methylfucose in the L. grisea sulfated L-fucan) were formed from the native polysaccharide.
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with a polysaccharide composed of 3-linked and 2-linked fucose residues, sulfated at the O-2 position,
O-4 and unsulfated units. These structures could be confirmed and further detailed by NMR analysis.







H. edulis L. grisea
1,5-di-O-acetyI-2,3,4-tri-O-methyl-L-fucitol 89, 101, 117,131, 161,175 4.02% (0.047) 4.86% (0.057)
1,3,5-tri-O-acetyI-2,4-di-O-methyl-L-fucitol 3 89,101,117, 131, 233, 247 30.44% (0.325) 26.39% (0.283)
1,2,3,5-tetra-O-acetyI-4-O-methyl-L-fucitol 2,3 89, 131, 201, 261 34.14% (0.335) 40.27% (0.397)
1,2,3,4,5-penta-O-acetyl-L-fucitol 2,3,4 128, 170, 231, 289 22.05% (0.200) 23.02% (0.201)
2.3. NMR Analysis
For the NMR analysis of the sulfated fucans, they give overlapping spectra with broad signals
hampering resolution, since line widths are several Hz, as expected for polysaccharides of high
molecular mass (616 and 554 kDa) [9]. Attempts to record two-dimensional NMR spectra for these
polysaccharides gave no useful result in this study. To further elucidate the structures in detail, their
depolymerized products (~15 kDa) were prepared according to previous reported methods on the
sulfated polysaccharide, which keep almost similar to chemical compositions and structures of native
compounds during the free radical depolymerization [21,22].
The 1H, 13C one- and two-dimensional spectra of the sulfated fucans from H. edulis and L. grisea
are shown in Figures 2–5. The chemical shifts in Table 3 are based on the interpretations of 1H/1H
correlated spectroscopy (COSY), total correlation spectroscopy (TOCSY), and 1H/13C heteronuclear
single-quantum coherence (HSQC) spectra (Figures 3–5). As shown in Figure 2A, the signals at about
1.10–1.40 ppm could be readily assigned to the methyl protons of fucose residues (CH3) [9,12]. In
addition, the chemical shifts of the envelope of anomeric signals at 4.9–5.6 ppm were consistent with
the existence of major five types of α-L-fucose units (designated by A–E in Figure 2A). Integration
of regions of the 1H NMR spectrum indicated that the five types of residues were present in equal
proportions (Figure 2B). Similarly, for the L. grisea sulfated fucan, it has five types of residues with a
ratio ~1:1:1:1:0.5.




1 2 3 4 5 6
Holothuria edulis
A →3)-α-L-Fucp-(2SO3−)-(1→ H 5.40 4.58
b 4.18 c 4.12 4.46 1.30
C 94.16 73.75 73.61 68.85 67.70 15.92
B →3)-α-L-Fucp-(2SO3−)-(1→ H 5.43 4.60 4.39 4.11 4.47 1.32C 98.89 75.12 73.07 68.89 67.71 16.17
C →3)-α-L-Fucp-(2,4SO3−)-(1→ H 5.47 4.63 4.48 4.98 4.51 1.33C 94.31 75.36 74.67 81.24 67.08 16.17
D →2,4)-α-L-Fucp-(1→ H 5.13 4.03 4.10 4.12 4.36 1.29
C 96.64 75.93 67.27 69.80 67.47 15.80
E α-L-Fucp-(1→ H 5.16 4.01 4.08 3.97 4.36 1.29
C 95.93 67.14 67.11 68.91 67.54 15.80
Ludwigothurea grisea
A →3)-α-L-Fucp-(2SO3−)-(1→ H 5.36 4.55 4.14 4.08 4.40 1.26C 94.29 73.78 73.60 69.25 68.01 15.97
B →3)-α-L-Fucp-(2SO3−)-(1→ H 5.39 4.57 4.36 4.08 4.32 1.26C 98.89 75.18 73.08 69.25 68.01 15.97




H 5.10 3.98 4.06 4.13 (4.09) 4.48 1.29
C 96.77 75.97 66.85 (67.11) 69.79 (68.92) 67.47 16.24
E α-L-Fucp-(1→ H 5.07 3.99 4.01 4.06 4.41 1.26
C 96.77 66.85 67.11 68.92 67.47 15.97
a Data were recorded on a Bruker Advance DRX 500 spectrometer; chemical shifts are given in ppm with reference
to trimethylsilyl-propionic acid (TSP) d4; b Values in boldface indicate positions bearing sulfate groups; c Values in
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Figure 2. 1H (A,B) and 13C (C) one-dimensional NMR spectra at 500 MHz of the sulfated fucan
from H. edulis. The spectra were recorded at 300 K for samples in D2O solution. Chemical shifts are
relative to external trimethylsilylpropionic acid at 0 ppm. The residual water has been suppressed by
pre-saturation. The anomeric signals assigned by 1H/13C HSQC (see Figure 5) are labeled A–E in the
sulfated fucan. Expansion of the 4.9–5.6 ppm region of the 1H spectrum is shown in the inset in (A).
The integrals were listed under the anomeric signals (B).
Furthermore, 1H/1H COSY and TOCSY spectra of the sulfated fucans from H. edulis and L. grisea
can be assigned to five spin systems C, B, A, D (D') and E (Figures 3 and 4), allowing the assignments
of almost all proton signals of five fucose residues as shown in Table 3, each consistent with fucose [17].
The contributions to the 1H NMR spectrum of residues A, B and C varied most significantly in their
H-2 and H-4 shifts. These differences may be attributed to sulfation shift. The values of δH-2 for them,
at 4.55–4.60 ppm, were shifted ~0.6 ppm downfield of δH-2 for D (D') and E, indicating that residues
A, B and C were 2-O-sulfated. The values of δH-4 of residue C was ~0.9 ppm downfield of δH-4 for
other four fucose residues, indicating that only residue C was 4-O-sulfated. Therefore, residue C bears
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Figure 3. 1H/1H COSY spectra of the sulfated fucans from H. edulis (A) and L. grisea (B). The
spectra were recorded at 300 K for samples in D2O solution. Chemical shifts are relative to external
trimethylsilylpropionic acid at 0 ppm. The residual water has been suppressed by pre-saturation. The
anomeric signals assigned by 1H/13C HSQC (see Figure 5) are labeled A–E in the sulfated fucans.
In addition, carbon chemical shifts for sulfated and unsulfated fucose residues were also observed
by the 13C (Figure 2C) and 1H/13C HSQC experiment (Figure 5A,B). Strong downshifts of C-2 of
residues A, B and C (~8 ppm) and C-4 of residues C (~13 ppm) (Figure 5A,B and Table 3) relative
to those of residues D and E indicate that three of the five residues are 2-O-sulfated, that one are 2,
4-dis-O-sulfated and that the other two are non-O-sulfated. Additionally, the anomeric carbon signals
labeled A–E in the sulfated fucan were also easily assigned by 1H/13C HSQC, giving the chemical
shifts ~95–99 ppm as shown in Table 3. Notably, strong downshifts of C-3 of residues A, B and C
(~7 ppm), C-2 (~9 ppm) and C-4 (~2 ppm) of residues D may display existence of 3-linked, 2-linked
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Figure 4. Expansions of the TOCSY (A,B) and ROESY (C,D) spectra of two sulfated fucans from H.
edulis and L. grisea (B,D).The TOCSY spectra (A,B)show some cross-peaks used in the assignment of the
fucose residue, especially positions bearing sulfate esters. The ROESY spectra (B,D) show ROEs, the
sequence-defining A1–B3, B1–C3, C1–D2, D1–A3 and E1–D4. The five fucose residues in the repeating
unit are marked A–E as described in the legend of Figure 6.
The order of the five residues can be easily deduced. The only possible array is one 2,
4-dis-O-sulfated residue followed by two consecutive 2-O-sulfated residues and one unsulfated
residues with an unsulfated residues as a side chain. Our proposition was confirmed by the ROESY and
HMBC spectra (Figures 4 and 5). As in the ROESY spectra of other fucans from echinoderms [12,17],
ROEs between protons of different units can be seen, and they were used to reveal the sequence
(besides, of course, ROEs on other protons in the same residue). In the two sulfated fucans, H-1 of
residue A shows cross-peaks to H-3 of residue B; H-1 of residue B shows cross-peaks to H-3 of residue
C; H-1 of residue C shows cross-peaks to H-2 of residue D; H-1 of residue D shows cross-peaks to
H-3 of residue A; and notably, H-1 of residue E shows cross-peaks to H-4 of residue D. Similarly,
the HMBC spectrum (Figure 5C,D) also show the sequence-defining A1–B3, B1–C3, C1–D2, D1–A3
and E1–D4. These evidences indicate the sequence and linkage -3-A-1→3-B-1→3-C-1→2-D-1→ as
the linear tetrasaccharide backbone and occurrence of linkage E-1→4-D as a side chain, as shown
in Figure 6.
To further estimate the configurations at the glycosidic linkages, the direct coupling constants
(1JC–H) of C-1 of each sugar were also obtained from HMBC spectrum (Figure 5).The large values of
170–175 Hz for these fucose residues indicate the protons are equatorial [23]. Taking account of the
vicinal coupling constant (3J1H–2H) of 3 Hz for fucose residues, the configurations at C-1 of these sugars
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for H. edulis and L. grisea fucan, respectively) and the proton shifts of anomeric signals of the sulfated
fucans (Table 3).
 
Figure 5. 1H/13C HSQC (A,B) and HMBC (C,D) spectra of two sulfated fucans from two sea cucumbers
H. edulis (A,C) and L. grisea (B,D). The assignments were based on TOCSY and COSY spectra. The
anomeric signals were identified by the characteristic carbon chemical shifts and are marked A–E. The
HMBC spectra (C,D) also show the sequence-defining A1–B3, B1–C3, C1–D2, D/D'1–A3 and E1–D4.
The five fucose residues in the repeating unit are marked A–E as described in the legends of Figure 6.
 
Figure 6. Proposed regular repeating units of sulfated fucan isolated from two sea cucumbers H. edulis
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Thus, the sulfated fucans from H. edulis and L. grisea are mostly a tetrasaccharide repeating
backbone unit consisting of 2- and 3-linked α-L-fucose residues and 4-linked unsulfated α-L-fucose
residue as a side chain.
Overall, the combination of chemical analysis, specific optical rotation, methylation experiments
and NMR spectroscopy has allowed us to determine the fine structure of the sulfated polysaccharides
isolated from the body walls of two species of sea cucumbers. The sulfated α-L-fucans from H. edulis
and L. grisea are essentially linear polymers, composed of a regular tetrasaccharide repeat backbone
unit defined by the pattern of O-sulfation with an unsulfated fucose residue as a side chain (Figure 6).
The proportion of unsulfated fucose residue in the side chain varies in the two species. The α-L-fucan
from H. edulis consists of total fucosylated at the O-4 position of the tetrasaccharide repeat backbone
(Figure 6A), while the sulfated α-L-fucan from L. grisea consists of about half fucosylated at the
backbone (Figure 6B).
A variety of sulfated fucoidans from marine algae have been described [11,17,24]. These
compounds are among the most abundant and widely studied of all sulfated polysaccharides of
non-mammalian origin [12]. The algal fucans have complex heterogeneous structures [11,24]. Their
regular repeating sequences are not easily deduced; even high-field NMR is at the limit of its resolution,
and complete description of their structure is much difficult at present [4,12,15,17,25]. In contrast
to the algal fucans, these sea cucumber polysaccharides have novel regular structures composed of
well-defined repeating units of oligosaccharides as shown in Figure 6. To our best knowledge, two new
sulfated polysaccharides composed of a 3-linked and 2-linked tetrasaccharide repeat backbone unit
defined by the pattern of O-sulfation with an unsulfated fucose residue as a side chain had not been
reported. Especially, the position (1→2) of the glycosidic linkage may be firstly found in the marine
invertebrate fucans, though it had been reported the occurrence of (1→2) linkage in the fucoidans from
a variety of brown seaweeds [26,27].
2.4. Anticoagulant Activities
Anticoagulant activities of the polysaccharides from the two sea cucumbers were assessed by
measuring the activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin
time (TT), and compared with the same activities of unfractionated heparin and dermatan sulfate from
mammalian sources. The APTT, PT, and TT are used to determine the ability to inhibit blood clotting
through the intrinsic, extrinsic and common pathways of the coagulation cascade, respectively [9,28].
As shown in Table 4, the assays indicated that the sulfated fucans from H. edulis and L. grisea had
similar APTT-prolonging activity (~10 heparin U/mg), but did not affect PT and TT in human plasma
at the concentrations tested (1–100 μg/mL). Its APTT-prolonging activity is two-fold greater than that
of mammalian dermatan sulfate, and is similar to that of another two sulfated fucans from marine
sea urchin in the literature [7]. The results indicated that the type of sulfated fucans may affect the
intrinsic but not the extrinsic and common coagulation process.
To further investigate mechanism of anticoagulant action, anti-thrombin activity in the presence
of heparin cofactor II, anti-factor Xa and anti-thrombin activities mediated by AT were also examined
with chromogenic substrates (Figures 7–9). Increasing concentrations of the sulfated fucans resulted in
essentially complete inhibition of thrombin activation by heparin cofactor II (Figure 7), corresponding
with a noncompetitive inhibition pattern [29]. As shown in Figures 7–9 and Table 4, the sea cucumber
polysaccharides displayed significantly weaker anti-factor Xa and anti-thrombin activities mediated
by AT than heparin and LMWH as positive anticoagulant drugs, suggesting that their anticoagulant
mechanisms are different from those of heparin-like drugs. Like DS as a positive reference, in the
presence of heparin cofactor II, the sulfated fucans showed very strong inhibition of thrombin (IC50
0.5–0.7 μg/mL, ~1 nM). In contrast, their thrombin and factor Xa inhibition activities mediated by AT
were much weaker (Figures 8 and 9, Table 4). As shown in Table 4, HCII-dependent anti-thrombin
activity of the type of the sulfated fucan is above 1000-fold higher than anti-factor Xa activity and
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sulfated polysaccharides selectively inhibit thrombin activity in the presence of heparin cofactor II.
Thus, the structural requirements for interaction of these polysaccharides with coagulation cofactors
(HCII and AT) and their target proteases may be macromolecularity such as conformation and length
of repetitive units, etc.
Interestingly, the sulfated fucans from two species of sea cucumber, which possess the same
tetrasaccharide repeat backbone unit but various proportions of fucosylated side chains, show
essentially the same anticoagulant activities such as APTT-prolonging activity and HCII-dependent
anti-thrombin activity (Figure 7 and Table 4). These results implied that anticoagulant action of the
sulfated α-L-fucan from sea cucumber might be assigned to the tetrasaccharide repeat backbone unit






















































































































































































































































































































































































































































































































































































































































































































































































Mar. Drugs 2015, 13, 2063–2084
















 Sulfated fucan from H. edulis 
 Sulfated fucan from L. grisea
 Buffer










 Sulfated fucan from H. edulis
















Figure 7. Inhibitory effects of the sulfated fucans, heparin, low molecular weight heparin (LMWH)
and dermatan sulfate (DS) on thrombin mediated by heparin cofactor II. (A) Shows the time course of
thrombin inhibition. HCII (~1 μM) was incubated with thrombin (20 NIH/mL) in the presence of 30
μL (625 ng/mL) samples at 37 ◦C. After 2 min, 30 μL of 4.5 mM CS-01 (38) was added, the residual
thrombin activity was recorded by absorbance at 405 nm; (B) Shows the dependence on the sulfated
polysaccharide concentration for thrombin inactivation in the presence of HCII. The reaction mixtures
were as described in (A), except that different concentrations of sulfated polysaccharides were used.
Results are shown as means of duplicates. See Table 4 for IC50 values.
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Figure 8. Inhibitory effects of the sulfated fucans, heparin, LMWH and DS on thrombin in the presence
of antithrombin. (A) Shows the time course of thrombin inhibition. Mixed samples of 30 μL of
polysaccharides (625 ng/mL) and 30 μL of 0.25 IU/mL AT were incubated at 37 ◦C for 2 min, and 30 μL
of 24 NIH/mL IIa was then added. After incubation for 2 min, 30 μL of 1.25 mM CS-01 (38) was added,
the residual factor IIa activity was recorded by absorbance at 405 nm; (B) Shows the dependence on the
sulfated polysaccharide concentration for thrombin inactivation mediated by AT. The reaction mixtures
were as described in (A), except that different concentrations of sulfated polysaccharides were used.
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Figure 9. Inhibitory effects of the sulfated fucans, heparin, LMWH and DS on factor Xa in the presence
of antithrombin. (A) Shows the time course of Xa inhibition. Mixed samples of 30 μL of polysaccharides
(625 ng/mL) and 30 μL of 1 IU/mL AT were incubated at 37 ◦C for 2 min, and 30 μL of 8 μg/mL
bovine Xa was then added. After incubation for 1 min, 30 μL of 1.20 mM CS-11(65) was added, the
residual Xa activity was recorded by absorbance at 405 nm; (B) Shows the dependence on the sulfated
polysaccharide concentration for Xa inactivation in the presence of AT. The reaction mixtures were as
described in (A), except that different concentrations of sulfated polysaccharides were used. Results
are shown as means of duplicates. See Table 4 for IC50 values.
There are few polysaccharides which provide a suitable comparison for the anticoagulant activity
of the sulfated fucans from sea cucumber. Polymers with sulfated fucose as their primary constituent,
the fucans from the egg jelly of sea urchin, also have anticoagulant properties [6–8]. A study of
the fucan from Strongylocentrotus pallidus established that the major anti-thrombin activity of this
preparation was mediated by heparin cofactor II, with low ability to potentiate anti-thrombin; however,
another species, Strongylocentrotus purpuratus, has yielded a fucan in which the balance of antithrombin
and heparin cofactor II mediated activities is more in favor of the former [7]. Our results suggested that
the type of novel fucans from sea cucumber possesses selectively HCII-dependent thrombin inhibition.
The structures of fucans vary from species to species [12,17,30], so this may give rise to variation in the
detailed mechanisms of anticoagulant action.
To investigate the structure-activity relationship, it may be valuable to compare anticoagulant
action of the fucans from different resources with each other, although differences in experimental
techniques between laboratories make direct comparisons between the results of different studies
difficult. A study of the fucans from sea urchin suggested that, the occurrence of 2,4-di-O-sulfated
units is an amplifying motif for 3-linked L-fucan enhanced thrombin inhibition by antithrombin;
the major structural requirement for anti-thrombin activity by heparin cofactor II becomes single
4-O-sulfated fucose units; the presence of 2-O-sulfated fucose residues always had a deleterious effect
on anticoagulant activity [7]. However, in this work, the sulfated fucans from sea cucumber without
single 4-O-sulfated fucose units possess strong thrombin inhibition mediated by heparin cofactor II
(Table 4). These sulfated L-fucans from sea urchins and sea cucumbers have similar charge density and
sulfate content (Table 1), but possess the specific pattern of sulfation and the position of the glycosidic
linkage as shown in Table 4 and Figure 6. Therefore, these specific structural characters of the sea
cucumber polysaccharides, especially the position of the glycosidic linkage, not merely a consequence
of their charge density and sulfate content, may contribute to the anticoagulant action.
Overall, our results demonstrated that combining structural analysis of sulfated polysaccharides
with specific biological assays is a useful tool to investigate anticoagulant activity. These studies may
help elucidate a closer relationship between structure and biological activity of sulfated polysaccharides.
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2.5. The Sea Cucumber Sulfated Fucans do not Induce Human Platelet Aggregation
The effects of the sea cucumber fucans on platelet aggregation were studied via a conventional
turbidimetric assay [31,32]. Aggregation was quantified by measuring the maximum extent of the
increase in light transmittance 5 min after the addition of the agonist. As shown in Figure 10, the results
showed that the fucans did not significantly cause platelets to aggregate in citrated human platelet
rich plasma at several concentrations (7.5–30 μg/mL), similar to saline as a negative control. However,
a study of fucoidans from marine alga established that they demonstrated dose-dependent irreversible
platelet aggregation [33]. Although the absence of a more detailed description on the structure of the
polysaccharide used in the study makes it difficult to compare with our results, various structures of
the fucans from different resources may account for their different effects on platelet aggregation. In
contrast, the aggregation response of another polysaccharide, the fucosylated glycosaminoglycan from
the sea cucumber H. edulis [9], was dose-dependent and was detected immediately after the addition
of the agonist. We observed a considerable effect of the glycosaminoglycan at 30 μg/mL, which was
~75% aggregation as the same as arachididonic acid (AA) at 0.5 mM as a positive control (Figure 10B).
The platelet aggregation induced by the sea cucumber glycosaminoglycan had been shown [28,34].
Therefore, the different structural polysaccharides from sea cucumber, in spite of the same species,
may demonstrate various effects on platelet aggregation.
  
Figure 10. Profile of the platelet aggregation induced by the sea cucumber polysaccharides: the sulfated
fucan from L. grisea (A); the sulfated fucan and fucosylated glycosaminoglycan from H. edulis (B). The
profile showed that the sulfated fucans from sea cucumber do not cause platelets to aggregate at
several concentrations.
It is known that a sequence of responses such as further platelet aggregation and fibrin formation
result in thrombosis [35]. Thus, the platelet aggregation of the compound as an anticoagulant agent
may be its undesirable effect. In this work, the sea cucumber fucans do not cause platelets to aggregate
in human plasma at the concentration of 100% thrombin inhibition medicated by HCII. Therefore, our




The sea cucumber H. edulis were obtained commercially (Qingdao, China), and the sea cucumber
L. grisea was kindly donated by Mourão (Instituto de BioquímicaMédica, Universidade Federal do Rio
de Janeiro, Rio de Janeiro, Brazil). The monosaccharides including glucuronic acid (GlcA), glucose
(Glc) and galactose (Gal) were purchased from Alfa Aesar. The N-acetylgalactosamine (GalNAc)
was purchased from TCI and fucose (Fuc) was from sigma Chemical Co. (Shanghai, China). The
1-phenyl-3-methyl-5-pyrazolone (PMP, 99%) was purchased from ACROS organics. Heparin (212 USP
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LMWH (Enoxaparin, 0.4 mL × 4000 AXaIU) was purchased from Sanofi-Aventis (Paris, France). The
activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) reagents
and standard human plasma were from Teco Medical (Neufahrn N.B., Germany). Biophen Heparin
Anti-IIa kits, Biophen Antithrombin 2.5 kits, Human HCII, ATIII, thrombin, thrombin chromogenic
substrate CS-01(38) and factor Xa chromogenic substrate SXa-11 were all from Hyphen Biomed (Paris,
France). Arachidonic acid (AA), adenosine diphosphate (ADP) and collagen were purchased from
Chronolog Corporation, (Havertown, PA, USA). All of other chemicals used were of reagent grade
and were obtained commercially.
3.2. Purification of the Sulfated Fucans and Preparation of Their Degraded Products
The polysaccharides were extracted from the body wall of sea cucumbers as the previous
description [9,16]. The tissue of the dried body wall was digested by 0.5 M sodium hydroxide
for 2 h, and then core protein combined with polysaccharides was released by the papain (EC 3.4.22.2)
for 6 h. The crude polysaccharides were purified by gel filtration with a Sephadex G-100 (2 cm ×
100 cm, GE Healthcare Technology, Uppsala, Sweden) and ion-exchange chromatography with a
DEAE-sephadex FF column (3 cm × 7 cm, Amersham Biosciences, Uppsala, Sweden). The purity
of preparation was assayed by high-performance gel permeation chromatography (HPGPC) using a
Agilent technologies1200 series (Agilent Co., Santa Clara, CA, USA) apparatus with RID (G1362A) and
DAD (G1315D) detectors, equipped with a Shodex OH-pak SB-804 HQ column (8 mm × 300 mm).
Chromatographic conditions and procedures were performed according to the previous method [19,36].
To further elucidate the structures in detail, their depolymerized products (~15 kDa) were
prepared according to previous reported methods on the sulfated polysaccharide [19]. The native fucan
(5.0 g) and 160 mg of copper (II) acetate monohydrate were dissolved in 180 mL of 6% sodium acetate
and sodium chloride solution at 35 ◦C. A 10% H2O2 solution was added. The pH of the solution was
maintained at 7.3~7.5 by addition of 1 M NaOH solution. The reaction was stopped at different time
and after the reaction, 0.5 g of disodium ethylenediamine tetra-acetate dihydrate was added to remove
contaminating copper from the product. Depolymerized product was precipitated with ethanol (1:4
(v/v) reaction mixture/ethanol). The crude product was collected by centrifugation (4000× g for 20
min) and washed with ethanol. The precipitate was dissolved in water, dialyzed with a molecular
weight cut-off of 3 kDa (Spectrum Laboratories Inc., Piscataway, NJ, USA) and lyophilized.
3.3. Monosaccharide Composition Analysis
The monosaccharide components of the sulfated fucans were analyzed by reverse-phase HPLC
according to PMP derivatization procedures [9]. Briefly, standard monosaccharides or hydrolyzed
sample were dissolved in 0.6 M NaOH (50 μL) and a 0.5 M PMP (50 μL) solution before the
derivatization, and incubated at 70 ◦C for 30 min in a heating block. Then the mixture was neutralized
by 50 μL of 0.3 M HCl solution and filtered through 0.22 μm membrane (Millipore, MA, USA).
10 μL of the resulting solution was injected into the RP-C18 column (Agilent Eclipse XDB C18,
150 mm × 4.6 mm). The flow rate was 1 mL/min, and UV absorbance of the effluent was monitored
at 250 nm. Buffers A and B were 0.1 M ammonium acetate, pH 5.5, containing 22% acetonitrile,
respectively. Sugar identification was achieved by comparison with reference sugars.
3.4. Methylation Analysis
Methylation of the sulfated fucan was carried out according to the literature with minor
modification [37–40]. Briefly, 5 mg of the sample was placed in a vacuum oven at 40 ◦C overnight in
the presence of phosphorus pentoxide. Then it was dissolved in 2 mL of anhyd DMSO and sonicated
completely. Afterwards, 0.6 mL NaOH–DMSO solution under nitrogen was added to the mixture,
which was sonicated for at least 30 min. The derivatization was triggered by loading 1 mL of cold
CH3I dropwise until it was fully cooled. The resulting solution was allowed to react for 30 min in
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mL of chloroform and dried at low pressure on a rotary evaporator. After hydrolysis with 10 mL of
2 M trifluoacetic acid, the fucanhydrolysates were dissolved in 2 mL of NaOH aqueous solution. A
total of 20 mg of NaBH4 were added to reduce the hemiacetal group. After incubation at 25 ◦C for 2 h,
100 μL of glacial acetic acid were used to terminate the reduction. The sample was dried under low
pressure, and then acetylated by adding 2 mL of acetic anhydride and 2 mL of pyridine. The reaction
was kept at 100 ◦C for 1 h. A total of 2 mL of distilled water were used to decompose the remained
acetic anhydride. The acetylated derivatives were extracted with 4 mL of methylene chloride. A gas
chromatography/ mass spectrometer (GCMS-QP 2010, Shimadzu, Kyoto, Japan) was used to analyze
the glycosidic linkage. The acetylated derivatives were loaded into a RTX-5 capillary column. The
temperature program was set as follows: the initial temperature of column was 150 ◦C, increased to
180 ◦C at 10 ◦C/min, then to 220 ◦C at 2 ◦C/min, increasing to 240 ◦C at 5 ◦C/min, holding for 5 min;
injection temperature: 230 ◦C. The ion source of mass spectrometer was set at 240 ◦C.
3.5. NMR Analysis
The structure analysis were performed by NMR analyses at 300 K in D2O with a Bruker Avance
spectrometer of 500 MHz equipped with a 13C/1H dual probe in FT mode, as previously described [12].
All samples were previously dissolved in deuterium (D2O, 99.9% D) and lyophilized thrice to replace
exchangeable protons with deuterium. The lyophilized samples were then dissolved in D2O at a 20–30 g/L
concentration. All spectra were recorded with HOD suppression by presaturation. The interpretations
of 1H/1H correlated spectroscopy (COSY), total correlation spectroscopy (TOCSY), rotating frame
overhauser effect spectroscopy (ROESY), and 1H/13C heteronuclear single-quantum coherence (HSQC),
heteronuclear multiple bond coherence (HMBC) spectra were recorded using state-time proportion phase
incrementation for quadrature detection in the indirect dimension. All chemical shifts were relative to
internal 3-trimethylsilyl-(2,2,3,3-2H4)-propionic acid (TSP, δH and δC = 0.00).
3.6. Determination of the Anticoagulant Activities
The activated partial thromboplastin time (APTT), prothrombin time (PT), and thrombin time (TT)
were determined with a coagulometer (TECO MC-4000, Teco Medical Inc., Neufahrn N.B., Germany)
by using APTT, PT, TT reagents and standard human plasma as previously described [41,42].
3.7. Inhibition of Thrombin by Heparin Cofactor II
Inhibition of thrombin by HCII was measured with thrombin chromogenic substrate CS-01(38)
using previously described method with modifications [28,43]. A mixture containing 30 μL of HCII
(1 μM) in 20 mM Tris-HCl (pH 7.4) and 0.1% PEG-8000, and 30 μL of various concentrations of each
glycosaminoglycan in 20 mM Tris-HCl (pH 7.4) was incubated at 37 ◦C for 1 min. A 30 μL aliquot of
20 NIH/mL thrombin in 20 mM Tris-HCl (pH 7.4) containing 0.1% PEG-8000 was then added. After
incubation at 37 ◦C for 1 min, 30 μL of 4.5 mM thrombin chromogenic substrate CS-01(38) solution
was added and the thrombin activity was measured. The absorbance at 405 nm was measured on a
Bio-Tek Microplate Reader (ELx 808, BioTek Instruments, Inc., Winooski, VT, USA).
3.8. Inhibition of Thrombin and Factor Xa by Antithrombin
The antithrombin and anti-factor Xa activities in the presence of AT were measured with Biophen
Heparin Anti-IIa kits and Biophen Heparin Anti-Xa kits [28]. A mixture of 30 μL samples and
30 μL 0.25 IU/mL AT (or 1 IU/mL AT) was incubated at 37 ◦C for 2 min; 30 μL of 24 NIH /mL
thrombin (or 8 μg/mL bovine factor Xa) was added. After incubation for 2 min (or 1 min for factor
Xa), the residual thrombin or factor Xa activity was measured by the addition of 30 μL of 1.25 mM
thrombin chromogenic substrate CS-01(38) or 1.20 mM factor Xa chromogenic substrate CS-11(65). The
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3.9. Platelet Aggregation Assays
Turbidometric measurements of platelet aggregation of the polysaccharides were performed in
a Chronolog Model 700 Aggregometer (Chronolog Corporation, Havertown, PA, USA) according
to Born’s method [28,31,32]. Venousblood from a young volunteer (31 years old, male, 72 kg) were
anticoagulated with 3.8% sodium citrate (9:1, v/v). Platelet-rich plasma (PRP) and platelet-poor plasma
(PPP) were prepared shortly after blood collection by spinning the sample at 180 g for 10 min at 22 ◦C.
The PRP was carefully removed and the remaining blood centrifuged at 2400 g for 10 min to obtain
PPP. The centrifuge temperature was maintained at 4 ◦C. Platelet counts were adjusted by the addition
of PPP to the PRP to achieve a count of 250 × 109 L−1. Platelet aggregation studies were completed
within 3 h of preparation of PRP. Immediately after preparation of PRP, 250 μL was transferred into
each of the three test tubes, with 250 μL PPP as a control. After 5 min of warming, PRP and PPP were
put in testing places and were warmed for a further 5 min. Final concentrations of agonists were: AA
0.5 mM and ADP 10 μM as positive references, respectively. The change of optical density as a result of
platelet aggregation was recorded. The present study was approved by the Research Ethics Committee
of Kunming Institute of Botany (SYXK-K2013-0004), Chinese Academy of Sciences. The study subject
provided written informed consent (20 September 2013).
4. Conclusions
In conclusion, structural characterization and pharmacological activities of two new sulfated
fucans from sea cucumber have been elucidated. As described above, the polysaccharides are
composed of a central core of regular α(1→3)- and α(1→2)-linked tetrasaccharide repeating units
together with an unsulfated fucose residue as a side chain. Investigation of the structure-activity
relationship suggested that novel tetrasaccharide repeating units of the sea cucumber polysaccharides
may contribute to the anticoagulant action. The anticoagulant and platelet aggregation assays further
indicated that the type of fucans possesses selectively anti-thrombin activity by heparin cofactor II
without causing platelets to aggregate, whose anticoagulant mechanisms are different from those of
heparin-like drugs. Further work on in vivo antithrombotic activity of the well-defined sulfated fucan
as a potential anticoagulant therapeutics is worthy to be conducted.
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Abstract: Anionic polysaccharides fucosylated chondroitin sulfates (FCS) from holothurian species
were shown to affect various biological processes, such as metastasis, angiogenesis, clot formation,
thrombosis, inflammation, and some others. To understand the mechanism of FCSs action, knowledge
about their spatial arrangement is required. We have started the systematic synthesis, conformational
analysis, and study of biological activity of the oligosaccharides related to various fragments of
these types of natural polysaccharides. In this communication, five molecules representing distinct
structural fragments of chondroitin sulfate have been studied by means of molecular modeling and
NMR. These are three disaccharides and two trisaccharides containing fucose and glucuronic acid
residues with one sulfate group per each fucose residue or without it. Long-range C–H coupling
constants were used for the verification of the theoretical models. The presence of two conformers for
both linkage types was revealed. For the Fuc–GlA linkage, the dominant conformer was the same as
described previously in a literature as the molecular dynamics (MD) average in a dodechasaccharide
FCS fragment representing the backbone chain of the polysaccharide including GalNAc residues.
This shows that the studied oligosaccharides, in addition to larger ones, may be considered as reliable
models for Quantitative Structure-Activity Relationship (QSAR) studies to reveal pharmacophore
fragments of FCS.
Keywords: fucosylated chondroitin sulfate; oligosaccharides; conformational analysis; glycosidic
linkage; Karplus equation; long range C–H coupling constants
1. Introduction
Anionic polysaccharides of a different nature were shown to affect various biological processes,
such as metastasis, angiogenesis, clot formation, thrombosis, inflammation, bacterial and viral
adhesion, and some others [1–4]. In some cases, exogenous polysaccharides act via the mechanism
of competitive inhibition of the natural ligand binding to the target protein. Thus, well known
glycosaminoglycan heparin was found to reduce inflammation and metastasis in a way of inhibition of
P- and L-selectins binding to their cellular ligands [4,5]. In other cases, carbohydrates could potentiate
interaction of two proteins with the formation of a ternary complex, which can be illustrated by
thrombin-antithrombin III-heparin complex formation playing the key role in inhibition of blood
coagulation [6,7]. However, side effects of heparin treatment, such as bleeding and thrombocytopenia,
force the search for and development of alternative drugs. Among the compounds under investigation
are the polysaccharides fucosylated chondroitin sulfates (FCSs) isolated from different holothurian
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species. These biopolymers demonstrated a wide range of biological activities including antimetastatic,
anti-inflammatory, anticoagulant, antithrombotic, immunostimulatory, antibacterial, antiviral, and
some others activities typical of heparin but with a lack of side effects [3,8–13].
The backbone of known FCSs is built up of alternating →4)-linked β-D-glucuronic acid and
→3)-linked N-acetyl β-D-galactosamine residues. Some of glucuronic acid units are substituted at
O-3 by selectively O-sulfated fucosyl residues (Figure 1) [3,13]. The presence of side chains in FCS
distinguishes them from mammalian chondroitin sulfates and was shown to be essential for biological
properties of FCS [13,14]. The pattern of O-sulfation and the structure of branches vary accordingly
to the type of holothurian species and are basically responsible for the level of biological effect of
FCSs [3,13]. Fine structural characteristics of these polysaccharides also depend on the geographic
range, season of harvesting, and the method of isolation [13,15]. In Figure 1 the known structures of
the branched fragments of FCSs are presented.
Figure 1. Branched fragments of fucosylated chondroitin sulfates and synthetic oligosaccharides
related to the knots.
It is known that the presence of sulfate groups in these polysaccharides is crucial for the observed
biological activity [1,3,11,13,14]. However, influence of certain sulfation patterns on the activity is
poorly understood. In our laboratory, we have started a complex investigation of oligosaccharides
related to various fragments of FCS, including their systematic synthesis, conformational analysis, and
study of biological action, particularly the role of sulfate groups.
To understand the mechanism of FCSs action, knowledge about the spatial arrangement of these
carbohydrates is required. In this communication, five molecules representing simple structural
fragments of chondroitin sulfate have been studied by means of molecular modeling and NMR. These
are three disaccharides (Figure 1) and two trisaccharides containing fucose and glucuronic acid residues
with a single sulfate group per each fucose residue. The synthesis and detailed characterization of
these compounds are described in [16].
2. Results and Discussion
The conformation of the glycosidic linkage is usually described in terms of two torsional angles,
ϕ and ψ. These are directly connected with values of long-range 13C–1H spin–spin coupling constants
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parameters may be formalized by the Karplus type equation [17] (Figure 2), which opens the way
towards the verification of the results of theoretical modeling by NMR methods.
Figure 2. Torsional angles describing a glycosidic linkage and the Karplus equation [17]. Angles ϕ and
ψ are defined as H1–C1–O–Cx and C1–O–Cx–Hx correspondingly.
First, conformational maps were constructed for each oligosaccharide. A simple dihedral driving
algorithm was used with a step of 10◦ for each torsion determining the conformation of the glycosidic
linkage. Energies of the conformations in each step were plotted as conformational maps (Figure 3).
In the modern conformational analysis of carbohydrates, such approach is considered as a very
rough estimate of the potential energy surface. For each linkage in the studied compounds, only one
populated area corresponding to the global minimum was revealed. Other minima had significantly
higher energies and were scarcely populated. Thus, these results were not used for the modeling of
the NMR parameters, and only two samples of the obtained maps are given in Figure 3.
The found minima were used as starting points for molecular dynamics (MD) calculations. These
were carried out in three modes: first in vacuo, then with the account for solvation using the Solvent
Accessible Surface Area (SASA) [18] continuum model, and with the explicit water molecules in a
droplet. Such an approach was successfully used by us previously [19] during the conformational
analysis of glucan fragments.
Figure 3. Sample confomational maps obtained by means of torsion scanning for Fuc–GlA (A) and
Fuc–Fuc (B) linkages.
The general MD procedure included a 20,000 ps run for each starting structure with a snapshot
being written at an interval of 2 ps, resulting in 10,000 snapshot structures in each trajectory. The
constant temperature (298 K) protocol was used. The snapshot structures collected during MD
simulations were used to calculate an ensemble of averaged SSCC values in order to compare them
with the experimentally observed ones. The latter were measured employing J-HMBC technique (see
the Experimental Section for details). Previously, the experimental error of thus measured 3JC–H was
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In vacuo calculations quite expectedly produced results inconsistent with the experiment in all the
cases (Table 1). An average difference between the experimental and calculated SSCC values was about
0.8 Hz. This can be attributed to the highly charged nature of the studied molecules and, obviously, a
consideration of the solvation effects was required.
Table 1. Experimental and calculated with different models spin–spin coupling constants (SSCC)
values for compounds 1–5, Hz.
Compound Number Jϕ (Fuc–GlA) Jψ (Fuc–GlA) Jϕ (Fuc–Fuc) Jψ (Fuc–Fuc)
1
3.8 (exp) 2.5 (exp)
n.a.* n.a.*
4.0 (in vacuo) 3.8 (in vacuo)
3.4 (SASA) 2.7 (SASA)
3.2 (water) 2.5 (water)
2
2.7 (exp) 2.9 (exp)
n.a.* n.a.*
4.0 (in vacuo) 3.7 (in vacuo)
3.6 (SASA) 2.3 (SASA)
3.2 (water) 2.4 (water)
3
3.0 (exp) 2.7 (exp)
n.a.* n.a.*
4.0 (in vacuo) 3.8 (in vacuo)
3.3 (SASA) 2.7 (SASA)
3.2 (water) 2.6 (water)
4
3.6 (exp) 3.0 (exp) 2.8 (exp) 2.5 (exp)
4.0 (in vacuo) 3.8 (in vacuo) 3.5 (in vacuo) 3.2 (in vacuo)
3.2 (SASA) 2.9 (SASA) 2.7 (SASA) 2.6 (SASA)
3.3 (water) 3.4 (water) 2.5 (water) 2.5 (water)
5
2.7 (exp) 2.5 (exp) 2.6 (exp) 2.9 (exp)
4.0 (in vacuo) 3.7 (in vacuo) 3.3 (in vacuo) 3.1 (in vacuo)
3.2 (SASA) 2.4 (SASA) 3.2 (SASA) 3.4 (SASA)
3.2(water) 2.4 (water) 2.8 (water) 2.6 (water)
* n.a.—Not applicable.
First, the continuum solvation model SASA was tested and its use significantly improved the
situation. As can be seen from Table 1, the calculated SSCC values became closer to those observed
experimentally. The average deviation in this case was 0.34 Hz, which is within the experimental error.
To identify the details of the conformational behavior of the studied molecules, graphs of angle change
in time during MD and plots of the conformers obtained from MD simulations were constructed in
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Figure 4. Molecular dynamics (MD) graphs and conformational plots obtained in the Solvent Accessible
Surface Area (SASA) approximation for disaccharides 1–3 ordered from (A) to (C). Angles ϕ and ψ
are defined as H1–C1–O–Cx and C1–O–Cx–Hx, respectively, for the sake of compatibility with the
Karplus equation.
For two types of the glycosidic linkages (Fuc–Fuc and Fuc–GlcA) in these compounds, slightly
different conformational distributions were observed. Both were characterized with the presence of
conformers which are common among carbohydrates, with the torsional angles ϕ lying around 20◦–40◦
(these are determined by the exo-anomeric effect), and ψ angles forming two clusters around +40◦
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Figure 5. Conformational plots obtained in the SASA approximation for glycosidic linkages in
structures 4 ((A), Fuc–GlA; (B), Fuc–Fuc) and 5 ((C), Fuc–GlA, (D), Fuc–Fuc). Angles ϕ and ψ
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In the case of Fuc–GlA linkages in all compounds, trace amounts of the inverted conformers were
found, which had ψ torsions in the region close to ±170–180◦ (conformer III). Such conformers are
sometimes encountered in the conformational distribution of carbohydrates but are usually poorly
populated. In this case, their appearance may be explained by the relatively free rotation around the
linkage Fuc–(1→3)–GlA due to the lack of axially oriented substituents in the glucuronic residue,
contrary to the case of the linkage Fuc–(1→3)–Fuc. In general, these distributions resemble the
conformational maps obtained by the dihedral scanning procedure (Figure 3). In this case, however,
one can see that the conformers that previously appeared minor and insignificant (namely, II and III)
now have become populated to a greater extent.
Graphical representations of the detected conformers are given in Figure 6. Interestingly,
conformer I, which, according to our results, seems to be predominant for the Fuc–GlcA linkage,
has the same orientation of the monosaccharide residues as determined for this fragment in [11] during
the MD analysis of two dodecasaccharides representing the backbone chain of the polysaccharide
including GalNAc residues.
Figure 6. Principal conformers of the Fuc(1→3)GlA linkage.
However, when the explicit water model was applied, the disappearance of the above mentioned
inverted conformers was observed. It was accompanied also by a slight improvement of coincidence
between the calculated and experimental SSCC values for all the studied compounds (Table 1).
The sample MD graphs of the glycosidic torsions and the conformational plots obtained under
these conditions for the Fuc–GlcA and difucoside fragments are shown in Figure 7. They are extracted
from trajectories obtained during the simulations of trisaccharide 4. It is noteworthy that during the
studies of β–(1→3)–glucan related oligosaccharides [19] the same tendency for the inverted conformers
was found. In fact, the dominating conformer for the Fuc–GlcA linkage was still that of type I (Figure 6),
indicating that the conformation of the fucosyl–glucuronyl branch is essentially the same both in the
presence and in the absence of the units of the backbone chain. The explanation of this fact can be
achieved by closer examination of conformer I. The mutual orientation of fucose and glucuronic acid
residue in it is such that the O-4 atom of the GlcA-unit is not hindered by the fucosyl substituent
(Figure 8). Thus, it can be thought that the introduction of a galactosamine residue at this position
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Figure 7. Torsional angles graph and conformational plots obtained using explicit water approximation
for the fucosyl–glucuronide (A) and difucoside (B) fragments. Data are extracted from simulations of
compound 4. Angles ϕ and ψ are defined as H1–C1–O–Cx and C1–O–Cx–Hx correspondingly for the
sake of compatibility with the Karplus equation.
Figure 8. The dominant conformer of the Fuc(1→3)GlA linkage with the position of GalNAc
residue introduction.
Additional evidence that actually no inverted conformers were present in the conformational
distribution was achieved by means of NOESY spectroscopy. The mixing time used in these
experiments was 500 ms. For the studied types of molecules in diluted solutions such mixing time
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fact was confirmed by conducting a series of 1D NOESY experiments using different mixing times on
compound 1 (Figure 9). Slight non-linearity at 50–100 ms could be explained by the relatively small
sensitivity in this range which increased the integration error.
Figure 9. The NOE build-up graph at different mixing times for compound 4. The measured NOE
values are for H1(Fuc)/H3(GlA) interaction.
The relative NOE values from MD simulations were calculated as the reciprocal ratio of the
averaged sixth order of the corresponding interatomic distances. The NOE were calculated with
respect to H1 atoms of the glycosylating residues. The obtained results indicated that in the SASA
approximation there should be a slight NOE from H-1 of the Fuc residue onto H-2 and H-3 of the GlcA
unit. For non-sulfated compounds 1 and 4, 2D-NOESY spectra were recorded and they showed no
corresponding cross-peaks (Table 2).
Table 2. Relative experimental and calculated at SASA and explicit water level NOE values for
structures 1 and 4.
Compound Number H1(Fuc)–H3(GlA) H1(Fuc)–H4(GlA) H1(Fuc)–H2(GlA) H1(Fuc‘)–H3(Fuc) H1(Fuc‘)–H4(Fuc)
1
1 (exp) 0 (exp) 0 (exp)
n.a.* n.a.*1 (SASA) 0.26 (SASA) 0.12 (SASA)
1 (water) 0.05 (water) 0.01 (water)
4
1 (exp) 0 (exp) 0 (exp) 0.62 (exp) 0.7 (exp)
1 (SASA) 0.33 (SASA) 0.09 (SASA) 0.81 (SASA) 3.0 (SASA)




The synthesis and detailed characterization of compounds 1–5 are described in [16]. For all NMR
experiments, D2O was used as a solvent (99.98% D, Merck, Darmstadt, Germany). Samples for NMR
spectroscopy were dissolved in D2O, lyophilized, dissolved in D2O again, and then transferred to
NMR tubes for analysis.
3.2. Methods
All molecular mechanics calculation were done using TINKER v. 5.1 software package [21] with
the implemented MM3 force field. The detailed description of MD simulations is provided in Section 2.
For explicit water simulations a structure in question was soaked into a droplet of 2500 TIP3P [22]
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for 1 ns and additional 20 ns simulation was run with the snapshots being written every 2 ps. All
hydrogen-involving bonds were constrained using RATTLE version of SHAKE [23] algorithm and
cutoff value of 5 Å was applied.
The NMR spectra of 1–5 (10–20 mg) were recorded in D2O solutions on Bruker spectrometers
AV-400 and AV-600 with 0.05% acetone as reference (1H 2.225 ppm, 13C 31.45 ppm) at the temperature
of 303 K. Shigemi microtubes (purchased from Sigma-Aldrich, Inc., St. Louis, MO, USA) were
sometimes used for sensitivity enhancement. The resonance assignment in 1H and 13C NMR spectra
was performed by gradient enhanced 2D gCOSY, gNOESY, gHSQC, gJ-HMBC experiments as well as
TOCSY and ROESY experiments.
NOE build-up was studied employing selective gradient enhanced 1D NOESY experiment with
different mixing times. Other experimental NOEs were measured using a field gradient enhanced 2D
gNOESY technique in D2O solutions at 303 K, mixing time 500 ms, relaxation delay 2 s. A sinusoidal
field gradient of 1 ms length and a recovery time of 1 ms were used. The processing was performed
with p/2 shifted sine-square function in both dimensions.
Experimental 3JC–H constants were measured using J-HMBC [24] experiment. The spectral widths
were about 2 ppm for 1H region and 40 ppm for 13C region and did not include resonances of aglycon
groups. The data were collected in the echo/anti-echo mode. The length of gradients was 1 ms, and
the recovery time was 100 us. The spectra were acquired with 80–120 t1 increments and 64–256 scans
per increment. 1024 points were collected during the acquisition time t2. The HMBC preparation delay
was set to 250 ms that corresponded to JC–Hmin = 2.0 Hz. The upscaling coefficient k was 25–60. The
relaxation delay was 1s. The third order low-pass J-filter was introduced for the suppression of one
bond constant (1JC–H) in the range from 125 to 180 Hz. The forward linear prediction to 1024 points was
used in F1. The processing was performed with p/2 shifted sine square function in both dimensions.
4. Conclusions
Five non-sulfated and selectively sulfated oligosaccharides of definite structure representing
Fuc–GlcA and Fuc–Fuc–GlcA fragments of the side chains of fucosylated chondroitin sulfates (FCS)
were studied by means of theoretical molecular mechanics calculations and NMR experiments.
Long-range C–H coupling constants were used for the verification of the theoretical models. The
presence of two conformers for both linkages was revealed. For the Fuc–GlA linkage, the predominant
conformer was the same as described by other authors [11] as the MD average in a dodechasaccharide
FCS fragment representing the backbone chain of the polysaccharide including GalNAc residues.
Apparently, the introduction of a GalNAc substituent slightly impacts the conformation of the
Fuc–GlA branch, just reducing the population of the second conformer. This shows that the studied
oligosaccharides, in addition to larger ones, may be considered as reliable models for further QSAR
studies in order to reveal pharmacophore fragments of FCS and particularly to understand the role of
sulfate groups.
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Abstract: Bullacta exarata is one of the most economically important aquatic species in China, noted
for not only its delicious taste and nutritional value, but also for its pharmacological activities. In
order to explore its potential in medical applications, a mannoglucan designated as BEPS-IB was
isolated and purified from the foot muscle of B. exarata after papain digestion. Chemical composition
analysis indicated BEPS-IB contained mainly D-glucose and D-mannose in a molar ratio of 1:0.52,
with an average molecular weight of about 94 kDa. The linkage information was determined by
methylation analysis, and the anomeric configuration and chain linkage were confirmed by IR and
2D NMR. The results indicated BEPS-IB was composed of Glcp6Manp heptasaccharide repeating unit
in the backbone, with occasional branch chains of mannose residues (14%) occurring in the backbone
mannose. Further antioxidant assay indicated BEPS-IB exhibited positive antioxidant activity in
scavenging superoxide radicals and reducing power. This is the first report on the structure and
bioactivity of the mannoglucan from the B. exarata.
Keywords: Bullacta exarata; structure; polysaccharide; mannoglucan
1. Introduction
There has been an increasing interest in recent years in the structures and functions of natural
polysaccharides from various sources because of their nutraceutical and pharmaceutical potential.
Glucans, a kind of neutral polysaccharides mainly consisting of glucose monomers, have been widely
isolated from medical herb or fungus. They have been reported to stimulate the immune system
and decrease infectious complications in humans [1–3] and experimental animals [4]. These activities
were related to their structural features. For example, β-(1→6)-linked side chains of glucose residues
increases antitumor activity [5], and a β-(1→3)-linked backbone seems essential for the antioxidant
effect [6,7]. However, most of the reports on the glucans were focused on medical herb or fungi
sources, with little knowledge on the structure and function of the glucans in the animals, especially
the marine invertebrates.
Polysaccharides from mollusks have attracted increasing attention in recent years because
of their potential pharmaceutical values, such as anti-tumor [8], immunity-enhancement [9],
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anti-inflammation [10] and anti-aging effects [11]. Several bioactive glucans from the mollusks have
also been reported, e.g., Zhang, Ye and Wang [12] reported a water soluble α-glucan from the soft body
of Bellamya purificata with a main chain of (1→4)-linked D-glucopyranosyl and branching points at O-6
of (1→6)-linked D-glucopyranosyl residues, which showed significant anti-inflammatory activity. A
glucan from Cyclina sinensis also showed antioxidant and hepatoprotective activities [13].
Bullacta exarata (Philippi), generally called Tutie or Niluo in China, belongs to the Mollusca
phylum, Gastropoda class, and Haminoeidae family, which is a species of bubble snail with a bullate,
spirally striate shell found in the coastlines of the South and East China Seas. As an important economic
resource in eastern China, B. exarata is noted not only for its delicious taste and nutritional value, but
also for its pharmacological activities. It is a highly acclaimed species in traditional Chinese medicine
(TCM) with a broad spectrum of health promoting effects on the kidney, lung, liver and immune
functions [14–16]. The foot muscle is the main edible part of B. exarata, and its abundance in proteins
and carbohydrates makes it attractive for exploiting. However, the structure and bioactivities of the
polysaccharides from this species are rarely researched and little is known about them.
In the present study, a mannoglucan was isolated from B. exarata and purified by anion-exchange
and gel-filtration chromatography. The sequence of the purified polysaccharide was determined by a
combination of composition analysis, methylation analysis, IR and NMR, and its antioxidant activity
was investigated by the reducing power assay and the superoxide radical scavenging assay.
2. Results and Discussion
2.1. Isolation and Purification of Polysaccharides
The extraction of B. exarata foot muscle by papain digestion retained an extract yield of 7.3%
(w/w) by dry weight, which was named as CBEPS. It was further fractionated by ion exchange
chromatography on a DEAE-52 column (Figure 1a). The major peak labeled as BEPS-I (3.62%, w/w)
was collected and further purified on a Sephacryl S-300 HR gel-permeation chromatography, two
factions designated as BEPS-IA (1.03%, w/w) and BEPS-IB (2.12%, w/w) was collected (Figure 1b).
The main fraction BEPS-IB showed a single peak on the GPC (Figure 1c), corresponding to an average
molecular weight around 94 kDa.
Chemical composition analysis indicated the BEPS-IB showed a total carbohydrate of 98.7% by
the phenol-sulfuric acid method, indicating the removing of the protein part after papain digestion.
Further monosaccharide composition analysis by the HPLC-PMP method indicated BEPS-IB had a
simpler composition than the crude polysaccharides after extensive purification, which was mainly
composed of Glc and Man, with a proportion of 1:0.52. A small proportion of Gal and Fuc was also
detected (Table 1). The protein content of BEPS-IB decreased from 10.7 to 2.1 after purification, whereas
the sulfated was around 0.47%–1.5% (w/w) in all the tested fractions.
Table 1. Yields, protein contents, sugar contents, sulfate contents and Mw of B. exarata polysaccharides.
Composition
Samples
a CBEPS BEPS-I BEPS-IA BEPS-IB
Yield (%) 7.3 3.6 1.03 2.2
Neutral sugar (%) 80.12 89.31 76.29 98.76
Protein (%) 10.7 2.4 2.7 2.1
Sulfate (%) 1.2 1.5 0.47 1.23
Mw (kDa) – b – b 127 94
Molar ratio of monosaccharides
Mannose 0.74 1.69 0.32 0.52
Glucose 0.43 1.26 0.57 1
Galactose 0.32 0.03 0.04 0.03
Fucose 0.18 0.12 ND 0.01
Rhamnose 0.56 0.22 0.31 ND
Arabinose 0.17 0.07 0.03 ND
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2.1.1. IR Spectrum and Elucidation of BEPS-IB
Figure 2 presents the IR spectrum of BEPS-IB. The broad and intense stretching at 3400 cm−1
is characteristic of hydroxyl groups, and the weak stretching at 2930 cm−1 is attributed to the C–H
bond [17]. The band at 1647 cm−1 can be attributed to water bound to the polysaccharide molecule,
and the bands between 950 and 1200 cm−1 are mostly attributed to C–O–C and C–O–H linkages [18].
Absorptions at 916 cm−1 are typical for D-Glc in the pyranose form. The fraction also exhibited an
obvious characteristic absorption at 920 and 809 cm−1 corresponding to the existence of mannose [19].
Moreover, the characteristic absorptions at 845 cm−1 in the IR spectra indicated the presence of
α-glycosidic linkages.
 
Figure 2. Infrared spectra of polysaccharide (BEPS-IB) from B. exarata.
2.1.2. Methylation Analysis
Methylation analysis GC-MS suggested BEPS-IB contained terminal Glc, 6-linked Glc, 3-linked
Man and 3,6-linked Man (assigned as X, V, U and W) at a molar ratio of 1.32:6.43:3.16:0.97 (Table 2). The
presence of the 3,6-linked Man linkages in the polysaccharide chain was indicative of the substitution
of the Man residues.
2.1.3. Structure Characteristics of BEPS-IB from NMR
Based on the methylation analysis, the structure characteristics of BEPS-IB, especially the chain
linkage and conformation of the sugar units, were completed and confirmed by 1D and 2D NMR.
The 1H NMR spectrum (600 MHz) (Figure 3a) of BEPS-IB was recorded at 60 ◦C. It showed
four anomeric proton signals at δ 5.338, 5.192, 4.943 and 4.603 ppm in a molar ratio of about 6:1:3:1
(Figure 3a), which were assigned to the four types of sugar units obtained in the methylation analysis
(U, V, W and X). The signals around 3.5–4.5 ppm were assigned to cross ring protons (Figure 3a).
Similarly, the 13C spectrum (Figure 3b) showed four signals δ 102.2, 100.8, 98.2 and 94.6 ppm in a
molar ratio of nearly 6:1:1:3, which were assigned to the anomeric carbon of sugar units U, V, W and V,
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Molar ratio Mass fragment (m/z) Type of linkage
time (min)
2,3,4,6-tetra-O-Me-Glc a 14.80 1.32 43, 45, 71, 87, 101, 117, 129, 145, 161, 205 Glc-(1→
2,4,6-tri-O-Me-Man 16.95 3.16 43, 45, 87, 101, 117, 129, 161, 233 →3)-Man-(1→
2,3,4-tri-O-Me-Glc 17.31 6.43 43, 45, 71, 87, 101, 117, 129, 161, 173, 189, 233 →6)-Glc-(1→
2,4-tri-O-Me-Man 19.16 0.97 43, 87, 101, 117, 129, 189 →3,6)-Man-(1→
a 2,3,4,6-tetra-O-Me-Glc = 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-glucose.
 
Figure 3. 1H NMR (a) and 13C NMR (b) spectrum (600 MHz, D2O, 60 ◦C) of BEPS-IB isolated from
B. exarata.
The complete assignment of the chemicals-shifts of the sugar units were obtained from 2D NMR
(Table 3), including 1H-1H COSY (Supplementary Figure S1), TOCSY (Supplementary Figure S2a),
NOESY (Supplementary Figure S2b), 1H-13C HMBC (data not shown) and HMQC (Figure 4), according
to the published methodology [20]. The down-shifts in carbon signals of the sugar units compared to
the native glucan may suggest possible linkage information, e.g., the down-shift in the C-3 position of
the unit W indicated it may be 3-linked Man. Similarly, unit U, V and X were deduced as 6-linked Glc,
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Figure 4. HMQC spectrum of BEPS-IB isolated from B. exarata.
Table 3. The 1H and 13C NMR chemical shifts for the polysaccharide BEPS-IB isolated from B. exarata.
Glycosidic linkage
Chemical shifts (ppm)
H-1 (C-1) H-2 (C-2) H-3 (C-3) H-4 (C-4) H-5 (C-5) H-6 (C-6)
U →6)-α-Glcp-(1→ 5.338 (102.2) 3.587 (72.1) 3.742 (76.8) 3.632 (73.2) 3.964 (76.8) 3.937/3.736 (68.9)
V α-Glcp-(1→ 5.192 (94.6) 3.517 (73.8) 3.811 (72.4) 3.342 (73.2) 3.623 (75.3) 3.831/3.792 (63.2)
W →3)-α-Man-(1→ 4.943 (100.8) 3.542 (75.4) 3.605 (80.1) 3.614 (74.8) 3.963 (76.3) 3.972/3.752 (69.2)
X →3,6)-α-Man-(1→ 4.603 (98.2) 3.211 (76.5) 3.729 (78.5) 3.412 (73.9) 3.574 (76.7) 3.833/3.925 (69.6)
The linkage information of the sugar units were further confirmed by NOESY and HMBC
experiments. In the HMBC spectrum, the intra- and inter-residual connectivities of both anomeric
protons and carbons of each of the glycosyl residues were summarized in Table 4. Cross peaks indicated
the correlation signals were found between C-1 of residue U (δ 102.2) with H-6 of residue X (U C-1,
X H-6), H-1 of residue U (δ 5.338) with C-6 of residue X (U H-1, X C-6), indicating the U was linked
to the 6-position of the X. Similarly, the correlation signals W H-1–X C-3 indicated the unit W linked
to the 3-position of X. Thus, both 3 and 6 positions of X were substituted. The correlation signals V
H-1–W C-3 and V C-1–W H-3 indicated unit V linked to the 3-position of the unit W; an intraresidual
coupling between H-1 of residue U with its own C-6 (U H-1, U C-6) indicated that the 6-linkage was
among different U repeats. In the NOESY spectrum (Supplementary Figure S2b), similar correlations
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Table 4. The connectivities observed in an HMBC spectrum for the anomeric protons/carbons of the






U →6)-α-Glcp-(1→ 5.338 69.6 U: H-1 X: C-6
73.2 U: H-1 U: C-4
102.3 3.83 U: C-1 X: H-6a
3.63 U: C-1 U: H-4
V α-Glcp-(1→ 5.192 80.1 V: H-1 W: C-3
73.8 V: H-1 V: C-2
72.4 V: H-1 V: C-3
94.6 3.61 V: C-1 W: H-3
3.52 V: C-1 V: H-2
3.81 V: C-1 V: H-3
W →3)-α-Man-(1→ 4.943 78.5 W: H-1 X: C-3
76.3 W: H-1 W: C-5
100.8 3.96 W: C-1 W: H-5
X →3,6)-α-Man-(1→ 4.603 68.9 X: H-1 U: C-6
3.94 X: C-1 U: H-6a
98.2 3.21 X: C-2 X: H-2
Based on all these results from methylation analysis and 2D NMR, the main repeating unit
structure of BEPS-IB was deduced and is shown in Figure 5.
Figure 5. Proposed structural features of the BEPS-IB isolated from B. exarata.
2.2. Antioxidant Activity
Figure 6 showed the antioxidant activity of BEPS-IB determined by scavenge superoxide radical
assay and reducing power assay. As shown in Figure 6a, BEPS-IB can scavenge superoxide radicals at
concentrations between 2 and 12 mg/mL in a dose dependent way. The IC50 was 6.23 mg/mL, similar
to the glucans isolated from other mollusks, which were usually around 4–10 mg/mL [13]. However,
the IC50 was much lower than those from medical fungus, which were usually bound with pigments
and caused an increase in the antioxidant activity.
In the reducing power assay (Figure 6b), reducing capacity was expressed as a percentage
of the activity shown by vitamin C. The reducing capacity was positively correlated with sample
concentration. At a concentration of 12 mg/mL, the reducing capacity of BEPS-IB was 75%. The
reducing properties are generally associated with the presence of reductones, which have been shown
to exert antioxidant action by breaking the free radical chain by donating a hydrogen atom. Our data of
the reduction potential suggested that there might be a direct correlation between antioxidant activity
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Figure 6. Antioxidant activity of the BEPS-IB. (a) Scavenging effects of BEPS-IB on superoxide radical
(O2•); (b) Reducing power. Values are means ± SD (n = 3). Significant differences from the control
were evaluated using Student’s t-test: * p < 0.05. Reducing power was expressed as a percentage of the
activity shown by vitamin C.
Reactive oxygen species (ROS), capable of causing damage to DNA, have been associated
with carcinogenesis, coronary heart disease, and many other health problems related to advancing
age [21,22]. The antioxidant activities of polysaccharides were not a function of a single factor but a
combination of several factors, such as content of sulfuric radicals, molecular weight, protein content
and type of sugar. The relatively lower potential of the BEPS-IB to other glucans may attribute to the
high content of mannose. However, it has been reported that addition of mannose in glucan can also
improve the antitumor action of the polysaccharides, as a polysaccharide receptor has been found
on human macrophages, which demonstrated high specificity for mannose [23]. Thus, the antitumor
potential of polysaccharides needs to be further investigated.
3. Materials and Methods
3.1. Materials and Reagents
Bullacta exarata snails were supplied by Huzhou Lurong Seafood Co., Ltd., China and stored at
−20 ◦C before use. TSK G4000PWXL columns were sourced from TOSOH BIOSEP (Tokyo, Japan), and
Sephacryl S-300 HR from Amersham Biosciences (Uppsala, Sweden). Diethyaminoethyl ion-exchange
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purchased from Sigma (St. Louis, MO, USA). Papain and cystein (Cys) were purchased from Fluka
(Seelze, Germany). The derivatization reagent 1-phenyl-3-methyl-5-pyrazolone (PMP) was from
Sinopharm Chemical Reagent (Shanghai, China). All other reagents used were analytical grade.
3.2. Isolation and Purification of Polysaccharides
The procedure used for the isolation of polysaccharides was similar to previously described [24].
B. exarata snails (30 kg) were shelled and the foot muscle was homogenized, and treated with acetone
to remove fats (1:1). After centrifugation (6000 rpm, 20 min) and overnight drying, the resulting pellets
were kept in distilled water at 60 ◦C for 8 h with constant stirring. The process was repeated three
times. The supernatant was concentrated and precipitated in 4 volumes of ethanol. The precipitate
was collected by centrifugation (6000 rpm, 20 min) and dissolved in distilled water and protein
was removed by the Sevag method [25]. Then, the crude polysaccharide fraction was obtained by
precipitation in 4 volumes of ethanol and washed with acetone and ethyl ether several times. The
crude polysaccharide preparation was separated using a DEAE ion-exchange column (2.6 cm × 30
cm), followed with a Sephacryl S-300 gel filtration column (1.6 cm × 100 cm). Carbohydrate content
was determined by the phenol/sulfuric acid assay. The isolation procedures were repeated three times
and showed no significant influenceon the composition of the polysaccharides.
3.3. Chemical Analysis of Polysaccharide Fractions
Estimation of average molecular weights was performed on HPLC using TSK-G4000 and -G3000
PWXL columns, at a sample injection volume of 20 μL (1 mg/mL) and flow rate of 0.5 mL/min on
a Waters 2870 system (Milford, MA, USA), with a 2414 refractive index detector. The mobile phase
consisted of 0.2 M NaCl. The column was maintained at 40 ◦C. Gel permeation chromatography
(GPC) were recorded on a computer with liquid chromatography (LC) solution version 1.25 software,
preliminary calibration of the column was performed using dextrin in a range of molecular weights
measured in kDa (I = 500; II = 66.9; III = 48; IV = 20; V = 5; Showa-Denko, Tokyo, Japan). The Breeze™
2 software was utilized for data acquisition and analysis.
The monosaccharide composition was determined using a PMP-HPLC method [26]. HPLC
analyses were performed on an Agilent ZORBAX Eclipse XDB-C18 column (5 μm, 4.6 mm × 150
mm) at 25 ◦C and UV detection at 250 nm. The mobile phase was 0.05 M KH2PO4 (pH 6.9) with 15%
(solvent A) and 40% (solvent B) acetonitrile in water. A gradient of B from 8% to 19% in 25 min was
used. Protein concentration was determined by the Lowry method [27].
3.4. Methylation Analysis
BEPS-IB (10 mg) was methylated with the method reported by Needs and Selvendran [28]. The
partially methylated sample hydrolyzed by 4 M trifluoroacetic acid at 100 ◦C for 4 h. The resultant
aldoses were reduced to their corresponding alditols by sodium borodeuteride (NaBD4). The partially
methylated alditols were then acetylated with a pyridine:acetic anhydride (1:1) solution at 100 ◦C for 1
h. The alditol acetates were analyzed by GC-MS, and the methylated sugar linkages were identified by
the retention time and fragmentation pattern [28,29].
3.5. Measurement of IR and NMR Spectra
Purified BEPS-IB was deuterium-exchanged by freeze-drying three times and then dissolved
in D2O to a final concentration of 60 mg/mL. 1H NMR spectra of BEPS-IB were measured at 600
MHz, in D2O on a Bruker AVANCE III 600 spectrometer at 60 ◦C, the 13C NMR was recorded at room
temperature. Signals at δH 2.22 and δC 31.1 for acetone were used as external standards. The 1H-1H
and 1H-13C connectivities were established by two-dimensional NMR (COSY, HMQC, NOESY, HMBC,
and TOCSY).
An infrared spectrum of the polysaccharide (2 mg) was recorded on a Perkin-Elmer instrument in
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3.6. Antioxidant Activity Assays
The antioxidant activity of BEPS-IB was tested with two in vitro assays: The reducing power assay
and the superoxide radical scavenging assay. The reducing power assay was performed as described
by Li, Zhou and Li [30] with modifications. Briefly, 1 mL samples of different concentrations (2–12
mg/mL) in phosphate buffer (0.2 M, pH 6.6) were mixed with 1 mL potassium ferricyanide (1%, w/v),
and incubated at 50 ◦C for 20 min. The reaction was terminated by the addition of 1 mL trichloroacetic
acid (10%, w/v) to the mixture and the solution was mixed with 0.2 mL ferric chloride (0.1%, w/v)
and the absorbance was measured at 700 nm. Reducing power was expressed as a percentage of the
activity shown by a 1 mM solution of vitamin C.
The superoxide radical scavenging activity assay was performed using the method of
photoreduction of NBT (nitroblue tetrazolium) [31], with some modifications. Superoxide radicals
were generated in 3 mL phosphate buffer (0.1 M, pH 7.4) containing 156 μM nicotinamide adenine
dinucleotide (NADH) (reduced form), 52 μM nitrotetrazolium blue chloride (NBT), 20 μM phenazin
methosulfate, and varying concentrations of polysaccharides (2–12 mg/mL). The color reaction of
superoxide radicals and NBT was detected by monitoring the absorbance at 560 nm. Vitamin C was
used as reference material. In the essential control, NADH was substituted with phosphate buffer. The
inhibition percentage was calculated using the following formula:
Scavenging effect (%) = (1 − ASample 560/AControl 560) × 100
3.7. Statistical Analysis
The data were reported as mean ± standard deviation (SD) (n = 3) and evaluated by one-way
analysis of variance (ANOVA) followed by the Student’s t-test. Differences were considered to be
statistically significant if p < 0.05. All statistical analyses were carried out using Statistical Product and
Service Solutions (SPSS) for Windows, Version 16.0 (SPSS Inc., Chicago, IL, USA).
4. Conclusions
A novel mannoglucan designated as BEPS-IB has been isolated and purified from the foot muscle
of B. exarata. Chemical composition analysis indicated that BEPS-IB mainly consisted of glucose,
mannose and minor contents of galactose and fucose, with a molar ratio of 1:0.52:0.03:0.01. The
complete molecular structure was established through several experiments, including methylation
analysis, NMR and IR spectra. The results indicated that BEPS-IB was a heptasaccharide backbone
([–(1→6Glcα)61→6Manα–]n), with a tetrasaccharides branch ([–(1→3Manα)31→3Glcα–]n) occurring
at the O-3 position of mannose residues in the backbone. The purified polysaccharide also showed
significant antioxidant activity in scavenging superoxide radicals (O2•) and reducing power. The
present study has demonstrated the potential of B. exarata as a rich and promising source of novel
bioactive polysaccharides.
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Abstract: Polysaccharides from marine clams perform various biological activities, whereas
information on structure is scarce. Here, a water-soluble polysaccharide MMPX-B2 was isolated
from Meretrix meretrix Linnaeus. The proposed structure was deduced through characterization
and its immunological activity was investigated. MMPX-B2 consisted of D-glucose and D-galctose
residues at a molar ratio of 3.51:1.00. The average molecular weight of MMPX-B2 was 510 kDa.
This polysaccharide possessed a main chain of (1Ñ4)-linked-α-D-glucopyranosyl residues, partially
substituted at the C-6 position by a few terminal β-D-galactose residues or branched chains
consisting of (1Ñ3)-linked β-D-galactose residues. Preliminary immunological tests in vitro showed
that MMPX-B2 could stimulate the murine macrophages to release various cytokines, and the
structure-activity relationship was then established. The present study demonstrated the potential
immunological activity of MMPX-B2, and provided references for studying the active ingredients in
M. meretrix.
Keywords: Meretrix meretrix Linnaeus; polysaccharide; structure; immunological activity
1. Introduction
Meretrix meretrix Linnaeus (M. meretrix, Meretrix, Veneridae) is a historically marine food
and a valuable source of traditional Chinese medicine (TCM), which is widely distributed in
coastal areas of South and Southeast Asia [1]. Documented in the ancient Chinese pharmacopeia
Compendium of material (the 16th century, by Li Shizhen), M. meretrix could diminish inflammation,
treat typhoid fever, hangover and relieve pain. Modern research has verified the effects of
M. meretrix on immuno-regulating [2], antioxidant [3], antineoplastic [4], antihypertensive and
hypolipidemic activities [5]. The noteworthy biological activities relied on the functional ingredients
it contains, including peptides, polysaccharides, amino acids, and enzyme inhibitors. Among
these compounds, polysaccharide is one of the major components which accounted for 4.1%–8.3%
of M. meretrix [2]. Various biological functions of polysaccharides including immunomodulation,
anti-inflammation, anti-coagulation, and anti-tumor have been explored and evaluated [6]. A series of
immunological indicators, including the phagocytic power, the number of leukocytes, and the level
of hemolysin antibody, were all ameliorated in the rats with damaged immune systems induced by
cyclophosphamide through the oral administration of a polysaccharide isolated from M. meretrix [2].
Zhang et al. also reported that the ethanol extract of M. meretrix could enhance the expression of T-
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and B- lymphocytes by 18% and 43%, respectively [7]. The underlying mechanism through which
polysaccharides exerted their physiological activities has experienced a long exploring process, but
a rapid advancement has been achieved recently, mainly because of the discovery of roles of gut
microbiota. Polysaccharides which could not be absorbed into the small intestine could be further
hydrolyzed and metabolized in the colon, which might exert some influences on the physiological
features and community structure of gut microbiota [8,9]. Chang et al. showed comprehensively that
the high molecular weight polysaccharides (4300 kDa) isolated from Ganoderma lucidum (a medicinal
mushroom) mycelium reduced body weight, inflammation and insulin resistance in mice fed a high-fat
diet (HFD) by reversing HFD-induced gut dysbiosis, maintaining the intestinal barrier integrity, and
reducing metabolic endotoxemia [10].
The progress in the mechanism elucidation further forced the interests in the research of novel
polysaccharides in clams and also in their structure-activity relationship. A polysaccharide extracted
from Cyclina sinensis performed high inhibitory activity in vitro against human gastric cancer cells.
It was composed of glucose linked by α-(1Ñ4) glycosidic bonds, with branches attached to the
backbone chain by (1Ñ6) glycosidic bonds [11]. Liao et al. also isolated a polysaccharide from
the clam of Corbicula fluminea with significant inhibitory effects on growth of human gastric cancer
cells and human ovarian carcinoma cells [12]. In addition, Vidhyanandhini et al. obtained purified
glycosaminoglycans from Meretrix casta, whose structural characterization was carried out by Fourier
transform-infrared (FT-IR) and 1H-NMR spectroscopy [13]. These glycosaminoglycans showed
comparable anticoagulant activity with heparin [14]. However, the current research on polysaccharides
of M. meretrix is still confined to the extraction method improvement and primary bio-activity
evaluation. Detailed characterization of structure and elucidation of structure-activity relationship are
still scarce.
In the present study, a polysaccharide was isolated from M. meretrix and purified. The structure
was deduced and proposed based on detailed chemical characterization, and the immuno-regulatory
activity was evaluated. An attempt to find a preliminary structure-activity relationship was carried
out as well.
2. Results and Discussion
2.1. Extraction and Purification of MMPX-B2
The crude polysaccharide (MMPX) was extracted from M. meretrix following an enzymatic
extraction method with addition of 2% trypsin. Under the optimized conditions, the yield of MMPX
reached 12.0%. As preliminary evaluation showed, this crude polysaccharide could increase NO
production in RAW264.7 cell; however, a higher purity and homogeneity of the polysaccharide was
needed in order to analyze its structure and bio-activity analysis. Therefore, MMPX was then isolated
by DEAE-52 cellulose anion-exchange chromatography. The chromatogram (Figure 1a) showed
three peaks, in which the major part eluted by 0.1 M NaCl was collected and denoted as MMPX-B.
MMPX-B was further purified by Superdex 200 dextran gel permeation chromatography, and two
fractions were isolated. As shown in Figure 1b, two peaks arose, and the constituent which performed
a symmetrical and sharper peak was collected for subsequent studies and denoted as MMPX-B2.
The purity and homogeneity of MMPX-B2 were further investigated. There was no absorption at
260 nm and 280 nm (data not shown) in UV spectrum, indicating no impurities of protein and nucleic
acids left. The high performance gel permeation chromatography (HP-GPC) profile in Figure 1c
showed only one symmetrical peak, indicating that MMPX-B2 was a homogenous polysaccharide,
with an apparent molecular weight of 510 kDa. Furthermore, the polydispersity index (PDI) was
determined as 1.11 corresponding to a narrow molecular weight distribution [15], suggesting a relative
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Figure 1. Purification of MMPX-B2. (a) Elution profile of crude polysaccharides by DEAE-52 cellulose;
(b) Purification profile of MMPX-B by Superdex 200; (c) HP-GPC profile of MMPX-B2.
2.2. Chemical Composition of MMPX-B2
A gas chromatography (GC) analysis (Figure 2) showed that MMPX-B2 was composed of
D-Glucose and D-Galactose with the molar ratio of 7.13:1.00, indicating that this polysaccharide
was neutral.
Figure 2. GC profile of MMPX-B2 with acid hydrolysis and acetylation. (A) D-glucose; (B) D-galactose;
(C) internal standard inositol.
The structure was further analyzed by FT-IR. As shown in Figure 3, a broad and intense
characteristic peak at 3390 cm´1 was attributed to the stretching vibration of O–H. The bands at
2930 cm´1 were assigned to C–H2 and C–H stretching vibrations [16]. The relatively strong absorption
at 1640 cm´1 was due to associated water [17]. Additionally, 1410 cm´1 and 1078 cm´1 corresponded
to exocyclic and endocyclic C–O stretching bands, respectively [18]. The peaks around 1400–1200 cm´1
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the vibrations of C–O–H side groups and C–O–C glycosidic bonds [16]. The band around 900 cm´1
was the characteristic absorption of β-linkage of pyranose [19,20]. The relatively intensive bonds at
700–900 cm´1 were assigned to skeletal modes of a pyranose ring, among which the absorption at
844 cm´1 suggested the presence of α-type glycosidic bonds [21].
Figure 3. FT-IR spectrum of MMPX-B2.
2.3. Linkage Analysis and Structure Speculation
Preliminary analysis of the glycosidic linkage locations was carried out by following periodate
oxidation and Smith degradation methods.
The results of periodate oxidation showed that, per mole sugar, 0.960 mol of periodate was
consumed and 0.112 mol formic acid was produced. The formation of formic acid suggested
the presence of pyranohexose in 1Ñ or 1Ñ6 linked forms in 11.2%. As the amount of periodate
consumption was more than two fold of the amount of formic acid produced, linkages which only
consumed periodate without formic acid production were therefore deduced to exist as 1Ñ2, 1Ñ2,6,
1Ñ4, and 1Ñ4,6 forms, which occupied 73.6% of the total glycosyl linkages. The ratio of other linkages
as 1Ñ3-linked forms were 15.2% which did not consume periodate.
Additionally, large amounts of glycerol and erythritol, examined by gas chromatography-mass
spectrometry (GC-MS) after the periodate-oxidized products of MMPX-B2, were reduced and
hydrolyzed indicating that most of the linkages were in 1Ñ, 1Ñ6, 1Ñ2, 1Ñ2,6, 1Ñ4, and 1Ñ4,6
forms. Combined with the results of periodate oxidation analysis, it could be inferred that linkages of
1Ñ2, 1Ñ2,6, 1Ñ4, 1Ñ4,6 were the major types. Nevertheless, small amounts of 1Ñ3 glycosyl linkages
also exist.
Methylation analysis was employed for further derivation of glycosyl linkages in MMPX-B2.
The results (Table 1) showed that the glucose residues were linked together as (1Ñ4)-Glcp and
(1Ñ4,6)-Glcp forms, while the galactose residues were present as terminal and (1Ñ3)-linked Galp
forms. Further, the ratio of four types of glycosyl linkages were determined by integrating peak
areas. The number of (1Ñ4)-linked and (1Ñ4,6)-linked Glcp residues accounted for 77.22% of the
total methylated sugar residues, suggesting that MMPX-B2 was probably consisted of a backbone of
1,4-linked and 1,4,6-linked Glcp, with terminal Galp residues (majority) and branches of 1,3-linked
Galp (minority) attached to the C-6 of some 1,4,6-linked Glcp residues. There is also some possibility
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Table 1. GC-MS analysis of the methylated products of MMPX-B2.
Methylated Sugar Residue Molar Ratio Ratio (%) Type of Linkage
2,3,4,6-Me4-Gal 1.03 17.64 Galp-(1Ñ
2,4,6-Me3-Gal 0.30 5.14 Ñ3)-Galp-(1Ñ
2,3,6-Me3-Glc 3.51 60.10 Ñ4)-Glcp-(1Ñ
2,3-Me2-Glc 1.00 17.12 Ñ4,6)-Glcp-(1Ñ
As the MMPX-B2 structure deduced was not complicated, 1D NMR spectroscopy was chosen to
provide a more exact structural information (Figure 4). The major chemical shifts are listed in Table 2,
and the assignments were mainly based on literature values. As MMPX-B2 was composed almost
exclusively by glucose, the signals of glucose and those of galactose could be easily differentiated.
In the 13C NMR spectrum, the resonances in the anomeric region (δ = 95–110 ppm) allowed for quick
assignments of the configurations of the sugar residues, as α-configuration at δ = 95–102 ppm and
β-configuration at δ = 103–110 ppm [22]. The signals at δ 98.70 and 99.92 ppm were attributed to
the anomeric carbon atoms of (1Ñ4,6)-linked α-D-Glcp and (1Ñ4)-linked α-D-Glcp [23,24], while
the signals at δ 103.78 and 102.39 ppm were ascribed to the terminal β-D-Galp and (1Ñ3)-linked
β-D-Galp [25]. The signal in the lower magnetic field at δ 60.50 ppm was attributed to C-6 resonance of
Ñ4)-α-D-Glcp-(1Ñ. In addition, 1H-NMR spectrum showed intensive and broad peaks in the range of
3.0–4.5 ppm, which gave additional information for structure derivation. The signals at δ 4.49, 4.75,
5.25, and 5.30 ppm were assigned to the anomeric protons of the terminal β-D-Galp, (1Ñ3)-linked
β-D-Galp, (1Ñ4)-linked α-D-Glcp, and (1Ñ4,6)-linked α-D-Glcp, respectively. The chemical shifts at
δ 3.4 to 4.2 ppm were assigned to the proton signals of carbons C-2 to C-6 of the sugar rings. NMR
information was consistent with the FT-IR results, and the possibility of the structure of a few 1,3-linked
Galp residues inside the Glcp main chain could be excluded.
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Table 2. 13C-NMR and 1H-NMR chemical shifts for resonances of glycosyl residues.
Residues
Chemical Shift (δ, ppm)
C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6
Ñ4)-α-Glcp-(1Ñ 99.92/5.25 71.45/3.63 73.30/3.97 76.88/3.63 71.25/3.83 60.50/3.71
Ñ4,6)-α-Glcp-(1Ñ 98.70/5.30 72.33/3.52 74.70/3.71 78.45/3.61 71.28/3.63 61.20/3.45
β-Galp-(1Ñ 103.78/4.49 72.30/3.54 74.10/3.63 69.94/4.12 76.70/3.71 61.90/3.73
Ñ3)-β-Galp-(1Ñ 102.39/4.75 71.73/3.83 83.10/3.90 69.90/4.17 75.73/3.73 61.90/3.71
Based on the above chemical composition and structural characterizations, the structure of
MMPX-B2 might then be inferred and demonstrated as shown in Figure 5. This polysaccharide
consisted of (1Ñ4)-linked α-D-Glcp residues, partially substituted at C-6 by branches consisting of
(1Ñ3)-linked β-D-Galp with terminal β-D-Galp residues.
Figure 5. Proposed structural model of MMPX-B2.
As the main chain of MMPX-B2 seemed to be composed of (1Ñ4)-linked α-D-Glcp residues,
which was similar to amylose, a verification experiment was conducted using α-amylase which
could cut off the α-(1Ñ4) glycosyl linkage between Glcp residues randomly. After being treated
with amylase at 40 ˝C for 5 h, the molecular weight of the MMPX-B2 hydrolysate reduced sharply
from 510 kDa to 4.8 kDa. The results verified the deduction that the backbone of MMPX-B2 was
composed of (1Ñ4)-linked α-D-Glcp residues, which coincided well with the structure derived from
the stoichiometric method.
Polysaccharides with β-(1Ñ3) and β-(1Ñ6) glycosyl linkages from clams have rarely been
reported. However, a galactan sulfate with a β-(1Ñ3)-glycosidic linkages that was isolated from
the marine clam species Meretrix petechialis showed anti-HIV activity by inhibiting the syncytia
formation [26]. In another experiment, Dai et al. obtained a polysaccharide from the clam of Hyriopsis
cumingii Lea, whose main chain showed to be composed by (1Ñ4)-linked β-D-glucopyranosyl residues,
performed immuno-stimulatory activity [27]. Nevertheless, polysaccharides with β-(1Ñ3) and β-(1Ñ6)
glycosyl linkages from mushrooms have relatively been deeply studied. Besides, it is known that
polysaccharides with β-(1Ñ3) linkages in the main chain and additional β-(1Ñ6) branch points seemed
to be necessary for the activity of immunomodulation [28,29]. Thus, considering its structural similarity,
MMPX-B2 might possess a similar immuno-regulating function.
2.4. Cell-Mediated Immunological Activity
Cell-mediated immunological tests were then conducted in order to verify the immunological
properties of MMPX-B2. The macrophages-mediated immunity plays an important role in the innate
immune system. The process of macrophage activation is associated with the production of various
inflammatory mediators and cytokines including interleukin (IL), tumor necrosis factor (TNF), and
NO [30]. The effects of the immunological activity of MMPX-B2 are indicated in Figure 6. NO, as
a messenger or effector, plays important roles in cardiovascular, neural, and immune systems [31].
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It is often induced together with IL-6, which plays a major regulatory role in acute local and systemic
inflammatory responses [28]. IL-1β is also produced by activated macrophages as a pro-protein
and involved in a variety of cellular activities, including cell proliferation, differentiation, and
apoptosis [32]. The results showed in Figure 6 indicate that MMPX-B2 possesses immuno-stimulating
properties. The levels of NO, IL-6, and IL-1β induced by 125 μg/mL MMPX-B2 matched well with
lipopolusaccharide (LPS) and performed in a dose-dependent manner. TNF-α secretion seemed not
to be significantly affected by the concentration of the polysaccharide: 25 μg/mL MMPX-B2 already
showed comparable effects with 1 μg/mL LPS. Therefore, it seems that there is a correlation between
β-(1Ñ3; 1Ñ6) linkages and the immune-regulating effect of MMPX-B2. However, further studies on
the immuno-regulation mechanisms are being carried out in order to confirm the initial hypothesis.
Figure 6. Effects of MMPX-B2 on macrophages-mediated immunity in vitro. (a) Nitrate accumulation;
(b) TNF-α; (c) IL-1β; (d) IL-6. ** is representative of p < 0.01 and *** is representative of p < 0.001, when
compared to the control group.
3. Experimental Section
3.1. Materials
The fresh tissue of M. meretrix was purchased from Nan Tong Changhua Aquatic Food Co.,
Ltd (Nantong, Jiangsu, China). Murine monocyte macrophage RAW264.7 was purchased from
Cobioer Biosciences Co., Ltd (Nanjing, Jiangsu, China). DEAE-52 cellulose, phosphate buffered
saline (PBS), 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), LPS and Griess
reagent were purchased from Sigma Chemical Company (St. Louis, MO, USA). The enzymes of
trypsin and α-amylase were purchased from Sinopharm Chemical Reagent Co., Ltd (Shanghai,
China). Superdex-200 gel prepacked column was purchased from GE Healthcare (Uppsala, Sweden).
Enzyme-linked immunosorbent assays (ELISA) kits for measurement of TNF-α, IL-1β, and IL-6, were
purchased from Ebioscience Biotechnology Co., Ltd (SanDiego, CA, USA). Penicillin-streptomycin
solution (PS) was from Gibco Company (Auckland, Newzealand). Dulbecco's modified eagle medium
(DMEM) was picked from Corning Biotechnology Co., Ltd (Tewksbury, MA, USA). Fetal calf serum
(FBS) was from PAA Laboratories (Pasching, Austria). The other chemical reagents were of analytical
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3.2. Extraction, Isolation and Purification of MMPX-B2
The crude polysaccharide of M. meretrix was extracted by modified water extraction method
coupled with enzyme hydrolysis. The fresh tissue of M. meretrix was firstly homogenized and then
extracted with distilled water which was four times the volume of the tissue with additional 2% trypsin
(calculated by the wet weight basis of tissue) at 50 ˝C for 4 h three times [33]. The obtained aqueous
extracts were centrifugated at 5000ˆ g at room temperature for 10 min. The collected supernatants
were concentrated under vacuum at 55 ˝C. Then, the concentrate was precipitated by 75% ethanol
at 4 ˝C overnight, followed by centrifugation at 5000ˆ g for 10 min. The precipitate was collected,
dissolved with water and protein impurities were removed with Sevage reagent (chloroform and
butanol in the ratio of 3:1) [34]. The mixture was centrifugated and the precipitate was washed twice
with absolute ethanol. The crude polysaccharide MMPX was obtained after lyophilization.
MMPX was dissolved in distilled water in order to obtain a solution with the concentration
of 5.0 mg/mL. After being loaded onto a DEAE-52 cellulose column (2.6 ˆ 20 cm), MMPX was
eluted stepwise with 0, 0.1, and 0.3 M NaCl at a flow rate of 2.0 mL/min. The elutes were collected
and lyophilized. Then, the major fraction was further purified by a Superdex 200 dextran column
(1.0 ˆ 24 cm) with distilled water as the eluent at a flow rate of 0.3 mL/min. The elutes were collected
and lyophilized. The purified polysaccharide MMPX-B2 was then obtained.
3.3. Homogeneity and Molecular Weight Determination
The homogeneity and molecular weight of MMPX-B2 were determined by HP-GPC method
on a Waters HPLC system (Allances 2695, Waters, Milliford, MA, USA) equipped with a TSK-GEL
G3000SWxl column (7.5 ˆ 300 mm) and a refractive index detector (RID) [35]. The PDI was calculated
by the ratio of weight-average molecular weight and number-average molecular weight (Mw/Mn).
The purified polysaccharide was dissolved in distilled water and eluted with 0.1 M NaCl solution at
a flow rate of 0.6 mL/min. The column was calibrated with the Dextran T-series standard samples
with different molecular weights (Dextran T 2000, T 500, T 70, T 40, T 10, and T 5).
3.4. Analysis of Monosaccharide Composition
GC analysis was employed to detect the monosaccharide composition. MMPX-B2 was hydrolyzed
with 2 mol/L trifluoroacetic acid (TFA) (2 mL) at 100 ˝C for 6 h. The hydrolysate was repeatedly
concentrated with methanol until drying, and was then acetylated with 10 mg hydroxylamine
hydrochloride and 1 mL pyridine at 90 ˝C for 30 min. After the addition of acetic anhydride (1 mL),
the aldononitrile acetate derivatives were obtained and analyzed by Agilent 6820 GC system (Agilent,
Santa Clara, CA, USA) equipped with an OV-17 capillary column (Agilent, USA). The oven was kept
at 200 ˝C for 2 min, then raised to 220 ˝C at a rate of 15 ˝C¨ min´1 where it remained for 10 min, and
finally increased to 240 ˝C at a rate of 10 ˝C¨ min´1 and held for 10 min [36].
3.5. FT-IR Analysis
An aliquot of MMPX-B2 was vacuum-dried overnight before being submitted to infrared
spectroscopy analysis. FT-IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer (Thermo
Scientific, Madison, WI, USA) within the frequency range of 4000–400 cm´1 with potassium bromide
(KBr) disc method [37].
3.6. Periodate Oxidation and Smith Degradation
For the experiment, 20 mg MMPX-B2 was oxidized with 15 mmol/L NaIO4 and kept in the
dark for nearly 48 h [38]. The absorbance was read at 223 nm every 6 h until the consumption of
NaIO4 reached a constant value. The reaction was stopped by the addition of 2 mL ethylene glycol.
The amount of formic acid generated was titrated with 5 mmol/L NaOH. The solution was dialyzed
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at 25 ˝C. The pH value was adjusted to 5.5 with 0.1 mol/L acetic acid. After being hydrolyzed with
TFA, the derivatives of alditol acetates were analyzed by GC. The GC method was the same as that of
monosaccharide composition analysis.
3.7. Methylation Analysis
According to the method of Ciucanu and Kerek, MMPX-B2 was methylated three times using
powdered NaOH in DMSO-MeI [39]. The absence of the peak (3700–3200 cm´1) corresponding to
the hydroxyl group on FT-IR spectra indicated complete methylation. The methylated products were
hydrolyzed with 2 mol/L TFA (2 mL) at 100 ˝C for 6 h and reduced with NaBH4. After correcting
the pH to 5.5 with 0.1 M acetic acid, the solution was acetylated with equivalent amounts of acetic
anhydride pyridine. The resulting products were then examined by GC-MS with a HP-1 capillary
column. The following temperature program was employed: 150 ˝C to 180 ˝C at a rate of 10 ˝C/min,
then 180 ˝C to 260 ˝C at a rate of 15 ˝C/min and held for 5 min.
3.8. NMR Spectroscopy
13C-NMR and 1H-NMR spectra were obtained on a Bruker DRX-500 NMR spectrometer
(Bruker Daltonics, Rheinstetten, Germany). MMPX-B2 was dissolved in D2O, and the spectra were
recorded at 50 ˝C. Acetone (not deuterated) was used as the internal standard for the 13C analysis.
3.9. Hydrolysis of MMPX-B2 with α-Amylase
The polysaccharide of MMPX-B2 was hydrolyzed using α-amylase to verify the backbone
structure speculated from chemical characterization. MMPX-B2 was dissolved in distilled water
to obtain a solution with the concentration of 1 mg/mL. After the addition of 1% α-amylase (calculated
by the weight of MMPX-B2), the enzymatic hydrolysis reaction was carried out at 40 ˝C for 5 h.
The α-amylase in the product was removed using Sevage reagent. The molecular weight of MMPX-B2
hydrolysate was determined with the same method as that of MMPX-B2. The standard samples were
Dextran T 40, T 10, T 5, and T 1.
3.10. Assay of Cell-Mediated Immunity
3.10.1. Cell Culture
Murine monocyte macrophages RAW264.7 were grown in DMEM medium supplemented with
10% FBS and 1% penicillin-streptomycin (PS) mixed solution under a humidified atmosphere of 5%
CO2 at 37 ˝C.
3.10.2. Quantitative Determination of NO and Cytokines
A density of 1.0 ˆ 105 of cells/well were seeded into a 96-well plate and incubated for 16 h at
37 ˝C. Thereafter, 100 μL of LPS (1 μg/mL, the positive control) or polysaccharide samples (5, 25,
125, 250, 500 μg/mL) were added in, while the equivalent DHEM medium was used as the control.
Each group was set with six replicates. The 96-well plate was incubated for 24 h and centrifuged at
1500ˆ g for 5 min to collect the supernatant.
To estimate NO level in RAW264.7 cells, nitrite was measured by Griess assay which is a stable
reaction product of NO with molecular oxygen [30]. Each cultured supernatant (100 μL) was collected
and mixed with 100 μL of Griess reagent. The optical density was measured at 540 nm (SpectraMax
M2, Danaher, CA, USA) after 15 min of incubation. The nitrate accumulation was then calculated
according to a calibration curve made with a series of known concentrations (2–60 μmol/L) of NaNO2
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4. Conclusions
A water-soluble polysaccharide MMPX-B2 was isolated and purified from the clam of M. meretrix.
MMPX-B2 showed to be a homogenous polysaccharide, with an apparent molecular weight of 510 kDa.
This polysaccharide was composed of residues of D-glucose and D-galactose at a molar ratio of 3.51:1.00.
After characterizing the chemical composition and glycosidic linkages, it was hypothesized that
MMPX-B2 possessed a main chain of (1Ñ4)-linked α-D-glucopyranosyl residues, partially substituted
at the C-6 position with branches consisting of (1Ñ3)-linked β-D-Galp and terminal β-D-Galp residues.
The in vitro immunological tests with murine macrophage RAW264.7 cells showed that the levels of
NO, TNF-α, IL-6, and IL-1β released increased with the addition of MMPX-B2 in a dose-dependent
manner, indicating that MMPX-B2 possessed immuno-stimulating properties. The structure-activity
relationship was also established.
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Abstract: Many marine bacteria produce exopolysaccharides (EPS) as a strategy for growth, adhering
to solid surfaces, and to survive adverse conditions. There is growing interest in isolating new EPS
producing bacteria from marine environments, particularly from extreme marine environments such
as deep-sea hydrothermal vents characterized by high pressure and temperature and heavy metal
presence. Marine EPS-producing microorganisms have been also isolated from several extreme niches
such as the cold marine environments typically of Arctic and Antarctic sea ice, characterized by
low temperature and low nutrient concentration, and the hypersaline marine environment found
in a wide variety of aquatic and terrestrial ecosystems such as salt lakes and salterns. Most of their
EPSs are heteropolysaccharides containing three or four different monosaccharides arranged in
groups of 10 or less to form the repeating units. These polymers are often linear with an average
molecular weight ranging from 1 × 105 to 3 × 105 Da. Some EPS are neutral macromolecules,
but the majority of them are polyanionic for the presence of uronic acids or ketal-linked pyruvate
or inorganic residues such as phosphate or sulfate. EPSs, forming a layer surrounding the cell,
provide an effective protection against high or low temperature and salinity, or against possible
predators. By examining their structure and chemical-physical characteristics it is possible to gain
insight into their commercial application, and they are employed in several industries. Indeed EPSs
produced by microorganisms from extreme habitats show biotechnological promise ranging from
pharmaceutical industries, for their immunomodulatory and antiviral effects, bone regeneration
and cicatrizing capacity, to food-processing industries for their peculiar gelling and thickening
properties. Moreover, some EPSs are employed as biosurfactants and in detoxification mechanisms of
petrochemical oil-polluted areas. The aim of this paper is to give an overview of current knowledge
on EPSs produced by marine bacteria including symbiotic marine EPS-producing bacteria isolated
from some marine annelid worms that live in extreme niches.
Keywords: chemical composition; exopolysaccharides; extremophiles; marine bacteria; biological activity
1. Introduction
Exopolysaccharides (EPSs) are high molecular weight carbohydrate polymers that make up a
substantial component of the extracellular polymers surrounding most microbial cells in the marine
environment. They constitute a large fraction of the reduced carbon reservoir in the ocean and enhance
the survival of marine bacteria influencing the physicochemical environment in proximity of the
bacterial cell. Moreover, they assist the microbial communities to endure extremes of temperature,
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salinity, and nutrient availability. In recent years the increased demand for natural polymers
for pharmaceutical, food and other industrial applications has led to a remarkable interest in
polysaccharides produced by microorganisms. Indeed, a substantial interest has aroused with regard
to the isolation and identification of new microbial polysaccharides that might have innovative
applications as gelling, emulsifier and stabilizer agents [1]. These biopolymers have emerged as new
polymeric materials with novel and unique physical characteristics and therefore they have found
extensive applications. Many microorganisms (many species of Gram-positive and Gram-negative
Bacteria, Archaea, Fungi and some Alga) are known to produce extracellular polysaccharides or
exopolysaccharides (EPS). This term was used for the first time by Sutherland in 1972 [2] in order
to describe carbohydrate polymers produced by marine bacteria with high molecular weight. The
advantages of microbial EPSs with regard to plants or marine macroalgal polymers are related to their
chemical and physical properties and they embody a stable supply as well [3]. As far as the microbial
biodiversity is concerned, bacterial EPSs exhibit a wide range of chemical structures: several EPSs
display a high molecular weight as well as a heteropolymeric composition. Bacterial EPS usually occur
in two forms: as capsular polysaccharides (CPS) where the polymers are covalently bound to the cell
surface, and as slime polysaccharides which either remain attached (loosely bound) to the cell surface
or are found in the extracellular medium as amorphous matrix [4,5].
In their natural environment, most bacteria occur in microbial aggregates whose structural and
functional integrity is based on the presence of a matrix of extracellular polymeric substances and
the EPS production seems to be essential for their survival [6]. In particular, marine polysaccharides,
together with other macromolecules such as proteins, lipids and nucleic acids, comprise the organic
matrix present in the intracellular space of microbial biofilms, which represents one of the largest
reservoirs of reduced carbon on earth [6,7]. Moreover, the recent focus on extreme marine habitat has
raised increasing attention on bacteria thriving in these conditions: extremophiles. These organisms,
adopting special metabolic pathways and protective mechanisms to survive, represent a model to
study the stability and the possibleroles of their biomolecules.
2. Roles of Microbial EPS in the Marine Environment
The physiological role of EPS depends on the ecological niches and the natural environment in
which microorganisms have been isolated as well. Indeed, the EPS production is a process that requires
a noticeable energy cost of up to 70%, representing a significant carbon investment for microorganisms.
However, the benefits related to EPSs are significantly higher than costs considering the increasing
growth and survival of microorganisms in their presence [8]. Indubitably, they possess a protective
nature: the EPSs, forming a layer surrounding a cell, provide an effective protection against high or low
temperature and salinity or against possible predators. They are essential in the aggregate formation,
in the mechanism of adhesion to surfaces and to other organisms, in the formation of biofilm and in
the uptake of nutrients [1,9,12]. In particular, studies of sea ice microbial communities have also found
bacteria strongly associated to particles and have pointed out that microbial EPS played an important
role in cryoprotection [13,14]. Moreover, the rate of synthesis and the amount of exopolysaccaride
accumulated as capsular form in pathogenic bacteria influence their pathogenicity, in that capsular
polysaccharides do not stimulate the immune system for their ability to mimic the cell surface of
host cells.
EPSs display an important role in biofilm matrix in regard to the biochemical interactions between
bacteria and surrounding cells [5,15]. The hydrated biofilms offer a stable micro-environment in
which extracellular enzymes can find storage and in the same time facilitating cellular uptake of
small molecules [11]. In addition, in a natural aquatic environment, the nutrients can interact with
exopolymers in order to increase the rate of substance uptake and concentrate dissolved organic
compounds, making them available to support microbial growth [5,15]. Finally, it has been proved that
strains isolated from deep-sea hydrothermal vents show resistance to heavy metals and their purified
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exhibit a polyanionic state in marine environment displaying a high binding affinity for cations as well
as trace metals. Since they generally contain uronic acids with a percentage between 20–50% of the total
polysaccharide content, the acidic carboxyl groups attached are ionizable at seawater pH. Furthermore,
EPS produced by some Antarctic bacterial isolates contain uronic acids and sulfate groups and may
act as ligands for cations present as trace metals in the Southern Ocean environment, enhancing the
primary production of microbial communities usually limited by poor availability of trace metals such
as iron (Fe+3) [19].
3. Structure and Production of EPS by Marine Bacteria
Most EPSs produced by marine bacteria are heteropolysaccharides containing three or four
different monosaccharides arranged in groups of 10 or less to form repeating units [5]. Components
most commonly found in marine EPS are monosaccharide such as pentoses (as D-arabinose, D-Ribose,
D-Xylose), hexoses (D-Glucose, D-Galactose, D-Mannose, D-Allose, L-Rhamnose, L-Fucose), amino
sugars (D-Glucosamine and D-Galactosamine) or uronic acids (D-Glucuronic acids, D-Galacturonic
acids). Organic or inorganic substituents such as sulfate, phosphate, acetic acid, succinic acid and
pyruvic acid may also be present [20]. Most polymers are linear, with an average molecular weight
ranging from 1 × 105 to 3 × 105 Da [21]. Some EPS are neutral macromolecules, but the majority of
them are polyanionic for the presence of uronic acids or ketal-linked pyruvate or inorganic residues
such as phosphate or sulfate as well [22]. Moreover, the linkages between monosaccharides that
have been most commonly found are 1,4-β- or 1,3-β- linkages in the backbones characterized by
strong rigidity and 1,2-α- or 1,6-α-linkages in the more flexible ones. The physical properties of
polysaccharides are deeply influenced by the way the monosaccharides are arranged together and the
assemblage of the single polymer chains [23]. It has been widely accepted that many EPSs undergo
transition from an ordered state, especially at low temperature or in the presence of some ions, to a
less ordered state at high temperature or in absence of ions, enabling the conversion of extracellular
matrices from a gel to a solid state. For instance, solutions of the EPS produced by Alteromonas strain
1644, originated from a polychaete annelid living in the proximity of deep-sea hydrothermal vents,
displayed very low viscosity values at low ionic concentration (below 0.03 M) [24]. As a result, it formed
a gel at higher ionic concentrations or exhibited an unusual high temperature-dependent viscosity in
solution at low polymer concentration. This behavior could also depend on the nature of the ions. In
addition, Alteromonas strain 1644 is able to produce two kind of EPS, and this a very peculiar microbial
characteristic, as only a few reports are known about simultaneous production of two different EPSs by
the same microorganism [25]. This may be attributed to the difficulty in separating possible mixtures
of exopolysaccharides but, in this case, the separation of the two polysaccharides produced by strain
1644 has been greatly facilitated by their different gelling properties.
Since the analysis of the extracellular matrix polysaccharides in the natural marine environment
is difficult due to the low abundance of each polymer, the possibility to grow a single isolated strain
under controlled laboratory conditions represents a suitable approach to investigate microbial EPS
production [19]. However, there is no single set of culture conditions that guarantees high EPS yields
since microorganisms differ in the critical factors for maximum EPS production: carbon and nitrogen
source utilization, mineral requirements, temperature and optimal pH. Moreover, it is possible to
modulate the molecular mass, the number of residues and the degree of branching of EPS by using
a physiological control. Indeed, the nutritional and environmental conditions (culture conditions)
can affect the yield and quality of microbial EPS [26]. Sutherland [4] showed that the EPS production
increased if marine bacteria were grown in laboratory conditions on limited nutrients (such as nitrogen,
phosphorus, sulfur and potassium). In general, suboptimal temperature of growth, osmotic stress or
other physical factors that restrict the growth may enhance the EPS production. Moreover, the choice of
selected carbon source (sugar or non-sugar sources) in the growth medium represents the first step for
the optimization of EPS production. Actually, Hahella chejuensis, a microorganism isolated from marine
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in a growth media emended with sucrose [27,28] while acetate was the most efficient carbon source
for EPS production in Halomonas alkaliantarctica, strain CRSS, an haloalkalophilic bacteria isolated
from saline lake in Antarctica [29,30]. In particular, strain CRSS was able to synthesize EPSs with
different chemical composition on various substrates utilized as nutrients: a mannan or a xylo-mannan
was produced in two different complex media and a fructo-glucan when the strain was grown on
minimal media containing acetate as sole carbon source [29]. This is a common occurrence described
for other strains, since culture conditions can modify the yield and the structure of polymers [31]. In
regard to the nitrogen source, in general for EPS production, ammonium sulfate, peptone, sodium
nitrate, urea and yeast extract are the components most currently used. In general, the presence
of an organic nitrogen source promotes both the growth rate and the EPS production [32], even if
there is some evidence showing that EPS production was higher at lower nitrogen concentration as
suggested by Gorret et al. [33]. Samain et al. [24] used the fed-batch method in order to improve the EPS
yield by an Alteromonas strain 1644: they controlled the growth by substituting the complex medium
with a mineral defined medium containing ammonium chloride as a sole nitrogen source (nitrogen
limitation). The initial ammonium chloride concentration was 0.4 g/L, and after the initial exponential
phase, an ammonium chloride solution was continuously fed into the medium in order to maintain a
small level of protein synthesis. During the entire feeding phase, the ammonium did not accumulate
indicating that the growth was nitrogen-limited. In these conditions, EPS production started as soon
as the ammonium had been depleted and continued almost linearly until the end of the fermentation,
reaching a yield of 50% higher than obtained previously with the complex medium.
Sutherland [4] stated that there is a competition between EPS and cell-wall polymer
(lipopolysaccharides, peptidoglycan, etc.) biosynthesis since the isoprenoid glycosyl lipid carriers
and, consequently, EPS production, is not growth-associated. Recently, it has been found that most
bacteria release the highest quantity of EPS in the stationary growth phase: Alteromonas strain 1644 [24],
strain 4004, a thermophilic bacterium belonging to Geobacillus genus isolated from sea sand in Ischia
Island (Italy) [34] and strain B3-15, isolated from marine hot spring at Vulcano Island, classified as a
new strain of Bacillus licheniformis [35], are examples of microorganisms that produce high amounts
of EPS in this phase. However, there are microorganisms that produce the maximum EPS during the
exponential growth phase as reported for Pseudoalteromonas antarctica strain NF3 isolated from a glacial
marine sludge at the South Shetland Island in Antarctica [36]. In Alteromonas macleodii subsp. fijiensis,
isolated from a deep sea vent, the production of EPS began at the end of the exponential phase and
continued throughout the stationary phase, reaching 6 g/L at 60 h of incubation [37].
Another shifting parameter during the EPS production is the rheology of the growth media: the
broth develops non-Newtonian characteristics acting as a pseudoplastic fluid where the viscosity
decreases with increasing shear rate. This change can be caused by the presence of EPS and their
metabolic products, as well as the lack of homogeneity in terms of mixing, mass and oxygen.
In these conditions, the EPS producer bacteria, exposed to such variable gradients, can produce
heterogeneous EPS in terms of molecular weight, branching capacity, etc. The rheological shifts during
the fermentation process could be used as a parameter to monitor the constancy of EPS quality and
production [38]. Indeed, the aeration rate could be a parameter that affects EPS production as well.
Lee et al. [28] reported that high aeration rates generally enhanced EPS production and increased the
viscosity of the culture broth regarding Hahella chejuensis. Moreover, the use of some detergents such as
Tween 40 (polyoxyethylene sorbital monopalmitate), Tween 80 (polyoxyethylene sorbital monooleate),
CHAPS (3-[(3-cholamidopropyl) dimethyl ammonio]-1-hydroxypropane-sulfonate) and Triton X 100
(nonaethylene glycol octylphenol ether) may ameliorate oxygen concentration in the growth media,
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4. Marine EPS-Producing Microorganisms Isolated from
4.1. Deep-Sea Hydrothermal Vents, Volcanic and Hydrothermal Marine Areas, Shallow Submarine Thermal
Springs
To date, mainly mesophilic heterotrophic bacteria have been investigated rather than thermophilic
microorganisms, even though the latter microorganisms possess thermostable enzymes with interesting
biotechnological application for large scale industrial production. Actually, although considerable
information related to the chemical composition, the rheological properties and metal binding
capability have been determined, only a few polymers have been fully characterized so far.
Deep-sea hydrothermal vents, volcanic and hydrothermal marine areas, and shallow submarine
thermal springs offer a new source of EPS producer bacteria (Table 1). Pseudoalteromonas strain 721
produced an EPS containing an octasaccharide repeating unit with two side chains (Figure 1), [39,40].
This EPS exhibited gel formation and viscoelastic behavior at increasing temperature.
Figure 1. The repeating unit of EPS secreted by Pseudoalteromonas strain 721 [39].
Alteromonas macleodii subsp. fijiensis is an aerobic, mesophilic bacterium isolated from a
hydrothermal vent at a depth of 2600 m in a rift system of the North Fiji basin [37,41]. This
strain produced an EPS with an high metal-binding maximum capacity of up to 316 mg Pb(II)/g
polymer [16,17]. The repeating unit consists of an hexasaccharide containing three uronosyl
residues with a branch point at a galacturonosyl residue and a side chain terminated by a
4,6-O-(1-carboxyethylidene)-β-D-Manp [41]. Proposed uses for this polymer include water treatment
and removal of heavy metal pollutants. Moreover, the xanthan-like EPS produced by Alteromonas
macleodii subsp. fijiensis could find application as a food-thickening agent [41]. In addition, experiments
conducted with this EPS encouraged its use in the bone healing application as it showed ability to
promote the adhesion of rat calvaria osteoblastic cells in vivo [42]. Additionally, it could also be used in
cardiovascular diseases as suggested by Colliec Jouault et al. [43].
Indeed, a valuable source of EPS is embodied by bacteria isolated from volcanic and hydrothermal
marine areas and, in particular, some thermophiles, including Methanosarcina, Haloferax, Haloarcula,
Sulfolobus and Bacillus species, and more recently Thermotoga marittima and Thermococcus litoralis have
been studied so far as producers of unusual extra-cellular polysaccharides [35,44]. In particular,
Thermococcus litoralis has been showed to produce EPS in a sulfur-free, defined growth medium with
growth rates and cell yields comparable to those obtained on complex media. This microorganism is
a heterotrophic facultative sulfur-dependent hyperthermophilic Archaeon, isolated from a shallow
submarine thermal spring with an optimal growth temperature of 88 ◦C. Although extracellular
polysaccharides have been identified in several marine extreme environments, the production of
polysaccharides by extremophiles has been investigated only to a minor extent. The EPS produced by
T. litoralis contains mannose as the only monosaccharidic constituent and this is a very peculiar feature
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such as plants or yeasts [45]. According to the initial dry weight of the material, 1 to 2% sulfate and 1.5
to 4.5% phosphorus were also found in T. litoralis EPS. Sulfated EPSs are common in all domains of life
and EPSs such as sulphoevernan, chondroitin sulfate, dextran sulfate, heparin, and mannan sulfate
may enable protection of eukaryotic cells from viruses, including human immunodeficiency virus type
1, by inhibiting virus particle adsorption to host cells [46]. In addition, T. litoralis displayed biofilm
formation on hydrophilic surfaces under a variety of conditions and, particularly, cell adhesion reached
high levels in culture media emended with maltose and/or yeast extract. Indeed, polysaccharide
levels in biofilms formed under different growth conditions were similar. The adhesion of marine
bacteria to surfaces - a process in which EPSs are likely to play a leading role - is not unusual. However,
this occurrence has not been investigated to any extent in hyperthermophilic archaea, though an
increasing number of organisms are isolated from hydrothermal vent sites. Further study regarding
the EPS productions could display new insights on the natural growth of these organisms providing
information on essential ecological interactions in microbial world [47].
Additionally, thermophilic bacteria belonging to Geobacillus species have been isolated from
shallow, marine hydrothermal vents of flegrean area in Italy and characterized as EPS producers as
well [48]. Accordingly, a thermophilic strain from the genus Geobacillus was isolated from sediment
samples in a marine hot spring near the seashore of Maronti (Ischia Island, Italy) and the EPS produced
was characterized (Figure 2).
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Among different strains isolated, the strain Geobacillus sp. 4004 was able to produce an EPS in
yields of 90 mg/L in Bacto Marine Broth 2216 (Difco) at the optimal temperature of 60 ◦C at pH 7.0.
Additionally, it was established that, by modulating the conditions of growth as well as emending the
culture medium with different carbon sources, the yield of the biopolymer increased and the biomass
production was directly proportional to EPS production. Therefore, the EPS produced by strain 4004 in
the sucrose medium was isolated via ethanol precipitation of the cell-free medium. The polysaccharide
fraction, tested for carbohydrate (85%), protein (10%), and nucleic acid (2%) content, was purified by
gel filtration chromatography. The average molecular mass of the strain 4004 EPS was determined to
be about 1 × 106 Da and the 1H and 13C-NMR spectra showed that there are five different residues
within the repeating saccharidic unit; two of them with a gluco/galacto configuration and three with a
manno configuration. One of the residues is an acetamido-sugar and at least one uronic acid is present.
Sugar analysis was performed on hydrolysed polysaccharide fraction and the EPS was reported to
be composed of Gal/Man/GlcN/Ara in a relative ratio of 1.0:0.8:0.4:0.2, respectively. The successful
application of EPS largely depends on their physicochemical properties rather than on yield alone.
Therefore, in order to gain insight about the viscometric properties, specific viscosity (η) was studied
with an Ubbelohde type viscometer under different water concentrations of EPS, in particular at 1%
CaCl2 and 1% NaCl. It was observed that at increasing concentration of EPS there was an increase in
viscosity in all the solutions and the maximum viscosity was found to be 1.08 dL/g in 1% CaCl2.
Furthermore, marine shallow hydrothermal vents around volcanic Eolian islands, close to Sicily
coasts (Italy), represent accessible fields for the isolation of thermophilic bacteria. Previous studies
described diversity and distribution of bacterial communities within deep and shallow hydrothermal
systems at Porto di Levante, Vulcano, revealing the presence of chemosynthetic, thermophilic, archaeal
and bacterial strains [49]. In addition, a thermophilic aerobic microorganism, able to produce two
exocellular polysaccharides (EPS1 and EPS2), was isolated from sea water of a shallow hydrothermal
vent at Vulcano island (Eolian Islands, Italy). This new eolian thermophilic isolate was identified
as Bacillus thermodenitrificans strain B3-72. This strain displayed the highest EPS production in a
Bacto Marine Broth 2216 (Difco) at an optimal temperature of 65 ◦C and pH 7.0 in aerobic conditions.
The production started at the end of the exponential phase of growth and continued during the
stationary phase. The highest concentrations of polysaccharide harvested after three days of culture
was approximately of 70 mg/L. In particular, EPS2, the polymeric fraction obtained after DEAE Gel
filtration (80% carbohydrate and 3% proteins content), displayed a molecular weight of approximately
4.0 × 105 Da. Moreover, the IR spectrum of EPS2 suggested the absence of uronic acid and sulfate
residues. Hydrolysed EPS2 from B. thermodenitrificans yielded mannose and glucose as principal
constituents in a relative ratio of 1:0.2. The 13C and 1H-NMR spectra of this polymer were performed
and it was possible to conclude that it possesses a trisaccharide repeating unit essentially constituted of
sugars having a manno-pyranosidic configuration. In subsequent experiments, the immunomodulatory
and antiviral effects of the B. thermodenitrificans EPS2 were evaluated, since polysaccharides with high
molecular weight have exhibited immunogenic activity so far [50]. In vitro studies have demonstrated
that sulfated polysaccharides, such as dextran sulfated, have antiviral effects against enveloped viruses
such as herpes simplex virus [51]. The sulfated-EPS are known to interfere with the absorption and
penetration of viruses into host cell and to inhibit various retroviral reverse transcriptases [52]. It
was established that the B. thermodenitrificans EPS2 obstructs HSV -2 replication in human peripheral
blood mononuclear cells (PBMC). Actually, high levels of IFN-α, IL-12, IFN-γ, TNF-α, IL-18 (IFN,
interferons; TNF, tumor necrosis factor; IL, interleukine) were detected in supernatants of EPS-2 treated
PBMC and, additionally, this effect was dose-dependent. Those results highlight the potential role of B.
thermodenitrificans EPS2 toward equilibrating the immune response during viral infection and that the
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Besides, a thermotolerant Bacillus licheniformis strain (B3-15), isolated from water of a shallow,
marine hot spring at Vulcano Island (Eolian Islands, Italy), produced an EPS with immuno-modulating
properties. This strain exhibited a production of 165 mg/L exocellular polysaccharide when grown
in liquid mineral medium with the addition of glucose. Furthermore, Bacillus licheniformis strain
B3-15 showed a high growth rate in media containing kerosene as sole carbon source. The purified
exopolymers fraction displayed a single fraction with high carbohydrate content. According to the
chemical structure analyses, the EPS was a tetrasaccharide repeating unit essentially constituted
by sugars having a manno-pyranosidic configuration [35]. Solutions of the Bacillus licheniformis EPS
added to in vitro cultures of human peripheral blood mononuclear cells (PBMC) exhibited a marked,
dose-dependent decrease in HSV-2 (Herpes simplex virus type 2) replication [54]. In order to assess
whether the antiviral activity induced by EPS in PBMC could be related to an immune-modulatory
mechanism, the production of different cytokines involved in the immune response toward virus
infection, such as IFN-a, IL-12, IFN-g, TNF-a, IL-18, was evaluated. As a result, high levels of all
these cytokines were detected in supernatants from PBMC treated with EPS. On the other hand, IL-4,
a strong hallmark of Th2 responses, was not detected in any of the supernatants tested. According
to the data collected, the effect of EPS was dose dependent when PBMC were treated with EPS and
simultaneously infected with HSV-2 and cytokine production was down-regulated. Consequently,
those data suggest that EPS may contribute to improve immune surveillance of PBMC toward virus
infection eliciting a therapeutic Th1-like response in clinical settings of viral diseases as well as in
immune-compromised host. Actually, a large number of immune-modulatory compounds have been
developed in recent years in order to enhance the response of the host to invading infectious agents.
However, the accomplishment of such therapeutic efforts relies upon the complete knowledge of cell
types and factors involved in the development of a protective antiviral response [54].
4.2. Cold Marine Environments: Deep-sea, Arctic and Antarctic Sea Ice
Psychrophilic (“cold loving”) bacteria prefer a growth temperature of less than 15 ◦C. Bacteria
that can grow at such cold temperatures, but which prefer a high growth temperature, are known as
psychrotrophs or psychrotolerants.
It has become widely accepted that bacteria isolated from deep-sea vents will represent a
valuable resource of unusual molecules for biotechnological purpose and at the same time provide
insight into the role of the peculiar molecules produced (Table 2). Most deep-sea environments are
influenced by high pressure, low temperature and low nutrient concentration. However, many
kinds of deep-sea psychrotolerant bacteria live in the abyssal ecological community and they
have been largely investigated as they may reveal important ecological characteristics enabling the
morphological, physiological and metabolic adaptation of bacteria to the continuously changing
deep-sea ecosystem [55].
Pseudoalteromonas sp. SM9913 is a gamma-proteobacterium isolated from 1855 m deep-sea
sediment in the Bohai Gulf, the innermost gulf of the Yellow Sea on the coast of north eastern
China. Qin et al. [56] studied the EPS producing capacity in well established laboratory conditions
and reported that the yield of the EPS increased at decreasing culture temperatures in the range
of 30–10 ◦C, and it reached a yield 5.25 g/L (dry weight) under optimal growth conditions (15 ◦C,
52 h). This is a very high yield compared with the data reported for the EPSs produced by other
psychrotolerant microorganisms [57]. Its structure is a linear arrangement of ;-(1→6) linkage of glucose
with a high degree of acetylation and with a molecular mass of 4 × 104 Da. It was established that
glucose is the main sugar component (61.8%) with minor monosaccharide units including terminal
arabinofuranosyl (t-Ara f, 11.0%) and terminal glucopyranosyl (t-Glc, 11.2%) as well as a small amount
of t-Gal (3.1%), 4-Xyl f (3.9%), 4-Glc (5.0%) and 3,6-Glc (4.0%). Furthermore, this EPS has been
investigated for its flocculation behavior and bio-sorption capacity, providing insight into its ecological
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bind a wide range of metal cations, such as Fe2+, Zn2+, Cu2+ and Co2+, indicating an helpful role in
concentrating metal ions to the surface of the strain in the microenvironment around the cell.
Besides, EPSs have a leading role for the survival of psychrophile microorganisms in permanently
cold environments. In line with their capacity to protect cells from freezing, high concentrations of
EPSs have been found in Antarctic marine bacteria [19] and in Arctic winter sea ice [14]. It has been
demonstrated that EPSs produced by sea-ice isolates possess a molecular weight 5–50 times larger
than the average of the other isolated marine EPSs and it ranges between 1–3 × 105 Da [5]. The
structure and physicochemical properties of the EPSs are influenced by the length of the polymer
chain. As the length of the polymer increases, the opportunity for complex entanglement of the chains
and intra-molecular associations increases, and these contribute to the tertiary structure and physical
behavior of the polymer [22].
It is very interesting to note that particulate aggregates are ubiquitous and abundant in the
world’s oceans. Marine bacteria benefit from living in aggregates since their proximity to other cells
and surfaces provides opportunities for interaction and nutrient uptake. EPSs excreted by bacteria are
polymeric substances that offer a network to hold these structures together [59]. Bacteria are found
in abundance in the bottom layers of the ice or in brine channels and are often attached to detrital
particles or living microalgal cells. Delille and Rosier [60] also suggested that the high numbers of
particle associated bacteria found in sea ice may explain observations of underlying water enriched in
bacterial biomass relative to the open ocean. More recently, studies of Arctic sea ice in winter showed
that active bacteria could be found in brine channels at temperatures as low as −20 ◦C and that they
were particle associated [13]. EPSs may provide a cryoprotectant role in these environments of high
salinities and low temperature [14]. According to this kind of investigation, Mancuso Nichols et al. [61]
studied the EPS production of two different strains isolated from particulate material and melted
sea ice collected in the Southern Ocean. In particular, the bacterial strain CAM025 was isolated from
particles collected in melted Antarctic sea ice and CAM036 was isolated from particles captured by a
plankton net towed through the Ocean. Both the psychrotolerant strains (growth at 4 ◦C and 25 ◦C)
displayed an enhanced mucoid morphology on marine agar medium supplemented with glucose.
According to the results of 16S rDNA gene sequencing and whole cell fatty acid analyses, these two
isolates were shown to be closely related to the genus Pseudoalteromonas. Both strains have been
cultivated in a Marine Broth Medium enriched with glucose in temperatures ranging from 4–20 ◦C
and the EPS yield data suggest that there is a decreased production of EPS at higher temperature
(20 ◦C) for the Antarctic sea ice strain tested; particularly, strain CAM025 was observed to produce
30-fold more EPS at −2 ◦C and 10 ◦C (100 mg/g dry cell weight) than at 20 ◦C. This result supports
the proposed assumption that EPS production by psychrotolerant bacteria may play an important role
in the sea ice microbial communities since bacterial EPS production in brine channels and, maybe,
other deep cold ecosystems, may offer a fence against the environmental extremes experienced by
bacterial cells attempting to modify water properties near the cells. Preliminary characterizations
showed that the structure of the EPS from CAM025 and CAM036 includes sulfate as well as high levels
of uronic acids, such as galacturonic acid, along with acetyl groups. In addition, the EPS from CAM036
was shown by NMR data to include a succinyl group. Monosaccharide composition was estimated
to be Glc/GalA/Rha/Gal (1:0.5:0.1:0.08) and GalA/Glc/Man/GalNAc/Ara (1:0.8:0.84:0.36:0.13) for
strain CAM025 and CAM036, respectively. These features suggest an overall polyanionic or ‘sticky’
capacity of the EPSs in the marine environment, since at the pH of seawater (pH 8.0) many of the
acidic groups present on these polymers are ionized. This ‘stickiness’ is important since these EPS
can bind cations, such as Fe+3, whose availability in the Southern Ocean is known to limit primary
metabolite production as well as for the uptake of other dissolved metals [62]. According to relative
monosaccharide molar ratio, those two EPS displayed some similarities in the composition including
the presence of the sole acidic sugar, galacturonic acid, in significant proportion, and glucose as one of
the major monosaccharide components as well. Nevertheless, further investigations on the ecological








Mar. Drugs 2008, 8, 1779–1802
Table 2. EPSs produced by microorganisms isolated from cold marine environments.
Microorganisms Source environment Description of EPS and
Chemical composition
Suggested Ecological Role and
Biotechnological Application
References
Pseudoalteromonas strain SM9913 Deep-sea sediment in the














high levels of uronic




Pseudoalteromonas strain CAM036 Isolated from particles
captured by a plankton




high levels of uronic




Trace metal binding [61]
Colwellia psychrerythraea strain 34H Arctic marine sediments n.r. Cryoprotection [63]
n.r. not reported.
Some EPS producing bacteria have been found to colonize either the Antartic or Artic ocean sea ice.
Therefore, the study of the EPS production and the optimal growth condition could provide insight into
the ecological role of the EPSs. Recently, Marx et al. [63] examined the relative effects of temperature,
pressure, and salinity on EPS production by a marine and psychrophilic gamma-proteobacterium,
Colwellia psychrerythraea strain 34H. This flagella-containing microorganism can be found in the
persistently cold marine environments including Arctic and Antarctic sea ice. Strain 34H, in particular,
was isolated from Arctic marine sediments. It has been exposed that at growth temperatures ranging
from −8 to −14 ◦C, the EPS production rose dramatically. Similarly, at higher pressures of 400 and
600 atm, the EPS production increased noticeably as well as in salinity tests at 10–100 parts per
million (at temperatures of both −1 and −5 ◦C). Extreme environmental conditions hence appeared to
stimulate EPS production by this strain. Furthermore, strain 34H recovered best from deep-freezing to
−80 ◦C if first supplemented with a preparation of its own EPS, rather than other cryoprotectants like
glycerol, suggesting that the EPS production is both a survival strategy and a source of compounds
with potentially novel properties for biotechnological applications.
4.3. Hypersaline Marine Environment: Salt Lakes and Marine Salterns
Hypersaline environments are found in a wide variety of aquatic and terrestrial ecosystems.
They are inhabited by halotolerant microorganisms as well as halophilic microorganisms (0.5 M and
2.5 M NaCl) and extreme halophiles (up above 2.5 M NaCl). Moderate and extreme halophiles have
been isolated not only from hypersaline ecosystems (salt lakes, marine salterns and saline soils) but
also from alkaline ecosystems (alkaline lakes). Halophilic microorganisms have developed various
biochemical strategies in order to survive in high saline conditions, including compatible solute
synthesis to maintain cell structure and function. Their products such as ectoine, bacteriorhodopsins,
exopolysaccharides, hydrolases, biosurfactants are noticeably of industrial interest.
Indeed, the genus Halomonas has received increasing interest as several species are able to produce
significant quantities of EPS with high surface activity and/or rheological properties [64,65]. Intriguing
properties of the EPS derived from Halomonas species, such as emulsification activity, appear to be
worthwhile for an ample range of products and application. Actually, large quantities of surface-active
agents, indispensable components in the food, cosmetic and pharmaceutical sector, are synthesized
from hydrocarbons and this represents a problem because they are derived from a non renewable
resource arousing concerns about their environmental impact and potential health risks. Conversely,
biosurfactants and bioemulsifiers of biological origin have received increasing interest since they are
renewable and less toxic compounds. Microbial production of surface-active agents offers a sustainable
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developments in industrial processing technologies, there is an increasing demand for new types
of biopolymers with novel or enhanced functionalities and new microbial isolates, particularly of a
marine origin, offer a relatively underexploited resource [67].
However, the first EPS to be described was produced by the extremely halophilic archaea Haloferax
mediterranei (Table 3), isolated from the Mediterranean Sea [68]. In laboratory conditions, the cells
were detected to be surrounded by an amorphous matrix in unshaken cultures. In addition, it was
recognized, by means of electron microscopy using thin sections and negative staining, a thick layer of
EPS surrounds the cells. The EPS production was scarcely influenced by the growth conditions studied
and, although the amount of polymer produced with yeast extract or glucose was not strikingly
different; the aggregation of the cells on top in unshaken cultures appeared to be dependent on
the presence of glucose. This EPS was obtained from the supernatant of shaken liquid cultures
by cold ethanol precipitation, and yielded 3 mg/mL. Three neutral sugars were detected such as
glucose, galactose, and mannose as major component. The IR spectrum of the EPS indicated the
presence of sulfate groups as well as carboxyl group of sterified organic acids such as uronic acids,
indicating that the EPS produced is an acidic heteropolysaccaride. The study of rheological properties
displayed a pseudo plastic behavior as the EPS solutions indicated a high apparent viscosity, increasing
noticeably with the concentration, but the viscosity remained quite constant over wide ranges of pH,
temperature and different salinities. Indeed, the extreme salt tolerance of this polysaccharide and
the producer organism showed that this microorganism is a valuable candidate for the recovery
of oil, especially in oil deposits with high salinity concentrations. In subsequent experiments,
Parolis et al. [69] elucidated completely the structure of the repeating unit of the EPS produced
by Haloferax mediterranei by using a combination of chemical and spectroscopic approaches. The EPS
was hydrolysed with 4M trifluoroacetic acid and the hydrolysate was converted into alditol acetates
to be analysed by GLC. GLC analysis showed only mannitol hexacetate, indicating that mannose
was the only neutral sugar present in the polymer. A further portion of the EPS was methanolysed,
then the methyl esters were reduced and the products were hydrolysed and converted into alditol
acetates as before. GLC analysis showed mannitol hexaacetate and 2-acetamido-2-deoxyglucitol
pentaacetate in the molar ratio 1.0:1.1, respectively, indicating that the acidic sugar present in the
EPS is 2-amino-2-deoxyglucuronic acid. 1D and 2D NMR spectroscopic analysis of the native and
periodate-oxidized/reduced polysaccharide provided the complete structure of repeating unit of EPS
as: →4)-β-D-GlcpNAcA-(1→6)-α-D-Manp-(1→4)-β-D-GlcpNAcA-3-O-SO3−-(1→.
Table 3. EPSs produced by microorganisms isolated from hypersaline marine environments.
Microorganisms Source environment Description of EPS and
Chemical composition








Candidate in oil recovery, especially
in oil deposits with high salinity
concentrations
[68,69]
Hahella chejuensis Marine sediment sample
collected from Marado, Cheju
Island, Republic of Korea
EPS named EPS-R
Glc:Gal (0.68:1.0)
Biosurfactant and detoxification of
polluted areas from petrochemical oils
[28]





A novel EPS, called EPS-R, produced by a slightly halophilic marine bacterium Hahella chejuensis,
was isolated from a marine sediment sample collected from Marado, Cheju Island, Republic of
Korea [28] and displayed a specific emulsifying capacity higher than that observed in commercial
polysaccharides such as xanthan gum, gellan gum or sodium alginate. EPS-R contains glucose and
galactose as the main sugars components in a molar ratio of 0.68:1.0, respectively; traces of minor
sugar components such as xylose and ribose have also been found. The average molecular mass, as
determined by gel filtration chromatography, is 2.2 × 103 KDa. The rheological behavior of EPS-R
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weak gel. Furthermore, EPS-R was stable to pH and salts, demonstrating proper capacity for future
applications as biosurfactant which may enhance hydrophobic substrate utilization and detoxification
of polluted areas from petrochemical oils. In fact, biosurfactants from microorganisms are worthwhile
more than their chemical counterparts as they are biodegradable and can be synthesized under
user-friendly conditions (e.g., low temperatures and pressures) and are effective over a wide range of
temperature, pH and salinity conditions [70].
A new halo-alkalophilic Halomonas strain has been shown to produce EPS [29,30] The new strain,
Halomonas alkaliantarctica strain CRSS, was isolated from salt sediments near the salt lake in Cape Russell
in Antarctica. The strain CRSS grew aerobically in a complex medium containing 100 g/L NaCl and,
among different carbon sources tested, acetate was established to be the most efficient one displaying
a yield of 2.9 g/g dry cells at 30 ◦C after 48 h of growth. The cell-free supernatant was precipated with
ethanol and the soluble fraction was further investigated. The hydrolysed EPS produced by strain
CRSS presented a monosaccharide composition of Glc/Fru/GlcN/GalN in relative proportion of
1.0:0.7:0.3:tr, respectively. The 1H and 13C-NMR spectra showed the presence of six different residues
in the repetitive saccharidic unit, five of them with α configuration and one with a manno configuration
indicating a complex primary structure of the biopolymer. Furthermore, in accordance with the
measurements of viscosity (η) performed on aqueous solutions of the polysaccharide (1% w/v), an
increase of solution viscosity at 2.0–3.0 pH values and at 2.5% (w/v) NaCl was detected according to
the size and number of macromolecules in solution [29].
4.4. Polychaete Annelid in Symbiotic Relationships
Mutually beneficial symbiotic relationships are widespread in marine ecosystems and complex
positive interactions have been shown to be common especially in extreme marine conditions such
as hydrothermal and deep sea vents. Recent insights have noticeably expanded the ecological
niche biodiversity and increase the number of microorganisms involved in a variety of systems.
Accordingly, some marine annelid worms have completely lost the digestive tract of their relatives
(the common earthworm) and it has been established that some species get their sustenance from
a large population of at least five different species of bacteria living underneath their outer skin.
Particularly a polychaete annelid, Alvinella pompejana, commonly known as the Pompeii worm, resides
in tubes near hydrothermal vents along the seafloor. While in the tube, the worm’s tail end might
be immersed in temperatures as hot as 81 ◦C, while its head rests in cooler water, as moderate
as 22 ◦C. Living in a symbiotic relationship, the worms secrete mucous from tiny glands on their
backs to feed the bacteria, and in return they are protected by some degree of insulation. Besides
the temperatures, the Pompeii worm has to deal with lethal chemicals too, like sulfides and heavy
metals such as lead, cadmium, zinc, and copper. It has been supposed that symbiotic bacteria
making the worm’s back their home may detoxify the water within the worm’s tube. Therefore, those
bacteria could prove useful in cleaning up toxic waste sites. An EPS-producing strain, designated as
HYD657 (Table 4), isolated from epidermis of a polychaete annelid, Alvinella pompejana, was collected
near an active hydrothermal vent of the East Pacific Rise [71]. Phylogenetic analyses showed that
strain HYD657 belonged to the gamma-subdivision of the phylum Proteobacteria and that it was
closely related to Alteromonas macleodii. According to the measurement of DNA-DNA homology,
the name of A. macleodii subsp. fijiensis biovar deepsane was assigned to the bacterium strain
HYD657. The monosaccharide composition of the polysaccharide excreted was determined by means
of GC, analysing monosaccharide derivates as trimethylsilyl glycosides following methanolysis, and it
presented Gal/Glc/Rha/Fuc/Man/GlcA/GalA/3-0-(1 carboxyethyl)-D-GlcA, an unusual diacidic
hexose found only in another EPS excreted by a bacterial strain originating from deep-sea vents [72]
in a molar ratio of 1:0.42:0.85:0.5:0.42:0.5:0.5:0.5, respectively. Preliminary structural studies on the
sugar derivatives by Nuclear Magnetic Resonance and GC-Mass Spectrometry revealed the repeating
unit of this polysaccharide was an undesaccharide with three side-chains. Although the definitive
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interesting biological activities and applications have already been found in cosmetics (patentPCT
94907582-4).
Furthermore, a new facultative anaerobic, heterotrophic and mesophilic bacterium was also
isolated from Pompei worm tube collected from a deep-sea hydrothermal field of the East Pacific
Rise and named Vibrio diabolicus [75]. During the stationary phase of growth in batch cultures on a
medium enriched with glucose, V. diabolicus strain HE800 produced an EPS characterized by equal
amounts of uronic acid and hexosamines (N-acetyl glucosamine and N-acetyl galactosamine) in a
molar ratio of approximately 1:0.5:0.5, respectively. Structural studies have recently been conducted on
this polymer demonstrating that it consists of a linear tetrasaccharide repeating unit [76]. This novel
bacterial polysaccharide has been recently investigated as a bone regeneration and cicatrizing material
and a patent has been obtained (patent US 7015206B2). As a result, the EPS excreted by V. diabolicus
make it possible to fill critical size bone defects in rat calvaria. It can form an attractive extracellular
matrix for the direct adhesion of osteoblasts, osteoprogenitor cells and pericytes and may protect
the growth and hormonal factors associated with the healing process. The high binding capacity of
calcium by this polysaccharide can also be another important parameter in its efficiency to induce
fast bone healing. Moreover, it was established that this EPS did not cause any inflammatory reaction
and it is completely absorbed by the surrounding tissues. Therefore, this EPS constitutes a material
which potentiates bone repair and its particular activity is probably due to its original physicochemical
characteristics [76].
Alteromonas infernus, strain GY785 was isolated from a sample of fluid collected among a dense
population of Riftia pachyptila in the proximity of an active hydrothermal vent of the Southern
depression of the Guaymas basin (Gulf of California). This strain, in a glucose enriched medium,
secreted a water-soluble acidic heteropolysaccharide consisting of glucose, galactose, glucuronic and
galacturonic acids (1:1:0.7:0.4), respectively. This high-molecular-weight polysaccharide (1 × 106 Da)
differed in monosaccharide content and/or ratio and sulfate content (10%) from other EPS isolated from
deep-sea hydrothermal bacteria. Different fractions of the purified EPS have been chemically modified
by sulfation and acidic depolymerization leading to an elevated increase of the attached sulfated groups
(33–40%) producing low-molecular-weight, low-viscous EPSs in yields ranging from 25–50% [43]. In
addition, the overall monosaccharide composition of all the fractions is not chemical modified by those
reactions and the high sulfate content up to 40% of the low-molecular-weight fractions along with the
nature of the sugar units should give rise to original bioactive compounds. However, regioselectivity
of the reaction is an important issue as the biological activity can be related to the position of the sulfate
groups in the polymers as it is reported for other highly sulfated polysaccharides, such as chondroitin
sulfate, mannans, dermatan sulfates, fucoidan [77,78] k-carrageenan and heparin [79], which have
been shown to possess important physiological functions and they have been applied as therapeutic
anticoagulant and antithrombotic agents. Moreover, the original backbone structure of A. infernus
EPS is made up primarily of glucose, galactose and uronic acid residues bound by→13 or/and 1→4
linkages, in the manner of most other anticoagulant 1 polysaccharides. Original sulfation patterns
were obtained due to this unique backbone structure consisting of many different monosaccharide
building units, glycosidic linkage types and unit branches. Consequently, this kind of marine EPS
can be used as a library of compounds useful for the elucidation of the structure-activity relationship
and would represent a valid alternative to mammalian sources of anticoagulant avoiding the risk of
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5. Conclusion
Microbial EPSs are ubiquitous in the extreme marine environment where they are essential for
microbial survival. Most of the functions ascribed to EPS are of a protective nature and their precise
roles are dependent on the ecological niches in which the microorganisms live. They could assist the
microbial communities to endure extremes of temperature, salinity and nutrient availability, creating
a boundary between the bacterial cell and its immediate environment. Several EPSs produced by
microorganisms from extreme habitats show biotechnological promise. By examining their structure
and chemical-physical characteristics, it is possible to gain insight into their commercial application
and they are employed in several industries ranging from pharmaceutical to food-processing fields,
through to the detoxification capability of polluted areas from petrochemical oils.
Considering that the microbial biodiversity of marine eco-systems is relatively unexplored, it is
reasonable to hypothesize that the isolation and identification of new microorganisms will provide
wide opportunities for new industrial fields.
Acknowledgments: This work was performed with the contribution of the Ministry of Foreign Affairs
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Abstract: This review provides a comprehensive summary of the most recent developments of
various aspects (i.e., production, purification, structure, and bioactivity) of the exopolysaccharides
(EPSs) from Paenibacillus spp. For the production, in particular, squid pen waste was first utilized
successfully to produce a high yield of inexpensive EPSs from Paenibacillus sp. TKU023 and P.
macerans TKU029. In addition, this technology for EPS production is prevailing because it is more
environmentally friendly. The Paenibacillus spp. EPSs reported from various references constitute
a structurally diverse class of biological macromolecules with different applications in the broad
fields of pharmacy, cosmetics and bioremediation. The EPS produced by P. macerans TKU029 can
increase in vivo skin hydration and may be a new source of natural moisturizers with potential
value in cosmetics. However, the relationships between the structures and activities of these EPSs
in many studies are not well established. The contents and data in this review will serve as useful
references for further investigation, production, structure and application of Paenibacillus spp. EPSs
in various fields.
Keywords: Paenibacillus spp.; exopolysaccharides; squid pen; production; purification; bioactivity
1. Introduction
Natural polysaccharides are highly susceptible to natural biodegradation and are less harmful
than synthetic polymers. Over the past few decades, the number of known polysaccharides produced
by microbial fermentation has been gradually increasing. Most of the polysaccharides derived from
microorganisms are of the exo-polysaccharide (EPS) type; these EPSs attach to the cell surfaces
or are released into the extracellular medium [1,2]. The microbial exo-polysaccharides can be
divided into homo-polysaccharides, which are composed of a single monosaccharide unit, and
hetero-polysaccharides, in which regular repeat units are formed from two to eight monosaccharides [3].
The repeating units of these EPSs are very regular, branched or unbranched, and interconnected by
glycosidic linkages. Microbial EPSs are water-soluble polymers and may be ionic or non-ionic in nature.
In addition, they are usually biodegradable, biocompatible, edible and nontoxic toward humans and
the environment. Due to their many interesting physico-chemical and rheological properties in that
they disperse in water to give a thickening or a viscosity building effect [4]. The shear thickening
effect of EPSs is one in which viscosity increases with the rate of shear strain. Microbial EPSs are
generally of uniform structure and fairly limited polydispersity, which depend on their molecular
weights and structure. For example, the microbial levan similar to bacterial dextran is a polymer of
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fructose linked by β-(2→6) fructofuranosidic bond. It is known that levans with different molecular
weights are needed for different purposes. The low molecular-weight, less branched levan usually
provides a low viscosity, and can be used as a tablet binder in immediate-release dosage forms, while
levans of medium- and high-viscosity grade are used in controlled-release matrix formulations [5].
Besides, curdlan, a linear glucan interconnected by β-(1→3) glucosidic linkages, is produced by the
Agrobacterium species or Alcaligenes faecalis in initial studies [6]. This biopolymer is a thickener with
unique thermal gelling properties; hence it is a good gelling material for the improvement of the
textural quality, water-holding capacity and thermal stability of various commercialized products in
food industry [6]. Microbial EPSs have found many applications in the food, pharmaceutical and other
industries, such as the production of textiles, detergents, adhesives, cosmetics, microbial enhanced oil
recovery, controlled drug delivery and wastewater treatment [6,7] because they showed properties
of various physiological activities, stabilization, suspension of particulates, control of crystallization,
inhibition of synaeresis, encapsulation and formation of film [8–10].
In recent years, significant progress has been made in the search for novel microbial EPSs
that possess novel and highly functional properties [5]. The different biopolymers that have been
extensively studied and are currently being marketed as commercial products include hyaluronic acid
from Streptococcus equii and Streptococcus zooepidemicus [11]; levan from Bacillus subtilis and Bacillus
polymyxa [12,13]; pullulan from Aureobasidium pullulans [14]; dextran from Leuconostoc mesenteroides [15];
xanthan from Xanthomonas campestris [16]; gellan from Sphingomonas paucimobilis [17]; alginate
from Pseudomonas species and Azotobacter chrococcum [18]; cellulose from Acetobacter xylinium [19];
curdlan from Agrobacterium and Alcaligenes species [20]; and succinoglycan from Rhizobium [1].
However, the novel EPSs from Paenibacillus spp. were only discovered in the past ten years.
The genus Paenibacillus consists of over 89 species of facultative anaerobes, endospore-forming,
neutrophilic, periflagellated heterotrophic and low G + C Gram-positive bacilli, which were originally
included within the genus Bacillus and then reclassified as a separate genus in 1993 [21]. Bacteria
belonging to this genus have been detected in a variety of environments, such as soil, water,
rhizospheres, vegetable matter, forage and insect larvae, as well as clinical samples [7]. Paenibacillus spp.
produced a wide variety of different EPSs with diverse physiological and biotechnological functions.
Paenibacillus spp. EPSs have also attracted great interest because of their biotechnological potential
in different industrial processes and wastewater treatment [6,7,22–32]. Thorough reviews on the
production and applications of Paenibacillus spp., EPSs have shown that there is a growing interest in
using Paenibacillus spp. EPSs as biomaterials; extensive research has been performed, leading to a large
number of publications in recent years [6,7,22–32]. The present review is devoted to a survey of the
main achievements in the production, isolation and structural composition of Paenibacillus spp. EPSs.
Furthermore, the applications of Paenibacillus spp. EPSs in various fields are extensively reviewed.
2. Production of EPSs from Paenibacillus spp.
As mentioned earlier, Paenibacillus spp. were discovered to produce various EPS. Some of the
production conditions have been investigated to optimize the production for commercial usage.
The production of EPS is not species-specific and each strain of the species produces different
types of EPSs with different biotechnological properties. In our reviews, very recently, researchers
observed that the culture of Paenibacillus spp. could produce two different, commercial, well-known
EPSs. One of these polymers is a levan-type EPS from P. polymyxa EJS-3 [25], and the second is
curdlan gum from P. polymyxa ATCC 21830 [6]. Levan is a polymer of fructose linked by a β-(2→6)
fructofuranosidic bond and is present in many plants and microbial products [33]. The microbial
levans are produced from sucrose-based substrate by a transfructosylation reaction of levansucrase
(beta-2,6-fructan:D-glucose-fructosyl transferase, EC 2.4.1.10) by microorganisms. Liu et al. [23–25,29]
reported that the shake flask cultures of the endophytic bacterium P. polymyxa EJS-3 grown in a
culture medium (sucrose 188.2 g/L, yeast extract 25.8 g/L, K2HPO4 5 g/L, CaCl2 0.34 g/L, and initial
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is a neutral, bacterial extracellular polysaccharide without branched chains, composed entirely of
β-(1→3)-d-glycosidic linkages. Curdlan is a thickener with unique thermal gelling properties and
is widely used in the food industry. Curdlan is biodegradable, nontoxic toward humans and the
environment, edible and it has growing capacity in the pharmaceutical industry because of its potent
biological activities [6]. Modified curdlan has pharmaceutical applications, such as controlled drug
delivery [34].
To improve the efficiency and productivity of Paenibacillus spp. EPSs fermentation processes,
many investigators have studied the effects of various process factors on the maximal production of
EPSs to optimize the fermentation conditions, such as medium composition, temperature, pH, and
culture vessel [6,7,22–32]. Table 1 provides a summary of the strains, culture conditions and EPS yields
of Paenibacillus spp. that have been reported in the literature. The EPS yields varied over a wide
range from 3.44 to 41.25 g/L with the bacterial species and culture conditions. In particular, our group
previously demonstrated that EPSs were induced from a squid pen powder (SPP)-containing medium
by Paenibacillus sp. TKU023 [31] and P. macerans TKU029 [32]. The production of inexpensive EPS
is an important factor in the utilization of fishery waste products. The discovery of an inexpensive
EPS not only solves environmental problems but promotes the economic value of marine waste. Until
now, there have only been some reports on the culture conditions for the production of EPSs from
Paenibacillus spp. Thus, there is a need to enhance the EPS productivity from Paenibacillus spp. through
effective strategies of process intensification in the future.
2.1. Influence of Carbon/Nitrogen (C/N) Sources, pH and Temperature
Studies of EPS have indicated that the medium composition plays a critical role in EPS
production [23,35]. The most commonly used carbon sources for EPS production are sugars, namely
glucose and sucrose [6,23,27–30,36]. As shown in Table 1, sucrose is often employed as the most suitable
carbon source for EPS production. It has been reported recently that the use of sucrose in the medium
results in high yields of levan-type EPSs [23,29]. This is consistent with the findings of many other
earlier investigators [33,37]. It has been reported that levansucrase with strong sucrose hydrolysing
activity is involved in many P. polymyxa strains, which may be responsible for the high yield of EPS
with sucrose as a carbon source [33,35,37]. However, the high cost of these carbon sources has a direct
impact on production costs, which limits the market potential of these biopolymers. To decrease
the production costs, it is important to look for less expensive carbon sources, such as wastes or
industrial by-products [9]. Fishery by-products contain a large amount of chitin, which is a long-chain
polysaccharide of a N-acetylglucosamine. Therefore, to lower the production cost of EPSs and efficiently
reutilize the chitin-containing fishery by-products, we screened and isolated EPS-producing bacteria
using squid pen powder (SPP) as the sole C/N source. We first produced and characterized the
EPSs from the SPP culture supernatant of two bacteria, Paenibacillus sp. TKU023 [31] and P. macerans
TKU029 [32]. Paenibacillus sp. TKU023 and P. macerans TKU029 have a chitin hydrolysing mechanism
because there is EPS production by TKU023 and TKU029 with SPP as the C/N source without sucrose
(Table 1). For media containing 1.5% (w/v) and 2% (w/v) SPP, the EPS yields from Paenibacillus sp.
TKU023 and P. macerans TKU029 were 4.55 g/L and 3.46 g/L, respectively. However, in other literature,
using high concentrations of sucrose in the medium resulted in EPS yields increasing up to 25.63
g/L [27] and 35.26 g/L [23,29]. This inspired us to increase the concentration of SPP to obtain higher
yields of EPSs. The results demonstrated that when media contained 10% (w/v) SPP, the EPS yields
from Paenibacillus sp. TKU023 and P. macerans TKU029 were 41.25 g/L and 35.75 g/L, respectively.
Additionally, during fermentation, due to liquefaction of protein and chitin, bioactive material rich
liquor is formed, including enzymes, biosurfactants, peptides, and chitooligosaccharides [31,32,38].
Furthermore, the fermented SPP in the culture broth could be recovered for biological applications in
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Many results have also reported that the production of EPS is cell growth-associated [7,31,32]. In
addition to the C/N source, the initial liquid culture pH and culture temperature are both important
and may affect the cell growth, the uptake of different nutrients and EPS production. An optimal
value of pH for the EPS production from Paenibacillus spp. lies in the range between 6.5 and 7.2
(Table 1) [6,7,22,26,27,31,32]. Rafigh et al. found that when the initial pH of the fermentation broth was
increased from 5.5 to 7.0, there was an increase in curdlan gum and biomass production, approximately
39.3% and 4.8%, respectively. However, higher values (pH 8.5) caused a decrease in their production [6].
These EPSs from Paenibacillus spp. were in agreement with previous study that for EPS production
by P. polymyxa KCTC 8648P, the optimum pH value of 7.0 was reported [37]. However, there were
only a few reports where the highest EPS content was achieved by cultivating the microorganism at
slightly alkaline pH [23–25,29]. In the experiments with the strain P. polymyxa EJS-3, Liu et al. [23–25,29]
found that the specific growth conditions of P. polymyxa EJS-3 might be due to its living in the tissues
of plants.
Incubation temperature is another critical factor for EPS biosynthesis [23]. Rafigh et al. [6] found
that when the temperature varied from 30 to 40 ◦C, the yield of curdlan production increased rapidly
and then slightly increased as the fermentation proceeded from 40 to 50 ◦C. Batch fermentation
processes were conducted at 25 ◦C separately, but the yield of curdlan production was very low,
only a few μg/L. In addition, above 50 ◦C, curdlan may be curdled. Therefore, a higher temperature
ratio was not employed in the production of curdlan [6]. However, Liu et al. reported that the
optimal temperatures of P. polymyxa EJS-3 for cell growth and EPS production were 27 ◦C and
24 ◦C, respectively [23]. P. polymyxa EJS-3 favoured lower temperature for EPS production compared
with others.
2.2. Fermentation Techniques
The influence of aeration on the vital activity of Paenibacillus spp. producing EPS was studied [6,
31,32]. Under anaerobic conditions, the cell population neither grows nor produces EPS. An intense
aeration during fermentation leads to a significant increase of the EPS concentration. Previous studies
also argued that agitation could be beneficial to the growth and performance of the microbial cells
through improving the characteristics of mass transfer with respect to substrates, products and
oxygen [40]. The findings by Rafigh et al. [6] also indicated that both biomass and curdlan production
from P. polymyxa ATCC 21830 underwent significant enhancements as the agitation speed increased
from 120 to 150 rpm. The highest yield of curdlan gum and biomass production was at an agitation
speed of 150 rpm. The curdlan gum and biomass production were low at 120 rpm, which can be
attributed to the limitation of oxygen transfer. However, at 180 rpm, lower levels of curdlan gum
and biomass were observed, which can be ascribed to bacterial fragmentation mediated by several
shearing mechanisms. However, for some other species of strains, higher agitation speed (600 rpm)
has been used for curdlan production, e.g., from Agrobacterium sp. [20], but not from Paenibacillus sp.
3. Isolation and Purification of EPS
In our previous studies, the EPS sample after SPP fermentation was immediately autoclaved for
20 min to reduce the ropy condition of the culture and was centrifuged (12,000 g for 20 min) to remove
the remaining SPP and biomass. The supernatant was filtered through a 0.45-μm membrane filter,
mixed with two volumes of methanol, stirred vigorously and kept overnight at 4 ◦C. The precipitate
from the ethanol dispersion was collected by centrifugation at 12,000 g for 15 min, washed three
times with sterilized distilled water, and then lyophilized to yield the crude EPS. This is the most
common and convenient method for isolating EPS from culture supernatant [7,23,27,30–32]. Figure 1








Mar. Drugs 2015, 13, 1847–1863
Figure 1. Schematic diagram for the isolation of EPS from Paenibacillus spp.
The crude EPS was re-dissolved in distilled water and stirred vigorously at 80 ◦C for 30 min, mixed
with four volumes of anhydrous ethanol, stirred vigorously and kept overnight at 4 ◦C. The precipitate
from the ethanol dispersion was collected by centrifugation at 12,000× g for 15 min, re-dissolved in
distilled water and deproteinized with 1/5 volume of Sevag reagent (CHCl3-BuOH, v/v = 5/1) seven
times [41]. The deproteinized solution was then dialyzed against distilled water, concentrated and
lyophilized to yield deproteinized EPS.
The deproteinized EPS was purified sequentially through column chromatography, including
ion-exchange chromatography, gel filtration chromatography and affinity chromatography [7,23,27,30–32].
Elution was conducted with an appropriate running buffer, followed by collection, concentration, dialysis,
and lyophilization, and the carbohydrates were determined by the phenol-sulfuric acid method using
glucose as the standard [42]. In addition, based on the different solubility of the EPSs in ethanol,
isopropanol, and other solvents, the EPSs were simply and effectively fractionated. Huang et al. recently
isolated EPS fractions from a fermentation medium by gradient ethanol precipitation [43]. Their results
suggest that the method is simple and workable for the initial fractionation of EPSs, proteins, and their
complexes with different molecular sizes and for further identification of bioactive components.
4. Physicochemical Characterization
Paenibacillus spp. EPSs with different monosaccharide constituents and chemical structures have
been isolated from their culture supernatant. Many research groups have elucidated the chemical
structures of purified EPSs using infrared spectroscopy, liquid-state nuclear magnetic resonance
(NMR) (one and two dimensions), solid-state NMR, gas chromatography (GC), GC-mass spectroscopy
(GC-MS), high-performance liquid chromatography (HPLC), acid hydrolysis, methylation analysis,
periodate-oxidation, and Smith degradation [7,23,27,30,44]. The different structural characteristics of
EPS from Paenibacillus spp. showing various bioactivities have been investigated. The sources and
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4.1. Molecular-Weight Distribution of EPS from Paenibacillus spp.
Various techniques, such as viscometry, osmometry, sedimentation, and HPLC, have been used
to determine the average polymer molecular weight (MW) and polydispersity index. Among them,
high-performance gel permeation chromatography (HPGPC) is a common method for determining the
MW of polysaccharides and has also been used by many researchers for the MW of EPSs. Size-exclusion
chromatography with multi-angle laser light scatter detection is also an efficient method for the
evaluation of the absolute MW of polysaccharides and provides greater resolution than traditional
GPC [6,7,23,27,30,45,46]. The average molecular weight of the EPS from Paenibacillus spp. varies in very
broad ranges, from hundreds to thousands of kDa, depending on the culture strain, pH, cultivation
techniques and C/N sources used. It has been reported that on a sucrose-containing medium, the
bacterium produces high-molecular-weight EPS [23]. The molecular weights of EPS-1 and EPS-2 from
P. polymyxa EJS-3 were estimated to be 1220 and 869 kDa, respectively [23]. The average molecular
weight of curdlan produced using glucose as the carbon source by P. polymyxa ATCC 21830 was 170
kDa [6]. The molecular weight of EPS from Paenibacillus spp. varies significantly and is affected by
variables such as temperature, pH and the initial carbon source concentration [11].
4.2. Monosaccharide Composition
The monosaccharide composition analysis usually involves cleavage of glycosidic linkages by
acid hydrolysis, derivatization, and detection and quantification by GC. In addition, high-performance
anion-exchange chromatography with pulsed amperometric detection has been developed to
supplement traditional methods because it does not require derivatization of the monosaccharide with
high resolution [47]. Recently, a 1-phenyl-3-methy-5-pyrazolone pre-column derivatization method
has been used to determine the monosaccharide composition [48].
Many different EPSs from Paenibacillus spp. have been obtained; the monosaccharide composition
is usually glucose, mannose, galactose and glucuronic acid in various mole ratios (Table 2). There
is a large variety of EPS produced by Paenibacillus spp. depending on the type of Paenibacillus sp.
strain, culture conditions and medium composition. The characterization of the EPS from Paenibacillus
sp. TKU023 demonstrated that it was mainly composed of glucose and maltose [31]. Madden et al.
reported that EPS produced by P. polymyxa NCIB 11429 was composed of glucose, mannose, galactose,
glucuronic acid and pyruvate [49]. Han and Clarke found that EPS from P. polymyxa NRRL B-18475
was β-(2-6) linked fructan [33]. The EPS produced by P. polymyxa KCTC 8648P was composed of
glucose, galactose, mannose, fucose and glucuronic acid [37]. Liu et al. reported that mannose, fructose
and glucose were the constituents of the EPS from P. polymyxa EJS-3 [23]. The EPS from P. polymyxa
SQR-21 was composed of mannose, glucose, fructose and glucuronic acid [7]. In particular, Li et al.
found that the EPS produced by P. elgii B69 was composed of glucose, glucuronic acid, xylose, and
mannose [27]. This finding differed from the EPS produced by other Paenibacillus strains. Xylose is
rarely described as a main component of other bacterial polysaccharides. These dissimilarities reflect
the species-specific production and biotechnological potential of EPS. Increasing numbers of microbial
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Table 2. Chemical structures of EPSs from Paenibacillus spp.
Microorganisms Chemical Composition of EPSs References
Paenibacillus sp. TKU023 glucose and maltose [31]
P. polymyxa KCTC 8648P Glucose, galactose, mannose, fucose and glucuronic acid [37]
P. polymyxa NCIB 11429 Glucose, mannose, galactose, glucuronic acid and pyruvate [49]
P. polymyxa NRRL B-18475 β-(2-6) linked fructan [33]
P. elgii B69 Glucose:glucuronic acid:xylose:mannose = 1:0.53:1.15:0.46 [27]
P. polymyxa ATCC 21830 linear glucan interconnected by β-(1→3) glucosidic linkages [6]
P. polymyxa JB115 glucan having β-(1,3) and β-(1,6) linkages [30]
P. polymyxa EJS-3 Mannose, fructose and glucose [23]
P. polymyxa SQR-21 Mannose, glucose, fructose and glucuronic acid [7]
5. Bioactivities and Application of Paenibacillus spp. EPSs
In recent years, microbial EPSs and their derivatives have found many applications in the food,
pharmaceutical and other industries because they have different physiological activities from natural
gums and synthetic polymers [9,10]. Moreover, they are highly susceptible to natural biodegradation
and are less harmful than synthetic polymers. Their applications are diverse, ranging from the
laboratory through clinical to tableting; they have found applications in such diverse bio-medical
fields as ophthalmology, orthopedic surgery, tissue engineering, implantation of medical devices and
artificial organs, prostheses, dentistry, bone repair and many other medical fields [5]. In addition, they
have therapeutic and pharmaceutical uses in that they enable the controlled, slow-release of drugs into
the body. They also make possible targeting of drugs into sites of inflammation or tumors for disease
treatment, and they can be used for skin rejuvenation and wound healing [5,32]. Several of these
microbial polysaccharides are commercial industrial products, whereas others are in various stages of
developments. The multiple bioactivities and environmental benefits of EPSs from Paenibacillus spp.
are summarized in Table 3 and are compared in detail below.
Table 3. Potential applications of EPSs from Paenibacillus spp.
Microorganisms EPSs Applications References
Paenibacillus sp. TKU023 Antioxidant [31]
P. macerans TKU029 Improvement of human skin hydration [32]
P. polymyxa EJS-3 Levan and its derivatives AntioxidantAntitumor [23–25]
P. jamilae CP-38 Reduction in the toxicity of olive mill wastewatersHeavy metal biosorption capacity [26]
P. elgii B69 Bioflocculant [27]
P. polymyxa ATCC 21830 Curdlan Drug-delivery carriers for the sustained release of drugs and asupport matrix for immobilization of enzymes [6]






P. polymyxa JB115 Glucan Animal feed additive for the purpose of enhancing immunity [30]
5.1. Antioxidant and Antitumor Activity
Free radicals are harmful to living organisms [50]. To reduce the damage caused by free radicals,
both synthetic and natural antioxidants are used. However, synthetic antioxidants are thought to
cause liver damage and carcinogenesis [23]. Therefore, it is essential to develop natural nontoxic
antioxidants to protect humans from free radicals. Novel natural antioxidants have gained importance
in science and medicine in recent decades. The antioxidant properties of EPSs have been reported
from many types of EPSs derived from filamentous fungi [51], such as Cordyceps militaris SU5-08 [51],
Fusarium solani SD5 [50], Pleurotus sajor-caju [52], Fomes fomentarius [53], Tremella fuciformis [54], Agrocybe
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relative to fungal EPS, reports concerning the antioxidant activities of bacterial polysaccharides [59–61]
are more rare, such as Paenibacillus spp. EPSs.
Antioxidant activities have been attributed to various reactions and mechanisms. The in vitro
antioxidant capacities of EPS were evaluated using various assay methods and activity indices [7,23–25,
29,31]. In our previous studies, Paenibacillus sp. TKU023 could produce EPS and antioxidant by using
SPP as the sole C/N source. The culture supernatant incubated for four days using a baffled base flask
showed strong 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity, reducing powers,
ferrous ion chelating activity and high total phenolic content, but maximum EPS production was found
at the fifth day when using a flat base flask. The production of two invaluable environmentally friendly
biomaterials (EPS and antioxidant) is unprecedented. In addition, the use of SPP (waste) is green, which
made the whole process more valuable and attractive [31]. Raza et al. reported that P. polymyxa SQR-21
produced one type of EPS using yeast extract and galactose as the best N and C sources, respectively.
Their EPS showed good superoxide scavenging and moderate inhibition of lipid peroxidation and
reducing activities [7]. Furthermore, Liu et al. studied the in vitro and in vivo antioxidant activity of
the levan-type EPSs from endophytic bacterium P. polymyxa EJS-3. In antioxidant assays in vitro, both
crude EPS and its purified fractions (EPS-1 and EPS-2) were found to have moderate DPPH radical
scavenging activity, hydrogen peroxide scavenging activity, lipid peroxidation inhibition effects, and
strong ferrous ion chelating activity. In antioxidant assays in vivo, mice were subcutaneously injected
with D-galactose for six weeks and administered EPS-1 via gavage. As a result, administration of EPS-1
significantly increased the thymus and spleen indices of D-galactose in aging mice. Moreover, EPS-1
administration significantly enhanced the activities of antioxidant enzymes and the total antioxidant
capacity and decreased the levels of malondialdehyde in both serums and livers of aging mice [23,24].
Very recently, Liu et al. successfully acetylated, phosphorylated and benzylated the levan-type EPSs
from P. polymyxa EJS-3 to obtain the derivatives of acetylated levan (AL), phosphorylated levan
(PL) and benzylated levan (BL). For the antioxidant and antitumor activities in vitro of the natural
polysaccharide and its derivatives, AL, BL and PL all exhibited higher reducing power, scavenging
activity against superoxide radicals and scavenging activity of hydroxyl radicals compared to the
natural polysaccharide, EPS-1. In addition, AL, BL and PL also exhibited higher antiproliferative
activity against human gastric cancer BGC-823 cells in vitro than EPS-1. The enhanced activities of
the derivatives were probably due to the introduction of acetyl, benzyl, or phosphoryl groups into
the EPS-1 molecules, which increased the electron-donating ability and affinity with the receptors on
immune cells. The results suggested that the derivatives could be explored as promising antioxidant
and antitumor agents [25].
5.2. Improvement of Skin Hydration
Polysaccharides of bacterial origin are very important in the cosmetic and pharmaceutical
industries [62]. One important criterion for the evaluation of cosmetic products is their effect on skin
hydration. We found that EPSs from P. macerans TKU029 can significantly increase skin hydration [32].
The same amount of TKU029 EPSs (5%, w/v), propylene glycol/butylene glycol/water (1.5:1.5:1; v/v),
and hyaluronic acid were applied to the skin of fifteen female volunteers (average age of 21 years). Skin
hydration was measured in the test and control areas of each volunteer at each time point. The changes
in skin capacitance 180 min after the application of TKU029 EPSs and hyaluronic acid were measured.
TKU029 EPSs increased skin hydration significantly more than hyaluronic acid. During the application
period, TKU029 EPSs increased skin hydration from 37.3% to 44.3%. Application of hyaluronic acid
led to a slight increase at the beginning of the period, but then skin hydration decreased from 41.0%
(at 30 min) to 37.0% (at 180 min). The untreated control remained nearly unchanged, i.e., 37.3% at 0
min and 36.2% at 180 min. The untreated control revealed an increase in skin hydration after 180 min
of 8.1% for TKU029 EPSs and of approximately 0.8% for hyaluronic acid [32]. The EPSs produced by P.
macerans TKU029 can increase in vivo skin hydration and may be a new source of natural moisturizers
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5.3. Bioremediation of Wastewater
Chemical contamination of water from a wide range of toxic compounds, particularly dyeing
pigments (from the textile industry), heavy metal ions, and other toxic suspended particles, remains a
serious environmental problem causing serious risk to public health. Various physical and chemical
processes have been developed for removing pollutants from wastewater. One of the most popular
methods is flocculation due to its economic advantages and potency. Bioflocculants are more
eco-friendly and biodegradable and are less harmful to the environment than inorganic flocculants
and organic synthetic flocculants [63]. Many research groups have evaluated the flocculating activity
of EPSs from Paenibacillus spp. Bioflocculation of high-ash Indian coals using P. polymyxa showed a
60% decrease in ash, suggesting that selective flocculation of coal is possible [64]. P. polymyxa P13 was
reported as an EPS producer that exhibited significant biosorption capacity of Cu2+ produced in several
industries [65]. The EPS from P. polymyxa SQR-21 showed a high flocculating activity towards activated
carbon [7]. P. jamilae CP-38 was able to grow and produce EPS using olive mill wastewaters as the sole
nutrient and energy source, with a concomitant reduction in the toxicity of the waste [26]. The EPS
produced by P. polymyxa had cadmium sorption capacity in aqueous solution [28]. In particular, Li et al.
discovered a new EPS-based broad-spectrum bioflocculant produced by a newly isolated strain, P. elgii
B69 [27]. This bioflocculant had high activities towards all tested pollutants, including kaolin clay,
dyeing pigment, heavy metal ion, and real wastewater. The multiple-pollutant-removal performance
of P. elgii B69 is a significant advantage [27].
5.4. Other Bioactivities
As aforementioned, Paenibacillus spp. could produce different types of EPSs with different
biotechnological properties. Many other important bioactivities of Paenibacillus spp. EPSs have also
been investigated. P. polymyxa JB115 was isolated from Korean soil as a glucan producer for the
development of animal feed additives showing activities as a biological response modifier, natural
immuno-modulator and a potential anti-tumor agent for livestock [30]. Rafigh et al. demonstrated that
P. polymyxa ATCC 21830 is capable of producing curdlan gum [6]. Curdlan has potential applications
in the manufacture of food products, and it is also known as a drug-delivery carrier for the sustained
release of drugs and as a support matrix for the immobilization of enzymes [66–68]. In addition,
curdlan has been used together with activated carbon adsorbents for heavy metal removal [69].
6. Conclusions and Perspectives
This review contains the most recent information on the production of various Paenibacillus spp.
EPSs with applications in bioactivity and bioremediation. Economical, environmentally friendly and
high quantity production of Paenibacillus spp. EPSs is necessary for various applications. Squid
pen waste was utilized to produce high yield, inexpensive EPSs. The discovery of inexpensive EPSs
not only solves environmental problems but also promotes the economic value of marine wastes.
Furthermore, this EPS produced by P. macerans TKU029 using SPP can increase in vivo skin hydration
and may be a new source of natural moisturizers with potential value in cosmetics. Novel uses of
Paenibacillus spp. EPSs due to its inexpensive production and its bulk will be developed. In addition,
the movement toward “greener” products and technologies that are more environmentally friendly is
prevailing. Production methods of EPSs are eagerly anticipated in the future, and many have already
reached the market. However, the relationship between the structural features, solution behavior, space
conformation, and the bioactivity of Paenibacillus spp. EPSs is unclear due to the structural diversity
and complexity of polysaccharide molecules. In addition, alteration of the chemical properties of
the original EPSs will also greatly enhance their values and extend their range of applications. The
elaboration of either biotechnological or technical procedures for the production of EPSs of diverse
structures (e.g., varied stereochemical composition or molecular sizes) and ultimate product functions
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are being launched and will soon provide a broad spectrum of new EPSs. These will be useful to
understand the chemical structures, chain conformations and the biological activities for applications
in various fields.
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Abstract: We have studied the exopolysaccharide produced by the type strain of Salipiger mucosus,
a species of halophilic, EPS-producing (exopolysaccharide-producing) bacterium belonging to the
Alphaproteobacteria. The strain, isolated on the Mediterranean seaboard, produced a polysaccharide,
mainly during its exponential growth phase but also to a lesser extent during the stationary phase.
Culture parameters influenced bacterial growth and EPS production. Yield was always directly related
to the quantity of biomass in the culture. The polymer is a heteropolysaccharide with a molecular mass
of 250 kDa and its components are glucose (19.7%, w/w), mannose (34%, w/w), galactose (32.9%,
w/w) and fucose (13.4%, w/w). Fucose and fucose-rich oligosaccharides have applications in the
fields of medicine and cosmetics. The chemical or enzymatic hydrolysis of fucose-rich polysaccharides
offers a new efficient way to process fucose. The exopolysaccharide in question produces a solution of
very low viscosity that shows pseudoplastic behavior and emulsifying activity on several hydrophobic
substrates. It also has a high capacity for binding cations and incorporating considerable quantities
of sulfates, this latter feature being very unusual in bacterial polysaccharides.
Keywords: exopolysaccharides; Salipiger mucosus; halophilic bacteria; fucose; sulfates
1. Introduction
Microbial exopolysaccharides (EPSs) are polymers that consist principally of carbohydrates and
are excreted by some bacteria and fungi onto the outside of their cell walls. Their composition and
structure is very varied: they may be either homo- or heteropolysaccharides and may also contain a
number of different organic and inorganic constituents [1]. Microbial EPSs occur naturally in many
habitats. They are important in the formation of biofilm, a structure involved in the adherence to
surfaces and in the protection of bacteria against noxious influences of the environment. They can be
readily prepared in the laboratory by fermentation. Increasing attention is being paid to these molecules
because of their bioactive role and their extensive range of potential applications in pharmaceuticals as
antiangiogenic [2] or antiviral agents [3], and in agriculture and various other industrial areas [4].
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The advantages of microbial polysaccharides over plant or marine macroalgal polymers are their
novel functionality, easily reproducible chemical and physical properties and stable cost and supply [5].
During the past 50 years a considerable number of EPSs have been described, but few have achieved
great commercial success, due either to their being unable to offer better properties than those already
on the market or to difficulties in finding new practical applications [4].
A new approach to encountering EPSs with novel properties might entail investigating different
environments such as hypersaline habitats, since most of the strains used so far for the industrial
production of EPSs belong to a small number of taxa, which are generally non-halophilic, soil-dwelling
diazotrophs and often plant-associated. Because of the extreme nature of hypersaline environments
they may feasibly harbor unusual microorganisms of biotechnological interest and so for the last few
years we have been carrying out a wide research program, looking at microorganisms living in habitats
such as these in an attempt to find new EPSs with different characteristics. This has resulted in our
describing the EPSs synthesized by several moderately halophilic species published by our group,
belonging to the γ-Proteobacteria: Halomonas eurihalina [6], H. maura [7], H. ventosae [8], H. anticariensis [9],
Alteromonas hispanica [10] and Idiomarina ramblicola and I. fontislapidosi [11]. In general, the polymers
produced by these bacteria show potential interest as viscosifying, jellifying and emulsifying agents and
as metal-binding compounds [12,14]. The most interesting polymers obtained so far from halophilic
bacteria are mauran, produced by H. maura, which has a viscosifying activity similar to that of xanthan
gum [15,16], and polymers from H. eurihalina species, which have emulsifying activity and jellifying
properties at acidic pH [17,23].
We describe here an EPS produced by the type strain (A3T) of Salipiger mucosus [24], a halophilic
bacterium belonging to the Alphaproteobacteria class. To our knowledge, this is the first time a halophilic
Alphaproteobacteria has been found to produce an EPS. To understand better the characteristics of EPSs
and thus be able to apply them successfully to biotechnological ends it is essential to optimize their
production and to identify their components and physical-chemical properties.
2. Results
2.1. Kinetics of Growth and EPS Production
To study the synthesis of the EPS as a function of the growth phase, S. mucosus strain A3T was
grown in MY medium containing 7.5% (w/v) total salts and an initial glucose concentration of 10 g/L
for eight days at 32 ◦C and 100 rpm without control over pH, as shown in Figure 1. Glucose metabolism
led to an increase in biomass (final OD520 of 2.6) and an EPS accumulation of 1.35 g/L (0.1 g of EPS
per gram of dry cell weight). The kinetics of EPS production by S. mucosus strain A3T showed that it
was excreted mainly during the exponential growth phase but continued to a lesser extent during the
stationary phase. Production ceased when residual glucose was about 1.5 g/L. The quantity of EPS in
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Figure 1. Growth profile and EPS production by S. mucosus strain A3T in MY medium at 7.5% total
salts versus consumption of glucose. 100% of residual glucose corresponds to 10 g/L of glucose.
2.2. Influence of Culture Parameters on Growth and EPS Synthesis
We studied the influence of different cultural parameters in order to be able to improve EPS
production by S. mucosus strain A3T. Yield was always directly related to the quantity of biomass in the
culture. A sea-salt concentration of 2.5% (w/v) proved best in terms of production. One noteworthy
result was that the bacterium grew and produced EPS with all the carbon sources assayed. Growth
remained unimpeded when glucose was increased to above 1% (w/v) in the culture but without
any significant increase in synthesis. As far as incubation temperature is concerned, yields were
substantially lower at both 22 ◦C and 42 ◦C than at 32 ◦C, concomitant with a significant inhibition in
bacterial growth. Similar results were obtained when the pH was lower or higher than 7.0. In the same
way, both static incubation and a stirring rate of more than 100 rpm gave similarly lower growth and
lower EPS yields.
2.3. Electron Microscopy
Figure 2 shows the appearance of strain A3T after 24 hours incubation. It is noteworthy that
during the early stage of incubation the EPS was in close contact with the cell, but afterwards it was
diffused fairly evenly throughout the medium as an amorphous slime with no indication of any higher
concentrations near the cell wall (data no shown). This phenomenon explains why we were able to
extract higher quantities of EPS from the third day onwards.
Figure 2. Transmission electronic microscopy photograph of S. mucosus strain A3T stained with the
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2.4. Chemical Composition
When collected under optimum conditions the EPS produced by S. mucosus strain A3T was
composed of 53.1% (w/w) carbohydrates, 1.6% (w/w) proteins, 0.9% (w/w) acetyls, 0.9% (w/w)
sulfates, 0.1% (w/w) phosphates, 1.9% (w/w) hexosamines and 6% (w/w) pyruvic acid; each value
representing the average of three measurements. The EPS collected under other conditions assayed
had the same basic composition but the carbohydrate content was always lower (data not shown). The
samples obtained under optimum conditions were purified by anion exchange chromatography (AEC).
A single major peak of sugar-bearing material was eluted from the column with NaCl concentrations
of about 1 M, indicating a single acidic EPS. The components of the carbohydrate fraction of the EPS
from S. mucosus strain A3T were (%, w/w): 19.7 glucose, 34 mannose, 32.9 galactose and 13.4 fucose;
each value representing the average of three measurements.
2.5. Physical Properties
The average molecular mass of the EPS produced by S. mucosus strain A3T extracted after three
days from MY medium with 2.5% (w/v) salts was 250 kDa. To evaluate the rheological properties of
the EPS we measured the viscosity of an aqueous solution with 0.5% (w/v) of EPS over a range of
different shear rates. The flow curve in Figure 3 shows the pseudoplastic character of a solution of
the polymer, its viscosity decreasing concomitantly with shear rate. The viscosity of the solution was
quite low.
Figure 3. Viscosity of a 0.5% (w/v) solution of EPSs produced by S. mucosus A3T in MY medium at
2.5% total salts.
The emulsifying activity of the EPS is shown in Table 1. It was capable of stabilizing different
mixtures of oil and water in which the hydrophobic phase was either a hydrocarbon or a vegetable or
mineral oil; the polymer’s activity was more efficient than the chemical surfactants (Triton X-100 and
Tween 80) used as controls when tetradecane, octane, kerosene and xylene were used as substrates.
The highest emulsifying activity was obtained with crude oil (higher than with xanthan). As far as
metal chelation is concerned, it chelated 15.7, 43.5 and 8.7 mg of copper, lead and cobalt, respectively,
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Table 1. Emulsifying activities of the EPS produced by S. mucosus strain A3T *.
S. mucosus A3T Triton X-100 Tween 80 Xanthan gum
Sunflower oil 70 ± 1.41 62.5 ± 1.82 62 ± 1.67 88.95 ± 1.60
Mineral oil 71 ± 1.60 67.5 ± 1.41 70 ± 1.15 90.3 ± 1.43
Olive oil 60.3 ± 1.52 60 ± 1.52 62.5 ± 1.64 100 ± 1.94
Tetradecane 75 ± 2.08 62.5 ± 1.82 62.5 ± 1.10 90.3 ± 0.98
Octane 70 ± 1.51 60 ± 1.52 60 ± 0.70 93.3 ± 2.18
Kerosene 70 ± 0.51 62.1 ± 2.12 60 ± 1.40 89 ± 1.02
Isopropyl myristate 67.5 ± 0.70 67.5 ± 0.70 67.5 ± 1.02 100 ± 1.34
Petrol 20 ± 3.01 70 ± 1.52 32.5 ± 2.60 92.5 ± 2.45
Diesel 37.5 ± 0.70 62.5 ± 2.12 65 ± 1.70 87.5 ± 3.01
Crude oil 95 ± 0.57 60 ± 0.70 60 ± 0.60 89.75 ± 1.32
Xylene 47.5 ± 0.70 12.5 ± 1.52 12.5 ± 1.30 86.5 ± 1.78
Toluene 52.6 ± 3.53 12.5 ± 0.70 60 ± 1.80 100 ± 1.75
Vaseline oil 52.6 ± 2.50 65 ± 0.57 60 ± 2.55 100 ± 1.67
Hexane 50 ± 2.51 50 ± 1.52 42 ± 0.66 100 ± 2.25
* Expressed as the percentage of the total height occupied by the oil-water emulsion after 24 h; 0.5% (w/v) EPS or
chemical surfactant was used as emulsifier. Each value represents the average of three measurements.
3. Discussion
We report here, the first isolation and characterization of an exopolysaccharide produced by a
halophilic bacterium belonging to the Alphaproteobacteria class. Salipiger mucosus A3T excretes significant
quantities of EPS when cultivated under optimum growth conditions, that is to say, the conditions
that result in the highest speed of cell division and ultimately the greatest quantity of bacterial growth.
These results do not agree with those of some other authors, who maintain that cell growth and EPS
formation usually have different nutritional requirements [25,26]. The different culture conditions
assayed did not change meaningfully the chemical composition of the EPS, although production
decreased significantly when they were unfavorable (data not shown). EPS production by S. mucosus
strain A3T exhibited a fermentation kinetic similar to that of mauran [15] and those produced by H.
ventosae and H. anticariensis [13] and Alteromonas hispanica and Idiomarina fontislapidosi [14]. It began
early, during the exponential growth phase, then increased concomitantly with the rise in number of
viable cells, only ceasing when the glucose substrate was almost completely consumed. The highest
quantity of EPS was obtained after a period of three days. After the optimum incubation time there
was a decrease in the quantity of EPS in the culture, which may well be due to enzymatic degradation,
as has also been reported with other EPSs [27].
With regard to the chemical composition of our EPS, its sulfate content, together with the presence
of phosphates and fucose, are especially interesting. Sulfates are not commonly found in microbial
EPSs, although they are present in all the EPSs produced by the halophilic bacteria described by our
group [see for example [13]–[15],[18]] and also in many marine bacteria and in cell wall polysaccharides
from red and brown macroalgae. Sulfated EPSs are of great potential interest in medicine since they
have a number of bioactive properties: anticoagulant, antiangiogenic, antiproliferative, antiviral,
etc. [2,3,28]. Phosphate groups, which have also been observed in other EPSs [13,29], could confer
important properties on them because they are essential to the activation of lymphocytes [30] and in
some antitumoral processes [31]. Fucose and fucose-rich oligosaccharides can be used in biocosmetics,
in the field of medicine and in the food industry [32]. The polymer from S. mucosus strain A3T may
prove to be a simple source of fucose, as reported for the EPSs excreted by Klebsiella pneumoniae
and Clavibacter michiganensis [32] since chemical synthesis or extraction from algae is laborious and
expensive and they are often in short supply.
One important feature of the emulsions produced by the EPS described here is that they are very
stable and are composed of small, uniform droplets, resulting in a fine, smooth consistency. Other
known polysaccharides, such as xanthan, are capable of producing stable emulsions but they tend to
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such as these are intended [33]. Proteins play an important role in the emulsifying capacity of some
exopolysaccharides [13,34]. The EPS from our halophilic strain contains protein concentrations of
1.6% (w/w). In the same way, emulsan, a biosurfactant obtained from Acinetobacter calcoaceticus, is
a complex of polysaccharides and proteins that emulsifies mixtures of water and aliphatic, aromatic
or cyclic hydrocarbons but cannot emulsify pure hydrocarbons [35]. Salipiger mucosus strain A3T, on
the other hand, produces an EPS capable of emulsifying higher percentages of pure hydrocarbons
(tetradecane, octane, kerosene, xylene and crude oil) than the chemical surfactants used in comparison,
and where crude oil is concerned, higher even than xanthan. Apart from this, the presence of acetyl
groups renders the EPS somewhat hydrophobic, which might contribute to its emulsifying capacity, as
Ashtaputre et al. [36] have described for the EPS produced by S. paucimobilis.
EPSs with high concentrations of charged components often form gels in the presence of metal
ions and have great potential for removing toxic metals from polluted environments and wastewater
as an alternative to other more aggressive methods [37]. EPS solutions from S. mucosus strain A3T did
not produce stable gels in the presence of the salts we tested, but they did chelate several metals with
considerable efficiency. Anionic EPSs generally prefer to bind cations with large ionic radii [38], which
agree with our findings, since our polysaccharide showed a high capacity to bind lead. It may well be
that acetyls bring more electron-donating groups into the vicinity of the binding site, thus allowing
the larger Pb ions to bind more firmly [38]. Although we are not yet sure of the actual mechanism
involved when ions bind to these polymers, this type of chelation could be classified as biosorption, as
mentioned by Valls and de Lorenzo [39]. Whatever the case may be, the strong chelating property of
this polymer offers the possibility of its being used as a biosorbent in the treatment of polluted water
and other such environments.
4. Experimental
4.1. Bacterial Strain
We used Salipiger mucosus strain A3T (=CECT 5855T), described by our group after an extensive
program of isolating halophilic EPS producers from 19 hypersaline environments in Spain and
Morocco [40]. S. mucosus strain A3T was isolated from a hypersaline soil located in a solar saltern in
Calbanche (Murcia) on the Spanish Mediterranean seaboard.
4.2. Optimization and Analysis of the Kinetics of EPS Production
The bacterial strain was cultivated in MY medium [41] supplemented with 7.5% (w/v) salts [42].
The EPS was isolated using the method described by Quesada et al. [23]. Briefly, the culture was
centrifuged and the supernatant precipitated with cold ethanol before being ultracentrifuged, dialyzed
against distilled water and lyophilized [43].
To establish which conditions lead to optimum EPS production, we assayed the following
variables: incubation time (1–8 days), incubation temperature (22, 32 and 42 ◦C), sea-salt concentration
(1, 2.5, 5, 7.5, 10, 15, and 20% (w/v)), carbon source (glucose, sucrose, mannose, galactose), glucose
concentration (0, 1, 2, 5, 7 and 10% (w/v)) and incubation either in a rotating shaker (100 and 200 rpm)
or static conditions.
Microbial growth and EPS production were monitored in batch cultures in 500-mL Erlenmeyer
flasks containing 100 mL medium (three replicate flasks per experiment). Bacterial growth was
determined by measuring optical density at 520 nm. Any residual carbon source was calculated using
the glucose-oxidase technique [44].
4.3. Electron Microscopy
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4.4. Chemical Analysis
Total carbohydrates [45], proteins [46], acetyls [47], pyruvate [48], hexosamines [49], sulfates and
phosphates [13] were analyzed.
The EPS was purified and its negative net charge analyzed by AEC on a 1.5 m × 20 cm quaternary
methyl ammonium Accel Plus column (Waters) eluted at a flow rate of 2 mL/min with 0.05 M
NH4HCO3 (pH 8.0), followed by a linear gradient of 0.05 to 2 M NaCl in the same buffer. It was also
monitored by UV detection at 210 nm. Five milliliters fractions were collected to determine their sugar
composition and molecular mass.
Sugar composition was determined as described by Chaplin [50]. The purified EPS (100 μg)
was subject to methanolysis with methanolic HCl (0.9 M) for 16 h at 80 ◦C. The resulting mixture of
methylglycosides was dried under nitrogen at room temperature and re-N-acetylated by the addition of
50 μL dry methanol, 5 μL pyridine and 5 μL acetic anhydride, dried under nitrogen and then derivated
with 15 μL trimethylsilylimidazole (Alltech) at room temperature for 30 min. The re-N-acetylated
trimethylsilylated glycosides were analyzed on a BP1 fused-silica capillary column (12 m × 0.32
mm, SGE) with a Peri 2000 GLC-FID chromatograph (Perichrom) using a temperature program of
140–240 ◦C at 6.1 ◦C/min followed by isothermal elution.
4.5. Physical Properties
Apparent molecular mass was determined by high-performance size-exclusion chromatography
(HPSEC) done on a 600 E system (Waters) equipped with a PL aquagel-OH 60, 8 μm column
(30 cm × 7.5 mm) (Polymer Laboratories), eluted with a 0.2 M sodium-acetate buffer (pH 5.1) at
a flow rate of 0.8 mL/min. The sample volume was 20 μL, containing 25 μg of EPS. Compounds
were detected using refractive-index monitoring (Model 475, Kontron Instruments) and dextrans
(7 × 104 Da to 4.9 × 106 Da, Sigma) were used as standards.
For rheological analysis the EPS was dissolved in distilled water (0.5%, w/v) and measurements
were made at 25 ◦C in a controlled-stress Bohlin CSR10 rheometer.
The emulsifying activity of the EPS was determined by a modified version of the procedure
described by Cooper and Goldenberg [51]. Equal volumes of the different EPS solutions (0.5%,
w/v) in distilled water and various hydrophobic substrates were added to 105 × 15 mm glass
tubes. The mixtures were shaken vigorously using a vortex and allowed to stand for 24 h at 4 ◦C.
Emulsifying activity was expressed as the percentage of the total height occupied by the emulsion. The
hydrophobic substrates were sunflower and olive oils (commercial brands), mineral oil, tetradecane,
octane, kerosene, isopropyl myristate, xylene, toluene, vaseline oil, hexadecane (all from Sigma), and
petrol, diesel and crude oil. Tween 80 and Triton X-100 (from Sigma) and xanthan were used as control
surfactants. The emulsions were observed under a light microscope to determine their size and the
uniformity of the drops in the oil phase and whether or not there was creaming or flocculation.
Metal-binding analyses were made as described by Geddie and Sutherland [38]. The EPS was
applied to an Amberlite IR 120H+ cation exchange column (Avocado) buffered with doubly distilled
water to convert it into the acidic form. 5 mL polysaccharide solutions (0.5%, w/v) were put into
dialysis tubing in flasks containing 200 mL of each appropriate metal-salt solution and shaken at
100 rpm for 24 h at 30 ◦C. The quantity of metal removed from the solution, i.e., bound to the polymer,
was calculated by measuring the ions in solution at 0 h and those remaining after 24 h by atomic
absorption spectrophotometry. Controls were made by placing 5 mL distilled water in dialysis tubing
with the various metal-salt solutions. The metal salts used were cupric sulfate, cobalt chloride and
lead acetate (Sigma).
5. Conclusions
Few EPSs with properties of interest to biotechnology have been described during the last
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the first halophilic, EPS-producing bacterium discovered belonging to the Alphaproteobacteria. The
most remarkable property of the EPS in question is its unusual composition—with a high fucose
content—and therefore it offers possible novel applications as a biological agent. We are currently
studying its antitumoral activity and also its use as a source of fucose and fucose-oligosaccharides.
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